last Updated 3/1/2026
Official Notice – Ministry of Health (Iraq)
This platform is developed to support transparency and regulatory compliance within the pharmaceutical and medical supply sector in Iraq. The products displayed in the table below represent items that have been reviewed and approved by the Iraqi Ministry of Health (MOH) for importation into Iraq, in accordance with applicable national regulations and registration requirements.
Only products that have successfully completed the official MOH evaluation and approval process are listed.
Unregistered, suspended, or non-approved products are not included on this platform.
This page is intended to serve as a reference source for healthcare professionals, importers, distributors, and regulatory stakeholders to verify the approval status of products authorized for import into Iraq.
Purpose of This Platform
The purpose of this website is to:
- Enhance regulatory transparency
- Support importers, distributors, and healthcare professionals
- Provide a central reference for MOH-approved products
- Reduce circulation of unregistered or non-compliant products
This platform is intended for professional and regulatory reference only.
Approval & Compliance
All products listed on this platform:
- Have obtained official approval from the Iraqi Ministry of Health (MOH)
- Comply with Iraqi pharmaceutical import regulations
- Are subject to ongoing regulatory review
Products that are suspended, expired, or under regulatory revision are removed or updated accordingly.
How to Use This Table
You may use the table below to:
- Verify whether a product is approved for import
- Check product name, strength, dosage form, and manufacturer
- Support procurement, registration, and compliance checks
For official legal confirmation, always refer to MOH certificates and formal communications.
Scope of This Platform
This website has been developed exclusively for the purpose of displaying products approved by the Iraqi Ministry of Health (MOH) for importation into Iraq.
The content presented here is limited strictly to this scope only and is intended for informational and regulatory reference purposes.
For any matters outside this scope — including but not limited to:
- Licensing
- Registration procedures
- Regulatory decisions
- Official announcements
- Legal confirmations
- Policy updates
Users are advised to contact or refer directly to the official website of the Iraqi Ministry of Health.
🔗 Official Iraqi MOH Website:
https://moh.gov.iq
| Column1 | Column2 | Column3 | Column4 | Column5 |
|---|---|---|---|---|
| NCDS | 01-AA0-001 | Digoxin 62.5mcg | Tablet | oral |
| NCDS | 01-AA0-002 | Digitoxin 100mcg | Tablet | oral |
| NCDS | 01-AA0-003 | Digoxin 125 mcg | Tablet | oral |
| NCDS | 01-AA0-004 | Digoxin 250 mcg | Tablet | oral |
| NCDS | 01-AA0-005 | Digoxin 50mcg /ml | 60ml Elixir | oral |
| NCDS | 01-AA0-006 | Digoxin 250 mcg/ml | 2ml Ampoule | injection |
| 1AB | PHOSPHODIESTERASE INHIBITORS | |||
| NCDS | 01-AB0-001 | Enoximone 5mg/1ml | 20ml Ampoule | injection |
| NCDS | 17-000-050 | Milrinone (as lactate) 1mg/ml | 10 ml Ampoule | injection |
| 1B | DIURETICS | |||
| NCDS | 01-B00-001 | Amiloride Hydrochloride anhydrous 5mg + Hydrochlorthiazide 50mg | Tablet | oral |
| NCDS | 01-B00-002 | Bumetanide 1 mg | Tablet | oral |
| NCDS | 01-B00-003 | Chlorthalidone 50mg | Tablet | oral |
| NCDS | 01-B00-005 | Furosemide(Frusemide) 10mg/ml | 2ml Ampoule or vial | injection IV IM or Slow IV , IM |
| NCDS | 01-B00-006 | Furosemide(Frusemide) 10mg/ml | 25ml Ampoule | IV infusion |
| NCDS | 01-B00-007 | Furosemide(Frusemide) 40mg | Tablet | oral |
| NCDS | 01-B00-008 | Furosemide(Frusemide) 500mg | Scored Tablet | oral |
| NCDS | 01-B00-011 | Furosemide(Frusemide) 40mg/5ml | oral Solution | oral |
| NCDS | 01-B00-021 | Furosemide(Frusemide) 20mg /5ml | oral solution | oral |
| NCDS | 01-B00-012 | Hydrochlorothiazide 25mg | Tablet | oral |
| NCDS | 01-B00-013 | Hydrochlorothiazide 50mg | scord Tablet | oral |
| NCDS | 01-B00-014 | Indapamide 2.5mg | Tablet | oral |
| NCDS | 01-B00-015 | Indapamide 1.5mg | sustained release tablet | oral |
| NCDS | 01-B00-016 | Spironolactone 25mg | Tablet | oral |
| NCDS | 01-B00-017 | Spironolactone 100mg | Tablet | oral |
| NCDS | 01-B00-020 | Spironolactone 50mg | Tablet | oral |
| NCDS | 01-B00-027 | Eplerenone 25 mg | Tablet | oral |
| NCDS | 01-B00-028 | Eplerenone 50 mg | Tablet | oral |
| NCDS | 01-B00-031 | Finerenone 10 mg | Tablet | oral |
| NCDS | 01-B00-032 | Finerenone 20 mg | Tablet | oral |
| NCDS | 01-B00-018 | Xipamide 20mg | Tablet | oral |
| NCDS | 01-B00-019 | Metolazone 5mg | Tablet | oral |
| NCDS | 01-B00-022 | Spironolactone 5 mg / 5 ml | oral suspension | oral |
| NCDS | 01-B00-025 | Torasemide(torsemide) 5mg | Tablet | oral |
| NCDS | 01-B00-026 | Torasemide(torsemide) 10 mg | Tablet | oral |
| NCDS | 01-B00-029 | Torasemide(torsemide) 20 mg | Tablet | oral |
| NCDS | 01-B00-030 | Torasemide(torsemide) 20 mg | 2ml ampoule solution | IV injection |
| NCDS | 09-D00-020 | Mannitol 10% | 500ml container | injection IV Infusion |
| NCDS | 09-D00-021 | Mannitol 20% | 500ml container | injection IV Infusion |
| 1C | BETA-ADRENOCEPTER BLOCKING DRUGS | |||
| NCDS | 01-C00-001 | Acebutolol 100mg | Tablet | oral |
| NCDS | 01-C00-002 | Acebutolol 200mg | Tablet | oral |
| NCDS | 01-C00-003 | Atenolol 100mg | Tablet | oral |
| NCDS | 01-C00-004 | Atenolol 50mg | Tablet or scored tablet | oral |
| NCDS | 01-C00-005 | Atenolol 25mg | Tablet | oral |
| NCDS | 01-C00-036 | Atenolol 500mcg /ml | 10ml Ampoule | IV or IV infusion |
| NCDS | 01-C00-006 | Bisoprolol fumarate 5mg | Scored Tablet | oral |
| NCDS | 01-C00-007 | Bisoprolol fumarate 10mg | Scored Tablet | oral |
| NCDS | 01-C00-041 | Bisoprolol fumarate 2.5mg | Tablet | oral |
| NCDS | 01-C00-044 | Bisoprolol Fumarate (hemifumarate) 10mg+hydrochlorothiazide 25mg | Tablet | oral |
| NCDS | 01-C00-045 | Bisoprolol Fumarate (hemifumarate) 5mg+hydrochlorothiazide 12.5mg | Tablet | oral |
| NCDS | 01-C00-008 | Carvedilol 6.25mg | Tablet | oral |
| NCDS | 01-C00-009 | Carvedilol 12.5mg | Tablet | oral |
| NCDS | 01-C00-010 | Carvedilol 25mg | Tablet | oral |
| NCDS | 01-C00-046 | carvedilol 6.25mg + ivabradine 5mg | Tablet | oral |
| NCDS | 01-C00-047 | carvedilol 6.25mg + ivabradine 7.5mg | Tablet | oral |
| NCDS | 01-C00-048 | carvedilol 12.5mg + ivabradine 5mg | Tablet | oral |
| NCDS | 01-C00-049 | carvedilol 12.5mg + ivabradine 7.5mg | Tablet | oral |
| NCDS | 01-C00-050 | carvedilol 25mg + ivabradine 5mg | Tablet | oral |
| NCDS | 01-C00-051 | carvedilol 25mg + ivabradine 7.5mg | Tablet | oral |
| NCDS | 01-C00-037 | Carvedilol 3.125mg | Tablet | oral |
| NCDS | 01-C00-011 | Esmolol Hydrochloride 10mg/ml | 10ml Vial | IV infusion |
| NCDS | 01-C00-012 | Labetalol hydrochloride 5mg/ml | 20ml Ampoule or Vial | IV, IV infusion |
| NCDS | 01-C00-013 | Labetalol 200mg | Tablet | Oral |
| NCDS | 01-C00-014 | Labetalol 400mg | Tablet | Oral |
| NCDS | 01-C00-042 | Labetalol Hydrochloride 50mg | Tablet | Oral |
| NCDS | 01-C00-043 | Labetalol Hydrochloride 100mg | Tablet | Oral |
| NCDS | 01-C00-015 | Metoprolol tartrate 50mg | Tablet | Oral |
| NCDS | 01-C00-016 | Metoprolol 200mg | extended releaseTablet | Oral |
| NCDS | 01-C00-017 | Metoprolol tartrate 1mg/1ml | 5ml Ampoule | IV |
| NCDS | 01-C00-018 | Metoprolol tartrate 100mg | Tablet | oral |
| NCDS | 01-C00-019 | Metoprolol Succinate 47.5mg ( Eq. Metoprolol tartrate 50mg) | extended releaseTablet | oral |
| NCDS | 01-C00-052 | metoprolol succinate 23.75 mg ( Eq. metoprolol tartrate 25 mg ) | Tablet | oral |
| NCDS | 01-C00-029 | Metoprolol succinate 190mg (Eq.Metoprolol tartrate 200mg ) | controlled release tablet | oral |
| NCDS | 01-C00-038 | Metoprolol succinate 95mg (Eq.Metoprolol tartrate 100mg ) | controlled release tablet | oral |
| NCDS | 01-C00-020 | Nadolol 80mg | Tablet | oral |
| NCDS | 01-C00-021 | Oxprenolol Hydrochloride 40mg | Tablet | oral |
| NCDS | 01-C00-022 | Pindolol 5mg | Tablet | oral |
| NCDS | 01-C00-023 | Propranolol Hydrochloride 1mg/ml | 1ml Ampoule | slow IV |
| NCDS | 01-C00-024 | Propranolol Hydrochloride 10mg | Tablet | oral |
| NCDS | 01-C00-025 | Propranolol Hydrochloride 40mg | Tablet or scored Tablet | oral |
| NCDS | 01-C00-026 | Propranolol Hydrochloride 80mg | sustained release Capsule | oral |
| NCDS | 01-C00-027 | Sotalol 40mg | Tablet | oral |
| NCDS | 01-C00-028 | Sotalol 80mg | Tablet | oral |
| NCDS | 01-C00-039 | nebivolol ( as Hydrochloride ) 5 mg | tablet | oral |
| NCDS | 01-C00-053 | Nebivolol (as Hydrochloride) 5 mg + 12.5mg hydrochlorothiazide | tablet | oral |
| 1D | ANTI-ARRHYTHMIC DRUGS | |||
| NCDS | 01-D00-001 | Amiodarone Hydrochloride 50mg/ml | (3ml Ampoule ) | injection |
| NCDS | 01-D00-002 | Amiodarone Hydrochloride 200mg | Tablet | oral |
| NCDS | 01-D00-004 | Disopyramide 100mg | Capsule | oral |
| NCDS | 01-D00-005 | Disopyramide 150mg | sustained release durules Tablet | oral |
| NCDS | 01-D00-006 | Disopyramide 250mg | modified release Tablet | oral |
| NCDS | 01-D00-007 | Disopyramide 10mg/ml | (5ml Ampoule ) | injection |
| NCDS | 01-D00-012 | Mexiletine Hydrochloride 200mg | Capsule | oral |
| NCDS | 01-D00-013 | Mexiletine Hydrochloride 25mg/ml | (10ml Ampoule) | IV , IV nfusion |
| NCDS | 01-D00-014 | Phenytoin sodium 50mg/ml | (5ml Ampoule ) | IV |
| NCDS | 01-D00-016 | Procainamide Hydrochloride 100mg/ml | (10ml Vial ) | slow IV , IV infusion |
| NCDS | 01-D00-017 | Procainamide Hydrochloride 500mg | Tablet | oral |
| NCDS | 01-D00-018 | Procainamide Hydrochloride 750mg | sustained release Tablet | oral |
| NCDS | 01-D00-019 | Propafenon Hydrochloride 150mg | Tablet | oral |
| NCDS | 01-D00-021 | Quinidine Sulphate 200mg | Tablet | oral |
| NCDS | 01-D00-022 | Verapamil Hydrochloride 2.5mg/ml | (2ml Ampoule) | slow IV |
| NCDS | 01-D00-023 | Verapamil Hydrochloride 40mg | Tablet | oral |
| NCDS | 01-D00-024 | Verapamil Hydrochloride 80mg | Tablet | oral |
| NCDS | 01-D00-025 | Verapamil Hydrochloride 120mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-D00-027 | Adenosine 3mg/ml | 2ml Vial or 2ml Ampoule | injection |
| NCDS | 01-D00-031 | Flecainide acetate 50mg | Tablet | oral |
| NCDS | 01-D00-034 | Lidocaine Hydrochloride 2% 20mg /ml | 2ml ampoule | injection |
| NCDS | 01-D00-035 | Flecainide acetate 10mg/ml | 15ml Ampoule | injection |
| NCDS | 01-D00-036 | Lidocaine Hydrochloride 20mg/ml | 5ml prefilled syringe | IV |
| NCDS | 01-D00-037 | Verapamil Hydrochloride 240 mg | prolonged release tablet | oral |
| NCDS | 01-D00-038 | Flecainide acetate 100mg | Tablet | oral |
| 1E | ANTI-HYPERTENSIVE DRUGS | |||
| NCDS | 01-E00-003 | Captopril 25mg | Tablet | oral |
| NCDS | 01-E00-004 | Captopril 50mg | Tablet | oral |
| NCDS | 01-E00-005 | Captopril 12.5mg | Tablet | oral |
| NCDS | 01-E00-087 | captopril 6.25 / 5 ml | oral liqiud | oral |
| NCDS | 01-E00-006 | Candesartan cilexetil 8mg | Scored Tablet | oral |
| NCDS | 01-E00-104 | Candesartan cilexetil 32 mg | Tablet | oral |
| NCDS | 01-E00-105 | Candesartan cilexetil 8 mg +Hydrochlorthiazide 12.5mg | Tablet | oral |
| NCDS | 01-E00-060 | Candesartan cilexetil 16mg | Tablet | oral |
| NCDS | 01-E00-081 | Candesartan cilexetil 16mg +Hydrochlorthiazide 12.5mg | Tablet | oral |
| NCDS | 01-E00-011 | Enalapril maleate 5mg | Tablet or Scored Tablet | oral |
| NCDS | 01-E00-012 | Enalapril maleate 10mg | Tablet or Scored Tablet | oral |
| NCDS | 01-E00-013 | Enalapril maleate 20mg | Tablet or Scored Tablet | oral |
| NCDS | 01-E00-073 | Enalapril maleate 20mg +Hydrochlorthiazide 12.5mg | Tablet | oral |
| NCDS | 01-E00-014 | Hydralazine Hydrochloride 20mg | Ampoule | IV infusion or slow IV injection |
| NCDS | 01-E00-015 | Hydralazine Hydrochloride 25mg | Tablet | oral |
| NCDS | 01-E00-016 | Hydralazine Hydrochloride 50mg | Tablet | oral |
| NCDS | 01-E00-017 | Lisinopril (as base) or Lisinopril anhydrous or lisinopril (as dihydrate) 5mg ( the same drug with or without water of hydration ) | Tablet | oral |
| NCDS | 01-E00-018 | Lisinopril (as base) or Lisinopril anhydrous or lisinopril (as dihydrate) 10mg ( the same drug with or without water of hydration ) | Tablet | oral |
| NCDS | 01-E00-019 | Lisinopril (as base) or Lisinopril anhydrous or lisinopril (as dihydrate) 20mg ( the same drug with or without water of hydration ) | Tablet | oral |
| NCDS | 01-E00-021 | Irbesartan 150mg | Tablet | oral |
| NCDS | 01-E00-022 | Irbesartan 300mg | Tablet | oral |
| NCDS | 01-E00-094 | Irbesartan 300 mg+Hydrochlorthiazide 25 mg | Tablet | oral |
| NCDS | 01-E00-076 | Irbesartan 300mg +Hydrochlorthiazide 12.5mg | Tablet | oral |
| NCDS | 01-E00-077 | Irbesartan 150mg +Hydrochlorthiazide 12.5mg | Tablet | oral |
| NCDS | 01-E00-120 | Irbesartan 150+ amlodipine (as besilate )5mg | Tablet | oral |
| NCDS | 01-E00-121 | Irbesartan 150+ amlodipine (as besilate ) 10mg | Tablet | oral |
| NCDS | 01-E00-122 | Irbesartan 300+ amlodipine (as besilate ) 10mg | Tablet | oral |
| NCDS | 01-E00-123 | Irbesartan 300+ amlodipine (as besilate ) 5mg | Tablet | oral |
| NCDS | 01-E00-023 | Methyldopate 50mg/ml | (5ml Ampoule) | injection |
| NCDS | 01-E00-024 | Methyldopa 250mg | tablet | oral |
| NCDS | 01-E00-025 | Minoxidil 5mg | tablet | oral |
| NCDS | 01-E00-026 | Minoxidil 10mg | tablet | oral |
| NCDS | 01-E00-029 | Phenoxybenzamine Hydrochloride 10mg | Capsule | oral |
| NCDS | 01-E00-030 | Phenoxybenzamine Hydrochloride 50mg/ml, | (2ml Ampoule) | injection |
| NCDS | 01-E00-031 | Phentolamine mesylate 10mg/ml | (1ml Ampoule) | injection |
| NCDS | 01-E00-036 | Quinapril Hydrochloride 5mg | Tablet | oral |
| NCDS | 01-E00-037 | Quinapril Hydrochloride 10mg | Tablet | oral |
| NCDS | 01-E00-038 | Quinapril Hydrochloride 20mg | Tablet | oral |
| NCDS | 01-E00-039 | Ramipril 2.5mg | capsule or Scored Tablet | oral |
| NCDS | 01-E00-041 | Ramipril 5mg | capsule or Scored Tablet | oral |
| NCDS | 01-E00-043 | Ramipril 10mg | capsule or Scored Tablet | oral |
| NCDS | 01-E00-045 | Ramipril 1.25mg | capsule | oral |
| NCDS | 01-E00-145 | Ramipril 10 mg + hydrochlorothiazide 12.5 mg | tablet | oral |
| NCDS | 01-E00-049 | Sodium nitroprusside 50mg | lypholysied powder with solvent or liquid concentrate Vial or Ampoule | IV infusion |
| NCDS | 01-E00-052 | Valsartan 40mg | Capsule | oral |
| NCDS | 01-E00-067 | Valsartan 80mg | tablet or capsule | oral |
| NCDS | 01-E00-068 | Valsartan 160mg | tablet or capsule | oral |
| NCDS | 01-E00-085 | Valsartan 160mg + hydrochlorothiazide 25 mg | caplet or film coated tablet | oral |
| NCDS | 01-E00-054 | Valsartan 80mg+hydrochlorthiazide 12.5mg | Capsule or tablet | oral |
| NCDS | 01-E00-056 | Valsartan 160mg+hydrochlorthiazide 12.5mg | Capsule or tablet | oral |
| NCDS | 01-E00-058 | Telmisartan 40mg | tablet | oral |
| NCDS | 01-E00-059 | Telmisartan 80mg | tablet | oral |
| NCDS | 01-E00-070 | Telmisartan 40mg +Hydrochlorthiazide 12.5mg | tablet | oral |
| NCDS | 01-E00-071 | Telmisartan 80mg +Hydrochlorthiazide 12.5mg | tablet | oral |
| NCDS | 01-F00-080 | Telmisartan 80mg + Amlodipine (as besilate) 5 mg | tablet | oral |
| NCDS | 01-F00-081 | Telmisartan 80mg + Amlodipine (as besilate) 10 mg | tablet | oral |
| NCDS | 01-E00-064 | Fosinopril sodium 10mg | tablet | oral |
| NCDS | 01-E00-065 | Fosinopril sodium 20mg | tablet | oral |
| NCDS | 01-E00-072 | Losartan potassium 50mg +Hydrochlorthiazide 12.5mg | tablet | oral |
| NCDS | 01-E00-062 | Losartan potassium 25mg | tablet | oral |
| NCDS | 01-E00-020 | Losartan potassium 50mg | tablet | oral |
| NCDS | 01-E00-078 | Losartan potassium 100mg | tablet | oral |
| NCDS | 01-E00-082 | Losartan pottasium 100mg +Hydrochlorothiazide 25 mg | tablet | oral |
| NCDS | 01-E00-086 | Bosentan( as monohydrate) 62.5 mg | tablet | oral |
| NCDS | 01-E00-088 | Bosentan(as monohydrate) 125 mg | tablet | oral |
| NCDS | 01-E00-142 | Selexipag 600 mcg | tablet | oral |
| NCDS | 01-E00-143 | Selexipag 200 mcg | tablet | oral |
| NCDS | 01-E00-140 | Ambrisentan 5 mg | tablet | oral |
| NCDS | 01-E00-141 | Ambrisentan 10 mg | tablet | oral |
| NCDS | 01-E00-090 | ILoprost (as trometamol) 10mcg/1ml | nebuliser solution 1ml ampoule | inhalation |
| NCDS | 01-E00-091 | ILoprost (as trometamol) 10mcg/1ml | nebuliser solution 2ml ampoule | inhalation |
| NCDS | 01-E00-092 | Perindopril Arginine 5 mg + indapramide 1.25 mg | tablet | oral |
| NCDS | 01-E00-093 | Perindopril Arginine 10 mg + indapramide 2.5 mg | tablet | oral |
| NCDS | 01-E00-095 | Perindopril Arginine 5 mg + Amlodipine (as besilate) 5 mg | tablet | oral |
| NCDS | 01-E00-096 | Perindopril Arginine 5 mg + Amlodipine (as besilate) 10 mg | tablet | oral |
| NCDS | 01-E00-097 | Perindopril Arginine 10 mg + Amlodipine (as besilate) 10 mg | tablet | oral |
| NCDS | 01-E00-098 | Perindopril Arginine 10 mg + Amlodipine (as besilate) 5 mg | tablet | oral |
| NCDS | 01-E00-116 | Perindopril arginine 5 mg+ Indapamide1.25 mg+ Amlodipine 5mg | tablet | oral |
| NCDS | 01-E00-117 | Perindopril arginine 10mg+ Indapamide2.5 mg+ Amlodipine 5mg | tablet | oral |
| NCDS | 01-E00-118 | Perindopril arginine 10mg+ Indapamide2.5 mg+ Amlodipine 10mg | tablet | oral |
| NCDS | 01-E00-107 | Perindopril Arginine 5 mg | tablet | oral |
| NCDS | 01-E00-108 | Perindopril Arginine 10 mg | tablet | oral |
| NCDS | 01-E00-100 | Azilsartan Medoxomil as potassium 40 mg + Chlorthaldion 12.5 mg | tablet | oral |
| NCDS | 01-E00-101 | Azilsartan Medoxomil as potassium 40 mg + Chlorthaldion 25 mg | tablet | oral |
| NCDS | 01-E00-102 | Azilsartan Medoxomil as potassium 40 mg | tablet | oral |
| NCDS | 01-E00-103 | Azilsartan Medoxomil as potassium 80 mg | tablet | oral |
| NCDS | 01-E00-109 | Eprosartan mesylate dehydrate eq 600mg eprosartan free base | tablet | oral |
| NCDS | 01-E00-110 | Eprosartan mesylate dehydrate eq. to 600mg eprosartan free base + Hydrochlorthiazide 12.5 mg | tablet | oral |
| NCDS | 01-E00-111 | sildenafil 20mg | tablet | oral |
| NCDS | 01-E00-112 | Lisinopril 20mg + Hydrochlorthiazide 12.5 mg | tablet | oral |
| NCDS | 01-E00-146 | Amlodipine (as besilate) 5 mg + Lisinopril eq.to anhydrous lisinopril 5 mg | tablet | oral |
| NCDS | 01-E00-113 | Sacubitril 24mg(24.3mg) +valsartan26mg (25.7mg ) | tablet | oral |
| NCDS | 01-E00-114 | Sacubitril 49mg(48.6mg) +valsartan 51mg(51.4mg ) | tablet | oral |
| NCDS | 01-E00-115 | Sacubitril 97mg(97.2mg )+valsartan103mg(102.8mg ) | tablet | oral |
| NCDS | 01-E00-133 | Olmesartan medoxomil 10 mg | film coated tablet | oral |
| NCDS | 01-E00-124 | Olmesartan medoxomil 20 mg | film coated tablet | oral |
| NCDS | 01-E00-125 | Olmesartan medoxomil 40 mg | film coated tablet | oral |
| NCDS | 01-E00-126 | Olmesartan medoxomil 20 mg + Hydrochlorothiazide 12.5 mg | film coated tablet | oral |
| NCDS | 01-E00-127 | Olmesartan medoxomil 20 mg + Hydrochlorothiazide 25 mg | film coated tablet | oral |
| NCDS | 01-E00-128 | Olmesartan medoxomil 40 mg+ Hydrochlorothiazide 12.5 mg | film coated tablet | oral |
| NCDS | 01-E00-129 | Olmesartan medoxomil 40 mg + Hydrochlorothiazide 25 mg | film coated tablet | oral |
| NCDS | 01-E00-130 | Olmesartan medoxomil 20 mg + amlodipine (as besilate) 5 mg | tablet | oral |
| NCDS | 01-E00-131 | Olmesartan medoxomil 40 mg + amlodipine (as besilate) 5 mg | tablet | oral |
| NCDS | 01-E00-132 | Olmesartan medoxomil 40 mg + amlodipine (as besilate) 10 mg | tablet | oral |
| NCDS | 01-E00-134 | Olmesartan medoxomil 40 mg + Amlodipin (as besilate) 10 mg + Hydrochlorothiazide 12.5 mg | film coated tablet | oral |
| NCDS | 01-E00-135 | Olmesartan medoxomil 40 mg + Amlodipin ( as besilate)10 mg + Hydrochlorothiazide 25 mg | film coated tablet | oral |
| NCDS | 01-E00-136 | Olmesartan medoxomil 20 mg + Amlodipin (as besilate) 5mg + Hydrochlorothiazide 12.5 mg | film coated tablet | oral |
| NCDS | 01-E00-137 | Olmesartan medoxomil 40 mg + Amlodipin ( as besilate)5 mg + Hydrochlorothiazide 12.5 mg | film coated tablet | oral |
| NCDS | 01-E00-138 | Olmesartan medoxomil 40 mg + Amlodipin (as besilate) 5 mg + Hydrochlorothiazide 25mg | film coated tablet | oral |
| 1F | VASODILATORS | |||
| NCDS | 01-F00-002 | Amlodipine (as besilate) or as maleate or as mesilate ) 5mg | tablet or capsule | oral |
| NCDS | 01-F00-001 | Amlodipine (as besilate) 2.5mg | Tablet | oral |
| NCDS | 01-F00-003 | Amlodipine (as besilate or as mesilat) 10mg | tablet or capsule | oral |
| NCDS | 01-F00-071 | Amlodipine (as besilate ) 10 mg +Atorvastatin( as calcium )10mg | Tablet | oral |
| NCDS | 01-F00-072 | Amlodipine (as besilate) 5 mg +Atorvastatin (as calcium) 10mg | Tablet | oral |
| NCDS | 01-F00-075 | Amlodipine (as besilate) 5 mg +valsartan 160 mg | Tablet | oral |
| NCDS | 01-F00-076 | Amlodipine (as besilate)10mg +valsartan 160 mg | Tablet | oral |
| NCDS | 01-F00-082 | Amlodipine( as besilate) 10 mg +valsartan 160 mg+hydrochlorothiazide 12.5mg | Tablet | oral |
| NCDS | 01-F00-083 | Amlodipine( as besilate) 5 mg +valsartan 160 mg+hydrochlorothiazide 25mg | Tablet | oral |
| NCDS | 01-F00-088 | Amlodipine (as Besilate) 5mg , valsartan 160mg + Hydrochlothiazide 12.5 mg | Tablet | oral |
| NCDS | 01-F00-089 | Amlodipine( as Besilate )10mg , valsartan 160mg +Hydrochlothiazide 25 mg | Tablet | oral |
| NCDS | 01-F00-007 | Diltiazem Hydrochloride 60mg | Capsule OR tablet | oral |
| NCDS | 01-F00-009 | Diltiazem Hydrochloride 90mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-011 | Diltiazem Hydrochloride 120mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-013 | Diltiazem Hydrochloride 180mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-015 | Diltiazem Hydrochloride 200mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-017 | Diltiazem Hydrochloride 240mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-019 | Diltiazem Hydrochloride 300mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-021 | Diltiazem Hydrochloride 25mg | Vial | injection IV or IV Infusion |
| NCDS | 01-F00-023 | Felodipine 5mg | extended release Tablet | oral |
| NCDS | 01-F00-024 | Glyceryl trinitrate 0.5mg | sublingulal Tablet | sublingulal |
| NCDS | 01-F00-026 | Glyceryl trinitrate patch releasing approx.5mg/24 hours | patch | transdermal |
| NCDS | 01-F00-027 | Glyceryl trinitrate patch releasing approx.10mg/24 hours | patch | transdermal |
| NCDS | 01-F00-028 | Glyceryl trinitrate patch releasing approx.15mg/24 hours | patch | transdermal |
| NCDS | 01-F00-030 | Glyceryl trinitrate 400 mcg/ 1 dose | spray | Sublingual |
| NCDS | 01-F00-031 | Glyceryl trinitrate 2.6mg | controlled releaseTablet | oral |
| NCDS | 01-F00-032 | Glyceryl trinitrate 6.4mg | controlled releaseTablet | oral |
| NCDS | 01-F00-069 | Glyceryl trinitrate 1mg/1ml | (10ml) vial or Ampoule | injection |
| NCDS | 01-F00-073 | Glyceryl trinitrate 5mg/ml | (5ml ) vial or Ampoule | injection |
| NCDS | 01-F00-070 | Isosorbide dinitrate 1mg/ml | (10ml Ampoule) | injection |
| NCDS | 01-F00-033 | Isosorbide dinitrate 5mg | Sublingual Tablet | Buccal |
| NCDS | 01-F00-034 | Isosorbide dinitrate 10mg | tablet | oral |
| NCDS | 01-F00-035 | Isosorbide dinitrate 20mg | sustained release Tablet or retard Capsule | oral |
| NCDS | 01-F00-036 | Isosorbide dinitrate 40mg | sustained release Tablet | oral |
| NCDS | 01-F00-037 | Isosorbide dinitrate 1.25mg/0.09ml | Spray | sublingulal |
| NCDS | 01-F00-038 | Isosorbide mononitrate 10mg | tablet | oral |
| NCDS | 01-F00-039 | Isosorbide mononitrate 20mg | Capsule or tablet | oral |
| NCDS | 01-F00-041 | Isosorbide mononitrate 40 mg | Tablet | oral |
| NCDS | 01-F00-042 | Isosorbide mononitrate 60 mg | Tablet | oral |
| NCDS | 01-F00-043 | Isosorbide mononitrate 25mg | sustained release Capsule or sustained release tablet | oral |
| NCDS | 01-F00-045 | Isosorbide mononitrate 50mg | sustained release Capsule or sustained release tablet | oral |
| NCDS | 01-F00-047 | Isosorbide 5 – mononitrate 60mg | controlled release Tablet | oral |
| NCDS | 01-F00-074 | Isosorbide mononitrate 40 mg | sustained release capsule | oral |
| NCDS | 01-F00-048 | Nicardipine Hydrochloride 25mg | Ampoule | Solution for IV infusion |
| NCDS | 01-F00-049 | Nicardipine Hydrochloride 50mg | sustained release Pellets or sustained release Capsule | oral |
| NCDS | 01-F00-053 | Nifedipine 10mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-055 | Nifedipine 20mg | sustained release Capsule or sustained release Tablet | oral |
| NCDS | 01-F00-078 | Nifedipine 30mg | modified release tablet or capsule | oral |
| NCDS | 01-F00-094 | Cilnidipine 5 mg | Tablet | oral |
| NCDS | 01-F00-095 | Cilnidipine 10 mg | Tablet | oral |
| NCDS | 01-F00-060 | Nimodipine 30mg | Tablet | oral |
| NCDS | 01-F00-061 | Nimodipine 200mcg/ml | (50ml Vial) | IV infusion |
| NCDS | 01-F00-062 | Oxpentiphylline (pentoxifylline) 400mg | Tablet | oral |
| NCDS | 01-F00-066 | Nitric oxide | gas (Cylinder) | inhalation |
| NCDS | 01-F00-084 | Ivabradine ( as Hydrochloride )5 mg | tablet | oral |
| NCDS | 01-F00-086 | Ivabradine( as Hydrochloride) 7.5 mg | tablet | oral |
| NCDS | 01-F00-090 | Ranolazine 750 mg | prolonged release tablet | oral |
| NCDS | 01-F00-085 | Ranolazine 500 mg | prolonged release tablet | oral |
| NCDS | 01-F00-087 | Ranolazine 375mg | sustained release tablet | oral |
| NCDS | 01-F00-091 | manidipine 20mg | tablet | oral |
| NCDS | 01-F00-092 | Lercanidipine Hydrochloride 10mg | tablet | oral |
| NCDS | 01-F00-093 | Lercanidipine Hydrochloride 20 mg | tablet | oral |
| 1G | SYMPATHOMIMETIC DRUGS | |||
| NCDS | 01-G00-001 | Dobutamine (asHydrochloride) 12.5 mg/ml | 20 ml vial or Ampoule | IV infusion |
| NCDS | 01-G00-012 | Dobutamine Hydrochloride Dobutamine 50mg /ml | 5ml ampoule | injection |
| NCDS | 01-G00-002 | Dopamine Hydrochloride 40mg/ml | 5ml Ampoule OR vial | injection |
| NCDS | 01-G00-004 | Isoprenaline Hydrochloride 20mg | sustained releaseTablet | oral |
| NCDS | 01-G00-005 | Metaraminol (as tartrate) 10mg/ml | 1ml Ampoule | injection |
| NCDS | 01-G00-006 | Methoxamine Hydrochloride 20mg/ml | 1ml Ampoule | injection |
| NCDS | 01-G00-007 | Phenylephrine Hydrochloride 10mg/ml | 1ml Ampoule | SC or IM or by slow IV or IV infusion |
| NCDS | 01-G00-008 | Phenylephrine hydrochloride 50 µg / ml | solution (10 ml ampoule) | IV injection |
| NCDS | 01-G00-015 | phenylephrine ( as Hydrochloride) 50mcg/ml | solution10 ml ampoule or prefilled syringe | IV injection |
| NCDS | 01-G00-016 | Etilefrine Hydrochloride 5mg | tablet | oral |
| NCDS | 01-G00-009 | Ephedrine Hydrochloride (3%) 30 mg / ml | 1ml ampoule | slow IV |
| NCDS | 01-G00-010 | Ephedrine Hydrochloride 3mg / ml | 10 ml ampoule | injection |
| NCDS | 01-G00-017 | Ephedrine Hydrochloride 0.05 gm / ml | solution ( 1 ml ampoule ) | IM / IV / S.C |
| NCDS | 01-G00-014 | Noradrenaline Acid Tartrate/Noradrenaline Tartrate/Norepinephrine Bitartrate 2mg/ml (equivalent to Noradrenaline1mg/ml | 2ml or 4ml ampoule | injection |
| 1H | SCLEROSING AGENTS | |||
| NCDS | 01-H00-001 | Ethanolamine oleate 5% | 5 ml Ampoule | Injection |
| NCDS | 01-H00-002 | Sodium tetradecyl sulphate 3% | 1ml Ampoule | Injection |
| NCDS | 01-H00-003 | Lauromacrogol 400 (Polidocanol) (0.5%) 10mg/2ml | solution 2ml ampoule | Injection |
| NCDS | 01-H00-004 | Lauromacrogol 400 (Polidocanol) (1%) 20mg/2ml | solution 2ml ampoule | Injection |
| 1I | Drugs used for ductus arteriosus | |||
| NCDS | 01-I00-001 | Alprostadil 500mcg/1ml alcohol for dilution | solution 1ml Ampoule | IV infusion |
| 1J | metabolic modulator | |||
| NCDS | 01-J00-001 | Trimetazidine di-Hydrochloride 35 mg | modified release tablet | oral |
| 2 | GASTRO-INTESTINAL SYSTEM | |||
| 2A | ANTACIDS | |||
| NCDS | 02-A00-001 | Alginic acid 500mg + magnesium trisilicate 25mg + Dried Aluminium hydroxide gel 100mg +sodium bicarbonate 170mg | chewable Tablet | oral |
| NCDS | 02-A00-024 | Alginic acid 4g+ Aluminium hydroxide (Colloidal)0.6g+ magnesium carbonate 0.8g+ silica hydrate 2.6g \ 100ml | Suspension | oral |
| NCDS | 02-A00-037 | sodium Alginate 500 mg + sodium bicarbonate 267 mg + calcium Carbarbonate 160 mg\10 ml | suspension or Liquid sachet | oral |
| NCDS | 02-A00-018 | Sodium alginate 250mg+sodium bicarbonate 133.5mg\5 ml | suspension | oral |
| NCDS | 02-A00-040 | Sodium alginate 225 mg + magnesium alginate 87.5mg \sachet | powder for suspension | oral |
| NCDS | 02-A00-002 | Aluminium hydroxide 215mg +magnesium hydroxide 80mg + Simethicone 25- 30 mg\5ml | suspension | oral |
| NCDS | 02-A00-003 | Aluminium hydroxide 225mg +magnesium hydroxide 200mg + Simethicone 25-30 mg \5ml | suspension | oral |
| NCDS | 02-A00-005 | Aluminium hydroxide 140mg+magnesium trisilicate 140mg+magnesium carbonate 452mg (or 560mg)+Bismuth subcarbonate 73mg +Sodium bicarbonate 452mg +Malt diastase 28mg+Belladona alkaloids 70mcg(or 75mcg) \teaspoonfull | Powder for suspension | oral |
| NCDS | 02-A00-006 | Magnesium carbonate\ Aluminium hydroxide (Co-dried) 282 + Simethicone 25-30 mg | chewable Tablet | oral |
| NCDS | 02-A00-060 | Magaldrate 540 mg / 5 ml | suspension | oral |
| NCDS | 02-A00-061 | Magaldrate 540 mg + Simethicone 40 mg / 5 ml | suspension | oral |
| NCDS | 02-A00-052 | Magnesium carbonate\ Aluminium hydroxide (Co-dried) 282mg + magnesium hydroxide 85mg | chewable Tablet | oral |
| NCDS | 02-A00-054 | Sodium Bicarbonate 2.81g. + Citric acid 0.80g. + Tartaric acid 1.34 g+ sweetner colour & Flavour to 5g powder / sachet | powder in sachet | oral |
| NCDS | 02-A00-043 | Dried aluminium hydroxide gel 200mg + Magnesium Hydroxide 200mg + activated polydimethylsiloxane 25mg \5ml | suspension | oral |
| NCDS | 02-A00-046 | Aluminium hydroxide (Equivalent to dried gel , USP) 220mg + Magnesium Hydroxide 195mg + simethicone 25mg \5ml | suspension | oral |
| NCDS | 02-A00-047 | Aluminium Hydroxide Dry Gel 132mg + Magnesium Hydroxide275mg | chewable Tablet | oral |
| NCDS | 02-A00-053 | Dried aluminium hydroxide gel 200mg + Magnesium hydroxide 200mg | chewable Tablet | oral |
| NCDS | 02-A00-048 | Aluminium hydroxide gel 400mg + Magnesium hydroxide 200mg \10ml | suspension | oral |
| NCDS | 02-A00-007 | Colloidal aluminium hydroxide 440mg | Tablet | oral |
| NCDS | 02-A00-008 | Colloidal aluminium hydroxide 290mg\5ml | Suspension | oral |
| NCDS | 02-A00-009 | Dried aluminium hydroxide gel 200mg +Magnesium hydroxide 200mg+Simethicone 25 – 30 mg | chewable Tablet | oral |
| NCDS | 02-A00-042 | Aluminium Hydroxide 200mg. + +Magnesium Hydroxide 200mg.+Simethicone 30mg | chewable Tablet | oral |
| NCDS | 02-A00-041 | aluminium Hydroxide 200mg + Magnesium hydroxide 200mg | chewable Tablet | oral |
| NCDS | 02-A00-050 | Dried aluminium Hydroxide gel 405 mg+Magnesium Hydroxide 100 | chewable Tablet | oral |
| NCDS | 02-A00-010 | Magnesium trisilicate B.P | Powder | oral |
| NCDS | 02-A00-011 | Magnesium trisilicate 250mg+ Dried Aluminium hydroxide gel 120mg | chewable Tablet | oral |
| NCDS | 02-A00-012 | Magnesium trisilicate 360mg + Aluminium hydroxide gel 180mg | chewable Tablet | oral |
| NCDS | 02-A00-013 | Magnesium trisilicate 200mg + Aluminium hydroxide\Magnesium carbarbonatr co-dried gel 400mg\5ml | suspension | oral |
| NCDS | 02-A00-049 | Magnesium Trisilicate 250mg + Aluminium Hydroxide 120mg + Dimethicone 25mg | chewable Tablet | oral |
| NCDS | 02-A00-014 | Magnesium hydroxide 200mg + Aluminium hydroxide (equivalent to dried gel) 225mg\5ml | Suspension | oral |
| NCDS | 02-A00-015 | Magnesium hydroxide 400mg + Aluminium hydroxide gel 400mg | chewable Tablet | oral |
| NCDS | 02-A00-016 | Oxethazaine 10mg + Aluminium hydroxide 300mg+ Magnesium hydroxide 100mg\ 5ml | Suspension | oral |
| NCDS | 02-A00-017 | Pancreatin 10mg+ thiamine 1mg+Atropin sulphate 0.1mg+Light Magnesium carbonate 300mg+Magnesium trisilicate 50mg+Diastase 10mg+Calcium carbonate 145mg+Sodium bicarbonate 373mg+Peppermint oil 0.6mg+Light kaolin 50mg+Dried aluminium hydroxide gel 50mg \ 1g | Powder | oral |
| NCDS | 02-A00-020 | Aluminium Hydroxide 220mg + Magnesium Hydroxide 200mg + Activated methyl polysiloxane 25mg + Peppermint oil 0.00075ml \5ml | oral Gel | oral |
| NCDS | 02-A00-021 | Atropin sulphate 0.1mg+Peppermint oil 0.5mg+Magnesium carbonate 381.4mg+Magnesium trisilicate 50mg+Calcium carbonate 145mg+Sodium bicarbonate 373mg+Dried aluminium hydroxide gel 50mg \1g | Powder | oral |
| NCDS | 02-A00-023 | Alginic acid 0.2 g + Aluminium hydroxide (Colloidal)0.03g+ Magnesium carbonate0.04g+ Amorphous ppt. hydrate silica 0.13g | chewable tablet | oral |
| NCDS | 02-A00-055 | 500 mg sodium alginate +213 mg sodium bicarbonate +325 mg calcium carbonate\ 10 ml | suspension in bottles or sachets | oral |
| NCDS | 02-A00-056 | 250 mg sodium alginate+106.5 mg sodium bicarbonate +187.5 mg calcium carbonate | chewable tablet | oral |
| NCDS | 02-A00-057 | Sodium Alginate 500 mg + sodium Bicarbarbonate 267 mg + calcium Carbbonate 160 mg | chewable tablet | oral |
| NCDS | 02-A00-058 | sodium Alginate 1000mg and Potassium hydrogen carbonate 200mg \10ml | liquid sachet | oral |
| NCDS | 02-A00-026 | Calcium Carbonate 680mg+Magnesium Carbonate 80 mg | chewable tablet | oral |
| NCDS | 02-A00-027 | Sodium bicarbonate 49 g+citric acid 37.5g \ 100g | effervescent powder | oral |
| NCDS | 02-A00-028 | sodium bicarbonate B.P 2.32g + citric acid B.P 2.18 g + anhydrous sodium carbonate 0.50 g\ 5g | powder sachet | oral |
| NCDS | 02-A00-044 | Sodium bicarbonate 2.9375g + Citric acid anhydrous 2.0575g + Sweetening agent and flavour \5g | granules | oral |
| NCDS | 02-A00-029 | sodium bicarbonate B.P 2.29 g + citric acid B.P 2.16 g + anhydrous sodium carbonate 0.50 g\5g | powder sachet | oral |
| NCDS | 02-A00-030 | sodium bicarbonate B.P 2.288 g + citric acid B.P 2.157g + anhydrous sodium carbonate 0.50 g \ 5 g | Effervescent Powder | oral |
| NCDS | 02-A00-031 | sodium bicarbonate B.P2.391 g + citric acid B.P 2.181g + anhydrous sodium carbonate 0.50 g\5 g | Effervescent Powder | oral |
| NCDS | 02-A00-032 | sodium bicarbonate B.P2.32 g + citric acid B.P 2.18g + anhydrous sodium carbonate 0.50 g\ 5 g | powder in bottle | oral |
| NCDS | 02-A00-033 | sodium bicarbonate B.P2.29 g + citric acid B.P 2.16g + anhydrous sodium carbonate 0.50 g \ 5 g | powder in bottle | oral |
| NCDS | 02-A00-045 | Sodium Bicarbonate 2.80gm + Tartaric acid 1.33gm + Citric acid 0.82gm + Flavour to 5gm | Effervescent Powder in sachet | oral |
| NCDS | 02-A00-051 | Sod. Bicarb. 2.95g + Tartaric acid 1.325g + Citric acid anhydrous 0.725g \5g | Effervescent Granules | oral |
| NCDS | 02-A00-034 | magnesium carbonate 365 mg | powder in sachet | oral |
| NCDS | 02-A00-035 | Dried Aluminium hydroxide gel 405mg +Magnesium hydroxide 100mg+Dimethicone 125mg \ 5ml | Suspension | oral |
| NCDS | 02-A00-004 | Simethicone 50 mg + active carbon 300 mg | Tablet | oral |
| NCDS | 02-A00-036 | simethcone 40mg | Tablet or chewable tablet | oral |
| NCDS | 02-A00-038 | Simethcone 21mg/ 2.5 ml | drop | oral |
| NCDS | 02-A00-059 | Simethicone 41.2 mg / 1 ml | suspension | oral |
| NCDS | 02-A00-039 | Simethicone 40 mg / 1 ml | drop with gratuated dropper | oral |
| 2B | ANTISPASMODIC | |||
| NCDS | 02-B00-001 | Atropine sulphate 0.6mg/ml | 1ml Ampoule | injection |
| NCDS | 02-B00-004 | Chlordiazepoxide 5mg + Clidinium Bromide 2.5mg | Tablet | oral |
| NCDS | 02-B00-023 | Clidinium Bromide 2.5mg | Tablet | oral |
| NCDS | 02-B00-005 | Dicyclomine Hydrochloride 10mg | Tablet | oral |
| NCDS | 02-B00-006 | Homatropine methylbromide 2mg/ml | Drop | oral |
| NCDS | 02-B00-007 | Hyoscine butylbromide 10mg | Tablet | oral |
| NCDS | 02-B00-008 | Hyoscine butylbromide 1mg/ml | Syrup | oral |
| NCDS | 02-B00-009 | Hyoscine butylbromide 20mg/ml | 1ml Ampoule or vial | injection IM , slow IV, SC OR IM , slow IV |
| NCDS | 02-B00-010 | Hyoscine butylbromide 7.5mg | Suppository | rectal |
| NCDS | 02-B00-011 | Hyoscine butylbromide 10mg | Suppository | rectal |
| NCDS | 02-B00-012 | Isopropamide( as iodide )5mg + Trifluoperazine( as Hydrochloride )1mg | Tablet | oral |
| NCDS | 02-B00-013 | Mepenzolate Bromide 25mg | Tablet | oral |
| NCDS | 02-B00-014 | Pipenzolate Bromide 5mg | Tablet | oral |
| NCDS | 02-B00-015 | Pipenzolate methylbromide 4mg + Phenobarbital 6mg / 1ml | Drop | oral |
| NCDS | 02-B00-016 | Prifinium Bromide 30mg | Tablet | oral |
| NCDS | 02-B00-017 | Prifinium Bromide 30mg + Paracetamol 325mg | Tablet | oral |
| NCDS | 02-B00-018 | Prifinium Bromide 7.5mg /ml | ampoule 2ml | injection |
| NCDS | 02-B00-019 | Propantheline Bromide 15mg | Tablet | oral |
| NCDS | 02-B00-020 | Paracetamol 350 + Homatropine methylbromide 4mg | Tablet | oral |
| NCDS | 02-B00-024 | Hyoscine-N-Butylbromide 10mg + paracetamol 500mg | Tablet | oral |
| NCDS | 02-B00-021 | DicyclomineHydrochloride 10mg /5ml | syrup | oral |
| NCDS | 02-B00-022 | Otilonium Bromide 40mg | tablet | oral |
| 2C | DRUGS THAT PROMOTE HEALING OF PEPTIC ULCERS | |||
| NCDS | 02-C00-001 | Bismuth chelate 300mg (Tri-potassium dicitrate bismuthate) | Tablet | oral |
| NCDS | 02-C00-002 | Bismuth chelate 120mg/5ml | Elixir | oral |
| NCDS | 02-C00-055 | Bismuth subsalicylate 262 mg | Tablet | oral |
| NCDS | 02-C00-056 | Bismuth subsalicylate 17.5 mg / ml | suspension | oral |
| NCDS | 02-C00-003 | Cimetidine 200mg | Tablet | oral |
| NCDS | 02-C00-004 | Cimetidine 400mg | Tablet | oral |
| NCDS | 02-C00-005 | Cimetidine 200mg/5ml | Syrup | oral |
| NCDS | 02-C00-006 | Cimetidine( as Hydrochloride salt)200mg/2mI | 2mI Ampoule | injection IV ,IM, IV infusion |
| NCDS | 02-C00-057 | Nizatidine 150mg | capsule | oral |
| NCDS | 02-C00-058 | Nizatidine 300mg | capsule | oral |
| NCDS | 02-C00-007 | Famotidine 20mg | Tablet | oral |
| NCDS | 02-C00-008 | Famotidine 40mg | Tablet or Scored Tablet | oral |
| NCDS | 02-C00-009 | Lansoprazole 15 mg | Enteric Coated Tablet | oral |
| NCDS | 02-C00-010 | Lansoprazole 15mg | Enteric Coated pellets filled in Capsule | oral |
| NCDS | 02-C00-011 | Lansoprazole 30 mg | Enteric Coated Tablet | oral |
| NCDS | 02-C00-012 | Lansoprazole 30mg | Enteric Coated pellets filled in Capsule | oral |
| NCDS | 02-C00-053 | Lansoprazole 15 mg | orodispersible tablet | oral |
| NCDS | 02-C00-054 | Lansoprazole 30 mg | orodispersible tablet | oral |
| NCDS | 02-C00-021 | Pirenzepine Hydrochloride 25mg | Tablet | oral |
| NCDS | 02-C00-022 | pantoprazole as sodium sesquihydrate or as sodium 40mg | enteric coated tablet | oral |
| NCDS | 02-C00-052 | Pantoprazole sodium anhydrous or sesquihydrate eq 40 mg | vial | injection |
| NCDS | 02-C00-031 | Pantoprazole as sodium sesquihydrate or as sodium 20mg | enteric coated tablet | oral |
| NCDS | 02-C00-027 | Rabeprazole sodium 10mg | enteric coated (or gastro-resistant) Tablet | oral |
| NCDS | 02-C00-028 | Rabeprazole sodium 20 mg | enteric coated (or gastro-resistant) Tablet | oral |
| NCDS | 02-C00-029 | Sucralfate 1g | Tablet | oral |
| NCDS | 02-C00-030 | Sucralfate 1g/5ml | Suspension | oral |
| NCDS | 02-C00-015 | Omeprazole 20mg | Enteric Coated Tablet or Enteric pellets in capsule | oral |
| NCDS | 02-C00-018 | Omeprazole 40mg | Enteric Coated Tablet or Enteric coated pellets in capsule | oral |
| NCDS | 02-C00-032 | Omeprazole( as magnesium) 10mg | enteric Coated pellets in Tablet or enteric coated pellets in capsule | oral |
| NCDS | 02-C00-033 | Omeprazole (as magnesium) 20mg | enteric Coated pellets in Tablet | oral |
| NCDS | 02-C00-034 | Omeprazole (as magnesium) 40mg | enteric Coated pellets in Tablet | oral |
| NCDS | 02-C00-035 | Omeprazole (as sodium salt) 40mg | vial powder for reconstitution with or without solvent | injection IV or IV infusion |
| NCDS | 02-C00-038 | Esomeprazole( as sodium) 40mg | powder for solution vial | injection IV or IV infusion |
| NCDS | 02-C00-036 | Esomeprazole (as magnesium trihydrate) 20mg | gastro resistant capsule or tablet | oral |
| NCDS | 02-C00-037 | Esomeprazole (as magnesium trihydrate) 40mg | gastro resistant capsule or tablet | oral |
| NCDS | 02-C00-041 | Esomeprazole (as magnesium dihydrate) 20mg | gastro resistant capsule or tablet | oral |
| NCDS | 02-C00-042 | Esomeprazole (as magnesium dihydrate) 40mg | gastro resistant capsule or tablet | oral |
| NCDS | 02-C00-050 | Esomeprazole ( as Esomeprazole Strontium) 20mg | gastro resistant Tablet | oral |
| NCDS | 02-C00-051 | Esomeprazole ( as Esomeprazole Strontium) 40mg | gastro resistant Tablet | oral |
| NCDS | 02-C00-044 | Esomeprazole (as magnesium dihydrate or trihydrate) 10mg \ sachet | gastro resistant granules for suspension | oral |
| NCDS | 02-C00-045 | Esomeprazole (as magnesium dihydrate) 20mg \ sachet | gastro resistant granules for suspension | oral |
| NCDS | 02-C00-059 | Esomeprazole 20mg ( as sodium salt) | gastro resistant tablet OR Gastro-resistant capsule | oral |
| NCDS | 02-C00-060 | Esomeprazole 40mg ( as sodium salt) | gastro resistant tablet OR Gastro-resistant capsule | oral |
| NCDS | 02-C00-046 | Dexlansoprazole 30 mg | modified release capsule or enteric coated tablet or dual delayed pellets in capsule | oral |
| NCDS | 02-C00-047 | Dexlansoprazole 60 mg | modified release capsule or enteric coated tablet or dual delayed pellets in capsule | oral |
| NCDS | 02-C00-061 | Vonoprazan Fumarate equivalent to 10 mg Vonoprazan | film coated caplet | oral |
| NCDS | 02-C00-062 | Vonoprazan Fumarate equivalent to 20 mg Vonoprazan | film coated caplet | oral |
| 2D | ANTIDIARRHOEAL DRUGS | |||
| NCDS | 02-D00-001 | Codeine phosphate 30 mg | Tablet | oral |
| NCDS | 02-D00-002 | Diphenoxylate Hydrochloride 2.5mg + Atropine sulphate 25mcg | Tablet | oral |
| NCDS | 02-D00-003 | Loperamide Hydrochloride 2mg | Tablet or capsule | oral |
| NCDS | 02-D00-008 | Glucose anhydrous 13.5g + Sodium Chloride 2.6g+Tri-sodium citrate dihydrate 2.9g + Potassium chloride 1.5g\ sachet to be dissolved in Sufficient water to produce 1liter (providing Na+ 75 mmol + K+ 20 mmol+ Cl- 65 mmol +citrate 10 mmol +glucose 75 mmol /Litre ) | powder | oral |
| NCDS | 02-D00-014 | Glucose 1.62 g + citric acid 672 mg+sodium from sodium chloride 34.5mg + potassium from potassium chloride 78 mg + sodium from sodium bicarbonate 103.5mg | effervescent tablet | oral |
| NCDS | 02-D00-015 | Glucose 2.91 gm + citric acid 880 mg +Sodium from sodium chloride 210 mg + Potassium from potassium citrate 160 mg | 4.9 gm powder in sachet | oral |
| NCDS | 02-D00-011 | Racecadotril 100 mg | capsule | oral |
| NCDS | 02-D00-012 | Racecadotril 10 mg | sachet | oral |
| NCDS | 02-D00-013 | Racecadotril 30 mg | sachet | oral |
| NCDS | 02-D00-010 | Diosmectite 3gm | sachet | oral |
| 2E | TREATMENT OF CHRONIC DIARRHEA | |||
| NCDS | 02-E00-001 | Mesalazine 400mg | enteric coated Tablet | oral |
| NCDS | 02-E00-004 | Mesalazine 1g | Suppository | Rectal |
| NCDS | 02-E00-012 | Mesalazine 1g | prolonged release tablet | oral |
| NCDS | 02-E00-005 | Mesalazine 500mg | Suppository | Rectal |
| NCDS | 02-E00-006 | Mesalazine 500mg | modified release ( enteric coated tablet or extended release capsule) | oral |
| NCDS | 02-E00-009 | Mesalazine 1g/Sachet | prolonged release granules | oral |
| NCDS | 02-E00-010 | Mesalazine 800mg | Tablet | oral |
| NCDS | 02-E00-011 | Mesalazine 1gm/100ml or 1gm/application | suspension enema or foam enema | Rectal |
| NCDS | 02-E00-007 | Sulphasalazine 500mg | enteric coated Tablet | oral |
| NCDS | 02-E00-008 | Sodium cromoglycate 100mg | Capsule | oral |
| 2F | LAXATIVES | |||
| NCDS | 02-F00-001 | Bisacodyl 5mg | Suppository | rectal |
| NCDS | 02-F00-002 | Bisacodyl 10mg Suppository | Suppository | rectal |
| NCDS | 02-F00-003 | Bisacodyl 5mg | enteric coated Tablet | oral |
| NCDS | 02-F00-007 | Dioctyl Sodium sulphosuccinate (Docusate sodium) 100mg | Tablet | oral |
| NCDS | 02-F00-008 | Dioctyl Sodium Sulphosuccinate 12.5mg/5ml | Drop (peadiatric) | oral |
| NCDS | 02-F00-014 | Lactulose 3.1- 3.7g/5ml | Syrup or liquid sachet | oral |
| NCDS | 02-F00-015 | Lactitol monohydrate 10g /Sachet | Powder | oral |
| NCDS | 02-F00-016 | Methylcellulose 900mg/10ml | Mixture | oral |
| NCDS | 02-F00-017 | Methylcellulose 250mg | Tablet | oral |
| NCDS | 02-F00-018 | Methylcellulose 500mg | Tablet | oral |
| NCDS | 02-F00-020 | Sorbitol 3.125g + sodium citrate 450mg + Sodium alkyl sulphoacetate 45mg/5ml | tube Enema | rectal |
| NCDS | 02-F00-023 | Sodium picosulfate 7.5mg/ml | Drop | oral |
| NCDS | 02-F00-024 | Sodium picosulfate 10mg/ml (i.e Each one drop contains sodium picosulfate 0.5mg) | Drop | oral |
| NCDS | 02-F00-026 | Glycerol (Glycerine) 700mg\g | Suppository | rectal |
| NCDS | 02-F00-027 | Glycerol (Glycerine)1400mg\2g | Suppository | rectal |
| NCDS | 02-F00-028 | Glycerol (Glycerine)2800mg\4g | Suppository | rectal |
| NCDS | 02-F00-031 | Glycerol (Glycerine) 900mg | Suppository | rectal |
| NCDS | 02-F00-032 | Glycerol (Glycerine) 1800mg | Suppository | rectal |
| NCDS | 02-F00-034 | Glycerol (Glycerin) 1365 mg / 1.5 g | Suppository | rectal |
| NCDS | 02-F00-035 | Glycerol (Glycerin) 2275 mg / 2.5 g | Suppository | rectal |
| NCDS | 02-F00-029 | citric acid 12 g + Magnesium oxide 3.5 g + sodium picosulfate 10 mg \sachet | powder | oral |
| NCDS | 02-F00-033 | citric acid 10.97 g + Magnesium oxide 3.5 g + sodium picosulfate 10 mg + Potassium ( 5 mmole or 195 mg ) \sachet | powder for solution | oral |
| NCDS | 19-000-020 | Liquid paraffin 1 ml\1ml | Liquid | oral |
| NCDS | 19-000-022 | Magnesium sulfate dried 1 mg per 1 mg Magnesium sulfate | powder | oral |
| 2G | RECTAL AND COLONIC DRUGS | |||
| NCDS | 02-G00-001 | Hydrosortisone 0.5%+Cinchocaine Hydrochloride 0.5%+ Framycetin sulphate 1%+ Aesculin 1% | Ointment | rectal |
| NCDS | 02-G00-002 | Hydrosortisone 5mg+ Cinchocaine Hydrochloride 5mg+ Framycetin sulphate 10mg+Aesculin 10mg | Suppository | rectal |
| NCDS | 02-G00-003 | Fluocinolone acetonide 0.1mg+Lidocaine Hydrochloride 20mg + Menthol 2.5mg+Bismuth subgallate 50mg\ 1g | Ointment | rectal |
| NCDS | 02-G00-004 | Fluocinolone acetonide 0.1mg+Lidocaine Hydrochloride 20mg + Menthol 2.5mg+Bismuth subgallate 50mg\1g | cream | rectal |
| NCDS | 02-G00-005 | Fluocinolone actonide 0.1mg + Lidocaine Hydrochloride 40mg | Suppository | rectal |
| NCDS | 02-G00-006 | Lidocaine Hydrochloride 50mg+Hydrocortisone acetate 2.75mg+ Aluminium subacetate 35mg+ Zinc oxide 180mg \1g | Ointment | rectal |
| NCDS | 02-G00-007 | Lidocaine Hydrochloride 60mg+Hydrocortisone acetate 5mg+Aluminium subacetate 50mg+Zinc oxide 400mg | Suppository | rectal |
| NCDS | 02-G00-008 | Prednisolon (as sodium phosphate) 20mg/100ml | (100ml) retention Enema | Rectal |
| NCDS | 02-G00-009 | Hydrocortisone acetate 10% | foam in Aerosol pack | Rectal |
| NCDS | 02-G00-010 | Budesonide 2.3mg/tablet + bottle contain 115ml solvent + Rectal nozzles – Retention Enema i-e (Budesonide ((0.02mg/ml)) | Retention Enema | Rectal |
| NCDS | 02-G00-011 | Zinc oxide 10.6%+Bismuth oxide 0.85%+Bismuth subgallate 2.1%+Hydrocortisone acetate 0.35% | suppository | Rectal |
| NCDS | 02-G00-012 | Tribenosid 5gm + Lidocaine Hydrochloride 2gm \100gm | cream | Rectal |
| NCDS | 02-G00-013 | Tribenoside 400mg + Lidocaine Hydrochloride 40mg | suppository | rectal |
| NCDS | 02-G00-014 | Lidocaine base 50mg+Hydrocortisone acetate 2.5mg \ 1g | Ointment | rectal |
| NCDS | 02-G00-015 | Lidocaine Hydrochloride 20mg+Fluocinolone acetonide 0.1mg\ 1g | Ointment | rectal |
| NCDS | 02-G00-017 | Shark liver oil 3.00g + phenylephrine hydrochloride 0.25g + Dibucaine1g\100g | cream | rectal |
| NCDS | 02-G00-016 | Fluocinolone acetonide 0.1mg+ lidocaine Hydrochloride 20mg \1g | cream | rectal |
| NCDS | 02-G00-018 | Glyceryl trinitrate (nitroglycerin )4 mg /g(0.4%) | Ointment | rectal |
| NCDS | 02-G00-020 | Glyceryl trinitrate (nitroglycerin ) 0.2% | Ointment | rectal |
| NCDS | 02-G00-019 | Hydrosortisone 0.5%+Cinchocaine Hydrochloride 0.5% | cream | rectal |
| 2H | DRUGS AFFECTING INTESTINAL SECRETIONS | |||
| NCDS | 02-H00-004 | Pancreatin 200mg | Tablet | Oral |
| NCDS | 02-H00-009 | Ursodeoxycholic acid 150mg | Tablet | Oral |
| NCDS | 02-H00-012 | Ursodeoxycholic acid 250mg | Capsule | Oral |
| NCDS | 02-H00-016 | Ursodeoxycholic acid 300mg | Tablet OR Capsule | Oral |
| NCDS | 02-H00-015 | Tauroursodeoxycholic acid 250 mg | capsule | Oral |
| NCDS | 02-H00-013 | Pancreatic enzyme , Protease 16000- 38000 USP units Lipase 5000 – 20000 USP units Amylase 17000 – 37000 USP unit | delayed release capsule or tablet or granules | Oral |
| NCDS | 02-H00-014 | Pancreatic enzyme , Lipase 2000 -10000IU Protease 200-600 IU Amylase 2000-10000 IU/g | sachet or capsule | Oral |
| NCDS | 02-H00-019 | Pancreatic enzyme , Amylase 10000 N.F.U protease 10000 N.F.U lipase 800 N.F.U | Tablet | Oral |
| NCDS | 02-H00-017 | Lipase 40000 ph Eur unit Amylase 25000 ph Eur unit Protease 1600 ph Eur unit | gastric resistant capsule | Oral |
| NCDS | 02-H00-018 | 300 mg Pancreatin corresponding to : Lipase 25000 ph Eur unit Amylase 18000 ph Eur unit Protease 1000 ph Eur unit | gastric resistant capsule or hard gelatin capsule filled with gastro resistant granules | Oral |
| 2K | DIRECT ACTING SPASMOLYTIC | |||
| NCDS | 02-K00-002 | Mebeverine Hydrochloride 135mg | Tablet | oral |
| NCDS | 02-K00-003 | Mebeverine Hydrochloride 135mg+Ispaghula husk 3.5g/sachet | Granules | oral |
| NCDS | 02-K00-004 | Mebeverine Hydrochloride 200mg | Retard capsule | oral |
| NCDS | 02-K00-005 | Drotaverine Hydrochloride 40 mg | tablet | oral |
| 2L | MOTILITY STIMULANT (PROKINETIC DRUG) | |||
| NCDS | 02-L00-001 | Domperidone as base or (as maleate) 10mg | tablet | oral |
| NCDS | 02-L00-002 | Domperidone 10mg/10ml | Suspension | oral |
| NCDS | 02-L00-003 | Domperidone 10mg/ml | Drop | oral |
| NCDS | 02-L00-004 | Metoclopramide Hydrochloride 5mg | Tablet | oral |
| NCDS | 02-L00-005 | Metoclopramide Hydrochloride 10mg | Tablet or Scored Table | oral |
| NCDS | 02-L00-006 | Metoclopramide Hydrochloride 5mg/5ml | Syrup | oral |
| NCDS | 02-L00-008 | Metoclopramide hydrochloride BP eq. to anhydrous Metoclopramide hydrochloride 5mg/ml or Metoclopramide hydrochloride eq. to Metoclopramide 5mg/ml | 2ml vial or ampoule | injection IM, IV |
| NCDS | 02-L00-010 | Metoclopramide Hydrochloride 1mg/ml | Drop(should supply with pipette with fixing drops number / 1ml ) 15 ml bottle | oral |
| 2M | BOWEL CLEANSING SOLUTIONS(not for chronic constipation) | |||
| NCDS | 02-M00-002 | Sodium Acid phosphate 21.4gm+sodium phosphate 9.4gm/ 118ml | 133ml single dose enema | rectal |
| NCDS | 02-M00-003 | Disodium hydrogen phosphate dodecahydrate 240 mg per 1 ml, Sodium dihydrogen phosphate dihydrate 542 mg per 1 ml (Phospho-soda 24.4g/10.8g ) | solution 45ml | oral |
| NCDS | 02-M00-005 | Sodium dihydrogen phosphate dihydrate 16 gm + Disodium hydrogen phosphate dodecahydrate 6 gm\100ml | solution enema ( 120 ml ) | rectal |
| NCDS | 02-M00-006 | Macrogol 4000 ( Polyethylene Glycol ) 4 gm | powder in sachet | oral |
| NCDS | 02-M00-004 | macrogol(polyethylene glycol) 3350 13.125g+Sodium Chloride 350.7mg+ Sodium Bicarbonate 178.5mg +Potassium Chloride 46.6mg\ 13.8 g sachet | powder for oral solution | oral |
| NCDS | 02-M00-001 | Macrogol 4000 (polyethlene glycol) 64g+Anhydrous sodium sulfate 5,700gm+sodium bicarbonate 1,680gm+sodium chloride 1,460gm+potassium chloride 0,750gm\ sachet | powder for oral solution | oral |
| 2N | others | |||
| NCDS | 02-N00-001 | Ethanol 98% | 5ml Ampoule | injection |
| NCDS | 02-N00-002 | L-ornithine-L-aspartate 3 g\sachet | GRANULES | oral |
| 2O | Helicobacter pylori infection | |||
| NCDS | 02-O00-001 | Bismuth subcitrate potassium 140mg + Metronidazole 125mg + Tetracycline hydrochloride 125 mg | capsule | oral |
| 3 | RESPIRATORY SYSTEM | |||
| 3A | BRONCHODILATORS | |||
| NCDS | 03-A00-001 | Aminophylline dihydrate 25mg/1ml (eq.Theophyline Anhydrous 19.7 mg/1ml) | 10 ml ampoule | IV injection |
| NCDS | 03-A00-003 | Aminophylline hydrate 100mg | sustained release Tablet | Oral |
| NCDS | 03-A00-004 | Aminophylline hydrate 225mg | sustained release Tablet | Oral |
| NCDS | 03-A00-005 | Aminophylline 100mg | Tablet | Oral |
| NCDS | 03-A00-006 | Aminophylline 50mg | Suppository | rectal |
| NCDS | 03-A00-008 | Aminophylline 250mg | Suppository | rectal |
| NCDS | 03-A00-011 | Theophyline 60mg/5ml | Syrup | Oral |
| NCDS | 03-A00-012 | Ephedrine Hydrochloride 30mg | Tablet | Oral |
| NCDS | 03-A00-014 | Ipratropium Bromide anhyrous 20mcg/metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-015 | Ipratropium Bromide 500mcg /2ml | solution 2ml nebuliser liquid unit dose vial | inhalation |
| NCDS | 03-A00-016 | Ipratropium Bromide 0.52mg (eq.0.5mg Ipratropium bromide anhydrous)+Salbutamol sulphate 3.01mg (eq. salbutamol base 2.5mg) in \2.5ml | Solution 2.5ml nebuliser liquid unit dose vial or ampoule | inhalation |
| NCDS | 03-A00-017 | Ipratropium Bromide ( anhydrous or monohydrate ) 250mcg/2ml | Solution 2ml nebuliser liquid unit dose vial | inhalation |
| NCDS | 03-A00-018 | Ipratropium Bromide anhydrous 20 mcg + Salbutamol sulphate 120mcg / metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-057 | Ipratropium bromide 250mcg/ml | 2ml nebuliser liquid unit dose vial | inhalation |
| NCDS | 03-A00-058 | Ipratropium bromide 250mcg/ml | 1ml nebuliser liquid unit dose vial | inhalation |
| NCDS | 03-A00-022 | Salbutamol 200mcg | powder in Rotacap | inhalation |
| NCDS | 03-A00-023 | Salbutamol 0.5mg/ml solution dilute to concentration 50 mcg/ ml | 1ml Ampoule | SC,IM , slow IV Injection |
| NCDS | 03-A00-024 | Salbutamol 0.5% w/v | 20ml or 30ml respirator solution | inhalation |
| NCDS | 03-A00-056 | Salbutamol sulphate eq. Salbutamol 1mg/1ml | Solution 2.5ml nebuliser liquid unit dose vial or ampoule | inhalation |
| NCDS | 03-A00-025 | Salbutamol ( as sulphate) 2mg/5ml | Syrup | Oral |
| NCDS | 03-A00-026 | Salbutamol (as sulphate ) 2mg | Tablet | Oral |
| NCDS | 03-A00-027 | Salbutamol ( as sulphate) 4mg | controlled release Tablet | Oral |
| NCDS | 03-A00-028 | Salbutamol ( as sulphate) 8mg | controlled release Tablet | Oral |
| NCDS | 03-A00-029 | Salmeterol (as xinafoate) 25mcg/metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-030 | Terbutaline sulphate 250mcg/ dose | powder in Turbuhalar | inhalation |
| NCDS | 03-A00-031 | Terbutaline sulphate 500mcg/dose | powder in Turbuhalar | inhalation |
| NCDS | 03-A00-032 | Terbutaline sulphate 500mcg/ml | 1ml Ampoule | SC injection |
| NCDS | 03-A00-033 | Terbutaline sulphate 300mcg/ml | Syrup | Oral |
| NCDS | 03-A00-034 | Terbutaline sulphate 2.5mg | Tablet | Oral |
| NCDS | 03-A00-035 | Terbutaline sulphate 5mg | durules Tablet | Oral |
| NCDS | 03-A00-036 | Terbutaline sulphate 2.5 mg\1 ml | solution 2ml nebuliser liquid unit dose vial | inhalation |
| NCDS | 03-A00-037 | Theophylline 250mg | sustained release Tablet or Tablet or Scored Tablet | Oral |
| NCDS | 03-A00-038 | Theophylline (Theophylline anhydrous is the same) 50mg + Glycerylguiacolate 30mg/5ml | solution | Oral |
| NCDS | 03-A00-039 | Theophylline 150mg +Glyerylguiacolate 90mg | Tablet | Oral |
| NCDS | 03-A00-040 | Theophylline 300mg | sustained release Capsule or sustained release Tablet (3scored ) | Oral |
| NCDS | 03-A00-043 | Theophylline 100mg | sustained release Tablet | Oral |
| NCDS | 03-A00-049 | Theophylline 120 | Tablet | oral |
| NCDS | 03-A00-044 | Salbutamol (as a base) or (as sulphate) 100mcg/metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-046 | Salmeterol (as xinafoate) 50mcg | dry powder in blister with disk- haler device(i-e . Diskhaler) | inhalation |
| NCDS | 03-A00-047 | Fenoterol hydro bromide 100mcg/ metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-055 | Tiotropium (as Bromide monohydrate) or ( as Br Anhydrous ) 18 mcg ( the delivere dose is 10 mcg of tiotropium) | powder in hard capsule+ handi haler device or (powder for inhalation in Discair) | inhalation |
| NCDS | 03-A00-062 | tiotropium ( as bromide ) 13 mcg ( the delivere dose is 10 mcg of tiotropium ) | powder in hard capsule with zephir inhaler | inhalation |
| NCDS | 03-A00-059 | Formoterol fumarate dihydrate 4.5mcg /1dose( for explanation:Each delievered dose (i-e the dose leaving the mouth piece) from turbuhaler contains 4.5mcg from fromoterol fumarate dihydrate which is derived from a metered dose of 6 mcg) | powder inTurbuhalar | inhalation |
| NCDS | 03-A00-060 | Formoterol fumarate 12mcg/ metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-A00-013 | Formoterol fumarate 12mcg | dry powder In Capsule with inhaler | inhalation |
| NCDS | 03-A00-048 | Formoterol fumarate dihydrate 9mcg /dose (Each delievered dose (i-e the dose leaving the mouth piece) from turbuhaler contains 9mcg from fromoterol fumarate dihydrate is derived from a metered dose of 12mcg) | powder in Turbuhalar | inhalation |
| NCDS | 03-A00-063 | Indacaterol maleate 143 mcg + Glycopyrronium bromide 63 mg ( each delivered dose (the dose that leaves the mouthpiece) contain: 85mcg Indacaterol + 43mcg Glycopyrronium ) | powder in hard capsule | inhalation |
| 3B | CORTICOSTEROIDS | |||
| NCDS | 03-B00-003 | Fluticasone propionate 125mcg / metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-B00-004 | Fluticasone propionate 50mcg | dry powder in blister with disk-haler device (i.e Diskhaler) | inhalation |
| NCDS | 03-B00-005 | Fluticasone propionate 100mcg | dry powder in blister with disk-haler device (i.e Diskhaler) | inhalation |
| NCDS | 03-B00-006 | Fluticasone propionate 250mcg | dry-powder in blister with disk-haler device (i.e Diskhaler) | inhalation |
| NCDS | 03-B00-007 | Fluticasone propionate 500mcg | dry powder in blister with disk-haler device (i.e Diskhaler) | inhalation |
| NCDS | 03-B00-025 | Fluticasone propionate 50 mcg / metered dose inhalar(evohaler) | metered aerosol | inhalation |
| NCDS | 03-B00-026 | Fluticasone propionate 250 mcg / metered dose inhalar(evohaler) | metered aerosol | inhalation |
| NCDS | 03-B00-028 | Fluticasone propionate 50 mcg + formoterol fumarate dihydrate 5mcg /dose | pressurized inhalation suspension in metered aerosol | inhalation |
| NCDS | 03-B00-029 | Fluticasone propionate 125 mcg + formoterol fumarate dihydrate 5mcg /dose | pressurized inhalation suspension in metered aerosol | inhalation |
| NCDS | 03-B00-012 | Salmeterol (as xinofoate) 50mcg + fluticasone propionate 500mcg/dose | powder in blister (pre-dispensed) with inhaler device (Diskus) or Powder in capsule with inhaler device (Qhaler) | inhalation |
| NCDS | 03-B00-013 | Salmeterol (as xinofoate) 50mcg + fluticasone propionate 250mcg/ dose | powder in blister (pre-dispensed) with inhaler device (Diskus) or Powder in capsule with inhaler device (Qhaler) | inhalation |
| NCDS | 03-B00-014 | Salmeterol (as xinofoate) 50mcg + fluticasone propionate 100mcg/ dose | powder in blister (pre-dispensed) with inhaler device (Diskus) or Powder in capsule with inhaler device (Qhaler) | inhalation |
| NCDS | 03-B00-023 | Salmeterol (as xinofoate) 25 mcg +Fluticasone propionate 125 mcg/ metered dose inhalar or inhalation powder | powder in blister with inhaler device or metered aerosol | inhalation |
| NCDS | 03-B00-024 | Salmeterol (as xinofoate) 25 mcg +Fluticasone propionate 250 mcg/ metered dose inhalar or inhalation powder | powder in blister with inhaler device or metered aerosol | inhalation |
| NCDS | 03-B00-027 | Salmeterol (as xinofoate) 25 mcg +Fluticasone propionate 50mcg\ metered dose inhalar (evohaler) | metered aerosol | inhalation |
| NCDS | 03-B00-017 | Mometasone furoate anhydrous 200mcg/ dose (actutation) | dry powder in blister with inhaler device(twisthalar) | inhalation |
| NCDS | 03-B00-018 | Mometasone furoate anhydrous 400mcg/dose (actutation) | dry powder in blister with inhaler device(twisthalar) | inhalation |
| NCDS | 03-B00-002 | Budesonide 200mcg/dose | powder in Turbuhalar | inhalation |
| NCDS | 03-B00-019 | Budesonide 200mcg+Formoterol fumarate dihydrate 6 mcg/1dose (Each delivered dose (the dose that leaves the mouthpiece) contains: budesonide 160 mcg + formoterol fumarate dihydrate 4.5 mcg /dose | powder in Turbuhaler or Discair or Powder in capsule with inhaler) or Aerosol inhaler | inhalation |
| NCDS | 03-B00-030 | Budesonide 400mcg+Formoterol fumarate dihydrate 12mcg/1dose (Each delivered dose (the dose that leaves the mouthpiece) contains: budesonide 320 mcg + formoterol fumarate dihydrate 9 mcg /dose | powder in Turbuhaler or powder in single dose strips or Powder in capsule with inhaler or Aerosol inhaler | inhalation |
| NCDS | 03-B00-032 | Beclometasone dipropionate anhydrous100 mcg +Formoterol fumarate dihydrate 6 mcg per dose | powder in hard capsule | inhalation |
| NCDS | 03-B00-031 | budesonide 200 mcg + formoterol fumarate dihydrate 6 mcg | powder in single dose strip with inhaler device | inhalation |
| NCDS | 03-B00-033 | budesonide 200 mcg + formoterol fumarate dihydrate 6 mcg\ acuation | Metered Dose Inhaler | inhalation |
| NCDS | 03-B00-020 | Budesonide 500mcg/ml | 2ml nebuliser liquid unit dose | inhalation |
| NCDS | 03-B00-034 | formoterol fumarate dihydrate 5mcg+ glycopyronium bromide 9 mcg (eq.7.2 of glycopyronium ) + budesonide 160mcg / single actuation | pressurized inhalation suspension Inhaler | inhalation |
| NCDS | 03-B00-021 | Ciclesonide 80 mcg /metered dose inhalar (actuation) | metered aerosol | inhalation |
| NCDS | 03-B00-022 | Ciclesonide 160 mcg /metered dose inhalar (actuation) | metered aerosol | inhalation |
| NCDS | 03-B00-008 | Beclomethasone dipropionate 100mcg | dry powder in Rota Capsule | inhalation |
| NCDS | 03-B00-009 | Beclomethasone dipropionate 200mcg | dry powder in Rota Capsule | inhalation |
| NCDS | 03-B00-010 | Beclomethasone dipropionate 400mcg | Rota Capsule dry powder | inhalation |
| NCDS | 03-B00-001 | Beclomethasone dipropionate 50mcg/metered dose inhalar | metered aerosol | inhalation |
| NCDS | 03-B00-015 | Beclomethasone dipropionate 250mcg/metered dose inhalar | metered aerosol | inhalation |
| 3C | PROPHYLAXIS OF ASTHMA | |||
| NCDS | 03-C00-001 | Ketotifen (as hydrogen fumarate) 1mg | Tablet or capsule | oral |
| NCDS | 03-C00-003 | Ketotifen (as hydrogen fumarate) 1mg/5ml | syrup or suspension | oral |
| NCDS | 03-C00-004 | Sodium cromoglycate 20mg | Spincaps with Spinhelar | inhalation |
| NCDS | 03-C00-006 | Sodium cromoglycate 10mg/ml | 2ml nebuliser liquid unit dose | inhalation |
| NCDS | 03-C00-007 | Sodium cromoglycate 5mg/ metered dose inhalar or Terbuhalar (without freon or freon free) | metered Aerosol or Terbuhalar | inhalation |
| 3D | ALLERGIC DISORDERS | |||
| NCDS | 03-D00-003 | Chlorpheniramine maleate 2 mg/5ml | Syrup | oral |
| NCDS | 03-D00-004 | Chlorpheniramine maleate 4mg | Tablet | oral |
| NCDS | 03-D00-007 | chlorpheniramine maleate10mg/ml | 1ml Ampoule | SC , IM , Slow IV injection |
| NCDS | 03-D00-008 | Clemastine (as hydrogen fumarate) 1mg | Tablet | oral |
| NCDS | 03-D00-009 | Clemastine (as hydrogen fumarate ) 0.1mg / ml | Syrup | oral |
| NCDS | 03-D00-010 | Cyproheptadine Hydrochloride 2mg/5ml | Syrup | oral |
| NCDS | 03-D00-052 | Cyproheptadine Hydrochloride USP 2mg +Thiamine hydrochloride (Vitamin B1) BP 1mg +Vriboflavin(Vitamin B2) BP 0.5mg +pyridoxine hydrochloride(Vitamin B6) BP 0.5mg+nicotinamide (Vitamin B3) 10mg+cyanocobolamine(Vitamin B12 ) 1mcg\5ml | Syrup | oral |
| NCDS | 03-D00-055 | Cyproheptadine Hydrochloride 2.00mg+ thiamine Hydrochloride(vitamin B1) 0.60 mg+ riboflavin (vitamin B2) 0.75mg + pyridoxine (vitamin B6) 0.60mg + niacinamide 5.00 mg + ascorbic acid (vitamin C) 20.00mg | 5 ml syrup | oral |
| NCDS | 03-D00-053 | Glutodine ( Cyproheptadine alpha- ketoglutarate ) 3 mg+ Arginine aspartate 1 g\10 ml | solution in ampoule | oral |
| NCDS | 03-D00-011 | Cyproheptadine Hydrochloride 4mg | Tablet | oral |
| NCDS | 03-D00-012 | Dexchlorpheniramine maleate 6mg | sustained release Tablet | oral |
| NCDS | 03-D00-013 | Dexchlorpheniramine maleate 2mg+ Dexamethasone 0.25mg | Tablet | oral |
| NCDS | 03-D00-014 | Diphenhydramine Hydrochloride 10mg/5ml | Elixir | oral |
| NCDS | 03-D00-015 | Diphenhydramine Hydrochloride10mg/ml | 1ml Ampoule | IM,IV injection |
| NCDS | 03-D00-016 | Diphenhydramine Hydrochloride25mg | Tablet | oral |
| NCDS | 03-D00-017 | Diphenpyraline Hydrochloride 5mg | sustained release Capsule | oral |
| NCDS | 03-D00-018 | Fexofenadine Hydrochloride 180mg | Film Coated Tablet | oral |
| NCDS | 03-D00-019 | Fexofenadine Hydrochloride 120mg | Film Coated Tablet | oral |
| NCDS | 03-D00-020 | Hydroxyzine Hydrochloride 10mg | Tablet | oral |
| NCDS | 03-D00-021 | Hydroxyzine Hydrochloride 25mg | Tablet | oral |
| NCDS | 03-D00-022 | loratadine 10mg | Tablet | oral |
| NCDS | 03-D00-023 | loratadine 5mg/5ml | Syrup | oral |
| NCDS | 03-D00-025 | Pheniramine P-amino salicylate 50mg | Tablet | oral |
| NCDS | 03-D00-026 | Pheniramine hydrogen maleate 15mg/5ml | Syrup | oral |
| NCDS | 03-D00-027 | Promethazine Hydrochloride 25mg/ml | 2ml Ampoule | injection |
| NCDS | 03-D00-028 | Promethazine Hydrochloride 5mg/5ml | Syrup | 0ral |
| NCDS | 03-D00-029 | Promethazine Hydrochloride 10 mg | Tablet | 0ral |
| NCDS | 03-D00-030 | Triprolidine Hydrochloride 2.5mg | Tablet | 0ral |
| NCDS | 03-D00-031 | Trimeprazine tartrate 10mg | Tablet | 0ral |
| NCDS | 03-D00-032 | Trimeprazine tartrate 7.5mg/5ml | Syrup | 0ral |
| NCDS | 03-D00-033 | Trimeprazine tartrate Forte 30mg/5ml | Syrup | 0ral |
| NCDS | 03-D00-039 | Desloratadine 5mg | tablet or orodispersible tablet | 0ral |
| NCDS | 03-D00-040 | Desloratadine 2.5mg /5ml | solution | 0ral |
| NCDS | 03-D00-043 | Cetirizine Hydrochloride (dihydrochloride) 1mg/ml (0.1 %) | solution | 0ral |
| NCDS | 03-D00-045 | Levocetirizine Hydrochloride or di-Hydrochloride 5mg | tablet or orodispersible tablet | oral |
| NCDS | 03-D00-054 | Levocetirizine Dihydrochloride 0.5 mg/1ml | solution | 0ral |
| NCDS | 03-D00-047 | Icatibant (as acetate) 10mg\ml | 3ml prefilled syringe | injection |
| NCDS | 03-D00-048 | Cetirizine Hydrochloride or Di-Hydrochloride 10 mg | tablet | oral |
| NCDS | 03-D00-049 | Bilastine 10 mg | orodispersible Tablet | oral |
| NCDS | 03-D00-050 | Bilastine 20 mg | tablet or orodispersible tablet | oral |
| NCDS | 03-D00-051 | Bilastine 2.5mg/ml | solution | oral |
| 3E | RESPIRATORY STIMULANTS | |||
| NCDS | 03-E00-001 | Doxapram Hydrochloride 20mg/ml | 5ml Ampoule | injection |
| NCDS | 03-E00-002 | caffeine citrate 10mg/ml (eq. to caffeine 5mg/ml) | 1ml or 2ml or 3ml ampoule | I.V. infusion |
| NCDS | 03-E00-004 | caffeine citrate 20mg/ml (eq.to caffeine 10mg/ml ) | 1ml or 2ml or 3ml ampoule or vial | I.V. infusion or (iv and oral) |
| NCDS | 03-E00-003 | Caffeine citrate 2 mg (eq.Caffeine base 1mg ) | liquid | oral |
| 3F | MUCOLYTICS | |||
| NCDS | 03-F00-001 | Bromhexine Hydrochloride 8 mg | Tablet | oral |
| NCDS | 03-F00-002 | Bromhexine Hydrochloride 4mg/5ml | Syrup | oral |
| NCDS | 03-F00-003 | Bromhexine Hydrochloride 2mg/1ml | 2ml ampoule | Slow IV , Deep IM injection |
| NCDS | 03-F00-005 | Bromhexine Hydrochloride 8mg/5ml | Syrup | oral |
| NCDS | 03-F00-006 | Bromhexine Hydrochloride 4 mg + Terbutaline sulphate 1.25 mg + Guaifensin 50 mg + Menthol 2.5 mg\5ml | Syrup | oral |
| NCDS | 03-F00-009 | Guaifenesin 100 mg / 5 ml | syrup | oral |
| NCDS | 03-F00-008 | Ambroxol Hydrochloride 3 mg / ml | Syrup | oral |
| NCDS | 03-F00-010 | Ambroxol Hydrochloride 6 mg / ml | Syrup | oral |
| NCDS | 03-F00-007 | Carbocistein 250 mg / 5 ml | Syrup | oral |
| NCDS | 03-F00-004 | N-acetylcysteine 100 mg / sachet | granules | oral |
| 3G | ANTITUSSIVES DEMULCENTS EXPECTORANTS | |||
| NCDS | 03-G00-001 | Sodium benzoate 0.025mg + syrup Tolu balsam 1.25ml+Syrup of ipecac 1.25ml+ Tr. comphor 1.25ml/5ml | Syrup | oral |
| NCDS | 03-G00-004 | Dextromethorphan hydrobromide 15mg | Tablet | oral |
| NCDS | 03-G00-006 | Dextromethorphan hydrobromide 15mg/5ml | syrup | oral |
| NCDS | 03-G00-007 | Dextromethorphan hydrobromide 2.5mg + Pot. Guaiacale sulphonate 37.5mg /5ml | Mixture | oral |
| NCDS | 03-G00-039 | Butamirate citrate 7.5 mg / 5 ml ( 0.15% ) | Syrup | oral |
| NCDS | 03-G00-008 | Dextromethorphan hydrobromide B.P 15mg+Guaiphenesin 100mg +Psuedoephedrine Hydrochloride 30mg/5ml | Syrup | oral |
| NCDS | 03-G00-022 | Dextromethorphan hydrobromide 10mg + Chlorpheniramine maleate 2mg/5ML | Syrup | oral |
| NCDS | 03-G00-035 | Chlorpheniramine Maleate 2mg + Dextromethorphan hydrobromide 7.5mg/5ml | Syrup | oral |
| NCDS | 03-G00-025 | Chlorpheniramine maleate 2mg + Ammonium chloride 131.5mg + menthol 1mg/5ml | syrup | oral |
| NCDS | 03-G00-026 | Chlorpheniramine maleate 2mg + Ammonium chloride 100mg + menthol 1.1mg/5ml | syrup | oral |
| NCDS | 03-G00-027 | diphenhydramine Hydrochloride 7mg + Menthol 0.55mg/5ml | syrup | oral |
| NCDS | 03-G00-028 | Diphyenhydramine Hydrochloride 14mg+Ammonium Chloride 135mg +Sodium Citrate 57mg +Menthol 1.1mg/ 5ml | syrup | oral |
| NCDS | 03-G00-029 | Diphenhydramine Hydrochloride 7mg + Ammonium chloride 67.5mg + Menthol 0.55mg/5ml | syrup | oral |
| NCDS | 03-G00-030 | Diphenhydramine Hydrochloride 12.5mg + Ammonium chloride 120mg + sodium Citrate dehydrate 50mg + Menthol 1mg/5ml | syrup | oral |
| NCDS | 03-G00-034 | Diphenhydramine Hydrochloride 13.5mg + Ammonium chloride 131.5mg /5ml | syrup | oral |
| NCDS | 03-G00-036 | Diphenhydramine Hydrochloride 14mg + Ammonium chloride 135mg + menthol 1.1ml/5ml | syrup | oral |
| NCDS | 03-G00-038 | Dextromethorphan hydrobromide 10mg + oxomemazine Hydrochloride 1.5mg + sodium benzoate 60mg / 5ml | syrup | oral |
| NCDS | 03-G00-009 | Tincture grindeliae 0.2ml+Tincture Pimpinellae 0.2ml+ Tincture primulae1ml+Tincture rosae1ml+Tincture Thym 1.2ml+ Mel 45g /100ml | syrup | oral |
| NCDS | 03-G00-010 | Tincture grindeliae 0.2ml+ Tincture Pimpinellae 0.2ml+ Tincture primulae1ml+Tincture rosae1ml+Tincture Thym 1.2ml+ Mel 45g+Codeine phosphate 100mg /100ml | syrup | oral |
| NCDS | 03-G00-040 | Cloperastine fendizoate 354mg /100ml | syrup | oral |
| NCDS | 03-G00-011 | Thym 5.8g+Herb droserae 1.45g+ Pinguiculae 2.4g/10ml | Drop | oral |
| NCDS | 03-G00-012 | Glyceryl guaiacolate 100mg+Chlorpheniramine maleate 1mg+ Phenylephrine hydrochloride 5mg +Codeine phosphate 10mg /5ml | syrup | oral |
| NCDS | 03-G00-024 | Paracetamol 250 mg + phenylephrine Hdrochloride 5mg + guaifenesin 100 mg | tablet | oral |
| NCDS | 03-G00-032 | Paracetamol 500mg + phenylephrine Hydrochloride 5mg | tablet | oral |
| NCDS | 03-G00-013 | Diphenhydramine Hydrochloride 13.5mg +Ammonium chloride131.5mg +Sodium citrate55mg+Menthol 1mg/5ml | Syrup | oral |
| NCDS | 03-G00-023 | Diphenhydramine Hydrochloride 12.5mg + Ammonium chloride 125.0mg + sodium citrate 50.0mg/5ml | Syrup | oral |
| NCDS | 03-G00-031 | Paracetamol 325mg + Phenylephrine hydrochloride 5mg + chlorpheniramine maleat 2mg | tablet | oral |
| NCDS | 03-G00-043 | Paracetamol 500 mg + Phenylephrine hydrochloride 10mg + Chlorphenamine maleate 4mg | tablet | oral |
| NCDS | 03-G00-033 | Paracetamol 500mg + Phenylephrine Hydrochloride 5mg +Caffeine 25 mg | tablet | oral |
| NCDS | 03-G00-037 | Clobutinol Hydrochloride 20mg + Orciprenaline sulphate 5mg/5ml | syrup | oral |
| NCDS | 03-G00-014 | Chlorpheniramine maleate 25mg + Ephedrine Hydrochloride 100mg + glyceryl guaiacolate 1g + Potassium citrate 3g+ Sodium benzoate 3g+liquid extract of liquorice 7.5g/100ml | syrup | oral |
| NCDS | 03-G00-016 | Glyceryl guaiacolate 50mg+ Chlorpheniramine maleate 1mg+ Phenylephrine Hydrochloride 2.5mg/5ml | Syrup | oral |
| NCDS | 03-G00-017 | Chlorpheniramine maleate 2mg +Phenylephrine Hydrochloride5mg+ Ephedrine Hydrochloride 15mg+ Codeine phosphate 8mg/10ml | Syrup | oral |
| NCDS | 03-G00-018 | Lemon juice 1ml+ Honey 250mg+ Ammonium chloride 30 mg+Ipecac liquid extract 0.003ml/5ml | Syrup | oral |
| NCDS | 03-G00-019 | Dextromethorphane hydrobromide 5mg/5ml | mixture | oral |
| NCDS | 03-G00-041 | Dropropizine 15 mg / 5ml | Syrup | oral |
| NCDS | 03-G00-020 | Chlorpheniramine maleate 2mg +Phenylephrine Hydrochloride 5mg+ Ephedrine Hydrochloride 5mg+ Codeine phosphate 8mg/10ml | Syrup | oral |
| NCDS | 03-G00-021 | Dextrometharphane hydrobromide 0. 15g+ephedrine Hydrochloride0.15g+Chlorpheniramie maleate 0.025g+guaifenesin 1g/100ml | Syrup | oral |
| 3H | ORALLY ADMINISTERED NASAL DECONGESTANTS | |||
| NCDS | 03-H00-001 | Paracetamol 450mg+ Promethazine Hydrochloride5mg+Phenylephrine Hydrochloride 5mg | Tablet | oral |
| NCDS | 03-H00-003 | dimethindene maleate 1mg/ml | Drop | oral |
| NCDS | 03-H00-004 | dimethindene maleate 4mg | Long Acting Capsule | oral |
| NCDS | 03-H00-005 | Chlorpheniramine maleate 2mg+Paracetamol 350mg | Tablet | oral |
| NCDS | 03-H00-028 | Paracetamol 400mg + chlorpheniramine maleate 2mg | Tablet | oral |
| NCDS | 03-H00-024 | Paracetamol 120mg + Chlorpheniramine maleate 2mg/5 ml | syrup | oral |
| NCDS | 03-H00-042 | Paracetamol 160mg + Chlorpheniramine maleate 1.0 mg / 5 ml syrup | syrup | oral |
| NCDS | 03-H00-027 | Triprolidine Hydrochloride 1.25mg + Pseudoephedrine Hydrochloride 30mg + Dextromethorphan Hydrobromide 10mg/ 5ml | syrup | oral |
| NCDS | 03-H00-031 | Paracetamol 500 mg + Phenylepherine Hydrochloride 5 mg + Chlorphenramine Maleate 2 mg | tablet | oral |
| NCDS | 03-H00-007 | Pseudoephedrine Hydrochloride 60mg + Triprolidine Hydrochloride 2.5mg | Tablet or capsule | oral |
| NCDS | 03-H00-008 | Pseudoephedrine Hydrochloride 30mg + Triprolidine Hydrochloride 1.25mg/5ml | Syrup | oral |
| NCDS | 03-H00-026 | Triprolidine Hydrochloride 1.25mg + Pseudoephedrine Hydrochloride 30mg + Guaifenesin 100mg/ 5ml | syrup | oral |
| NCDS | 03-H00-009 | Pseudoephedrine Hydrochloride 60mg+ Triprolidine Hydrochloride 2,5mg+ Codeine phosphate 20mg | Tablet | oral |
| NCDS | 03-H00-010 | Pseudoephedrine Hydrochloride 30mg + Triprolidine Hydrochloride 1.25mg+ Codeine phosphate 10mg/5ml | Syrup | oral |
| NCDS | 03-H00-012 | Pseudoephedrine Hydrochloride 50mg + Triprolidin Hydrochloride 2.5mg + Paracetamol 300mg | Tablet | oral |
| NCDS | 03-H00-013 | Pseudoephedrine Hydrochloride 0.5g + Triprolidin Hydrochloride 0.025g + Paracetamol 2.5g/100ml | Solution | oral |
| NCDS | 03-H00-029 | Ibuprofen 200mg + Pseudoephedrine Hydrochloride 30mg | caplet or tablet | oral |
| NCDS | 03-H00-035 | Ibuprofen 200 mg +Pseudoephedrine Hydrochloride 30 mg + Chlorpheniramine Maleate 2 mg | tablet | oral |
| NCDS | 03-H00-025 | Dextrometharphan Hydrobromide 7.5mg + Pseudoephedrine Hydrochloride 15mg + Chlorpheniramine maleate 1mg/5ml | syrup | oral |
| NCDS | 03-H00-036 | chlorpheniramine maleate 1 mg + Pseudoephedrine Hydrochloride 15 mg + Dextromethorphan Hydrobromide 5 mg /5ml | syrup | oral |
| NCDS | 03-H00-037 | Ibuprofen 100mg + pseudoephedrine Hydrochloride 15mg+ chlorpheniramine maleate 1mg / 5 ml | suspension | oral |
| NCDS | 03-H00-015 | dimethindene maleate 0.01g/100ml | Syrup | oral |
| NCDS | 03-H00-017 | Paracetamol 500mg+PseudoephedrineHydrochloride 30mg | tablet or caplet | oral |
| NCDS | 03-H00-018 | Paracetamol 500mg+Pseudoephedrine Hydrochloride 30mg+Chlorpheniramine maleate 2mg | tablet or caplet | oral |
| NCDS | 03-H00-038 | Paracetamol 500mg+Pseudoephedrine Hydrochloride 30mg+Chlorpheniramine maleate 4mg | tablet | oral |
| NCDS | 03-H00-019 | Pseudoephedrine sulphate 120mg + loratadine 5mg | repetab | oral |
| NCDS | 03-D00-041 | Desloratadine 2.5 mg + Pseudoephedrine 120 mg | extended release tablet | oral |
| NCDS | 03-H00-021 | Paracetamol 500mg + diphenyhydramine Hydrochloride 25mg | tablet or capsule | oral |
| NCDS | 03-H00-032 | Dextromethorphan Hydobromide 4.5 mg +Chlorpheniramine maleate 1 mg+Pseudoephedrine Hydrochloride 15 mg+Paracetamol 160 mg/ 5ml | syrup | oral |
| NCDS | 03-H00-033 | Paracetamol 160 mg+Chlorpheniramine maleate 1 mg +Pseudoephedrine Hydrochloride 15 mg/5ml | syrup | oral |
| NCDS | 03-H00-034 | Diphenhydramine hydrochloride 12.5 mg+ Dextromethorphan hydrbromide 15 mg+ Pseudoephedrine hydrochloride 30 mg In 5ml | syrup | oral |
| 3I | OTHERS | |||
| NCDS | 03-I00-002 | Lidocaine Hydrochloride 40mg/ml (4%) | Jet spray | topical |
| NCDS | 03-I00-005 | anhydrous Lidocaine Hydrochloride 40mg/ml (4%) | solution | topical |
| NCDS | 03-I00-006 | Phospholipids 25mg(derived from bovine lung lipid extract) Beractant +Nacl 9mg in water for injection /1ml | vial of 4ml | intratrachral only |
| NCDS | 03-I00-007 | Calfactant 35mg/ml | suspension 3ml vial | intratrachral instillation only |
| 3J | LEUKETRIN RECEPTOR ANTAGONIST | |||
| NCDS | 03-J00-001 | Zofirlukast 20mg | Tablet | oral |
| NCDS | 03-J00-002 | Montelukast ( as sodium salt ) 4mg | cheweble Tablet | oral |
| NCDS | 03-J00-003 | Montelukast( as sodium salt) 10mg | Tablet | oral |
| NCDS | 03-J00-004 | Montelukast (as sodium ) 5mg | cheweble Tablet | oral |
| NCDS | 03-J00-005 | Montelukast ( as sodium ) 4mg/ sachet | granules | oral |
| IMMUNOSUPPRESSANTS › MONOCLONAL ANTIBODIES | ||||
| NCDS | 03-J00-006 | Benralizumab 30 mg/ 1ml | solution prefilled pen or prefilled syringe | injection SC |
| NCDS | 03-J00-007 | Tezepelumab 210 mg / 1.91 ml | prefilled pen | injection SC only |
| 4 | CENTRAL NERVOUS SYSTEM | |||
| 4A | HYPNOTICS AND ANXIOLYTICS | |||
| NCDS | 04-A00-001 | Amylobarbitone sodium 60mg | Capsule | oral |
| NCDS | 04-A00-003 | Alprazolam 0.5mg | scored Tablet | oral |
| NCDS | 04-A00-004 | Alprazolam 0.25mg | Tablet | oral |
| NCDS | 04-A00-038 | Alprazolam 1mg | Tablet | oral |
| NCDS | 04-A00-005 | Buspirone Hydrochloride 5mg | Tablet | oral |
| NCDS | 04-A00-006 | Buspirone Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-A00-007 | Chlordiazepoxide 5mg | Tablet | oral |
| NCDS | 04-A00-008 | Bromazepam 1.5mg | scored Tablet | oral |
| NCDS | 04-A00-009 | Bromazepam 3mg | scored Tablet | oral |
| NCDS | 04-A00-010 | Chlordiazepoxide 10mg | Tablet | oral |
| NCDS | 04-A00-012 | Clobazam 10mg | Tablet | oral |
| NCDS | 04-A00-013 | Diazepam 5mg/ml | 2ml Ampoule | injection |
| NCDS | 04-A00-016 | Diazepam 10mg | sustained release Capsule | oral |
| NCDS | 04-A00-017 | Diazepam 2mg/ml | 1.25ml Rectal tube | rectal |
| NCDS | 04-A00-036 | Diazepam 2mg/ml | 2.5 ml Rectal tube | rectal |
| NCDS | 04-A00-018 | Diazepam 2mg/5ml | Syrup | oral |
| NCDS | 04-A00-020 | Diazepam 2mg | Tablet | oral |
| NCDS | 04-A00-021 | Diazepam 5mg | Tablet | oral |
| NCDS | 04-A00-022 | Diazepam 10mg | Tablet | oral |
| NCDS | 04-A00-024 | Lorazepam 1mg | Scored Tablet | oral |
| NCDS | 04-A00-025 | Lorazepam 2mg | Tablet | oral |
| NCDS | 04-A00-027 | Lorazepam 4mg/ml | 1ml Ampoule | injection |
| NCDS | 04-A00-028 | Medazepam 5mg | Capsule | oral |
| NCDS | 04-A00-029 | Medazepam 10mg | Capsule | oral |
| NCDS | 04-A00-031 | Nitrazepam 5mg | Tablet | oral |
| NCDS | 04-A00-032 | Triazolam 125mcg | Tablet | oral |
| NCDS | 04-A00-033 | Triazolam 250mcg | Tablet | oral |
| NCDS | 04-A00-034 | Zolpidem tartrate 5mg | Tablet or orodispersible tablet | oral |
| NCDS | 04-A00-035 | Zolpidem tartrate 10mg | Tablet or orodispersible tablet | oral |
| NCDS | 04-A00-042 | Tizanidine (as Hydrochloride) 2 mg | tablet | oral |
| NCDS | 04-A00-040 | Tizanidine (as Hydrochloride) 4 mg | tablet | oral |
| NCDS | 04-A00-043 | Lemborexant 5 mg | film coated tablet | oral |
| NCDS | 04-A00-044 | Lemborexant 10 mg | film coated tablet | oral |
| NCDS | 04-A00-039 | Chloral Hydrate 200mg/5ml | syrup | oral |
| NCDS | 04-A00-041 | Chloral Hydrate 500mg/5ml | solution (Battle of 200 ml ) | oral |
| 4B | ANTIPSYCHOTICS | |||
| NCDS | 04-B00-001 | Chlorpromazine Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-B00-002 | Chlorpromazine Hydrochloride 25mg | Tablet | oral |
| NCDS | 04-B00-003 | Chlorpromazine Hydrochloride 50mg | Tablet | oral |
| NCDS | 04-B00-004 | Chlorpromazine Hydrochloride 100mg | Tablet | oral |
| NCDS | 04-B00-005 | Chlorpromazine Hydrochloride 25mg/5ml | Syrup | oral |
| NCDS | 04-B00-006 | Chlorpromazine Hydrochloride 5mg/ml | Drop | oral |
| NCDS | 04-B00-007 | Chlorpromazine Hydrochloride 10mg/ml | 5ml Ampoule | injection |
| NCDS | 04-B00-008 | Chlorpromazine Hydrochloride 25mg/ml | 2ml Ampoule | IV , IM injection |
| NCDS | 04-B00-009 | Clozapine 25mg | Tablet | oral |
| NCDS | 04-B00-010 | Clozapine 100mg | Tablet | oral |
| NCDS | 04-B00-011 | Flupentixol (Flupenthixol) as di-Hydrochloride 1mg | Tablet | oral |
| NCDS | 04-B00-012 | Flupentixol (Flupenthixol) 2mg | Tablet | oral |
| NCDS | 04-B00-013 | Flupentixol (Flupenthixol) 3mg | Tablet | oral |
| NCDS | 04-B00-014 | Flupentixol (Flupenthixol) decanoate 20mg/ml | 1ml depot-Ampoule | IM injection |
| NCDS | 04-B00-015 | Flupentixol (Flupenthixol) decanoante 20mg/ml | 2ml oily-Ampoule | IM injection |
| NCDS | 04-B00-016 | Flupentixol (Flupenthixol) decanoate 100mg/ml Concentrated | 1ml depot-Ampoule | IM injection |
| NCDS | 04-B00-084 | Flupentixol (Flupenthixol) as di-Hydrochloride 0.5 mg + Melitracen (as hydrochloride) 10 mg | Tablet | oral |
| NCDS | 04-B00-017 | Fluphenazine hydrochloride 1mg | Tablet | oral |
| NCDS | 04-B00-018 | Fluphenazine decanoate 25mg/ml | 1ml depot-Ampoule | IM injection |
| NCDS | 04-B00-019 | Fluphenazine decanoate 100mg/ml | 1ml depot-Ampoule | IM injection |
| NCDS | 04-B00-020 | Haloperidol 0.5mg | Capsule or Tablet | oral |
| NCDS | 04-B00-022 | Haloperidol 1.5mg | Tablet | oral |
| NCDS | 04-B00-023 | Haloperidol 5mg | Tablet | oral |
| NCDS | 04-B00-024 | Haloperidol 10mg | Tablet | oral |
| NCDS | 04-B00-025 | Haloperidol 5mg/ml | 1ml Ampoule | injection |
| NCDS | 04-B00-026 | Haloperidol ( as decanoate) 50mg/ml | 1ml sustained release oily Ampoule | IM injection |
| NCDS | 04-B00-027 | Haloperidol ( as decanoate ) 100mg/ml | 1ml sustained release oily Ampoule | IM injection |
| NCDS | 04-B00-028 | Haloperidol 2mg/ml liquid (1ml equivalent to 20 drops) | Drop | oral |
| NCDS | 04-B00-029 | Haloperidol 10mg/ml concentrateed | Liquid | oral |
| NCDS | 04-B00-030 | Haloperidol 20mg | Tablet | oral |
| NCDS | 04-B00-031 | Lithium carbonate 250mg | Tablet | oral |
| NCDS | 04-B00-033 | Lithium carbonate 400mg | controlled release Tablet | oral |
| NCDS | 04-B00-032 | Olanzapine 10mg | Tablet | oral |
| NCDS | 04-B00-034 | Olanzapine 5mg | Tablet | oral |
| NCDS | 04-B00-108 | Olanzapine 2.5mg | Tablet or orodispersible Tablet | oral |
| NCDS | 04-B00-076 | Olanzapine 5mg | orodispersible Tablet | oral |
| NCDS | 04-B00-077 | Olanzapine 10mg | orodispersible Tablet | oral |
| NCDS | 04-B00-080 | Olanzapine 10mg | vial | IM injection |
| NCDS | 04-B00-041 | Pimozide 1mg | Tablet | oral |
| NCDS | 04-B00-042 | Pimozide 4mg | Tablet | oral |
| NCDS | 04-B00-050 | Risperidone 2mg | Tablet | oral |
| NCDS | 04-B00-112 | Risperidone 3mg | Tablet | oral |
| NCDS | 04-B00-051 | Risperidone 4mg | Tablet | oral |
| NCDS | 04-B00-081 | Risperidone 1mg | Tablet | oral |
| NCDS | 04-B00-082 | Risperidone 1mg/ml | solution | oral |
| NCDS | 04-B00-090 | Risperidone 0.5mg | Tablet | oral |
| NCDS | 04-B00-091 | Risperidone 6mg | Tablet | oral |
| NCDS | 04-B00-113 | Risperidone 25mg / vial | powder and solvent for prolonged-release suspension ( 1 vial + PFS 2 ml ) | IM injection |
| NCDS | 04-B00-114 | Risperidone 37.5mg / vial | powder and solvent for prolonged-release suspension ( 1 vial + PFS 2 ml ) | IM injection |
| NCDS | 04-B00-115 | Risperidone 50mg / vial | powder and solvent for prolonged-release suspension ( 1 vial + PFS 2 ml ) | IM injection |
| NCDS | 04-B00-104 | Lurasidone hydrochloride 20 mg | Tablet | oral |
| NCDS | 04-B00-105 | Lurasidone hydrochloride 40 mg | Tablet | oral |
| NCDS | 04-B00-106 | Lurasidone hydrochloride 80 mg | Tablet | oral |
| NCDS | 04-B00-107 | Lurasidone hydrochloride 120 mg | Tablet | oral |
| NCDS | 04-B00-061 | Trifluoperazine (as Hydrochloride) 1mg | Tablet | oral |
| NCDS | 04-B00-062 | Trifluoperazine ( as Hydrochloride ) 5mg | Tablet | oral |
| NCDS | 04-B00-063 | Trifluoperazine (as Hydrochloride) 2mg | sustained release spansules capsule | oral |
| NCDS | 04-B00-064 | Trifluoperazine (as Hydrochloride) 10mg | sustained release spansules capsule | oral |
| NCDS | 04-B00-065 | Trifluoperzine ( as Hydrochloride) 1mg/5ml | Syrup | oral |
| NCDS | 04-B00-069 | Zuclopenthixol dihydrochloride 25mg | Tablet | oral |
| NCDS | 04-B00-070 | Zuclopenthixol acetate 50mg/ml | 1ml Ampoule | IM injection |
| NCDS | 04-B00-071 | Zuclopenthixol decanoate 200mg/ml | 1ml Ampoule | IM injection |
| NCDS | 04-B00-072 | Amisulpride 50mg | Tablet | oral |
| NCDS | 04-B00-073 | Amisulpride 200mg | Tablet | oral |
| NCDS | 04-B00-111 | Amisulpride 100mg | Tablet | oral |
| NCDS | 04-B00-078 | Quetiapine ( as fumarate )100mg | tablet | oral |
| NCDS | 04-B00-079 | Quetiapine ( as fumarate) 200mg | tablet | oral |
| NCDS | 04-B00-083 | Quetiapine (as fumarate) 300mg | Tablet | oral |
| NCDS | 04-B00-088 | Quetiapine (as fumarate) 200mg | Extended Release Tablet | oral |
| NCDS | 04-B00-089 | Quetiapine (as fumarate ) 300mg | Extended Release Tablet | oral |
| NCDS | 04-B00-101 | Quetiapine ( as fumarate) 25 mg | tablet | oral |
| NCDS | 04-B00-102 | Quetiapine (as fumarate ) 50 mg | extended release tablet | oral |
| NCDS | 04-B00-103 | Quetiapine (as fumarate) 400 mg | extended release tablet | oral |
| NCDS | 04-B00-085 | Paliperidone 3 mg | Extend Release tablet | oral |
| NCDS | 04-B00-086 | Paliperidone 6 mg | Extend Release tablet | oral |
| NCDS | 04-B00-087 | Paliperidone 9 mg | Extend Release tablet | oral |
| NCDS | 04-B00-035 | Paliperidone 50 mg ( as Paliperidone palmitate) | prolonged release suspension in prefilled syringe | IM injection |
| NCDS | 04-B00-037 | Paliperidone 75 mg ( as Paliperidone palmitate) | prolonged release suspension in prefilled syringe | IM injection |
| NCDS | 04-B00-040 | Paliperidone 100 mg ( as Paliperidone palmitate) | prolonged release suspension in prefilled syringe | IM injection |
| NCDS | 04-B00-066 | Paliperidone 150 mg ( as Paliperidone palmitate) | prolonged release suspension in prefilled syringe | IM injection |
| NCDS | 04-B00-099 | Aripiprazole 5 mg | Tablet | oral |
| NCDS | 04-B00-092 | Aripiprazole 10 mg | Tablet | oral |
| NCDS | 04-B00-0100 | Aripiprazole 10 mg | orodispersible tablet | oral |
| NCDS | 04-B00-093 | Aripiprazole 15mg | orodispersible tablet | oral |
| NCDS | 04-B00-094 | Aripiprazole 15mg | tablet | oral |
| NCDS | 04-B00-109 | Aripiprazole 1mg / ml | solution | oral |
| NCDS | 04-B00-095 | Cariprazine(as hydrochloride ) 1.5 mg | capsule | oral |
| NCDS | 04-B00-096 | Cariprazine(as hydrochloride) 3 mg | capsule | oral |
| NCDS | 04-B00-097 | Cariprazine(as hydrochloride) 4.5 mg | capsule | oral |
| NCDS | 04-B00-098 | Cariprazine(as hydrochloride ) 6 mg | capsule | oral |
| 4C | ANTIDEPRESSANT DRUGS | |||
| 4CA | TRICYCLIC AND RELATED ANTIDEPRESSANT DRUGS | |||
| NCDS | 04-CA0-001 | Amitriptyline Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-CA0-002 | Amitriptyline Hydrochloride 25mg | Tablet | oral |
| NCDS | 04-CA0-003 | Amitriptyline Hydrochloride 50mg | Tablet | oral |
| NCDS | 04-CA0-004 | Amitriptyline Hydrochloride 75mg | sustained release Capsule | oral |
| NCDS | 04-CA0-005 | Amitriptyline Hydrochloride 10mg/5ml | syrup | oral |
| NCDS | 04-CA0-006 | Clomipramine Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-CA0-007 | Clomipramine Hydrochloride 25mg | Tablet | oral |
| NCDS | 04-CA0-008 | Clomipramine Hydrochloride 12.5mg/ml | 2ml Ampoule | injection |
| NCDS | 04-CA0-009 | Clomipramine Hydrochloride 75mg | sustained release Tablet | oral |
| NCDS | 04-CA0-012 | Imipramine Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-CA0-013 | Imipramine Hydrochloride 25mg | Tablet | oral |
| NCDS | 04-CA0-014 | Imipramine Hydrochloride 12.5mg/ml | 2ml Ampoule | injection |
| NCDS | 04-CA0-017 | Maprotiline Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-CA0-018 | Maprotiline Hydrochloride 25mg | Tablet | oral |
| NCDS | 04-CA0-019 | Maprotiline Hydrochloride 50mg | Tablet | oral |
| NCDS | 04-CA0-025 | Trimipramine 25mg | Tablet | oral |
| NCDS | 04-CA0-026 | Trimipramine 10mg | Tablet | oral |
| NCDS | 04-CA0-034 | Doxepin (as Hydrochloride) 10mg | Capsule | oral |
| NCDS | 04-CA0-035 | Doxepin (as Hydrochloride ) 25mg | Capsule | oral |
| NCDS | 04-CA0-036 | Doxepin (as Hydrochloride ) 75mg | Capsule | oral |
| NCDS | 04-CA0-042 | Doxepin (as Hydrochloride ) 50mg | Capsule | oral |
| NCDS | 04-CA0-039 | Trazodone Hydrochloride 50mg | Capsule | oral |
| NCDS | 04-CA0-040 | Trazodone Hydrochloride 100mg | Capsule | oral |
| NCDS | 04-CA0-041 | Trazodone Hydrochloride 150mg | Tablet | oral |
| 4CC | Selective serotonin re-up take inhibitors | |||
| NCDS | 04-CC0-001 | Citalopram (as Hydrobromide) 20mg | Tablet | oral |
| NCDS | 04-CC0-030 | Citalopram (as Hydrobromide) 10mg | Tablet | oral |
| NCDS | 04-CC0-028 | Fluoxetine (as Hydrochloride) 10mg | Capsule | oral |
| NCDS | 04-CC0-002 | Fluoxetine (as Hydrochloride) 20mg | Capsule | oral |
| NCDS | 04-CC0-003 | Fluoxetine (as Hydrochloride) 20mg | film coated Tablet | oral |
| NCDS | 04-CC0-004 | Fluvoxamine maleate 50mg | Tablet | oral |
| NCDS | 04-CC0-005 | Fluvoxamine maleate 100mg | Tablet | oral |
| NCDS | 04-CC0-006 | Sertraline ( as Hydrochloride ) 50mg | Tablet or capsule | oral |
| NCDS | 04-CC0-011 | Paroxetine (as Hydrochloride) 20mg | Tablet | oral |
| NCDS | 04-CC0-012 | Paroxetine ( as Hydrochloride) 30mg | Tablet | oral |
| NCDS | 04-CC0-016 | Escitalopram (as oxalate) 10mg | Tablet | oral |
| NCDS | 04-CC0-017 | Escitalopram (as oxalate) 20mg | Tablet | oral |
| NCDS | 04-CC0-029 | Escitalopram (as oxalate ) 5 mg | Tablet | oral |
| NCDS | 04-CC0-018 | Sertraline (as Hydrochloride) 100 mg | Tablet or capsule | oral |
| NCDS | 04-CC0-019 | Vortioxetine 5mg | tablet | oral |
| NCDS | 04-CC0-022 | Vortioxetine hydrobromide eq.to 10mg vortioxetine | tablet | oral |
| NCDS | 04-CC0-023 | Vortioxetine hydrobromide eq.to 15mg vortioxetine | tablet | oral |
| NCDS | 04-CC0-027 | Vortioxetine hydrobromide eq.to 20 mg Vortioxetine | tablet | oral |
| NCDS | 04-CC0-025 | Desvenlafaxine 50 mg (as succinate monohydrate) | extended release tablet | oral |
| NCDS | 04-CC0-026 | Desvenlafaxine 100 mg (as succinate monohydrate) | extended release tablet | oral |
| NCDS | 04-CC0-031 | Vilazodone Hydrochloride 10 mg | film coated tablet | oral |
| NCDS | 04-CC0-032 | Vilazodone Hydrochloride 20 mg | film coated tablet | oral |
| NCDS | 04-CC0-033 | Vilazodone Hydrochloride 40 mg | film coated tablet | oral |
| NCDS | 04-CC0-020 | Dapoxetine (as Hydrochloride) 30 mg | tablet | oral |
| NCDS | 04-CC0-021 | Dapoxetine (as Hydrochloride) 60 mg | tablet | oral |
| 4CD | Other antidepressant drugs | |||
| NCDS | 04-CD0-002 | Venlafaxine (as Hydrochloride) 50mg | Tablet | oral |
| NCDS | 04-CD0-003 | Venlafaxine ( as Hydrochloride ) 75mg | Tablet | oral |
| NCDS | 04-CD0-013 | Venlafaxine (as Hydrochloride )75mg | extended release capsule | oral |
| NCDS | 04-CD0-015 | Venlafaxine (as hydrochloride) 150mg | extended release capsule | oral |
| NCDS | 04-CD0-017 | Venlafaxine ( as Hydrochloride)37.5mg | tablet | oral |
| NCDS | 04-CD0-020 | Venlafaxine (as Hydrochloride) 75 mg | prolonged release tablet | oral |
| NCDS | 04-CD0-021 | Venlafaxine (as Hydrochloride ) 150mg | prolonged release tablet | oral |
| NCDS | 04-CD0-014 | Duloxetine (as Hydrochloride) 60 mg | gastro-resistant capsule | oral |
| NCDS | 04-CD0-016 | Duloxetine (as Hydrochloride ) 30 mg | gastro-resistant capsule | oral |
| NCDS | 04-CD0-018 | Mirtazapine 30mg | Tablet or oral dispersible tablet | oral |
| NCDS | 04-CD0-001 | Mirtazapine 30mg | Tablet | oral |
| NCDS | 04-CD0-019 | Agomelatine 25 mg | film coated tablet | oral |
| 4CE | Major depressive disorder | |||
| NCDS | 04-CE0-001 | Esketamine hydrochloride 32.3 mg eq. to 28 mg OF Esketamine /device. | Pack of 3 spray device (84 mg ) | nasal |
| 4D | CENTRAL NERVOUS SYSTEM STIMULANTS | |||
| NCDS | 04-D00-001 | Dexamphetamine sulphate 5mg | Tablet | oral |
| NCDS | 04-D00-002 | Methylphenidate Hydrochloride 10mg | Tablet | oral |
| NCDS | 04-D00-009 | Methylphenidate Hydrochloride 18mg | prolong release Tablet | oral |
| NCDS | 04-D00-010 | Methylphenidate Hydrochloride 36mg | prolong release Tablet | oral |
| NCDS | 04-D00-003 | Modafinil 100mg | Tablet | oral |
| NCDS | 04-D00-004 | Atomoxetine (as Hydrochloride) 10mg | Capsule | oral |
| NCDS | 04-D00-005 | Atomoxetine ( as Hydrochloride) 25mg | Capsule | oral |
| NCDS | 04-D00-006 | Atomoxetine ( as Hydrochloride )18mg | Capsule | oral |
| NCDS | 04-D00-007 | Atomoxetine (as Hydrochloride ) 40mg | Capsule | oral |
| NCDS | 04-D00-008 | Atomoxetine (as Hydrochloride ) 4 mg/ ml | solution | oral |
| NCDS | 04-D00-011 | Solriamfetol ( as Hydrochloride) 75 mg | Tablet | oral |
| NCDS | 04-D00-012 | Solriamfetol ( as Hydrochloride) 150 mg | Tablet | oral |
| 4E | DRUG USED IN THETREATMENT OF OBESITY | |||
| 4EA | Anti -obesity drug acting on GIT | |||
| NCDS | 04-EA0-002 | Orlistat 120mg | Capsule | oral |
| NCDS | 04-EA0-010 | Liraglutide 6 mg\ml pen abel to deliver upto 3 mg as maintenance dose | pen | s.c injection |
| NCDS | 04-EA0-008 | Semaglutide 2.27mg / ml | solution in3ml prefilled pen | s.c injection |
| NCDS | 04-EA0-009 | Semaglutide 3.2mg / ml | solution in3ml prefilled pen | s.c injection |
| NCDS | 04-EA0-013 | Naltrexone hydrochloride 8mg + Bupropion hydrochloride 90 mg | extended release tablet | oral |
| NCDS | 04-EA0-012 | specification L112 of β- 1,4- polymer of D-glucosamine and N-acetyl- D-glucosamine from the shell of crustaceans | Tablet | oral |
| 4F | DRUGS USED IN NAUSEA AND VERTIGO | |||
| NCDS | 04-F00-001 | Betahistine Hydrochloride or di-Hydrochloride 8mg | Tablet | oral |
| NCDS | 04-F00-002 | Betahistine di-Hydrochloride 16mg | Scored Tablet | oral |
| NCDS | 04-F00-003 | Flunarizine (as Hydrochloride) 5mg | Capsule | oral |
| NCDS | 04-F00-033 | Doxylamine succinate 20 mg + Pyridoxine Hydrochloride 20 mg | prolonged release tablet | oral |
| NCDS | 04-F00-004 | Prochlorperazine maleate 5mg | Tablet | oral |
| NCDS | 04-F00-005 | Prochlorperazine mesilate 5mg/5ml | Syrup | oral |
| NCDS | 04-F00-006 | Prochlorperazine mesilate 12.5mg/ml | 1m Ampoule | deep IM injection |
| NCDS | 04-F00-007 | Prochlorperazine maleate (as Prochlorperazine) 5mg | Suppository | rectal |
| NCDS | 04-F00-008 | Prochlorperazine maleate (as Prochlorperazine) 25mg | Suppository | rectal |
| NCDS | 04-F00-013 | Ondansetron (as Hydrochloride) or( as Hydrochloride dihydrate) 4mg | Tablet | oral |
| NCDS | 04-F00-015 | Ondansetron 4mg | oral lyophilisate or orodispersible tablet or oral soluble film | oral |
| NCDS | 04-F00-016 | Ondansetron or Ondansetron (as Hydrochloride or as Hydrochloride dihydrate) 8mg | oral lyophilisate or orodispersible or film coated Tablet or oral soluble film | oral |
| NCDS | 04-F00-017 | Ondansetron (as Hydrochloride) 4mg/5ml Suger Free | Syrup | oral |
| NCDS | 04-F00-018 | Ondansetron( as Hydrochloride or as Hydrochloride dihydrate ) 2mg/ml | 2ml Ampoule | IM , slow IV , IV infuson injection |
| NCDS | 04-F00-019 | Ondansetron (as Hydrochloride or as Hydrochloride dihydrate) 2mg/ml | 4ml Ampoule or vial | IM , slow IV , IV infuson injection |
| NCDS | 04-F00-020 | Ondansetron (as Hydrochloride) 16mg | Suppository | rectal |
| NCDS | 04-F00-023 | Cinnarizine 25mg | Tablet | oral |
| NCDS | 04-F00-024 | Cinnarizine 15mg | Tablet | oral |
| NCDS | 04-F00-025 | Aprepitant 125 mg one hard capsule + Aprepitant 80 mg hard capsule/pack | 2 capsules/pack | oral |
| NCDS | 04-F00-026 | Netupitant 300mg+palonosetron ( as Hydrochloride )0.5mg | capsule | oral |
| NCDS | 04-F00-036 | Fosaprepitant Dimeglumine 245.32 eq.to 150 mg Fosaprepitant | powder for concentrate for solution vial | I.V infusion |
| NCDS | 04-F00-031 | Palonosetron ( as Palonosetron Hydrochloride ) 0.25 mg / 5ml | vial | IV injection |
| NCDS | 04-F00-032 | Palonosetron ( as Palonosetron Hydrochloride ) 0.075 mg / 1.5ml | vial | IV injection |
| NCDS | 04-F00-027 | Granisetron ( as Hydrochloride ) 1mg/ml | concentrate solution 3ml ampoule | IV or IV infusion injection |
| NCDS | 04-F00-034 | Granisetron ( as Hydrochloride ) 2mg | Tablet | oral |
| NCDS | 04-F00-035 | Granisetron ( as Hydrochloride ) 1mg in 1 ml isotonic saline | Ampoule | IV injection |
| NCDS | 04-F00-037 | Granisetron (as hydrochloride ) 1 mg | Tablet | oral |
| NCDS | 04-F00-030 | Doxylamine succinate 10 mg + Pyridoxine Hydrochloride 10 mg | modified release tablet | oral |
| 4G | ANALGESICS USED FOR MILD, MODERATE PAIN | |||
| NCDS | 04-G00-002 | Acetylsalicylic acid 100mg | enteric coated Tablet | oral |
| NCDS | 04-G00-044 | Acetylsalicylic acid 100 mg | tablet | oral |
| NCDS | 04-G00-010 | Acetylsalicylic acid ( 75mg-165mg ) | Coated Tablet | oral |
| NCDS | 04-G00-040 | Acetylsalicylic acid 75mg | dispersable tablet | oral |
| NCDS | 04-G00-003 | Acetylsalicylic acid 300mg | Tablet | oral |
| NCDS | 04-G00-009 | Acetylsalicylic acid 300mg | Soluble Tablet | oral |
| NCDS | 04-G00-008 | Acetylsalicylic acid 325mg or 300mg | enteric Coated Tablet | oral |
| NCDS | 04-G00-004 | Acetylsalicylic acid 500mg | Tablet | oral |
| NCDS | 04-G00-005 | Acetylsalicylic acid 500mg | Enteric Coated Tablet | oral |
| NCDS | 04-G00-006 | Acetylsalicylic acid 500mg (Micro-encapasulated forms of aspirine ) | Tablet | oral |
| NCDS | 04-G00-014 | Dihydrocodeine tartrate 30mg | Tablet | oral |
| NCDS | 04-G00-015 | Dihydrocodeine tartrate 50mg/ml ( | 1ml Ampoule | injection |
| NCDS | 04-G00-017 | Paracetamol 100mg/ml | drops or oral solution with Dropper | oral |
| NCDS | 04-G00-019 | Paracetamol 250mg/5ml | Suspention or Syrup (100 ml) | oral |
| NCDS | 04-G00-020 | Paracetamol 125mg | Suppository | rectal |
| NCDS | 04-G00-021 | Paracetamol 250mg | Suppository | rectal |
| NCDS | 04-G00-022 | Paracetamol 500mg | Suppository | rectal |
| NCDS | 04-G00-027 | Paracetamol 500mg | Tablet or effervescent tablet | oral |
| NCDS | 04-G00-047 | Paracetamol 665mg | modified release tablet | oral |
| NCDS | 04-G00-046 | Paracetamol 500mg + Caffeine 65mg | Tablet | oral |
| NCDS | 04-G00-051 | Paracetamol 250 mg +Ibuprofen 200 mg + Caffeine 50 mg | film coated tablet | oral |
| NCDS | 04-G00-028 | Paracetamol 325mg + Codeine phosphate10mg + Caffeine 50mg | Tablet | oral |
| NCDS | 04-G00-030 | Paracetamol 325mg + Codeine phosphate( 8mg – 10 mg ) | Tablet | oral |
| NCDS | 04-G00-053 | paracetamol 500 mg+ codeine phosphate hemihydrate 30 mg | Tablet | oral |
| NCDS | 04-G00-054 | paracetamol 500 mg + codeine phosphate 8 mg | Tablet | oral |
| NCDS | 04-G00-031 | Pentazocine( as lactate) 30mg/ml | 1ml Ampoule | IV, IM & SC injection |
| NCDS | 04-G00-032 | Pentazocine (as Hydrochloride) 50mg | Tablet | oral |
| NCDS | 04-G00-035 | Paracetamol 325mg + Codeine phosphate 8 mg + Caffeine 50mg | caplet | oral |
| NCDS | 04-G00-036 | Paracetamol 10 mg /ml | 100 ml container | IV Infusion |
| NCDS | 04-G00-037 | Paracetamol 10 mg /ml | 50ml vial | IV Infusion |
| NCDS | 04-G00-038 | Paracetamol 125mg /5ml | suspension or syrup (100 ml) | oral |
| NCDS | 04-G00-050 | Paracetamol 500 mg + Ibuprofen 200 mg | tablet | oral |
| NCDS | 04-G00-041 | Nefopam Hydrochloride 10 mg /1ml | 2ml ampoule | IM,IV injection |
| NCDS | 04-G00-052 | Nefopam Hydrochloride 20 mg /1ml | 1ml ampoule | IM injection |
| 4H | ANALGESICS USED FOR SEVERE PAIN | |||
| NCDS | 04-H00-003 | Morphine sulphate 10mg | sustained release Tablet or sustained release capsule | oral |
| NCDS | 04-H00-004 | Morphine sulphate 30mg | sustained release Tablet or sustained release capsule | oral |
| NCDS | 04-H00-005 | Morphine sulphate 60mg | sustained release Tablet or sustained release capsule | oral |
| NCDS | 04-H00-006 | Morphine sulphate 100mg | sustained release Tablet or sustained release capsule | oral |
| NCDS | 04-H00-007 | Morphine sulphate 10mg/ml | 1ml Ampoule | injection IM , IV , SC |
| NCDS | 04-H00-008 | Morphine sulphate 15mg/ml | 1ml Ampoule | injection IM ,slow IV , SC |
| NCDS | 04-H00-009 | Morphine sulphate 20mg/ml | Ampoule | Injection |
| NCDS | 04-H00-039 | Meptazinol Hydrochloride 115.6 mg eq.to Meptazinol 100 mg | 1ml Ampoule | IV or IM injection |
| NCDS | 04-H00-010 | Pethidine Hydrochloride 50mg/ml | 2ml Ampoule | Injection |
| NCDS | 04-H00-034 | Morphine Hydrochloride 5mg /5 ml | syrup | oral |
| NCDS | 04-H00-035 | Morphine sulphate 10 mg/5ml | syrup | oral |
| NCDS | 04-H00-036 | Morphine sulphate 10 mg/ml | 2ml Ampoule | Injection |
| NCDS | 04-H00-011 | Pethidine hydrochloride 50mg | Tablet | oral |
| NCDS | 04-H00-021 | Oxycodone Hydrochloride 5mg +Paracetamol 325mg | tablet | oral |
| NCDS | 04-H00-012 | Tramadol Hydrochloride 50mg /ml | 2ml ampoule or vial | injection IM,SC,slow IV,IV Infusion |
| NCDS | 04-H00-013 | Tramadol Hydrochloride 100mg | Suppository | rectal |
| NCDS | 04-H00-015 | Tramadol Hydrochloride 50mg | Tablet or capsule | oral |
| NCDS | 04-H00-016 | Tramadol Hydrochloride 100mg/ml | Drop | oral |
| NCDS | 04-H00-022 | Tramadol Hydrochloride 100mg | effervescent Tablet | oral |
| NCDS | 04-H00-023 | Tramadol Hydrochloride 100mg | soluble Tablet | oral |
| NCDS | 04-H00-024 | Tramadol Hydrochloride 50mg | effervescent Tablet | oral |
| NCDS | 04-H00-025 | Tramadol Hydrochloride 50mg | soluble Tablet | oral |
| NCDS | 04-H00-033 | Tramadol Hydrochloride 100mg | Capsule | oral |
| NCDS | 04-H00-038 | Tramadol Hydrochloride 100mg | retared tablet or capsule | oral |
| 4I | DRUGS USED IN MIGRAINE | |||
| NCDS | 04-I00-002 | Ergotamine tartrate 2mg + Cyclizine Hydrochloride 50mg + Caffeine hydrate 100mg | Tablet | oral |
| NCDS | 04-I00-003 | Ergotamine tartrate 1mg + caffeine 100mg | Tablet | oral |
| NCDS | 04-I00-004 | Pizotifen (as hydrogen maleate) 0.5mg | Tablet | oral |
| NCDS | 04-I00-005 | Sumatriptan (as succinate) 25 mg | Tablet | oral |
| NCDS | 04-I00-006 | Sumatriptan (as succinate) 50mg | Tablet | oral |
| NCDS | 04-I00-007 | Sumatriptan (as succinate) 12mg/ml (6mg/0.5ml) | 0.5ml prefilled syringe | SC injection |
| NCDS | 04-I00-008 | Sumatriptan 20mg/0.1ml | spray | NASAL |
| NCDS | 04-I00-009 | Zolmitriptan 2.5mg | Tablet or orodispersible tablet | oral |
| NCDS | 04-I00-013 | Zolmitriptan 5 mg | orodispersible tablet | oral |
| NCDS | 04-I00-012 | Eletriptan (as Hydrobromide) 40 mg | Tablet | oral |
| NCDS | 04-I00-010 | Pizotifen ( as hydrogen maleate) 0.5mg / 10 ml | SYRUP | oral |
| 4J | ANTIEPILEPTICS | |||
| NCDS | 04-J00-001 | Carbamazepine 100mg | Chewable Tablet | oral |
| NCDS | 04-J00-002 | Carbamazepine 200mg | Tablet | oral |
| NCDS | 04-J00-003 | Carbamazepine 200mg | controlled releaseTablet | oral |
| NCDS | 04-J00-004 | Carbamazepine 400mg | controlled releaseTablet or Tablet | oral |
| NCDS | 04-J00-005 | Carbamazepine 100mg/5ml | liquid | oral |
| NCDS | 04-J00-006 | Carbamazepine 125mg | Suppository | rectal |
| NCDS | 04-J00-007 | Carbamazepine 250mg | Suppository | rectal |
| NCDS | 04-J00-008 | Chlormethiazole edisylate 8mg/ml | vial or ampoule | Iv infusion |
| NCDS | 04-J00-009 | Clonazepam 2.5mg/ml | drop | oral |
| NCDS | 04-J00-010 | Clonazepam 0.5mg | Tablet | oral |
| NCDS | 04-J00-011 | Clonazepam 1mg | scored Tablet | oral |
| NCDS | 04-J00-012 | Clonazepam 2mg | Tablet | oral |
| NCDS | 04-J00-039 | Clonazepam 1mg/ml | 1ml Ampoule | injection |
| NCDS | 04-J00-013 | Ethosuximide 250mg/5ml | Syrup | oral |
| NCDS | 04-J00-014 | Ethosuximide 250mg | Capsule | oral |
| NCDS | 04-J00-015 | Paraldehyde 10%, | 10ml vial or ampoule | Rectally or IM divided diluted not more than 5ml |
| NCDS | 04-J00-016 | Phenobarbitone sodium 60mg water soluble | vial or ampoule | injection |
| NCDS | 04-J00-017 | Phenobarbitone sodium 200mg/ml | 1ml Ampoule | injection IM , IV or (SC , IM or IV) |
| NCDS | 04-J00-018 | Phenobarbitone 15mg | Tablet | oral |
| NCDS | 04-J00-019 | Phenobarbitone 30mg | Tablet | oral |
| NCDS | 04-J00-020 | Phenobarbitone 60mg | Tablet | oral |
| NCDS | 04-J00-023 | Phenytoin sodium 100mg | Capsule or tablet | oral |
| NCDS | 04-J00-027 | Primidone 250mg/5ml | Syrup | oral |
| NCDS | 04-J00-028 | Primidone 250mg | Tablet | oral |
| NCDS | 04-J00-031 | Sodium valproate 200mg/ml | solution Drop | oral |
| NCDS | 04-J00-032 | Sodium valproate 200mg/5ml | Syrup | oral |
| NCDS | 04-J00-034 | Sodium valproate 200mg | Tablet | oral |
| NCDS | 04-J00-035 | Sodium valproate 500mg | Tablet or enteric coated tablet | oral |
| NCDS | 04-J00-036 | Sodium valproate 500mg | chrono or sustained release Tablet | oral |
| NCDS | 04-J00-068 | Sodium valproate 200 mg | enteric coated tablet | oral |
| NCDS | 04-J00-061 | Sodium valproate (Powder) 400mg + 4ml ampoule water for injection | Vial | injection |
| NCDS | 04-J00-086 | Sodium Valproate 50 mg / ml | syrup | oral |
| NCDS | 04-J00-040 | Lamotrigine 25mg | Tablet | oral |
| NCDS | 04-J00-041 | Lamotrigine 50mg | Tablet | oral |
| NCDS | 04-J00-042 | Lamotrigine 100mg | Tablet | oral |
| NCDS | 04-J00-043 | Topiramate 25mg | Tablet | oral |
| NCDS | 04-J00-044 | Topiramate 50mg | Tablet | oral |
| NCDS | 04-J00-045 | Topiramate 100mg | Tablet | oral |
| NCDS | 04-J00-046 | Levetiracetam 250mg | Tablet | oral |
| NCDS | 04-J00-047 | Levetiracetam 500mg | Tablet | oral |
| NCDS | 04-J00-048 | Levetiracetam 1000mg | Tablet | oral |
| NCDS | 04-J00-082 | Brivaracetam 50 mg | coated caplet | oral |
| NCDS | 04-J00-085 | Brivaracetam 75 mg | coated caplet | oral |
| NCDS | 04-J00-083 | Brivaracetam 100 mg | coated caplet | oral |
| NCDS | 04-J00-084 | Brivaracetam 10 mg/ ml | solution | oral |
| NCDS | 04-J00-076 | Levetiracetam 500mg | extended release tablet | oral |
| NCDS | 04-J00-077 | Levetiracetam 750mg | extended release tablet | oral |
| NCDS | 04-J00-065 | Levetiracetam 100 mg /ml | syrup | oral |
| NCDS | 04-J00-074 | Levetiracetam 100 mg /ml | 5 ml vial concentrate for solution | injection IV infusion |
| NCDS | 04-J00-049 | Oxcarbazepine 150mg | Tablet | oral |
| NCDS | 04-J00-050 | Oxcarbazepine 300mg | Tablet | oral |
| NCDS | 04-J00-051 | Oxcarbazepine 600mg | Tablet | oral |
| NCDS | 04-J00-060 | Oxcarbazepine 60mg/ml (6%) | suspension | oral |
| NCDS | 04-J00-052 | Gabapentin 100mg | Tablet or capsules | oral |
| NCDS | 04-J00-053 | Gabapentin 300mg | Tablet or capsules | oral |
| NCDS | 04-J00-054 | Gabapentin 600mg | Tablet | oral |
| NCDS | 04-J00-055 | Gabapentin 800mg | Tablet | oral |
| NCDS | 04-J00-067 | Gabapentin 400mg | capsule | oral |
| NCDS | 04-J00-058 | Vigabatrin 500mg | Tablet | oral |
| NCDS | 04-J00-059 | Vigabatrin 500mg | powder in sachet | oral |
| NCDS | 04-J00-073 | Pregabalin 25 mg | capsule | oral |
| NCDS | 04-J00-063 | Pregabalin 75 mg | capsule | oral |
| NCDS | 04-J00-064 | Pregabalin 150 mg | capsule | oral |
| NCDS | 04-J00-069 | Pregabalin 50 mg | capsule | oral |
| NCDS | 04-J00-078 | Pregabalin20 mg / ml | solution | oral |
| NCDS | 04-J00-087 | Mirogabalin besylate eq.to 5 mg mirogabalin | film coated caplet | oral |
| NCDS | 04-J00-088 | Mirogabalin besylate eq.to 10 mg mirogabalin | film coated caplet | oral |
| NCDS | 04-J00-089 | Mirogabalin besylate eq.to 15 mg mirogabalin | film coated caplet | oral |
| NCDS | 04-J00-070 | Lacosamide 50 mg | tablet | oral |
| NCDS | 04-J00-071 | Lacosamide 100 mg | tablet | oral |
| NCDS | 04-J00-072 | Lacosamide 150 mg | tablet | oral |
| NCDS | 04-J00-075 | Lacosamide 10 mg / 1 ml | solution | oral |
| NCDS | 04-J00-079 | Perampanel 2 mg | tablet | oral |
| NCDS | 04-J00-080 | Perampanel 4 mg | tablet | oral |
| NCDS | 04-J00-081 | Perampanel 6 mg | tablet | oral |
| 4K | DRUG USED IN PARKINSONISM | |||
| NCDS | 04-K00-001 | Amantadine Hydrochloride 100mg | Capsule | oral |
| NCDS | 04-K00-002 | Trihexyphenidyl hydrochloride (Benzhexol Hydrochloride) 5mg | controlled release Capsule | oral |
| NCDS | 04-K00-003 | Trihexyphenidyl hydrochloride (Benzhexol Hydrochloride) 2mg | Tablet | oral |
| NCDS | 04-K00-004 | Trihexyphenidyl hydrochloride (Benzhexol Hydrochloride) 5mg | Tablet | oral |
| NCDS | 04-K00-005 | Benztropine mesylate 2mg | Tablet | oral |
| NCDS | 04-K00-006 | Bromocriptine (as Mesylate) 2.5mg | Tablet | oral |
| NCDS | 04-K00-007 | Levodopa 100mg + Carbidopa (as monohydrate or anhydrous)10mg | tablet | oral |
| NCDS | 04-K00-008 | Levodopa 250mg + Carbidopa (as monohydrate or anhydrous) 25mg | tablet | oral |
| NCDS | 04-K00-009 | Levodopa 50mg + Benserazide (as Hydrochloride ) 12.5mg | Capsule | oral |
| NCDS | 04-K00-010 | Levodopa 100mg + Benserazide ( as Hydrochloride ) 25mg | Capsule | oral |
| NCDS | 04-K00-021 | Levodopa 200mg + Carbidopa (as monohydrate or anhydrous)25mg | modified release Tablet | oral |
| NCDS | 04-K00-022 | Levodopa 150mg + Carbidopa 37.5mg+Entacapone 200mg | Tablet | oral |
| NCDS | 04-K00-023 | Levodopa 50mg + carbidopa 12.5mg + 200mg Entacapone | Tablet | oral |
| NCDS | 04-K00-024 | Levodopa 100mg + carbidopa 25mg + 200mg Entacapone | Tablet | oral |
| NCDS | 04-K00-025 | Levodopa 200mg + carbidopa 50mg + 200mg Entacapone | Tablet | oral |
| NCDS | 04-K00-038 | Levodopa 100mg + Carbidopa (as monohydrate or anhydrous)25 mg | Tablet | oral |
| NCDS | 04-K00-011 | Orphenadrine Hydrochloride 50mg | Tablet | oral |
| NCDS | 04-K00-012 | Orphenadrine Hydrochloride 100mg | Tablet | oral |
| NCDS | 04-K00-013 | Orphenadrine citrate 100mg | Tablet | oral |
| NCDS | 04-K00-014 | Orphenadrine citrate 30mg/ml | 2ml Ampoule | injection |
| NCDS | 04-K00-015 | Procyclidine Hydrochloride 5mg/ml | 2ml Ampoule | injection |
| NCDS | 04-K00-016 | Procyclidine Hydrochloride 5mg | Tablet | oral |
| NCDS | 04-K00-020 | Selegiline Hydrochloride 5mg | Tablet | oral |
| NCDS | 04-K00-026 | pramipexole 0.18 mg (eq. pramipexole di-Hydrochloride monohydrate 0.25mg | Tablet | oral |
| NCDS | 04-K00-027 | Pramipexol 2.1 mg ( eq. pramipexol di-Hydrochloride monohydrate 3 mg) | Extended release Tablet | oral |
| NCDS | 04-K00-028 | Pramipexol 1.05 mg (eq. pramipexol di-Hydrochloride monohydrate 1.5 mg) | Extended release Tablet | oral |
| NCDS | 04-K00-029 | Pramipexol 0.52mg (eq. pramipexol di-hydrochloride monohydrate 0.75mg) | Extended release Tablet | oral |
| NCDS | 04-K00-030 | Pramipexol 0.26mg (eq. pramipexol di-Hydrochloride monohydrate 0.375mg) | Extended release Tablet | oral |
| NCDS | 04-K00-031 | Ropinirole 250 mcg | Tablet | oral |
| NCDS | 04-K00-032 | Ropinirole 1mg | Tablet | oral |
| NCDS | 04-K00-033 | Rotigotine 2mg/24hr | patch | transdermal |
| NCDS | 04-K00-034 | Rotigotine 4mg/24hr | patch | transdermal |
| NCDS | 04-K00-035 | Rotigotine 6mg/24hr | patch | transdermal |
| NCDS | 04-K00-037 | Rasagiline ( as mesilate or tartrate ) 1 mg | Tablet | oral |
| 4L | DRUGS USED IN CHOREA, TICS AND RELATED DISORDERS | |||
| NCDS | 04-L00-001 | Tetrabenazine 25mg | Tablet | oral |
| NCDS | 04-L00-002 | Botulinum A neurotoxin complex 100 unit | vial powder for reconstitution | injection |
| NCDS | 04-L00-003 | Clostridium Botulinum neurotoxin type A 50 units | vial powder for solution | injection |
| NCDS | 04-L00-005 | Clostridium botulinum toxin type A ( in base ) 200 unit + Human serum Albumin 1.0 mg + Sodium chloride 18 mg | vial for IM | injection |
| NCDS | 04-L00-004 | Clostridium Botulinum neurotoxin type A 100 units | vial powder for solution | injection |
| 4M | DRUGS USED IN TRIGEMINAL NEURALGIA | |||
| NCDS | 04-M00-001 | Baclofen 10mg | Tablet | oral |
| NCDS | 04-M00-002 | Baclofen 25mg | Tablet | oral |
| NCDS | 04-M00-003 | Baclofen 50mcg/ml | 1ml ampoule for use with implantable pump | intrathecal injection |
| NCDS | 04-M00-010 | Baclofen 5 mg / 5ml | solution | oral |
| NCDS | 04-M00-004 | Baclofen 500mcg/ml (20ml) or Baclofen 2mg/ml (5ml) | 5ml or 20ml ampoule for use with implantable pump | intrathecal injection |
| 4N | Drugs used in Substance Dependence | |||
| 4 NA | Drugs used in alcohol dependence | |||
| NCDS | 04-NA0-001 | Citrated calcium carbamide 50mg | Tablet | oral |
| NCDS | 04-NA0-002 | Disulfiram 200mg | Tablet | oral |
| NCDS | 04-NA0-003 | Acamprosate calcium 333 mg | Tablet | oral |
| 4 NB | Cigarette smoking | |||
| NCDS | 04-NB0-001 | Nicotine 2 mg | lozenges | oral |
| NCDS | 04-NB0-002 | Nicotine 21 mg | patch | transdermal |
| NCDS | 04-NB0-003 | Nicotine 2 mg | chewing gum | oral |
| NCDS | 04-NB0-004 | Nicotine 4 mg | chewing gum | oral |
| NCDS | 04-NB0-005 | Nicotine 14 mg | patch | transdermal |
| 4 NC | Opioid dependence | |||
| NCDS | 04-NC0-001 | Naltrexone Hydrochloride 50mg | tablet | oral |
| 4O | NOOTROPICS | |||
| NCDS | 04-O00-001 | Piracetam 800mg | tablet | oral |
| NCDS | 04-O00-002 | Piracetam 1g/5ml | 15ml Ampoule | injection IM ,IV |
| NCDS | 04-O00-003 | Piracetam 12g/60ml | vial | injection IV Infusion |
| NCDS | 04-O00-004 | Piracetam 333.3 mg/ml | syrup | oral |
| NCDS | 04-O00-005 | Citicoline (as Sodium salt) 500mg | 4ml ampoule | IM , IV injection |
| NCDS | 04-O00-007 | Cerebrolysin 215.2 mg / ml concentrate for solution | 5 & 10 ML Aampoule | infusion for IV use |
| NCDS | 04-O00-008 | Rivastigmine 4.6 mg / 24 hours | patch ( 5 cm2 patch contain 9 mg ) | transdermal |
| NCDS | 04-O00-009 | Rivastigmine 9.5 mg / 24 hours | patch ( 10 cm2 patch contain 18 mg ) | transdermal |
| NCDS | 04-O00-006 | Cytidine-5-disodium monophosphate 10mg + uridine-5 Trisodium triphosphate , uridine-5 Trisodium triphosphate, uridine-5-disodium monophosphate On the whole 6mg(eq to 2.660 mg of uridine) | vial injection lyophilized powder + solvent | IM injection |
| 4P | Others | |||
| NCDS | 04-P00-002 | Bupropion Hydrochloride (Amfebutamone hydrochloride)150mg | Tablet OR sustained release tablet | oral |
| 4Q | Drugs for dementia | |||
| NCDS | 04-Q00-001 | Memantine Hydrochloride 10mg | Tablet or orodispersible tablet | oral |
| NCDS | 04-Q00-002 | Memantine Hydrochloride 5mg/actuation (10mg/ml) | pump pack | oral |
| NCDS | 04-Q00-003 | Donepezil Hydrochloride 5 mg | tablet or orodispersible | oral |
| NCDS | 04-Q00-004 | Donepezil Hydrochloride 10 mg | tablet or orodispersible | oral |
| 4R | Multiple sclerosis, IMMUNOSUPPRESSANTS › IMMUNOMODULATING DRUGS | |||
| NCDS | 04-R00-001 | Fingolimod (as hydrochloride) 0.5 mg | capsule | oral |
| NCDS | 04-R00-003 | Dimethyl Fumarate 240 mg | gastro-resistant Capsules | oral |
| NCDS | 04-R00-004 | Dimethyl Fumarate120 mg | gastro-resistant Capsules | oral |
| 4S | migraine prophylaxis and treatment of episodic cluster headaches (Monoclonal antibody) | |||
| NCDS | 04-S00-001 | Galcanezumab 100 mg \1ml | prefilled syringe | SC injection |
| NCDS | 04-S00-002 | Galcanezumab 120 mg \1ml | prefilled Pen | SC injection |
| 5 | DRUGS USED IN TREATMENT OF INFECTIONS | |||
| 5A | ANTIBACTERIAL DRUGS | |||
| 5AA | Penicillins | |||
| NCDS | 05-AA0-001 | Amoxicillin ( as trihydrate ) 250mg | Capsule | oral |
| NCDS | 05-AA0-002 | Amoxicillin (as trihydrate ) 500mg | Capsule or tablet | oral |
| NCDS | 05-AA0-085 | Amoxicillin ( as trihydrate ) 500 mg | Dispersable tablet | oral |
| NCDS | 05-AA0-080 | Amoxicillin (as trihydrate ) 500mg | Tablet | oral |
| NCDS | 05-AA0-003 | Amoxicillin (as trihydrate) 125mg/5ml | 100 ml powder for oral suspension | oral |
| NCDS | 05-AA0-004 | Amoxicillin (as trihydrate) 250mg/5ml | 100 ml powder for oral suspension | oral |
| NCDS | 05-AA0-005 | Amoxicillin (as trihydrate) 50 mg/ml | Drop powder for oral suspension 20 ml | oral |
| NCDS | 05-AA0-006 | Amoxicillin (as sodium) 250mg | Vial | injection |
| NCDS | 05-AA0-007 | Amoxicillin (as sodium) 500mg | Vial | injection |
| NCDS | 05-AA0-008 | Amoxicillin (as sodium) 1gm | Vial | injection IV ,IM |
| NCDS | 05-AA0-028 | Amoxicillin (as trihydrate )250mg + Clavulanic acid (as potassium salt) 125mg | Tablet | oral |
| NCDS | 05-AA0-029 | Amoxicillin (as trihydrate) 500mg+ Clavulanic acid (as potassium salt)125mg | Tablet | oral |
| NCDS | 05-AA0-030 | Amoxicillin (as trihydrate) 125mg + Clavulanic acid (as potassium salt) 31.25mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AA0-031 | Amoxicillin (as trihydrate) 250mg+ Clavulanic acid (as potassium salt)62.5mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AA0-032 | Amoxicillin (as sodium) 500mg+ Clavulanic acid (as potassium salt)100mg | Vial | injection IV,IV infusion |
| NCDS | 05-AA0-082 | Amoxicillin (as sodium) 1000mg + clavulanic acid (as potassium Salt) 200mg | Vial | injection IV,IV infusion |
| NCDS | 05-AA0-060 | Amoxicillin (as trihydrate) 875mg+Clavulanic acid (as potassium) 125mg | Tablet | oral |
| NCDS | 05-AA0-081 | Amoxicillin (as trihydrate) 400mg + clavulanic acid (as potassium salt) 57mg\5ml | 70 ml powder for oral suspension | oral |
| NCDS | 05-AA0-084 | Amoxicillin (as trihydrate) 600mg + Clavulanic acid (as potassium 42.9mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-009 | Ampicillin ( as trihydrate ) 250mg | Capsule | oral |
| NCDS | 05-AA0-010 | Ampicillin (as trihydrate ) 500mg | Capsule | oral |
| NCDS | 05-AA0-011 | Ampicillin (as trihydrate ) 125mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-012 | Ampicillin (as trihydrate) 250mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-014 | Ampicillin ( as sodium) 250mg | Vial | injection |
| NCDS | 05-AA0-015 | Ampicillin (as sodium) 500mg | Vial | injection IV, IM |
| NCDS | 05-AA0-061 | Ampicillin (as trihydrate) 250mg+Flucloxacillin (as sodium ) 250mg | Capsule | oral |
| NCDS | 05-AA0-062 | Ampicillin (as trihydrate) 125mg +Flucloxacillin (as magnesium salt) 125mg /5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-063 | Ampicillin (as sodium salt) 250mg+Flucloxacillin (as sodium salt ) 250mg | Vial | injection |
| NCDS | 05-AA0-039 | Flucloxacillin (as sodium) 250mg | Capsule | oral |
| NCDS | 05-AA0-040 | Flucloxacillin (as sodium) 500mg | Capsule | oral |
| NCDS | 05-AA0-041 | Flucloxacillin (as sodium) 125mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-042 | Flucloxacillin (as sodium ) 250mg | Vial | injection |
| NCDS | 05-AA0-043 | Flucloxacillin (as sodium ) 500mg | Vial | injection IM,IV, ,with or with out other route |
| NCDS | 05-AA0-077 | Flucloxacillin (as Magnesium) 125mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AA0-018 | Benzathine Penicillin 0.6MU | Vial | injection IM |
| NCDS | 05-AA0-019 | Benzathine Penicillin 1.2MU | Vial | injection IM |
| NCDS | 05-AA0-020 | Benzathine Penicillin 2.4MU | Vial | injection IM |
| NCDS | 05-AA0-021 | Benzathine Penicillin 0.6MU + Procaine Penicillin 0.3MU+Benzyl Penicillin 0.3MU | Vial | injection IM |
| NCDS | 05-AA0-023 | BenzylPenicillin (as sodium or potassium) 1MU (1mega unit) | Vial | injection IM, slow IV , IV infusion |
| NCDS | 05-AA0-083 | BenzylPenicillin (as sodium or potassium) 2MU (2 mega unit) vial IM, slow IV , IV Infusion | Vial | injection IM, slow IV , IV infusion |
| NCDS | 05-AA0-024 | BenzylPenicillin (as sodium or potassium) 5MU (5 mega unit) | Vial | injection IM, slow IV , IV infusion |
| NCDS | 05-AA0-025 | BenzylPenicillin (as sodium or potassium) 10MU (10 mega unit) | Vial | injection IM, slow IV , IV infusion |
| NCDS | 05-AA0-051 | Procaine penicillin 300 000 IU (300mg)+Benzyl penicillin sodium 100 000 IU (60mg) | Vial | injection IM |
| NCDS | 05-AA0-054 | Procaine penicillin 600 000 U +Benzylpenicillin 200 000 U | Vial | injection IM |
| NCDS | 05-AA0-052 | procaine benzyl penicillin 600 000 U | Vial | injection IM |
| NCDS | 05-AA0-053 | Procaine penicillin 1MU | Vial | injection IM |
| NCDS | 05-AA0-044 | Phenoxymethylpenicillin (as potassium) (Penicillin V) 250mg | Tablet | oral |
| NCDS | 05-AA0-048 | Piperacillin (as sodium ) 1g | vial | IV & IM Injection |
| NCDS | 05-AA0-049 | Piperacillin (as sodium) 2g | vial | IV & IM Injection |
| NCDS | 05-AA0-050 | Piperacillin ( as sodium ) 4g | vial | IV Injection |
| NCDS | 05-AA0-075 | piperacillin (as sodium salt) 3gm | Vial | Injection |
| NCDS | 05-AA0-056 | ticarcillin (as disodium) 750mg + clavulanate (as potassium )50mg | vial Powder for solution | intravenous infusion (30 min.) |
| NCDS | 05-AA0-057 | ticarcillin (as disodium) 1.5g + clavulanate (as potassium )100mg | vial Powder for solution | intravenous infusion (30 min.) |
| NCDS | 05-AA0-058 | ticarcillin (as disodium) 3g + clavulanate (as potassium )200mg | vial Powder for solution | intravenous infusion (30 min.) |
| NCDS | 05-AA0-069 | Tazobactam (as sodium salt) 250mg + piperacillin (as sodium salt ) 2gm(with or without EDTA) | vial | injection IV infusion |
| NCDS | 05-AA0-070 | Tazobactam (as sodium salt) 375mg + piperacillin (as sodium salt) 3gm (with or without EDTA) | vial | injection IV infusion |
| NCDS | 05-AA0-071 | Tazobactam (as sodium salt) 500mg + piperacillin (as sodium salt) 4gm (with or without EDTA) | vial | injection IV infusion |
| 5AB | Cephalosporins | |||
| NCDS | 05-AB0-003 | Cefadroxil 500mg | tablet or capsule | oral |
| NCDS | 05-AB0-088 | Cefadroxil ( as trihydrate ) 1 gm | tablet | oral |
| NCDS | 05-AB0-005 | Cefixime trihydrate (eq. cefixime anhydrous 200mg ) | Capsule or tablet | oral |
| NCDS | 05-AB0-006 | Cefixime trihydrate (eq. cefixime anhydrous 400mg ) | Capsule or tablet | oral |
| NCDS | 05-AB0-085 | Cefixime or cefixime as trihydrate 100mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AB0-008 | Cefotaxime (as sodium salt ) 500mg + solvent (10ml) water for injection | Vial | injection IV& IM |
| NCDS | 05-AB0-076 | Cefotaxime (as sodium salt ) 500mg + solvent(2ml) 1% lidocaine hydrochloride | Vial | injection IM |
| NCDS | 05-AB0-009 | Cefotaxime (as sodium salt )1g + solvent(10ml) water for injection | Vial | injection IV |
| NCDS | 05-AB0-010 | Cefotaxime (as sodium salt ) 1g+ solvent (3.5ml_4ml) 1% lidocaine Hydrochloride | Vial | injection IM |
| NCDS | 05-AB0-011 | Cefotaxime (as sodium salt ) 2g +solvent(10ml) water for injection | Vial | injection Slow IV within 3 -5 min. or IV Infusion within10 – 60 min.) |
| NCDS | 05-AB0-012 | Cephalexin (as monohydrate ) 250mg | Capsule | oral |
| NCDS | 05-AB0-013 | Cephalexin (as monohydrate )eq. 500mg anhydrous cephalexin | Capsule | oral |
| NCDS | 05-AB0-014 | Cephalexin (as monohydrate) 125mg/5ml | 100ml powder for oral Suspension | oral |
| NCDS | 05-AB0-015 | Cephalexin ( as monohydrate) 250mg/5ml | 100ml powder for oral Suspension | oral |
| NCDS | 05-AB0-016 | Cephalexin (as monohydrate) 100mg/ml | Drop powder for ora Suspension | oral |
| NCDS | 05-AB0-029 | Ceftriaxone ( as Sodium or as di-soduim) or (disodium sesquihydrate) salt 250mg + solvent (5ml) water for injection . | vial | IM . IV Injection |
| NCDS | 05-AB0-079 | Ceftriaxone (as Sodium or as disodium salt) 500mg +solvent (2ml )1% lidocaine hydrochloride | vial | IM Injection |
| NCDS | 05-AB0-031 | Ceftriaxone (as Sodium or as disodium) or (disodium sesquihydrate) salt 1g +solvent(10ml) water for Injection | vial | IV Injection |
| NCDS | 05-AB0-032 | Ceftriaxone (as Sodium or as disodium )or (disodium sesquihydrate) salt 1g + solvent (3.5ml_4ml)1% lidocaine hydrochloride | vial | IM Injection |
| NCDS | 05-AB0-033 | Ceftriaxone (as Sodium or as disodium ) or (disodium sesquihydrate) salt 2g | vial powder for reconsitution | IV infusion |
| NCDS | 05-AB0-034 | Ceftriaxone (as Sodium or as disodium) or (disodium sesquihydratee) salt 500mg + solvent(10ml) water for injection | vial | IM . IV Injection |
| NCDS | 05-AB0-036 | Cefazolin 1 gm + solvent water for Injection | vial | IV infusion |
| NCDS | 05-AB0-037 | Cefazolin 500mg +solvent water for Injection | vial | IM . IV Injection |
| NCDS | 05-AB0-039 | Cefazolin 1gm + solvent 1% lidocaine hydrochloride I.M. | vial | IM Injection |
| NCDS | 05-AB0-080 | Cefazolin 500mg +solvent 1% lidocaine hydrochloride | vial | IM Injection |
| NCDS | 05-AB0-041 | Cefaclor (as monohydrate) 250mg | Capsule | oral |
| NCDS | 05-AB0-042 | Cefaclor (as monohydrate) 375mg | modified release or extend release Tablet | oral |
| NCDS | 05-AB0-043 | Cefaclor (as monohydrate) 500mg | Capsule | oral |
| NCDS | 05-AB0-044 | Cefaclor (as monohydrate) eq. cefaclor anhydrous 125mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AB0-066 | Cefaclor (as monohydrate ) eq. cefaclor anhydrous 250mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AB0-087 | Cefaclor (as monohydrate) 375mg /5ml | 75 ml granules for oral suspension | oral |
| NCDS | 05-AB0-069 | Cefaclor (as monohydrate) 750mg | modified release Tablet or extend release tablet | oral |
| NCDS | 05-AB0-046 | Cefuroxime (as axetil) 250mg | Tablet | oral |
| NCDS | 05-AB0-045 | Cefuroxime (as axetil) 125mg | Tablet | oral |
| NCDS | 05-AB0-047 | Cefuroxime (as axetil) 500mg | Tablet | oral |
| NCDS | 05-AB0-048 | Cefuroxime ( as axetil) 125mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AB0-067 | Cefuroxime (as sodium) 750 mg | vial | injection IM, IV,IV infusion |
| NCDS | 05-AB0-089 | Cefuroxime (as sodium ) 1500 mg | vial | injection IV,IV infusion |
| NCDS | 05-AB0-092 | Cefuroxime (as sodium ) 50 mg | powder for solution vial | intracrameral injection |
| NCDS | 05-AB0-049 | Cefepime (as hydrochloride or as di-hydrochloride monohydrate) 500mg + solvent water for injection( Arginine formula) | vial | injection IM, IV |
| NCDS | 05-AB0-050 | Cefepime (as hydrochloride or as di-hydrochloride monohydrate) 1g+ solvent( 3-4 ml)1% lidocaine hydrochloride ( Arginine formula) | vial | IM Injection |
| NCDS | 05-AB0-051 | Cefepime (as hydrochloride or as di-hydrochloride monohydrate ) 2g + solvent water for injection ( Arginine formula) | vial | only for IV Infusion over 1\2 hour |
| NCDS | 05-AB0-058 | Cefepime (as hydrochloride or as di-hydrochloride monohydrate) 1g+ solvent water for injection (Arginine formula) | vial | only for IV Infusion over 1\2 hour |
| NCDS | 05-AB0-075 | Cefepime (as hydrochloride or as di-hydrochloride monohydrate) 500mg Vial + solvent 1% lidocaine hydrochloride ( Arginine formula) | vial | IM Injection |
| NCDS | 05-AB0-054 | Cefpodoxime (as Cefpodoxime proxetil) 100mg | Tablet | oral |
| NCDS | 05-AB0-055 | Cefpodoxime (as Cefpodoxime proxetil) 200mg | Tablet | oral |
| NCDS | 05-AB0-086 | Cefpodoxime (as proxetil ) 100 mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AB0-059 | Cephalothin (as sodium salt) 1g + solvent 1% lidocaine hydrochloride | vial | IM Injection |
| NCDS | 05-AB0-063 | Cefdinir 300 mg | tablet or capsule | oral |
| NCDS | 05-AB0-084 | Cefdinir 125 mg/5ml | powder for oral suspension | oral |
| NCDS | 05-AB0-061 | Ceftazidime ( as pentahydrate ) 1g + solvent 1% lidocaine hydrochloride (Carbonate or Arginine formula) | vial | IM Injection |
| NCDS | 05-AB0-065 | Ceftazidime as pentahydrate (Carbonate or Arginine formula) 500mg+ solvent water for injection | vial | injection IM, IV |
| NCDS | 05-AB0-024 | Ceftazidime as pentahydrate (Carbonate or Arginine formula) 1g+solvent water for injection | vial | IV Injection |
| NCDS | 05-AB0-077 | Ceftazidime (as pentahydrate) 500mg +solvent 1% lidocaine hydrochloride (Carbonate or Arginine formula) | vial | IM Injection |
| NCDS | 05-AB0-090 | Avibactam (as Avibactam sodium) 500 mg+Ceftazidime (as Ceftazidime pentahydrate) 2 gram | vial powder for concentrate for solution | IV Infusion |
| NCDS | 05-AB0-091 | Ceftaroline fosamil (as Ceftaroline fosamil acetic acid solvate monohydrate) 600 mg | vial powder for concentrate for solution | IV Infusion |
| NCDS | 05-AB0-072 | Cefditoren (as pivoxil) 200 mg | tablet | oral |
| 5AC | Aminoglycosides | |||
| NCDS | 05-AC0-001 | Amikacin (as sulphate) 250mg/ml | 2ml vial or ampoule | injection IM or slow IV or IV infusion |
| NCDS | 05-AC0-002 | Amikacin (as sulphate) 50mg/ml | 2ml vial or ampoule | injection IM or slow IV or IV infusion |
| NCDS | 05-AC0-003 | Gentamicin (as sulphate) 40mg/ml | 2ml vial or ampoule | injection IM , IV |
| NCDS | 05-AC0-005 | Gentamicin (as sulphate) 10mg/ml | 2ml vial or ampoule | injection IM , IV |
| NCDS | 05-AC0-006 | Neomycin sulphate 500mg | Tablet | oral |
| NCDS | 05-AC0-007 | Netilmicin (as sulphate) 25mg/ml | 2ml vial | injection |
| NCDS | 05-AC0-008 | Netilmicin (as sulphate) 100mg/ml | 1.5ml Vial | injection |
| NCDS | 05-AC0-009 | Tobramycin (as sulphate) 40mg/ml | 2ml vial | injection |
| 5AD | Tetracyclines | |||
| NCDS | 05-AD0-001 | Doxycycline (as Hyclate) 100mg | tablet or Capsule | oral |
| NCDS | 05-AD0-005 | Tetracycline hydrochloride 250mg | Capsule | oral |
| NCDS | 05-AD0-007 | Tetracycline (as pyrrolidinomethyl ) 250mg | Vial | injection |
| NCDS | 05-AD0-008 | Tigecycline 50mg | vial | Injection IV Infusion |
| NCDS | 05-AD0-009 | Doxycycline (as monohydrrate) 100mg | dispersable tablet or tablet | oral |
| NCDS | 05-AD0-011 | Minocycline hydrochloride dihydrate 55 mg | extended realease tablet | oral |
| NCDS | 05-AD0-012 | Minocycline hydrochloride dihydrate 80 mg | extended realease tablet | oral |
| NCDS | 05-AD0-013 | Minocycline hydrochloride dihydrate 105 mg | extended realease tablet | oral |
| 5AE | Chloramphenicol | |||
| NCDS | 05-AE0-004 | Chloramphenicol (as sodum Succinate) 1g | vial | IV Injection |
| 5AF | Sulphonamide and trimethoprim | |||
| NCDS | 05-AF0-001 | Cotrimoxazol 480mg | Tablet | oral |
| NCDS | 05-AF0-002 | Cotrimoxazol 960mg | Tablet | oral |
| NCDS | 05-AF0-003 | Cotrimoxazol 240mg/5ml | Suspension | oral |
| NCDS | 05-AF0-004 | Cotrimoxazol 320mg/ml | 3ml Ampoule | IM Injection |
| NCDS | 05-AF0-005 | Cotrimoxazol 96mg/ml | 5ml Ampoule | Injection IV Infusion |
| NCDS | 05-AF0-006 | Sulphadiazine 500mg | Tablet | oral |
| NCDS | 05-AF0-007 | Trimethoprim 100mg | Tablet | oral |
| NCDS | 05-AF0-008 | Trimethoprim 50mg/5ml | Suspension | oral |
| 5AG | Others | |||
| NCDS | 05-AG0-001 | Aztreonam 500mg vial I.V.& I.M. | vial | injection IM, IV |
| NCDS | 05-AG0-002 | Aztreonam 1g vial I.V.& I.M. | vial | injection IM, IV |
| NCDS | 05-AG0-015 | Meropenem (as trihydrate or anhydrous) 500mg | vial | injection IV,IV infusion |
| NCDS | 05-AG0-059 | Meropenem 1g (as trihydrate or anhydrous) | vial | injection IV,IV infusion |
| NCDS | 05-AG0-076 | Doripenem (as monohydrate) 500 mg | vial | injection I.V infusion |
| NCDS | 05-AG0-039 | Imipenem (as monohydrate or as anhydrous) 500mg + Cilastatin (as sodium salt) 500mg | vial | Injection IV Infusion |
| NCDS | 05-AG0-044 | Teicoplanin 200mg | vial | injection IM , IV , I.V infusion and oral, Intraperitoneal injection |
| NCDS | 05-AG0-070 | Teicoplanin 400mg | vial | injection IM , IV , I.V infusion and oral |
| NCDS | 05-AG0-072 | Daptomycin 500 mg | vial | injection I.V infusion |
| NCDS | 05-AG0-023 | Clindamycin (as hydrochloride) 150mg | Capsule | oral |
| NCDS | 05-AG0-024 | Clindamycin (as palmitate hydrochloride ) 75mg/5ml | Suspension | oral |
| NCDS | 05-AG0-025 | Clindamycin (as phosphate) 150mg/ml | 2ml Ampoule or vial | injection IM, IV |
| NCDS | 05-AG0-026 | Clindamycin (as phosphate) 150mg/ml | 4ml Ampoule or vial | injection IM, IV |
| NCDS | 05-AG0-028 | Erythromycin (as ethyl succinate) 100mg/2.5ml | Drop | oral |
| NCDS | 05-AG0-029 | Erythromycin (as ethyl succinate) 250mg | Enteric Coated Tablet | oral |
| NCDS | 05-AG0-030 | Erythromycin (as ethyl succinate) 500mg | Enteric Coated Tablet | oral |
| NCDS | 05-AG0-031 | Erythromycin (as stearate) 250mg | Film Coated Tablet | oral |
| NCDS | 05-AG0-032 | Erythromycin (as stearate) 500mg | Film Coated Tablet | oral |
| NCDS | 05-AG0-033 | Erythromycin ( as ethyl succinate) 250mg | Capsule | oral |
| NCDS | 05-AG0-034 | Erythromycin ( as ethyl succinate) 500mg | capsule or Scored Tablet | oral |
| NCDS | 05-AG0-036 | Erythromycin (as ethyl succinate) 125mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AG0-037 | Erythromycin (as ethyl succinate ) 250mg/5ml | powder for oral Suspension | oral |
| NCDS | 05-AG0-038 | Erythromycin (as Lactobionate) eq. 1g erythromycin | vial | Injection IV Infusion after dilution |
| NCDS | 05-AG0-041 | Roxithromycin 150mg | Tablet | oral |
| NCDS | 05-AG0-042 | Roxithromycin 300mg | Tablet | oral |
| NCDS | 05-AG0-052 | Azithromycin (as dihydrate)or (as monohydrate) eq. base anhydrous Azithromycin 250mg | tablet or capsule | oral |
| NCDS | 05-AG0-049 | Azithromycin (as dihydrate)or ( as monohydrate) eq. base anhydrous 500 mg | tablet or capsule | oral |
| NCDS | 05-AG0-050 | Azithromycin (as dihydrate ) or ( as monohydrate) or base(anhydrous) 200mg/5ml | (15ml or 22.5ml or30ml) powder for oral suspention | oral |
| NCDS | 05-AG0-053 | Azithromycin (as dihydrate) or (as monohydrate)orbase(anhydrous) 100mg | kid Tablet | oral |
| NCDS | 05-AG0-064 | Clarithromycin 125 mg/5ml | suspension (70ml) or (100ml) | oral |
| NCDS | 05-AG0-068 | Clarithromycin 250 mg/ 5ml | suspension (70ml) or (100ml) | oral |
| NCDS | 05-AG0-021 | Clarithromycin 250mg | Tablet | oral |
| NCDS | 05-AG0-022 | Clarithromycin 500mg | Tablet | oral |
| NCDS | 05-AG0-071 | Clarithromycin Extended Release 500 mg | tablet | oral |
| NCDS | 05-AG0-051 | Ciprofloxacin (as lactate or as Hydrochloride) 2mg/ml in 0.9% normal saline | 100 ml container | Injection IV Infusion |
| NCDS | 05-AG0-056 | Ciprofloxacin (as lactate or as Hydrochloride) 2mg/ml in 5% dextrose | 100 ml container | Injection IV Infusion |
| NCDS | 05-AG0-057 | Ciprofloxacin (as lactate as orHydrochloride) 2mg/ml in 5% dextrose | 200 ml container | Injection IV Infusion |
| NCDS | 05-AG0-054 | Ciprofloxacin (as base or as Hydrochloride)10mg /1ml (1%) | 20ml Vial | Injection IV |
| NCDS | 05-AG0-055 | Ciprofloxacin (as base or as Hydrochloride) 10mg /1ml (1%) | 40ml Vial | Injection IV |
| NCDS | 05-AG0-078 | Ciprofloxacin 1000 mg | sustained release tablet or sustained release capsule | oral |
| NCDS | 05-AG0-004 | Ciprofloxacin (as Hydrochloride or as Hydrochloride monohydrate ) 250mg | Tablet | oral |
| NCDS | 05-AG0-005 | Ciprofloxacin (as Hydrochloride or as Hydrochloride monohydrate ) 500mg | Tablet | oral |
| NCDS | 05-AG0-006 | Ciprofloxacin (as Hydrochloride or as Hydrochloride monohydrate ) 750mg | Tablet | oral |
| NCDS | 05-AG0-011 | Levofloxacin ( as hemihydrate ) 250mg | Scored Tablet | oral |
| NCDS | 05-AG0-012 | Levofloxacin ( as hemihydrate ) 500mg | Scored Tablet | oral |
| NCDS | 05-AG0-084 | Levofloxacin ( as hemihydrate ) 100mg | Tablet | oral |
| NCDS | 05-AG0-081 | Levofloxacin ( as hemihydrate ) 750mg | Tablet | oral |
| NCDS | 05-AG0-013 | Levofloxacin Hemihydrate 5.12 mg (eq. Levofloxacin 5 mg/ ml | 100 ml-vial or pouch \ bag | injection IV Infusion within 1hr |
| NCDS | 05-AG0-018 | Ofloxacin 200mg | Scored Tablet | oral |
| NCDS | 05-AG0-019 | Ofloxacin 400mg | Tablet | oral |
| NCDS | 05-AG0-020 | Ofloxacin (as hydrochloride) 2mg/ml | 100ml bottle | injection IV Infusion |
| NCDS | 05-AG0-074 | Gemifloxacin (as mesylate) 320 mg | tablet | oral |
| NCDS | 05-AG0-075 | Moxifloxacin (as hydrochloride) 400 mg | tablet | oral |
| NCDS | 05-AG0-077 | Moxifloxacin (as Moxifloxacin hydrochloride) 1.6 mg/ 1ml (400mg/250ml ) | 250ml vial solution | IV infusion |
| NCDS | 05-AG0-040 | Norfloxacin 400mg | Tablet | oral |
| NCDS | 05-AG0-043 | Sodium Fusidate 250mg | Tablet | oral |
| NCDS | 05-AG0-062 | Sodium Fusidate 500mg | vial | injection IV Infusion |
| NCDS | 05-AG0-063 | Vancomycin (as hydrochloride) 1g | vial | injection IV Infusion |
| NCDS | 05-AG0-047 | Vancomycin (as hydrochloride) 500mg | vial | injection IV Infusion |
| NCDS | 05-AG0-069 | Vancomycin (as hydrochloride) 125mg | capsule | oral |
| NCDS | 05-AG0-079 | Colistimethate sodium 1000000 IU | vial powder for solution | injection or inhalation |
| NCDS | 05-AG0-080 | Fosfomycin (trometamol) 3g or Fosfomycin base\ 3g sachet | Granules | oral |
| NCDS | 05-AG0-083 | Fosfomycin ( Disodium Fosfomycin ) 4 g / 100 ml solvent | vial | IV injection |
| NCDS | 05-AG0-082 | Tobramycin 300 mg / 5 ml | nebulizer solution in ampoule | inhalation |
| 05-AH | Antitubercular drugs حصر تداوله في المراكز الصحية المعنية(المراكز التخصصية للامراض الصدرية) فقط ومنع تداولها في القطاع الخاص 840 | |||
| NCDS | 05-AH0-001 | Capreomycin (as sulphate) 1g(1g=1milion unit) | Vial | deep IM injection |
| NCDS | 05-AH0-053 | Capreomycin ( as sulphate) 1g (1g=1milion unit) | Vial | IV infusion injection |
| NCDS | 05-AH0-002 | Cycloserine 250mg | Tablet or capsule | oral |
| NCDS | 05-AH0-003 | Ethambutol hydrochloride 400mg | Tablet | oral |
| NCDS | 05-AH0-004 | Ethambutol hydrochloride 500mg | Tablet | oral |
| NCDS | 05-AH0-005 | Ethambutol hydrochloride 300mg+ Isoniazide 100mg | Tablet | oral |
| NCDS | 05-AH0-006 | Ethionamid 250mg | Tablet | oral |
| NCDS | 05-AH0-007 | Isoniazid 50mg | Tablet | oral |
| NCDS | 05-AH0-008 | Isoniazid 100mg | Tablet or dispersible tablet | oral |
| NCDS | 05-AH0-009 | Isoniazid 10mg/ml | Syrup | oral |
| NCDS | 05-AH0-010 | Isoniazid 300mg | Tablet | oral |
| NCDS | 05-AH0-011 | Rifampicin 600mg + Isoniazid 300mg tablet + pyrazinamide 2 gm tablet + Ethambutol 1.5 gm tablet\Kit | tablet or capsule | oral |
| NCDS | 05-AH0-012 | Rifampicin 600mg + Isoniazid 300mg tablet + pyrazinamide 1.5 gm tablet + Ethambutol 1.2 gm tablet\Kit | tablet or capsule | oral |
| NCDS | 05-AH0-013 | Prothionamid 250mg | Tablet | oral |
| NCDS | 05-AH0-074 | Ethionamide 250 mg | Tablet | oral |
| NCDS | 05-AH0-014 | Pyrazinamide 500mg | Tablet | oral |
| NCDS | 05-AH0-015 | Rifampicin 150mg | Capsule | oral |
| NCDS | 05-AH0-016 | Rifampicin 300mg | Capsule | oral |
| NCDS | 05-AH0-017 | Rifampicin 100mg/5ml | Syrup or suspension | oral |
| NCDS | 05-AH0-020 | Rifampicin 300mg+ Isoniazid 150mg | Tablet | oral |
| NCDS | 05-AH0-022 | Rifampicin 300mg | vial | Injection IV |
| NCDS | 05-AH0-023 | Rifampicin 600mg | vial | Injection IV |
| NCDS | 05-AH0-024 | Streptomycin (as sulphate) 500mg | vial | Injection |
| NCDS | 05-AH0-025 | Streptomycin (as sulphate) 750mg | vial | Injection |
| NCDS | 05-AH0-026 | Streptomycin (as sulphate) 1g | vial | Injection |
| NCDS | 05-AH0-027 | Thiacetazone 150mg | Tablet | oral |
| NCDS | 05-AH0-028 | Thiacetazone 150mg + isoniazid 300mg | Tablet | oral |
| NCDS | 05-AH0-031 | Isoniazid 50mg | scored dispersable Tablet | oral |
| NCDS | 05-AH0-032 | Pyrazinamide 350mg | scored dispersable Tablet | oral |
| NCDS | 05-AH0-033 | Rifampicin 100mg + Isoniazid 50mg | scored dispersable or dispersable Tablet | oral |
| NCDS | 05-AH0-034 | Rifampicin 120mg + Isoniazid 60mg uncoated dispersable Tablet + Pyrazinamide 300mg \ Kit | uncoated dispersable Tablet | oral |
| NCDS | 05-AH0-039 | Rifampicin 150mg + Isoniazid 75mg + Ethambutol 275 mg+ pyrazinamide 400 mg\ Kit (RHEZ kit ) | Tablet | oral |
| NCDS | 05-AH0-040 | Rifampicin 150mg + Isoniazid 75mg\ Kit (RH kit) | Tablet | oral |
| NCDS | 05-AH0-042 | Para-amino salicylic acid (PAS) 4gm/ | sachet | oral |
| NCDS | 05-AH0-043 | Pyrazinamide 400mg | Tablet | oral |
| NCDS | 05-AH0-041 | Thiacetazone 50mg | Tablet | oral |
| NCDS | 05-AH0-044 | Rifampicin 60mg + Isoniazid 30mg + Pyrazinamide 150mg | Tablet | oral |
| NCDS | 05-AH0-045 | Rifampicin 60mg + Isoniazid 30mg | Tablet | oral |
| NCDS | 05-AH0-046 | Ethambutol hydrochloride 100mg | film coated tablet or dispersible tablet | oral |
| NCDS | 05-AH0-047 | Rifampicin 150mg + Isoniazid 75mg + Ethambutol hydrochloride 275 mg | 3tablet kit | oral |
| NCDS | 05-AH0-048 | Rifampicin 150mg + Isoniazid 75mg + Ethambutol hydrochloride 275 mg+ pyrazinamide 400 mg | 4 tablet kit | oral |
| NCDS | 05-AH0-049 | Rifampicin 150mg + Isoniazid 75mg | film coated tablet | oral |
| NCDS | 05-AH0-050 | Rifampicin60mg + Isoniazid 30mg + Pyrazinamide 150mg | Uncoated Dispersable tablet | oral |
| NCDS | 05-AH0-051 | Rifampicin 60mg + Isoniazid 30mg | Uncoated Dispersable tablet | oral |
| NCDS | 05-AH0-052 | Rifaximin 200 mg | tablet | oral |
| NCDS | 05-AH0-061 | Rifaximin 550 mg | tablet | oral |
| NCDS | 05-AH0-054 | kanamycin 1gm | vial | injection |
| NCDS | 05-AH0-055 | Gatifloxacin 250mg | tablet | oral |
| NCDS | 05-AH0-056 | Bedaquiline 100mg | tablet | oral |
| NCDS | 05-AH0-072 | Bedaquiline 20 mg | dispersable tablet | oral |
| NCDS | 05-AH0-057 | Delamanide 50mg | tablet | oral |
| NCDS | 05-AH0-060 | Linezolid 600 mg | tablet | oral |
| NCDS | 05-AH0-073 | Linezolid 150mg | dispersable tablet | oral |
| NCDS | 05-AH0-070 | Pretomanid 200mg | tablet | oral |
| NCDS | 05-AH0-071 | Rifapentine 150 mg | tablet | oral |
| 5AI | Anti-leprosy drugs | |||
| NCDS | 05-AI0-001 | Dapsone 50mg | tablet | oral |
| NCDS | 05-AI0-002 | Dapsone 100mg | tablet | oral |
| NCDS | 05-AI0-003 | Clofazimine 100mg | Capsule | oral |
| NCDS | 05-AI0-004 | Thiambutosine 500mg | tablet | oral |
| 5AJ | Drugs for UTI | |||
| NCDS | 05-AJ0-003 | Nitrofurantoin 50mg | Capsule or tablet | oral |
| NCDS | 05-AJ0-005 | Nitrofurantoin 100mg | Capsule | oral |
| NCDS | 05-AJ0-006 | Nitrofurantoin 100mg | Tablet | oral |
| NCDS | 05-AJ0-007 | Nitrofurantoin 100mg | Retard (macrocrystals) Capsule | oral |
| NCDS | 05-AJ0-008 | Nitrofurantoin 25mg/5ml | solution | oral |
| 5B | ANTIVIRAL DRUGS | |||
| NCDS | 05-B00-001 | Acyclovir (as sodium salt) 250mg | Vial | injection IV Infusion |
| NCDS | 05-B00-002 | Acyclovir 200mg | Tablet | oral |
| NCDS | 05-B00-003 | Acyclovir 200mg/5ml | Suspension | oral |
| NCDS | 05-B00-004 | Acyclovir 400mg | Tablet | oral |
| NCDS | 05-B00-005 | Acyclovir 800mg | Tablet | oral |
| NCDS | 05-B00-007 | Ganciclovir 500mg | Vial | injection IV Infusion |
| NCDS | 05-B00-008 | Vidarabine 200mg/ml | Vial 5ml | injection IV |
| NCDS | 05-B00-012 | Foscarnet sodium hexahydrate 24mg/ml | 250ml bottle | injection IV Infusion |
| NCDS | 05-B00-013 | Famciclovir 250mg | Tablet | oral |
| NCDS | 05-B00-014 | Famciclovir 500mg | Tablet | oral |
| NCDS | 05-B00-021 | Ribavirin (Tribavirin) inhalation 6g \ vial | vial | (vial 6 gm for inhalation with erosol inhalation or nebulisation ( via small partical aerosol generator) |
| NCDS | 05-B00-022 | Ribavirin (Tribavirin) 200mg | Capsule | oral |
| NCDS | 05-B00-050 | Ribavirin (Tribavirin) 200mg/5ml | solution 100 ml | oral |
| NCDS | 05-B00-059 | Ribavirin (Tribavirin) 200 mg | tablet or capsule | oral |
| NCDS | 05-B00-031 | Valaciclovir (as hydrochloride) 500mg | Tablet | oral |
| NCDS | 05-B00-032 | Acyclovir 400mg/5ml | Suspension | oral |
| NCDS | 05-B00-046 | Valganciclovir (as hydrochloride) 450 mg | Tablet | oral |
| NCDS | 05-B00-047 | Famciclovir 125mg | Tablet | oral |
| influenza A and B viruses | ||||
| NCDS | 05-B00-049 | Oseltamivir (as phosphate) 45mg | capsule | oral |
| NCDS | 05-B00-037 | Oseltamivir (as phosphate) 75mg | capsule | oral |
| NCDS | 05-B00-036 | zanamivir 5mg/ dose | Dry powder in blister | inhalation with disk haler device |
| NCDS | 05-B00-058 | oseltamivir (as phosphate) for 30 mg /5ml | reconstitution with water for suspension | oral |
| DRUGS FOR RESPIRATORY DISEASES › MONOCLONAL ANTIBODIES › respiratory syncytial virus (RSV) | ||||
| NCDS | 05-B00-052 | Palivizumab 100 mg | vial | injection |
| NCDS | 05-B00-053 | Palivizumab 50 mg | vial | injection |
| Chronic hepatitis B | ||||
| NCDS | 05-B00-055 | Entecavir (as monohydrate) 0.5 mg | tablet | oral |
| NCDS | 05-B00-056 | Entecavir (as monohydrate) 1 mg | tablet | oral |
| NCDS | 05-B00-057 | Entecavir (as monohydrate )50 µg/ml | solution | oral |
| NCDS | 05-B00-071 | Tenofovir alafenamide (as Tenofovir alafenamide fumarate) 25 mg | tablet | oral |
| Chronic hepatitis C infection | ||||
| NCDS | 05-B00-060 | Ombitasvir 12.5mg + paritaprevir75mg + ritonavir 50 mg | tablet or capsule | oral |
| NCDS | 05-B00-061 | Dasabuvir 250 mg | tablet or capsule | oral |
| NCDS | 05-B00-062 | Sofosbuvir 400 mg | tablet or capsule | oral |
| NCDS | 05-B00-063 | Ledipasvir 90mg +Sofosbuvir 400mg | film coated tablet | oral |
| NCDS | 05-B00-064 | Tenofovir disoproxil fumarate 300mg (eq.Tenofovir disoproxil 245mg) | tablet | oral |
| NCDS | 05-B00-066 | Glecaprevir 100mg+Pibrentasvir 40mg | film coated tablet | oral |
| NCDS | 05-B00-067 | Sofosbuvir 400mg+Velpatasvir 100mg | film coated tablet | oral |
| HIV infection (AIDS) | ||||
| NCDS | 05-B00-070 | Zidovudine 60mg+ lamivudine 30mg | dispersible tablet | oral |
| NCDS | 05-B00-069 | Lopinavir 80 + Ritonavir 20mg/ml | syrup | oral |
| NCDS | 05-B00-068 | Tenofovir disoproxil fumarate 300mg + Lamivudine 300mg+Dolutegravir 50mg | tablet | oral |
| NCDS | 05-B00-026 | Zidovudine 50mg / 5ml | Solution | oral |
| NCDS | 05-B00-051 | Lopinavir 200 mg+ Ritonavir 50 mg | tablet | oral |
| NCDS | 05-B00-054 | Lopinavir 100 mg+ Ritonavir 25 mg | tablet | oral |
| NCDS | 05-B00-045 | Lamivudine 50mg/5ml oral | Solution | oral |
| NCDS | 05-B00-078 | Darunavir (DRV) 600 mg +ritonavir (RTV) 100 mg | single tablet | oral |
| NCDS | 05-B00-077 | Dolutegravir 50 mg | Tablet | oral |
| NCDS | 05-B00-076 | Atazanavir 300 mg + Ritonavir 100mg | single tablet | oral |
| NCDS | 05-B00-075 | Tenofovir 300mg + Lamivudine 300 mg(TDF/3TC) | single tablet | oral |
| NCDS | 05-B00-079 | Abacavir 120 mg (ABC/3TC)+ Lamivudine 60mg (FDC) | Dispersible tablet | oral |
| NCDS | 05-B00-080 | Dolutegravir 10 mg | Dispersible tablet | oral |
| NCDS | 05-B00-039 | Lamivudine 150mg +Zidovudine 300mg | Tablet | oral |
| NCDS | 05-B00-040 | Efavirenz (EFZ)600mg | Tablet or capsule | oral |
| NCDS | 05-B00-065 | Efavirenz 600 mg + emtricitabin 200 mg + tenofovir dispoproxil ( as tenofovir dispoproxil fumarate ) 245 mg | tablet | oral |
| NCDS | 05-B00-016 | Lamivudine (3TC) 150mg | Tablet | oral |
| NCDS | 05-B00-017 | Lamivudine 100mg | Tablet | oral |
| NCDS | 05-B00-018 | Lamivudine 25mg/5ml | solution | oral |
| NCDS | 05-B00-015 | Indinavir (as sulphate) 400mg | Capsule | oral |
| NCDS | 05-B00-019 | Stavudine (d4t) 15mg | Capsule | oral |
| NCDS | 05-B00-020 | Stavudine (d4T) 20mg | Capsule | oral |
| NCDS | 05-B00-043 | Nevirapine 200mg | Tablet | oral |
| NCDS | 05-B00-023 | Zalcitabine (Dideoxycytidine,DDC) 375mcg | Tablet | oral |
| NCDS | 05-B00-024 | Zalcitabine (Dideoxycytidine,DDC) 750mcg | Tablet | oral |
| NCDS | 05-B00-009 | Didanosine (Dideoxyinosine,DDI) 25mg | Tablet | oral |
| NCDS | 05-B00-010 | Didanosine (Dideoxyinosine,DDI) 100mg | Tablet | oral |
| NCDS | 05-B00-011 | Didanosine (Dideoxyinosine,DDI) 150mg | Tablet | oral |
| NCDS | 05-B00-035 | Didanosine (Dideoxyinosine,DDI) 100mg | Chewable Tablet | oral |
| 5C | ANTIFUNGAL DRUGS | |||
| NCDS | 05-C00-001 | Amphotericin 50mg | Vial | injection IV Infusion |
| NCDS | 05-C00-002 | Amphotericin B 10mg | Lozenges | oral |
| NCDS | 05-C00-003 | Amphotericin 100mg | Tablet | oral |
| NCDS | 05-C00-004 | Griseofulvin 125mg/5ml | Suspension | oral |
| NCDS | 05-C00-005 | Griseofulvin 125mg | Tablet | oral |
| NCDS | 05-C00-006 | Griseofulvin 500mg | Tablet | oral |
| NCDS | 05-C00-007 | Itraconazole 100mg | Capsule | oral |
| NCDS | 05-C00-010 | Miconazole 250 mg | Tablet | oral |
| NCDS | 05-C00-042 | Miconazole nitrate B.P 0.3g in aerosol propellant/canister | SPRAY | topical |
| NCDS | 05-C00-043 | Miconazole nitrate 20mg/1g | powder | topical |
| NCDS | 05-C00-012 | Nystatin 500000 IU | Tablet | oral |
| NCDS | 05-C00-013 | Nystatin 100000 IU/ml | Suspension(30 ml ) | oral |
| NCDS | 05-C00-014 | Nystatin 100000 IU | Pastilles | oral |
| NCDS | 05-C00-015 | Fluconazole 50mg | Capsule or film coated tablet or plain tablet | oral |
| NCDS | 05-C00-018 | Fluconazole 100mg | Scored Tablet or plain Tablet | oral |
| NCDS | 05-C00-019 | Fluconazole 150mg | Capsule or film coated tablet or plain tablet | oral |
| NCDS | 05-C00-022 | Fluconazole 200mg | Capsule or film coated tablet or plain tablet | oral |
| NCDS | 05-C00-025 | Fluconazole 50mg/5ml | Suspension | oral |
| NCDS | 05-C00-026 | Fluconazole 200mg / 5ml | Suspension | oral |
| NCDS | 05-C00-027 | Fluconazole 2mg /ml in Normal Saline 0.9% (Electrolyte Na+ 15mmol/100ml bottle.) | 25ml bottle | injection IV Infusion |
| NCDS | 05-C00-028 | Fluconazole 2mg /ml in Normal Saline 0.9% (Electrolyte Na+ 15mmol/100ml bottle.) | 100ml bottle | injection IV Infusion |
| NCDS | 05-C00-029 | Terbinafine (as hydrochloride) 125mg | Tablet | oral |
| NCDS | 05-C00-030 | Terbinafine(as hydrochloride) 250mg | Tablet | oral |
| NCDS | 05-C00-032 | Caspofungin (as acetate ) 50mg | Vial powder for reconstitution | injection IV Infusion |
| NCDS | 05-C00-044 | Caspofungin (as acetate ) 70mg | Vial powder for concentration for solution | IV Infusion |
| NCDS | 05-C00-033 | voriconazole 200 mg | Tablet | oral |
| NCDS | 05-C00-034 | voriconazole 50 mg | Tablet | oral |
| NCDS | 05-C00-035 | voriconazole 200 mg powder for soution for infusion eqivalent to 10 mg/ml when reconstituted as recommended | vial | injection IV Infusion |
| NCDS | 05-C00-045 | Anidulafungin 100 mg powder for concentrate for solution | vial | IV infusion |
| NCDS | 05-C00-036 | Amphotericin lipid complex 100mg | vial | injection IV Infusion |
| NCDS | 05-C00-041 | Liposomal Amphotericin B 50 mg | vial | injection IV Infusion |
| NCDS | 05-C00-039 | Micafungin (as sodium) 50mg | vial | injection IV Infusion |
| NCDS | 05-C00-040 | posaconazole 40mg/ml | Suspension | oral |
| 5D | ANTIPROTOZAL DRUGS | |||
| NCDS | 05-D00-001 | Chloroquine phosphate 250 mg (eq.Chloroquine base 150mg) | Tablet | oral |
| NCDS | 05-D00-003 | Chloroquine sulphate 68mg/5ml (eq.Chloroquine base 50mg/5ml) | Syrup | oral |
| NCDS | 05-D00-039 | Chloroquine sulphate 54.5mg/ml (eq. Chloroquine base 40mg/ml | 5ml Ampoule | injection |
| NCDS | 05-D00-005 | Diloxanide furoate 500mg | Tablet | oral |
| NCDS | 05-D00-008 | Hydroxychloroquine sulphate 200mg | Tablet | oral |
| NCDS | 05-D00-009 | Metronidazole 200mg | coated Tablet | oral |
| NCDS | 05-D00-010 | Metronidazole 250mg | coated Tablet | oral |
| NCDS | 05-D00-011 | Metronidazole 400mg | coated Tablet | oral |
| NCDS | 05-D00-012 | Metronidazole 500mg | coated Tablet | oral |
| NCDS | 05-D00-013 | Metronidazole 5mg/ml ( 0.5%) | (100ml) Vial | injection IV Infusion |
| NCDS | 05-D00-014 | Metronidazole(as benzoate)200mg/5ml | Suspension | oral |
| NCDS | 05-D00-017 | Nimorazole 250mg | Tablet | oral |
| NCDS | 05-D00-037 | Ornidazole 500mg | Tablet | oral |
| NCDS | 05-D00-028 | Tinidazole 500mg | Tablet | oral |
| NCDS | 05-D00-018 | Primaquine (as phosphate ) 15mg | Tablet | oral |
| NCDS | 05-D00-019 | Proguanil hydrochloride 100mg | Tablet | oral |
| NCDS | 05-D00-020 | Pyrimethamine 25mg | Tablet | oral |
| NCDS | 05-D00-021 | Pyrimethamine 25mg + sulphadoxine 500mg | Tablet | oral |
| NCDS | 05-D00-024 | Spiramycin 1500000 IU (eq. 468.75mg) or Spiramycin 1600000 IU (eq. 500mg) | Tablet | oral |
| NCDS | 05-D00-026 | Spiramycin 3000000 IU | Tablet | oral |
| NCDS | 05-D00-045 | Spiramycin 1.5 M.I.U . + 250 mg Metronidazole | Tablet | oral |
| NCDS | 05-D00-030 | Pentamidine isetionate 300mg | Vial powder | injection IV Infusion |
| NCDS | 05-D00-031 | Pentamidine isethionate300mg | bottle nebuliser solution | inhalation |
| NCDS | 05-D00-038 | Mefloquine hydrochloride 275 mg eq. to Mefloquine 250 mg | tablet or Lactab | oral |
| NCDS | 05-D00-040 | Quinine di-hydrochloride 300mg/ ml | 2ml Ampoule | injection |
| NCDS | 05-D00-042 | Quinine sulphate 200mg | tablet | oral |
| NCDS | 05-D00-043 | Artemether 20 mg +Lumefantrine 120 | tablet | oral |
| leishmaniasis | ||||
| NCDS | 05-D00-023 | Sodium stibogluconate ( eq. Pentavalant antimony 100mg/ml or sodium antimony gluconate 100mg/ml (is the same sodium stibogluconate which is approved previously ) | 100ml Vial | injection |
| NCDS | 05-D00-029 | meglumine antimoniate 1.5g Corresponding amount of antimony 0.4050g/5ml | 5ml Ampoule | IM injection |
| NCDS | 05-D00-044 | paromomycin 15%+ methylbenzethonium chloride 12% | ointment | topical |
| 5E | ANTIHELMINTHIC DRUGS | |||
| NCDS | 05-E00-001 | Albendazole 200mg | chewable or plain Tablet | oral |
| NCDS | 05-E00-002 | Albendazole 100mg/5ml | Suspension | oral |
| NCDS | 05-E00-003 | Levamisole 40mg or Levamisole( as hydrochloride) 50mg | Tablet | oral |
| NCDS | 05-E00-005 | Levamisole 40-50mg/5ml | Syrup | oral |
| NCDS | 05-E00-006 | Mebendazole 100mg | plain or chewable Tablet | oral |
| NCDS | 05-E00-015 | Mebendazole 500mg | Tablet | oral |
| NCDS | 05-E00-007 | Mebendazole 100mg/5ml | Suspension | oral |
| NCDS | 05-E00-008 | Niclosamide 500mg | chewable Tablet | oral |
| NCDS | 05-E00-009 | Piperazine (as citrate ) 750mg/5ml | Elixir | oral |
| NCDS | 05-E00-010 | Praziquantel 600mg | Tablet | oral |
| NCDS | 05-E00-011 | Pyrvinium pamoate 50mg base/5ml | Suspension | oral |
| NCDS | 05-E00-012 | Albendazole 200mg/5ml | 10ml Suspension | oral |
| NCDS | 05-E00-013 | Albendazole 400mg | Tablet or chewable tablet | oral |
| NCDS | 05-E00-014 | Triclabendazole 250mg | Tablet | oral |
| NCDS | 05-e00-016 | Ivermectin 3 mg | Tablet | oral |
| 6 | DRUGS FOR ENDOCRINE AND METABOLIC DISORDERS | |||
| 6A | DRUGS USED IN DIABETES | |||
| 6AA | Insulins (human) | |||
| NCDS | 06-AA0-002 | insulin Human (soluble,regular) (rDNA) 100 IU\ml (eq. 3.5mg) | 10ml vial | injection SC. or IV |
| NCDS | 06-AA0-023 | insulin Human (soluble,regular) (rDNA) 100 IU\ml (eq. 3.5mg) SC. or IV | prefilled pen | injection SC. or IV |
| NCDS | 06-AA0-003 | insulin Human suspention (rDNA) as( 30% soluble+70% isophane ) 100IU\ml (3.5mg) | 10ml vial | injection SC |
| NCDS | 06-AA0-025 | insulin Human suspention (rDNA) as( 30% soluble+70% isophane ) 100iu\ml (eq. 3.5mg) | 3ml cartridge or prefilled pen | injection SC |
| NCDS | 06-AA0-006 | insulin Human (soluble,regular) (rDNA) 100 IU\ml (eq. 3.5mg) | prefilled Syringe | injection SC. or IV |
| NCDS | 06-AA0-005 | insulin Human suspention (rDNA) as( 30% soluble+70% isophane ) 100iu\ml (eq. 3.5mg) | prefilled Syringe | injection SC |
| NCDS | 06-AA0-001 | insulin Human (rDNA) ( isophane ,NPH) suspention 100IU\ml( (eq. 3.5mg) | 10ml vial | injection SC |
| NCDS | 06-AA0-009 | insulin Human (soluble,regular) (rDNA) 100 IU\ml (eq. 3.5mg) | 3ml cartridge | injection SC. or IV |
| NCDS | 06-AA0-010 | insulin Human (rDNA) ( isophane,NPH) suspention 100IU\ml (eq. 3.5mg) | 3ml prefilled pen | injection SC |
| NCDS | 06-AA0-012 | insulin Human (rDNA) isophane (NPH)suspention 100IU\ml (eq. 3.5mg) | 3ml cartridge | injection SC |
| NCDS | 06-AA0-013 | Insulin rapitard (mixture of 25% soluble porcine Insulin and 75% bovine Insulin crystals.) 100 IU/ml | Penfill | injection |
| NCDS | 06-AA0-014 | insulin aspart suspention (rDNA) as(Soluble insulin aspart 30% + insulin aspart crystallized with protamine 70%) contain 100IU\ml (eq. 3.5mg) | 3ml cartridge and 3ml PreFilled pen | injection SC |
| NCDS | 06-AA0-015 | insulin aspart (r-DNA) 100IU\ml (eq. 3.5 mg) | preFilled pen or 3ml cartidge solution | injection SC. or IV |
| NCDS | 06-AA0-018 | insulin lispro (r-DNA) 100IU\ml | solution 10ml vial | injection SC. or IV |
| NCDS | 06-AA0-024 | insulin lispro (r-DNA) 100IU \ml | 3ml preFilled pen or 3ml cartidge solution | injection SC. or IV |
| NCDS | 06-AA0-020 | Insulin Lispro (r-DNA) suspension Biphasic as (25% Insulin lispro+75% Insulin lispro protamine suspension) 100IU/ml | 3ml cartidge or prefilled pen or 10ml vial | injection SC |
| NCDS | 06-AA0-021 | Insulin Lispro (r-DNA) suspension as(insulin lispro solution50%+insulin lispro protamine suspension50%) 100IU/ml (eq.3.5mg) | 3ml cartidge or prefilled pen or 10ml vial | injection SC |
| NCDS | 06-AA0-019 | insulin Human(rDNA) suspention as( 50% soluble+50% isophane ) 100IU\ml (eq. 3.5mg) | vial | injection SC |
| NCDS | 06-AA0-022 | Insluin glargine (r-DNA) 100iU\ml (eq. 3.64mg ) | solution 3ml preFilled pen | injection SC |
| NCDS | 06-AA0-031 | Basaglar Kwikpen :Insluin glargine (r-DNA) 100IU\ml (eq.3.64mg) | solution 3ml preFilled pen | injection SC |
| NCDS | 06-AA0-035 | BASALOG One: INSULIN Glargine (rDNA) 100 IU/ml | solution3ml preFilled pen | injection SC |
| NCDS | 06-AA0-016 | Insluin glargine (r-DNA) 100IU\ml (eq. 3.64mg ) | solution 10ml vial | injection SC |
| NCDS | 06-AA0-027 | insulin glargine (r-DNA) 300IU\ml | solution 1.5ml preFilled pen | injection SC |
| NCDS | 06-AA0-033 | insulin glargine (r-DNA)100 units + Lixisenatide 50 mcg\ml | solution 3ml preFilled pen | injection SC |
| NCDS | 06-AA0-034 | insulin glargine (r-DNA)100 units + Lixisenatide33mcg\ml | solution 3ml preFilled pen | injection SC |
| NCDS | 06-AA0-028 | Insluin degludec (r-DNA) 100IU\ml | solution 3ml prefilled pen or 3ml cartridge | injection SC |
| NCDS | 06-AA0-029 | Insluin degludec (r-DNA) 200IU\ml | solution 3ml prefilled pen or 3ml cartridge | injection SC |
| NCDS | 06-AA0-030 | insulin degludec 70% + 30% insulin asprat (eq to 2.56mg\1.05mg)solution 100IU\ml | 3ml cartridge or prefilled pen | injection SC |
| NCDS | 06-AA0-032 | insulin degludec 100IU+3.6 mg liraglutide\ ml | solution 3ml prefilled pen | injection SC |
| NCDS | 06-AA0-017 | insulin Detemir (r-DNA) 100IU\ml (eq.14.2 mg) | solution 3ml preFilled pen or 3ml cartidge | injection SC |
| NCDS | 06-AA0-026 | Insluin Glulisine (r-DNA) 100IU\ml | solution 3ml preFilled pen | injection SC |
| 6AB | hypoglycaemic agents | |||
| NCDS | 06-AB0-001 | Acarbose 50mg | Tablet | oral |
| NCDS | 06-AB0-002 | Acarbose 100mg | Tablet | oral |
| NCDS | 06-AB0-007 | Chlorpropamide 250mg | Tablet | oral |
| NCDS | 06-AB0-008 | Glibenclamide 5mg | Tablet | oral |
| NCDS | 06-AB0-009 | Glimepiride 1mg | Tablet | oral |
| NCDS | 06-AB0-010 | Glimepiride 2mg | Tablet | oral |
| NCDS | 06-AB0-025 | Glimepiride 3mg | Tablet | oral |
| NCDS | 06-AB0-026 | Glimepiride 4mg | Tablet | oral |
| NCDS | 06-AB0-012 | Gliclazide 80mg | Tablet | oral |
| NCDS | 06-AB0-043 | Gliclazide 60 mg | modified release Tablet | oral |
| NCDS | 06-AB0-013 | Glipizide 5mg | Tablet | oral |
| NCDS | 06-AB0-014 | Metformin hydrochloride 500mg | Tablet | oral |
| NCDS | 06-AB0-015 | Metformin hydrochloride 850mg | Retard Tablet | oral |
| NCDS | 06-AB0-022 | Metformin hydrochloride 850mg | Tablet | oral |
| NCDS | 06-AB0-041 | Metformin hydrochloride 500 mg | extended release or sustained release tablet | oral |
| NCDS | 06-AB0-042 | Metformin hydrochloride 1000 mg | extended release or sustained release tablet | oral |
| NCDS | 06-AB0-019 | Metformin hydrochloride 1000mg | Tablet | oral |
| NCDS | 06-AB0-051 | Metformin hydrochloride 750 mg | extended release tablet | oral |
| NCDS | 06-AB0-020 | Metformin hydrochloride 500mg + Glibenclamide 2.5mg | Tablet | oral |
| NCDS | 06-AB0-052 | Metformin hydrochloride 1000 mg + Glibenclamide 5mg | Tablet | oral |
| NCDS | 06-AB0-033 | Metformin hydrochloride 500mg + Glibenclamide 5mg | Tablet | oral |
| NCDS | 06-AB0-063 | Glimepiride 2 mg + Metformin hydrochloride 500 mg | Tablet | oral |
| NCDS | 06-AB0-016 | Nateglinide 60mg | Tablet | oral |
| NCDS | 06-AB0-017 | Nateglinide 120mg | Tablet | oral |
| NCDS | 06-AB0-023 | Repaglinide 2mg | Tablet | oral |
| NCDS | 06-AB0-011 | Repaglinide 1mg | Tablet | oral |
| NCDS | 06-AB0-034 | Linagliptin 5 mg | Tablet | oral |
| NCDS | 06-AB0-035 | Linagliptin 2. 5 mg + Metformin hydrochloride 850mg | Tablet | oral |
| NCDS | 06-AB0-082 | Linagliptin 2. 5 mg + Metformin hydrochloride 1000 mg tablet | Tablet | oral |
| NCDS | 06-AB0-038 | Vildagliptin 50 mg | Tablet | oral |
| NCDS | 06-AB0-039 | Vildagliptin 50 mg + metformin hydrochloride 1000 mg | Tablet | oral |
| NCDS | 06-AB0-040 | Vildagliptin 50 mg + metformin hydrochloride 850 mg | Tablet | oral |
| NCDS | 06-AB0-029 | Sitagliptin (as phosphate monohydrate or hydrochloride monohydrate or anhydrous) 50mg+metformin hydrochloride 500mg | Tablet | oral |
| NCDS | 06-AB0-030 | Sitagliptin (as phosphate monohydrate or hydrochloride monohydrate or anhydrous) 50mg+metformin hydrochloride 1000mg | Tablet or modified release tablet | oral |
| NCDS | 06-AB0-024 | Sitagliptin (as phosphate monohydrate or hydrochloride monohydrate )100mg | film coated Tablet | oral |
| NCDS | 06-AB0-080 | Sitagliptin (as phosphate monohydrate or hydrochloride monohydrate ) 50mg | film coated Tablet | oral |
| NCDS | 06-AB0-091 | Sitagliptin (as hydrochloride monohydrate )50 mg + Metformin hydrochloride 850 mg | Tablet | oral |
| NCDS | 06-AB0-085 | Sitagliptin ( as hydrochloride monohydrate or as phosphate monohydrate ) 100 mg +metformin hydrochloride 1000mg | modified release tablet | oral |
| NCDS | 06-AB0-089 | Alogliptin benzoate 34 mg eq. to 25mg alogliptin + 16.53 mg pioglitazone hydrochloride eq. to 15mg pioglitazone tablet | Tablet | oral |
| NCDS | 06-AB0-090 | Alogliptin benzoate 34 mg eq. to 25mg alogliptin + 33.06 mg pioglitazone hydrochloride eq. 30mg pioglitazone | Tablet | oral |
| NCDS | 06-AB0-031 | Saxagliptin (as hydrochloride ) 2.5mg | tablet | oral |
| NCDS | 06-AB0-032 | Saxagliptin (as hydrochloride ) 5mg | tablet | oral |
| NCDS | 06-AB0-036 | Saxagliptin (as hydrochloride ) 5mg + Metformin hydrochloride 500 mg | Extended release tablet | oral |
| NCDS | 06-AB0-037 | Saxagliptin (as hydrochloride ) 5mg + Metformin hydrochloride 1000 mg | Extended release tablet | oral |
| NCDS | 06-AB0-044 | Saxagliptin (as hydrochloride ) 2.5mg + Metformin hydrochloride 1000 mg | Extended release tablet | oral |
| NCDS | 06-AB0-073 | saxagliptin (as hydrochloride ) 5mg + dapagliflozin 10 mg (as propanediol ) | film coated tablet | oral |
| NCDS | 06-AB0-045 | Dapagliflozin ( as propanediol monohydrate or as base ) 5 mg | tablet | oral |
| NCDS | 06-AB0-046 | Dapagliflozin ( as propanediol monohydrate or as base ) 10 mg | tablet | oral |
| NCDS | 06-AB0-067 | Dapagliflozin (as propanediol ) or base 5 mg + Metformin hydrochloride 500 mg | Extended release Tablet | oral |
| NCDS | 06-AB0-068 | Dapagliflozin ( as propanediol monohydrate) or as base 5 mg + Metformin hydrochloride 1000 mg | Extended release Tablet | oral |
| NCDS | 06-AB0-069 | Dapagliflozin ( as propanediol ) 10 mg + Metformin hydrochloride 500 mg | Extended release Tablet | oral |
| NCDS | 06-AB0-070 | Dapagliflozin ( as propanediol monohydrate) 10 mg+ Metformin hydrochloride 1000 mg | Extended release Tablet | oral |
| NCDS | 06-AB0-047 | Empagliflozin 10 mg | tablet | oral |
| NCDS | 06-AB0-048 | Empagliflozin 25 mg | tablet | oral |
| NCDS | 06-AB0-064 | Pioglitazone (as hydrochloride ) 30 mg | tablet | oral |
| NCDS | 06-AB0-049 | Pioglitazone (as hydrochloride ) 15 mg | tablet | oral |
| NCDS | 06-AB0-050 | pioglitazone (as hydrochloride ) 15mg +metformin hydrochloride 850mg | film coated tablet | oral |
| NCDS | 06-AB0-074 | Pioglitazone (as hydrochloride) 15 mg +Metformin hydrochloride 500 mg | film coated tablet | oral |
| NCDS | 06-AB0-071 | Pioglitazone (as hydrochloride ) 30 mg +Glimepiride 2 mg | tablet | oral |
| NCDS | 06-AB0-072 | Pioglitazone (as hydrochloride) 30 mg + Glimepiride 4 mg | tablet | oral |
| NCDS | 06-AB0-053 | Ertugliflozin 5mg | film coated tablet | oral |
| NCDS | 06-AB0-054 | Ertugliflozin 15mg | film coated tablet | oral |
| NCDS | 06-AB0-055 | Ertugliflozin 5mg+Sitagliptin (as phosphate monohydrate) 100mg | film coated tablet | oral |
| NCDS | 06-AB0-056 | Ertugliflozin15mg+ Sitagliptin (as phosphate monohydrate) 100mg | film coated tablet | oral |
| NCDS | 06-AB0-057 | Ertugliflozin 2.5mg+metformin hydrochloride 1000mg | film coated tablet | oral |
| NCDS | 06-AB0-058 | Ertugliflozin 7.5mg+metformin hydrochloride 1000mg | film coated tablet | oral |
| NCDS | 06-AB0-059 | Empagliflozin 5mg+ Metformin hydrochloride 850mg | film coated tablet | oral |
| NCDS | 06-AB0-060 | Empagliflozin 5mg+ Metformin hydrochloride 1000mg | film coated tablet | oral |
| NCDS | 06-AB0-061 | Empagliflozin 12.5mg+Metformin hydrochloride 850mg | film coated tablet | oral |
| NCDS | 06-AB0-062 | Empagliflozin 12.5 + Metformin hydrochloride 1000mg | film coated tablet or Extended release tablet | oral |
| NCDS | 06-AB0-065 | Empagliflozin 10 mg +Linagliptin 5 mg | film coated tablet | oral |
| NCDS | 06-AB0-066 | Empagliflozin 25 mg+ Linagliptin 5 mg | film coated tablet | oral |
| NCDS | 06-AB0-086 | Empagliflozin 12.5 mg + Linagliptin 2.5 mg + Metformin hydrochloride 1000 mg | extended release tablet | oral |
| NCDS | 06-AB0-087 | Empagliflozin 10 mg + Linagliptin 5 mg + Metformin hydrochloride 1000 mg | extended release tablet | oral |
| NCDS | 06-AB0-088 | Empagliflozin 25 mg + Linagliptin 5 mg + Metformin hydrochloride 1000 mg | extended release tablet | oral |
| NCDS | 06-AB0-083 | Empagliflozin 25mg + Metformin hydrochloride 1000mg | extended release tablet | oral |
| NCDS | 06-AB0-084 | Empagliflozin 10mg + Metformin hydrochloride 1000mg | extended release tablet | oral |
| NCDS | 06-AB0-028 | Liraglutide 6 mg\ml (Note:pen able to deliver upto 0.6mg upto 1.8 mg ) | pen | SC injection |
| NCDS | 04-EA0-003 | Dulaglutide 1.5 mg / 0.5ml | pre-filled pen | SC injection |
| NCDS | 04-EA0-011 | Dulaglutide 0.75 mg / 0.5ml | pre-filled pen | SC injection |
| NCDS | 04-EA0-007 | Dulaglutide 3 mg/ 0.5 ml (6 mg/1 ml) | solution prefilled pen | injection SC |
| NCDS | 04-EA0-004 | Semaglutide 1.34 mg / ml ( each dose 1mg/0.74 ml ) | solution Prefilled pen | injection SC |
| NCDS | 04-EA0-005 | Semaglutide 1.34 mg / ml (each dose 0.5 mg\0.37 ml) | solution Prefilled pen | injection SC |
| NCDS | 04-EA0-006 | Semaglutide 1.34 mg / ml (each dose 0.25 mg\0.19 ml) | solution Prefilled pen | injection SC |
| NCDS | 06-AB0-018 | Tolbutamide(as sodium) 1g | vial | injection |
| 6B | TREATMENT OF HYPOGLYCAEMIA | |||
| NCDS | 01-E00-007 | Diazoxide 50mg | Tablet | oral |
| NCDS | 06-B00-001 | Glucagon 1mg (eq. 1 I.U as hydrochloride Biosynthetic )/ml with solvent | Vial | injection IV IM SC |
| NCDS | 06-B00-002 | Glucagon 1mg (eq. 1 I.U as hydrochloride Biosynthetic )/ml + syring of 1ml water for injection(in kit) | Vial | injection IM SC |
| 6C | HYPOTHALAMIC AND PITUITARY HORMONES | |||
| NCDS | 06-C00-021 | Choriogonadotropin alfa( Recombinant human choriogonadotropin alfa,r-hCG ) 250mcg (6500 IU ) | prefilled syringe | injection SC |
| NCDS | 06-C00-003 | higly purified Urinary human chorionic gonadotrophin (HCG) 500 units | Ampoule | injection |
| NCDS | 06-C00-004 | higly purified Urinary human chorionic gonadotrophin (HCG) 1500 units | Ampoule | injection |
| NCDS | 06-C00-053 | higly purified Urinary human chorionic gonadotrophin (HCG) 10000 I.U + 1ml sodium chloride as solvent | vial or ampoule | injection IM SC |
| NCDS | 06-C00-046 | higly purified Urinary human chorionic gonadotrophin (HCG) 5000 IU | vial or ampoule powder + solvent | injection IM SC |
| NCDS | 06-C00-006 | Desmopressin acetate 4 mcg/ml | 1ml Ampoule | injection IV IM SC |
| NCDS | 06-C00-007 | Desmopressin acetate 0.1mg (eq. Desmopressin base 0.089mg(89mcg)/1ml) (10 mcg/dose) | metered Nasal Spray | nasal |
| NCDS | 06-C00-008 | Desmopressin acetate 0.1mg | Tablet | oral |
| NCDS | 06-C00-009 | Desmopressin acetate 0.2mg | Tablet | oral |
| NCDS | 06-C00-028 | Desmopressin (as acetate ) 120 mcg | sublingual Tablet oral lyophilisate tablet | Buccal |
| NCDS | 06-C00-058 | Desmopressin (as acetate ) 60 mcg | sublingual Tablet oral lyophilisate tablet | Buccal |
| NCDS | 06-C00-043 | Desmopressin acetate 150 mcg/dose | metered spray delivering 25 doses | nasal |
| NCDS | 06-C00-018 | Vasopressin (aqueous) 20 units/ml | 1ml Ampoule | injection |
| NCDS | 06-C00-062 | Tolvaptan 15 mg | tablet | oral |
| NCDS | 06-C00-063 | Tolvaptan 30 mg | tablet | oral |
| NCDS | 06-C00-031 | Terlipressin acetate 200 microgram per 1 ml ( 1mg/5ml) | solution vial | injection IV |
| NCDS | 06-C00-042 | Terlipressin acetate 120 microgram per 1 ml ( 1mg/8.5ml) | solution ampoule | IV injection |
| NCDS | 06-C00-015 | Tetracosactide (Tetracosactrin) acetate 1mg\1ml | Solution 1ml ampoule | IV or IM injection |
| NCDS | 06-C00-030 | Tetracosactide (Tetracosactrin) acetate1mg/1ml | 1ml suspension Depot-ampoule | IM injection |
| NCDS | 06-C00-016 | Tetracosactide (Tetracosactrin) acetate 250mcg\1ml | 1ml Solution ampoule | IV IM injection |
| NCDS | 06-C00-017 | Tetracosactide (Tetracosactrin) acetate 0.5mg/1ml | 2ml suspension Depot-ampoule or vial | IM injection |
| NCDS | 06-C00-023 | Somatropin (Recombinant Human Growth Hormone,rhGH) 10mg /1.5ml liquid | prefilled multidose pen or cartridge+pen | injection SC |
| NCDS | 06-C00-024 | Somatropin (Recombinant Human Growth Hormone,rhGH) 15mg /1.5ml liquid | prefilled multidose pen or cartridge+pen | injection SC |
| NCDS | 06-C00-026 | Somatropin (Recombinant Human Growth Hormone,rhGH) 5mg /1.5ml liquid | prefilled multidose pen or cartridge+pen | injection SC |
| NCDS | 06-C00-048 | Omnitrope:Somatropin(Recombinant Human Growth Hormone,rhGH) 10mg /1.5ml liquid | cartridge+pen | injection SC |
| NCDS | 06-C00-057 | Omnitrope:Somatropin (Recombinant Human Growth Hormone,rhGH) 5mg /1.5ml liquid | cartridge+pen | injection SC |
| NCDS | 06-C00-059 | Cinnatropin:Somatropin (Recombinant Human Growth Hormone,rhGH) 5 mg ( 15 IU ) in 1.5 ml solution | prefilled pen | injection SC |
| NCDS | 06-C00-060 | Cinnatropin: Somatropin (Recombinant Human Growth Hormone,rhGH) 10 mg ( 30 IU ) in 1.5 ml solutionin | prefilled pen | injection SC |
| NCDS | 06-C00-027 | Somatropin (rbe) (Recombinant Human Growth Hormone,rhGH) 5.3mg (16 IU) | prefilled multidose pen or cartridge+pen powder +solvent | injection SC |
| NCDS | 06-C00-041 | Somatropin (rbe) (Recombinant Human Growth Hormone,rhGH) 12mg (36 IU) | prefilled multidose pen or cartridge+pen powder +solvent | injection SC |
| NCDS | 06-C00-049 | Somatropin (Recombinant Human Growth Hormone,rhGH) 8mg/ml (12mg\1.5ml ) | multidose cartridge | injection SC |
| NCDS | 06-C00-025 | Somatropin (Recombinant Human Growth Hormone,rhGH) 8mg(24 IU) | vial+cartridage click easy powder +solvent | injection SC |
| NCDS | 06-C00-010 | Somatropin (Recombinant Human Growth Hormone,rhGH) 1.3 – 1.33 mg | Vial or pen | injection |
| NCDS | 06-C00-034 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 300IU (eq.22 mcg) /0.5ml cartridage | prefilled pen | injection SC |
| NCDS | 06-C00-035 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 450 IU (eq.33 mcg )/0.75ml cartridage | prefilled pen | injection SC |
| NCDS | 06-C00-036 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 900 IU (eq.66 mcg) /1.5 ml cartridage | prefilled pen | injection SC |
| NCDS | 06-C00-054 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 150 IU (eq.11 mcg)/0.25ml | prefilled multidose pen | injection SC |
| NCDS | 06-C00-039 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 75 IU | prefilled syringe | injection SC |
| NCDS | 06-C00-011 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 75 IU | vial | injection SC,IM |
| NCDS | 06-C00-055 | Follitrope:Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 75 IU\ 0.15ml | prefilled syringe | injection SC,IM |
| NCDS | 06-C00-061 | Cinnal – F : Follitropin Alfa 75 IU (recombinant human follicle stimulating hormone ,r-hFSH)5.5 mcg | lyophilized powder for injection after reconstitution vial | injection SC |
| NCDS | 06-C00-032 | Follitropin beta (recombinant human follicle stimulating hormone ,r-hFSH) 100 IU/0.5ml | solution vial or ampoule | injection SC,IM |
| NCDS | 06-C00-012 | Recombinant FSH (Follitropin Beta) 50 IU/0.5ml | solution vial or ampoule | injection SC,IM |
| NCDS | 06-C00-037 | Follitropin beta (recombinant human follicle stimulating hormone ,r-hFSH) 600 IU/0.72 ml cartridge | prefilled pen | injection SC |
| NCDS | 06-C00-038 | Follitropin beta (recombinant human follicle stimulating hormone ,r-hFSH) 300 IU/ 0.36ml cartridge | prefilled pen | injection SC |
| NCDS | 06-C00-029 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 150 IU(eq.11mcg) +Lutropin alfa (Recombinant human luteinising hormone,r-hLH )75 I.U (eq.3mcg) | vial powder+solvent | injection |
| NCDS | 06-C00-050 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 900 IU +Lutropin alfa (Recombinant human luteinising hormone,r-hLH )450 IU\1.44 ml | prefilled pen | injection SC |
| NCDS | 06-C00-051 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 450 IU +Lutropin alfa (Recombinant human luteinising hormone,r-hLH )225 IU\0.72ml | prefilled pen | injection SC |
| NCDS | 06-C00-052 | Follitropin alfa (recombinant human follicle stimulating hormone ,r-hFSH) 300 IU +Lutropin alfa (Recombinant human luteinising hormone,r-hLH )150IU\0.48ml | prefilled pen | injection SC |
| NCDS | 06-C00-022 | Lutropin alfa (Recombinant human luteinsing hormone/r-HLH) 75 IU | Vial | injection SC |
| NCDS | 06-C00-047 | Urofollitropin (highly purified human postmenopausal urinary follicle stimulating hormone,HP-uFSH) 150 IU | vial | injection SC,IM |
| NCDS | 06-C00-044 | Urofollitropin (highly purified human postmenopausal urinary follicle stimulating hormone,HP-uFSH) 75 IU | vial | injection SC,IM |
| NCDS | 06-C00-056 | menotrophin 150 (human menopausal gonadotrophin, HMG) corresponding to highly purified human postmenopausal urinary follicle stimulating hormone,FSH 150 IU +highly purified human postmenopausal urinary luteinising hormone,LH 150IU | vial powder+solvent | injection |
| NCDS | 06-C00-045 | menotrophin 75 (human menopausal gonadotrophin, HMG) corresponding to highly purified human postmenopausal urinary follicle stimulating hormone,FSH 75 IU +highly purified human postmenopausal urinary luteinising hormone,LH 75 IU | ampoule or vial powder+solvent | I.M ,S.C |
| NCDS | 06-C00-033 | thyrotropin alfa (Recombinant human thyroid stimulating hormone; rhTSH ) 0.9 mg | vial | injection IM |
| 6D | THYROID HORMON ES AND ANTITHYRO ID DRUGS | |||
| NCDS | 06-D00-001 | Carbimazole 5mg | Tablet | oral |
| NCDS | 06-D00-002 | Liothyronine sodium (T3) 20 mcg | Tablet | oral |
| NCDS | 06-D00-003 | Potassium iodide 60mg | Tablet | oral |
| NCDS | 06-D00-004 | Propylthiouracil 50mg | Tablet | oral |
| NCDS | 06-D00-005 | Methimazole 15mg | Tablet | oral |
| NCDS | 06-D00-011 | Methimazole ( Thiamazole ) 10 mg | Tablet | oral |
| NCDS | 06-D00-007 | levothyroxine sodium ( Anhydrous) 50mcg | Tablet | oral |
| NCDS | 06-D00-008 | levothyroxine sodium ( Anhydrous) 100mcg | Tablet | oral |
| NCDS | 06-D00-009 | levothyroxine sodium ( Anhydrous) 25 micrograms / 5 ml | solution | oral |
| NCDS | 06-D00-010 | levothyroxine sodium ( Anhydrous) 25mcg | Tablet | oral |
| 6E | CORTICOSTEROIDS | |||
| NCDS | 06-E00-001 | Betamethasone (as sodium phosphate) 4mg/1ml | 1ml Ampoule | injection |
| NCDS | 06-E00-002 | Betamethasone 0.5mg | Tablet | oral |
| NCDS | 06-E00-003 | Betamethasone acetate 3mg + betamethasone (as sodium phosphate) 3mg /1ml | solution 1ml Ampoule | injection |
| NCDS | 06-E00-034 | Betamethasone (as sodium phosphate) 4mg+Betamethasone (as dipropionate)10mg/2ml | 2ml Ampoule suspension | IM injection |
| NCDS | 06-E00-045 | Dexamethasone 4 mg tablet | Tablet | oral |
| NCDS | 06-E00-043 | Triamcinolone acetonide 40mg / ml | 1ml ampoule aqueous suspension | IM or Intra – articular njection |
| NCDS | 06-E00-004 | Cortisone acetate 25mg | Tablet | oral |
| NCDS | 06-E00-005 | Deflazacort 6mg | Tablet | oral |
| NCDS | 06-E00-006 | Deflazacort 30mg | Tablet | oral |
| NCDS | 06-E00-007 | Dexamethasone 0.5mg | Tablet | oral |
| NCDS | 06-E00-008 | Dexamethasone 0.5mg/5ml | solution | oral |
| NCDS | 06-E00-009 | Dexamethasone phosphate as di-sodium salt or as sodium salt 4mg/1ml | 2ml Ampoule or Vial | injection IV ,IM or IV infusion (or IV , IM , Intraarticular , Intralesional) |
| NCDS | 06-E00-011 | Dexamethasone phosphate as di-sodium salt or as sodium salt 4mg/ml | 1 ml Ampoule | injection IV ,IM |
| NCDS | 06-E00-013 | Dexamethasone phosphate as di-sodium salt or as sodium salt 20mg/1ml | ampoule | shock pack Injection |
| NCDS | 06-E00-014 | Fludrocortisone acetate 0.1mg | Tablet | oral |
| NCDS | 06-E00-015 | Hydrocortisone 20mg | Tablet | oral |
| NCDS | 06-E00-016 | Hydrocortisone 25mg | Tablet | oral |
| NCDS | 06-E00-018 | Hydrocortisone (as sodium Succinate or as hydrogen succinate) 100mg with 2ml ampoule solvent | vial or ACT-O-vial system (single dose vial) | injection slow IV ,IM or IV infusion |
| NCDS | 06-E00-032 | Hydrocortisone (as sodium succinate) 100mg\1ml | 5ml Vial | injection |
| NCDS | 06-E00-020 | Methylprednisolone acetate 40mg/ml | 1ml Vial aqueous suspention | injection I.M, intra-articular,.&into soft tissue (i-e intra lesional)} |
| NCDS | 06-E00-021 | Methylprednisolone acetate 40mg/ml | 2ml Vial or ampoule aqueous suspention | injection I.M, intra-articular,.&into soft tissue (i-e intra lesional)} |
| NCDS | 06-E00-036 | Methylprednisolone acetate 40mg/ml | 2ml prefilled syringe aqueous suspention | injection I.M, intra-articular,.&into soft tissue (i-e intra lesional)} |
| NCDS | 06-E00-041 | Methylprednisolone 4 mg | tablet | oral |
| NCDS | 06-E00-042 | Methylprednisolone 16 mg | tablet | oral |
| NCDS | 06-E00-024 | Prednisolone 1mg | tablet | oral |
| NCDS | 06-E00-025 | Prednisolone 2.5mg | Enteric Coated Tablet | oral |
| NCDS | 06-E00-026 | Prednisolone 5mg | tablet | oral |
| NCDS | 06-E00-027 | Prednisolone 10mg | tablet | oral |
| NCDS | 06-E00-028 | Prednisolone steaglate 7mg/ml | drop | oral |
| NCDS | 06-E00-033 | Prednisolone 5mg | Enteric Coated Tablet | oral |
| NCDS | 06-E00-037 | Prednisolone ( as Sodium Phosphate ) 5mg | soluble Tablet | oral |
| NCDS | 06-E00-039 | Prednisolone ( as Sodium Phosphate ) 20mg | tablet OR soluble Tablet | oral |
| NCDS | 06-E00-038 | Prednisolone ( as sodium phosphate) 15mg/5ml | syrup | oral |
| NCDS | 06-E00-040 | Prednisolone ( as sodium phosphate) 5mg/5ml | syrup | oral |
| 6F | FEMALE SEX HORMONES | |||
| NCDS | 06-F00-005 | Dydrogesterone 10mg | Tablet | oral |
| NCDS | 06-F00-011 | Gestonorone caproate 100mg/ml | 2ml Ampoule | injection |
| NCDS | 06-F00-016 | Lynoestrenol 5mg | Tablet | oral |
| NCDS | 06-F00-001 | Ethinylestradiol (Ethinyloestradiol) 35mcg + Cyproterone acetate 2mg | Tablet | oral |
| NCDS | 06-F00-006 | Estradiol benzoate 1mg + estradiol phenylpropionate 4mg + testosterone phenylpropionate 40mg +testosterone propionate20mg /ml | 1ml Ampoule | injection |
| NCDS | 06-F00-007 | Estradiol 1mg +Norethisterone Acetate 500mcg | Film Coated Tablet | oral |
| NCDS | 06-F00-008 | Estradiol (anhydrous or as hemihydrate) 2mg +Norethisterone Acetate 1mg | Tablet | oral |
| NCDS | 06-F00-044 | Estradiol (as hemihydrate) 2mg +Norethisterone Acetate 1mg | Tablet | oral |
| NCDS | 06-F00-009 | Estradiol (as Hemihydrate) 2mg | Tablet | oral |
| NCDS | 06-F00-010 | Estradiol (as Hemihydrate) 4mg | Tablet | oral |
| NCDS | 06-F00-027 | estradiol (oestradiol) Releasing Approx. 25mcg/24hr | Patch self adhesive | transdermal |
| NCDS | 06-F00-028 | estradiol (oestradiol) Releasing Approx. 50mcg/24hr | Patch self adhesive | transdermal |
| NCDS | 06-F00-045 | estradiol (oestradiol) valerate micronise 2mg (11 Tablet) +{Estradiol valerate micronise 2mg+Cyproteron acetate micronise 1mg (10 Tablet) } | Tablet | oral |
| NCDS | 06-F00-050 | Estradiol valerate 2mg (11 Tablet) + {Estradiol valerate 2mg+norgestel 0.5 mg (10 tablet)} | Tablet | oral |
| NCDS | 06-F00-058 | Estradiol ( as hemihydrate ) 1mg + Dydrogesterone 5mg | Tablet | oral |
| NCDS | 06-F00-018 | Medroxyprogesterone acetate 5mg | Tablet | oral |
| NCDS | 06-F00-019 | Medroxyprogesterone acetate 10mg | Tablet | oral |
| NCDS | 06-F00-020 | Norethisterone 5mg | Tablet | oral |
| NCDS | 06-F00-021 | Norethisterone acetate 5mg | Tablet | oral |
| NCDS | 06-F00-043 | Norethisterone 10mg +(Ethinylestradiol (Ethinyloestradiol 0.02mg | Tablet | oral |
| NCDS | 06-F00-029 | Progesterone 25mg / ml | 1ml Ampoule OR vial | injection |
| NCDS | 06-F00-030 | Progesterone 400mg | Suppository or Pessaries | vaginal |
| NCDS | 06-F00-031 | Progesterone 200mg | Suppository or ovules( Pessaries) | same for vaginal or rectal |
| NCDS | 06-F00-053 | Progesterone (micronized )200mg | capsule or soft capsule | same for vaginal or oral |
| NCDS | 06-F00-055 | Progesterone 100 mg | tablet | vaginal |
| NCDS | 06-F00-003 | Progesterone (micronized) 100mg | capsule or tablet or soft capsule | same for vaginal or oral |
| NCDS | 06-F00-051 | Progesterone 100 mg | effervescent tablet | vaginal |
| NCDS | 06-F00-032 | Progesterone 12.5mg + estradiol (oestradiol) benzoate 2.5mg/1ml | 1ml Ampoule | injection |
| NCDS | 06-F00-049 | Progesterone 25mg / ml | 2ml Ampoule | injection |
| NCDS | 06-F00-048 | Progesterone 90mg /application (8%) | Gel in Single use pre-filled applicators | vaginal |
| NCDS | 06-F00-034 | Progestin (19-nor-progesterone) | Tablet | oral |
| NCDS | 06-F00-039 | estradiol (oestradiol) valerate 2mg (16 white tab) + {Ostradiol valerate 2mg + Levonorgestrel 75mcg ( 12 pink Tablet)} | Tablet | oral |
| NCDS | 06-F00-040 | estradiol (oestradiol) as hemihydrate 2mg(12 tab) +10 tab contain (Oestradiol as hemihydrate 2mg + Norethisterone acetate 1mg) +6 Tablet containe(Oestradiol as hemihydrate ) Tablet | Tablet | oral |
| NCDS | 06-F00-022 | estradiol (oestradiol) valerate 10mg/ml | 1ml Ampoule | injection |
| NCDS | 06-F00-023 | estradiol (oestradiol) succinate 2mg | Tablet | oral |
| NCDS | 06-F00-024 | estradiol (oestradiol) 1mg | scored Tablet | oral |
| NCDS | 06-F00-025 | conjugated Oestrogens 1.25mg | Tablet | oral |
| NCDS | 06-F00-026 | conjugated Oestrogens 625mcg | Tablet | oral |
| NCDS | 06-F00-004 | conjugated Oestrogens 0.625mg (28 tablet)+ Norgestrel 150mcg(as levonorgestrel 75mcg) (12 Tablet) | Tablet | oral |
| NCDS | 06-F00-042 | Quinestrol 4mg | (1& 2 Tablet) | oral |
| NCDS | 06-F00-054 | Oestriol 0.1% | cream with applicator | vaginal |
| NCDS | 06-F00-035 | Raloxifene hyrochloride 60mg | Film Coated Tablet | oral |
| NCDS | 06-F00-036 | Testosterone enanthate 90.3mg+ estradiol (oestradiol) valerate 4mg/ml | 1ml Ampoule | injection |
| NCDS | 06-F00-037 | Tibolone 2.5mg | Tablet | oral |
| NCDS | 06-F00-057 | Ulipristal acetate 30 mg | Film Coated Tablet | oral |
| 6G | MALE SEX HORMONES AND ANTI-ANDROGENS | |||
| NCDS | 06-G00-004 | Cyproterone 10mg | Tablet | oral |
| NCDS | 06-G00-005 | Cyproterone acetate 50mg | Tablet | oral |
| NCDS | 06-G00-006 | Fluoxymesterone 5mg | Tablet | oral |
| NCDS | 06-G00-007 | Finasteride 5mg | Tablet | oral |
| NCDS | 06-G00-028 | Finasteride 1mg | Tablet | oral |
| NCDS | 06-G00-008 | Goserelin acetate equivalent to 3.6 mg Goserelin | syringe application | injection |
| NCDS | 06-G00-009 | Mesterolone 25mg | Tablet | oral |
| NCDS | 06-G00-010 | Testosterone aq. propionate 25mg | 1ml ampoule | IM injection |
| NCDS | 06-G00-011 | Testosterone propionate 20mg + Testosterone phenylpropionate 40mg + Testosterone isocaproate 40mg/ml | 1ml ampoule | IM injection |
| NCDS | 06-G00-012 | Testosterone propionate 30mg + Testosterone phenyl propionate 60mg + Testosterone isocaproate 60mg + Testosterone decanoate 100mg/ml | 1ml ampoule | IM injection |
| NCDS | 06-G00-017 | Testosterone enanthate 250mg/ml | 1ml ampoule | IM injection |
| NCDS | 06-G00-013 | Triptorelin ( as acetate )3.75mg | depot vial or pfs with solvent | S.C OR Deep IM injection |
| NCDS | 06-G00-014 | Triptorelin (as acetate) 0.1 mg | vial or Pfs powder & solvent | s.c. injection |
| NCDS | 06-G00-015 | Triptorelin (as acetate) 3mg | vial powder & solvent | injection |
| NCDS | 06-G00-016 | Triptorelin (as embonate) 11.25 mg +diluent | vial | injection IM |
| NCDS | 06-G00-018 | Testosterone undecanoate 40 mg | capsule | oral |
| NCDS | 06-G00-030 | Testosterone 20.25 mg / pump actuation ( 1.62 % ) | gel pump | topical |
| NCDS | 06-G00-022 | Dutasteride 0.5mg | capsule | oral |
| NCDS | 06-G00-025 | Dutasteride 0.5mg + Tamsulosin hydrochloride 0.4 mg | capsule | oral |
| NCDS | 06-G00-026 | Dutasteride 0.5mg + Tamsulosin hydrochloride 0.4 mg | tablet | oral |
| NCDS | 06-G00-027 | Goserelin (as acetate) 10.8mg | implant in safe system syringe applicator | injection |
| 6H | ANABOLIC STEROIDS | |||
| NCDS | 06-H00-001 | Nandrolon decanoate 25mg/ml | 1ml Ampoule | injection IM |
| NCDS | 06-H00-002 | Nandrolon decanoate 25mg/ml | 1ml Vial | injection IM |
| NCDS | 06-H00-003 | Nandrolon decanoate 50mg/ml | 1ml Ampoule | injection IM |
| NCDS | 06-H00-004 | Nandrolon decanoate 50mg/ml | 1ml Vial | injection IM |
| 6I | DRUGS AFFECTING BONE METABOLISM | |||
| 6IA | Calcitonin | |||
| NCDS | 06-IA0-001 | Calcitonin 100 MRC unit eq. 100 IU calcitonin synthetic/1ml | 1ml Ampoule | injection IM , SC , IV Infusion |
| NCDS | 06-IA0-002 | Calcitonin synthetic salmon 50 IU | Spray | Nasal |
| NCDS | 06-IA0-003 | Calcitonin synthetic salmon 100 IU | Spray | Nasal |
| NCDS | 06-IA0-004 | Calcitonin 200 IU | driop | Nasal |
| NCDS | 06-IA0-005 | Cinacalcet ( as hydrochloride) 30 mg | tablet | oral |
| NCDS | 06-IA0-006 | Cinacalcet (as hydrochloride) 60 mg | tablet | oral |
| 6IB | Bisphosphonates and other drug affecting bone metabolism | |||
| NCDS | 06-IB0-003 | Alendronic acid (as Alendronate soduim or mono sodium or sodium trihydrate) 5 mg | Tablet | oral |
| NCDS | 06-IB0-013 | Alendronic acid (as Alendronate soduim or mono sodium or sodium trihydrate) 70 mg | Tablet | oral |
| NCDS | 06-IB0-016 | Alendronic acid ( as sodium Alendronate ) 70 mg | effervescent tablet | oral |
| NCDS | 06-IB0-018 | Abaloparatide 2000mcg / ml | Prefilled Syringe | injection |
| NCDS | 06-IB0-005 | Pamidronate disodium 30mg | Vial | injection |
| NCDS | 06-IB0-001 | Pamidronate disodium 3mg/ml | 5ml vial | injection IV infusion |
| NCDS | 06-IB0-019 | Pamidronate disodium 90 mg / 30 ml | solution Vial | injection IV infusion |
| NCDS | 06-IB0-006 | Disodium clodronate 400mg | Tablet | oral |
| NCDS | 06-IB0-007 | Disodium clodronate 400mg | Capsule | oral |
| NCDS | 06-IB0-014 | Zoledronic acid 4mg/100ml | solution vial or ampoule | I.V. infusion |
| NCDS | 06-IB0-010 | Zoledronic acid ( as monohydrate ) 4mg/5ml concentrate | vial or ampoule | I.V. infusion |
| NCDS | 06-IB0-011 | Ibandronic acid (as mono sodium salt monohydrate) 150mg | Tablet | oral |
| NCDS | 06-IB0-015 | Risedronate sodium 35 mg | Tablet | oral |
| NCDS | 06-IB0-017 | Denosumab 60 mg /1 ml | solution prefilled syringe | injectio SC |
| 6J | OTHER ENDOCRINE DRUGS | |||
| NCDS | 06-J00-001 | Bromocriptine 5mg | Capsule | oral |
| NCDS | 06-J00-002 | Bromocriptine 5mg | Tablet | oral |
| NCDS | 06-J00-003 | Cabergoline 500mcg | scored Tablet | oral |
| NCDS | 06-J00-004 | Clomiphene citrate 50mg | Tablet | oral |
| NCDS | 06-J00-005 | Danazol 100mg | Capsule | oral |
| NCDS | 06-J00-006 | Danazol 200mg | Capsule | oral |
| NCDS | 06-J00-007 | Gestrinone 2.5mg | Capsule | oral |
| NCDS | 06-J00-008 | Cetrorelix (as acetate) 3mg | vial (one single injection) | SC Injection |
| NCDS | 06-J00-009 | Cetrorelix (as acetate ) 250mcg | 1 ml vial or 0.5 ml PFS | SC Injection |
| NCDS | 06-J00-010 | mecasermin (Recombinant human insulin – like growth factor, rhIGF-I) 10 mg /ml | 4 ml vial | injection |
| NCDS | 06-J00-011 | Ganirelix 0.25 mg \0.5 ml | aqueous solution prefilled syringe | injection SC |
| NCDS | 06-J00-013 | Dienogest 2mg | tablet | Oral |
| 6K | DRUGS USED IN HYPERLIPIDAEMIA | |||
| NCDS | 06-K00-001 | Atorvastatin (as calcium trihydrate or as calcium )10mg | Tablet | oral |
| NCDS | 06-K00-002 | Atorvastatin (as calcium trihydrate or as calcium ) 20mg | Tablet | oral |
| NCDS | 06-K00-022 | Atorvastatin (as calcium trihydrate or as calcium ) 40mg | Tablet | oral |
| NCDS | 06-K00-026 | Atorvastatin 80 mg | Tablet | oral |
| NCDS | 06-K00-004 | Fluvastatin 20mg | Capsule | oral |
| NCDS | 06-K00-005 | Fluvastatin 40mg | Capsule | oral |
| NCDS | 06-K00-006 | Fluvastatin sodium 80mg | long acting Tablet | oral |
| NCDS | 06-K00-009 | Lovastatin 20mg | Tablet | oral |
| NCDS | 06-K00-018 | Lovastatin 40mg | Tablet | oral |
| NCDS | 06-K00-012 | Simvastatin 10mg | Tablet | oral |
| NCDS | 06-K00-013 | Simvastatin 20mg | Tablet | oral |
| NCDS | 06-K00-015 | Simvastatin 40mg | Tablet | oral |
| NCDS | 06-K00-019 | Rosuvastatin (as calcium ) 10mg | film coated tablet | oral |
| NCDS | 06-K00-021 | Rosuvastatin (as calcium ) 20mg | film coated tablet | oral |
| NCDS | 06-K00-024 | Rosuvastatin (as calcium ) 40mg | film coated tablet | oral |
| NCDS | 06-K00-028 | Rosuvastatin ( as calcium ) 10mg + Ezetimibe 10mg | tablet | oral |
| NCDS | 06-K00-029 | Rosuvastatin ( as calcium )20mg + Ezetimibe 10mg | tablet | oral |
| NCDS | 06-K00-030 | Rosuvastatin ( as calcium )40mg + Ezetimibe 10mg | tablet | oral |
| NCDS | 06-K00-032 | Rosuvastatin ( as zinc ) 10mg + Ezetimibe 10mg | capsule | oral |
| NCDS | 06-K00-033 | Rosuvastatin ( as zinc ) 20mg + Ezetimibe 10mg | capsule | oral |
| NCDS | 06-K00-014 | Pravastatin sodium 20mg | tablet | oral |
| NCDS | 06-K00-034 | Pitavastatin calcium eq.to pitavastatin 2mg | tablet | oral |
| NCDS | 06-K00-035 | Pitavastatin calcium eq.to pitavastatin 4mg | tablet | oral |
| NCDS | 06-K00-010 | Fenofibrate Micronized 200mg | tablet | oral |
| NCDS | 06-K00-011 | Fenofibrate Micronized 200mg | Capsule | oral |
| NCDS | 06-K00-027 | fenofibrate 145 mg nanoparticle | film coated tablet | oral |
| NCDS | 06-K00-003 | Bezafibrate 200mg | tablet | oral |
| NCDS | 06-K00-031 | Gemfibrozil 600 mg | film coated tablet | oral |
| NCDS | 06-K00-025 | Ezetimibe 10 mg | tablet | oral |
| NCDS | 06-K00-007 | Cholestyramine 4g/9g sachet | Powder sachet | oral |
| 6L | DIAGNOSTIC AGENTS FOR ENDOCRINE DISORDERS | |||
| NCDS | 06-L00-002 | Protirelin 40mg | Tablet | oral |
| NCDS | 06-L00-009 | Gonadorelin (Gonadotrophin-releasing hormone; GnRH; LH– RH) as hydrochloride 100 mcg | vial powder for solution | injection |
| NCDS | 06-L00-004 | Parathyroid Hormone (Recombinant) (PTH) (parathrin) Ampoule | ||
| Cushing’s syndrome and disease | ||||
| NCDS | 06-L00-001 | Metyrapone 250mg | Capsule | oral |
| NCDS | 06-L00-011 | Osilodrostat (as phosphate) 1 mg | Tablet | oral |
| NCDS | 06-L00-012 | Osilodrostat (as phosphate) 5 mg | Tablet | oral |
| 6M | Others(also use in 4i) | |||
| NCDS | 06-M00-001 | Clonidine hydrochloride 50mcg | Tablet | oral |
| NCDS | 06-M00-002 | Clonidine hydrochloride 75mcg | Tablet | oral |
| NCDS | 06-M00-003 | Clonidine hydrochloride 150mcg | Tablet | oral |
| 7 | GENITO-URINARY DISORDERS | |||
| 7A | UTERINE STIMULANTS | |||
| NCDS | 07-A00-001 | Carboprost as trometamol 5mg/ml , | (5ml) Ampoule | Injection |
| NCDS | 07-A00-017 | carboprost {as trometamol salt (tromethamine salt) }250 micrograms/ml | 1ml Ampoule | injection deep I.M or Intrauterine |
| NCDS | 07-A00-002 | Dinoprostone 0.5mg | Tablet | oral |
| NCDS | 07-A00-005 | Dinoprostone 1mg/ml | vial or ampoule | Injection |
| NCDS | 07-A00-006 | Dinoprostone 10mg/ml | vial or ampoule | Injection |
| NCDS | 07-A00-007 | Dinoprostone 3mg | Tablet | Vaginal |
| NCDS | 07-A00-015 | Dinoprostone 5mg | pessary | Vaginal |
| NCDS | 07-A00-019 | Dinoprostone 10mg | sustained release system | Vaginal |
| NCDS | 07-A00-013 | Ergometrine maleate 500mcg/ml | vial or ampoule | injection |
| NCDS | 07-A00-008 | Methylergometrine(Methylergonovine) maleate 200mcg | Tablet | oral |
| NCDS | 07-A00-009 | Methylergometrine(Methylergonovine) maleate 200mcg/ml | 1ml Ampoule | injection |
| NCDS | 07-A00-010 | Oxytocin 2 units | vial or ampoule | injection |
| NCDS | 07-A00-011 | Oxytocin 5 units/ml | 0.5ml ampoule or 1ml ampoule | injection IV.,IM |
| NCDS | 07-A00-012 | Oxytocin 10 units/ml | 1ml Ampoule | injection IV,IV infusion ,IM |
| NCDS | 07-A00-018 | Carbetocin 100mcg/ml(oxytocin activity approx 50 IU/Ampoule vaso pressor activity <0.025 IU/Ampoule) | 1ml Ampoule | injection |
| NCDS | 02-C00-013 | Misoprostol 200mcg | Scored Tablet | oral |
| NCDS | 07-A00-014 | Mifepristone 200mg | tablet (3tablet\ packet) | oral |
| 7B | UTERINE RELAXANTS | |||
| NCDS | 07-B00-001 | Ritodrine hydrochloride 10mg | Tablet | oral |
| NCDS | 07-B00-002 | Ritodrine hydrochloride 10mg/ml | vial or ampoule | injection |
| NCDS | 07-B00-003 | Atosiban (as Atosiban acetate) 7.5 mg per 1 ml (6.75mg/0.9ml) | concentrate for solution vial | IV infusion |
| NCDS | 07-B00-004 | Atosiban (as acetate) 7.5mg /ml | 5ml Vial | injection |
| 7C | TREATMENT OF VULVAL AND VAGINAL DISEASES | |||
| NCDS | 07-C00-001 | Acetic acid 0.92% in buffered base (PH 7.4) | Jelly with applicator | Vaginal |
| NCDS | 07-C00-002 | Chlorhexidine gluconate 5% W/V | obstetric Cream | Vaginal |
| NCDS | 07-C00-057 | Chlorhexidine digluconate 20% solution 0.533 gm and Hexamidine diisetionate 0.1 gm | 100 ml solution | Vaginal |
| NCDS | 07-C00-060 | Sodium Bicarbonate 10gm | powder | external use |
| NCDS | 07-C00-003 | Chloramphenicol 250mg+Cloponone 2.5mg+ myralact 10mg | Tablet | Vaginal |
| NCDS | 07-C00-055 | Clotrimazole 1% | Cream | vaginally |
| NCDS | 07-C00-005 | Clotrimazole 100mg | Tablet | Vaginal |
| NCDS | 07-C00-008 | Clotrimazole 0.5g/5g | single dose Cream with applicator | Vaginal |
| NCDS | 07-C00-006 | Clotrimazole 500mg | Tablet | Vaginal |
| NCDS | 07-C00-056 | Clotrimazole 200 mg | Tablet | Vaginal |
| NCDS | 07-C00-012 | Diiodohydroxyquinoline 100mg | Tablet with applicator | Vaginal |
| NCDS | 07-C00-013 | Econazole nitrate 150mg | Ovules | Vaginal |
| NCDS | 07-C00-014 | Isoconazole nitrate 300mg | Tablet | Vaginal |
| NCDS | 07-C00-015 | Furazolidone 0.25% + Nifuroxime 0.376%, | suppository | Vaginal |
| NCDS | 07-C00-016 | Furazolidone 7.5% + Nifuroxime 12mg | suppository | Vaginal |
| NCDS | 07-C00-017 | Nifuratel 250mg | Tablet | Vaginal |
| NCDS | 07-C00-018 | Nifuratel 10% (3g/30g) | Ointment | Vaginal |
| NCDS | 07-C00-019 | Miconazole nitrate 200mg | Ovule or Suppository capsule or tablet | Vaginal |
| NCDS | 07-C00-021 | Miconazole nitrate 400mg | Ovule or Suppository capsule or tablet | Vaginal |
| NCDS | 07-C00-042 | Miconazole nitrate 1200mg | Ovule or Suppository capsule or tablet | Vaginal |
| NCDS | 07-C00-062 | Metronidazole 750mg + Miconazole nitrate 200 mg+ Lidocaine Hydrochloride 100 mg | Tablet or Ovule | Vaginal |
| NCDS | 07-C00-063 | Metronidazole 750mg + Miconazole nitrate 200 mg | pessary | Vaginal |
| NCDS | 07-C00-053 | Fenticonazole nitrate 600 | capsule | Vaginal |
| NCDS | 07-C00-054 | Fenticonazole nitrate 2% | cream | topical |
| NCDS | 07-C00-024 | Miconazole nitrate 2% | Cream | Vaginal |
| NCDS | 07-C00-025 | Nystatin 100000 units | Tablet (pessaries) with applicator | Vaginal |
| NCDS | 07-C00-026 | Nystatin 100000 units/4g application | Cream (with applicator) | Vaginal |
| NCDS | 07-C00-027 | Nystatin 100000 units/g | ointment | topical |
| NCDS | 07-C00-039 | Nystatin 100000 units/g | Cream | topical |
| NCDS | 07-C00-045 | Neomycin sulfate 35000 IU+Polymyxin B sulfate 35000 IU+Nystatin sulfate 100000 IU | capsule | Vaginal |
| NCDS | 07-C00-030 | Sulphathiazole 3.42%+ Sulphacetamide 2.86%+ Sulphabenzamide 3.7% | Cream (with applicator) | Vaginal |
| NCDS | 07-C00-031 | Tetracycline hydrochloride 100mg + Amphotericin 50mg | Tablet | Vaginal |
| NCDS | 07-C00-032 | conjugated Estrogen (equine) 625mcg/g | Cream | Vaginal |
| NCDS | 07-C00-033 | Estradiol 25mcg | Tablet in a disposable applicators | Vaginal |
| NCDS | 07-C00-044 | Estradiol 10 mcg | Tablet | Vaginal |
| NCDS | 07-C00-036 | Metronidazole 0.75% | gel with applicators | Vaginal |
| NCDS | 07-C00-050 | Metronidazole 500mg | ovul | Vaginal |
| NCDS | 07-C00-052 | metronidazole 1.3% | gel | Vaginal |
| NCDS | 07-C00-037 | Clindamycin ( as phosphate) 2% | cream with applicators | Vaginal |
| NCDS | 07-C00-046 | Dequalinium chloride 10 mg | Tablet | Vaginal |
| NCDS | 07-c00-047 | Povidone iodine 10 % | Douche | vaginal |
| NCDS | 07-C00-048 | lactic acid 0.250 g + Sodium lactate 0.247 g + Glycogen 0.10 g + propylene glycol 0.750 g + Hypromellose 0.100 g | 5ml gel tube | vaginal |
| NCDS | 07-C00-051 | Tioconazole 2% (20mg/g) | Cream | vaginal |
| 7D | CONTRACEPTIVES | |||
| 7DA | Combined contraceptives | |||
| NCDS | 07-DA0-010 | Intra-uterine contraceptive devices copper 7 | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-011 | Intra-uterine contraceptive devices small copper 7 | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-012 | Intra-uterine contraceptive devices copper T (380) or UT 380 standard | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-014 | Intra-uterine contraceptive devices T-shape plastic | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-017 | Intra-uterine contraceptive devices Multi load Cu 375 | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-018 | Intra-uterine contraceptive device coppr-T model tcu 380 A | contraceptive device | Intra-uterine |
| NCDS | 07-DA0-020 | Etonogestrel 68 mg | implant/1 device | SUBDERMAL IMPLANTATION |
| NCDS | 07-DA0-001 | Ethinylestradiol (Ethinyloestradiol) 20mcg+Desogestrel 150mcg | Tablet | oral |
| NCDS | 07-DA0-002 | Ethinylestradiol (Ethinyloestradiol) 0.030mg +Drospirenone 3mg | Tablet | oral |
| NCDS | 07-DA0-004 | Ethinylestradiol (Ethinyloestradiol) 30 mcg+ levonorgestrel 150 mcg | Tablet | oral |
| NCDS | 07-DA0-005 | Ethinylestradiol (Ethinyloestradiol) 50mcg + levonorgestrel 150mcg | Tablet | oral |
| NCDS | 07-DA0-006 | Gestodene 75mcg + Ethinylestradiol (Ethinyloestradiol) 20mcg | Tablet | oral |
| NCDS | 07-DA0-007 | Levonorgestrel 50mcg+Ethinylestradiol (Ethinyloestradiol) 30mcg(6 tab) and levonorgestrel 75mcg+ Ethinylestradiol (Ethinyloestradiol) 40mcg(5 tab) and levonorgestrel 125mcg+ Ethinylestradiol (Ethinyloestradiol) 30mcg(10 Tablet) /calender pack | Tablet | oral |
| NCDS | 07-DA0-008 | Norethisterone acetate 1mg + Ethinylestradiol (Ethinyloestradiol) 20mcg | Tablet | oral |
| NCDS | 07-DA0-013 | Gestodene 75 mcg +Ethinylestradiol (Ethinyloestradiol) 30 mcg | Tablet | oral |
| NCDS | 07-DA0-015 | Ethinylestradiol (Ethinyloestradio) 30mcg+Desogestrel 150mcg | Tablet | oral |
| NCDS | 07-DA0-021 | Blue tablet contains :0.025 mg Desogestrel + 0.040 mg Ethinylestradiol White tablet contains : 0.125 mg Desogestrel + 0.30 mg Ethinylestradiol | Tablet | oral |
| NCDS | 07-DA0-016 | Ethinylestradiol (Ethinyloestradiol) approx. 33.9 mcg /24 hours + norelgestromin approx. 203 mcg/24 hours | self-adhesive patch | transdermal |
| NCDS | 07-DA0-019 | Ethinylestradiol (Ethinyloestradiol) 0.02 mg + Drospirenone 3mg | Tablet | oral |
| 7DB | Progesterone only-Contraceptive | |||
| NCDS | 07-DB0-001 | Ethynodiol diacetate 500 mcg | Tablet | oral |
| NCDS | 07-DB0-002 | levonorgestrel 30mcg | Tablet | oral |
| NCDS | 07-DB0-007 | Levonorgestrel 1.5 mg | Tablet | oral |
| NCDS | 07-DB0-003 | Norethisterone 350mcg | Tablet | oral |
| NCDS | 07-DB0-004 | Intra-uterine contraceptive devices T-shaped plastic frame (imprenated with barium sulphate and with threads attached to base) with polydimethylsiloxane reservoire releasing levonorgestrel 20micrograms/24hours | contraceptive device | Intra-uterine |
| NCDS | 07-DB0-005 | Desogestrel 75 mcg | Tablet | oral |
| NCDS | 06-F00-017 | Medroxyprogesterone acetate 150mg/ml | 1ml Vial | injection deep IM |
| NCDS | 07-DB0-006 | drospirenone 4 mg | film coated tablet | oral |
| 7DC | Spermicidal contraceptives | |||
| NCDS | 07-DC0-001 | Nonoxinol-9 5% | Cream | Vaginal |
| NCDS | 07-DC0-002 | Nonoxinol-9 12.5% | Foam | Vaginal |
| NCDS | 07-DC0-003 | Nonoxinol-9 100mg | Ovules or Suppository | Vaginal |
| NCDS | 07-DC0-004 | Menfegol 60mg Vaginal | Foaming Tablet | Vaginal |
| NCDS | 07-DC0-005 | Monalazone disodium 9.5mg Vaginal | Tablet | Vaginal |
| NCDS | 07-DC0-006 | Nonoxinol-9 2% | gel | Vaginal |
| NCDS | 07-DC0-007 | Benzalkonium chloride 18.9 mg | suppository | Vaginal |
| 7E | DRUGS USED IN URINARY TRACT DISORDERS | |||
| NCDS | 07-E00-001 | Bethanechol chloride 25mg | Tablet | oral |
| NCDS | 07-E00-004 | Distigmine Bromide 5mg | Tablet | oral |
| NCDS | 07-E00-005 | Distigmine Bromide 500mcg/ml | ampoule or vial | injection |
| NCDS | 07-E00-006 | Emepronium Bromide 100mg | Tablet | oral |
| NCDS | 07-E00-007 | Flavoxate hydrochloride 200mg | Tablet | oral |
| NCDS | 07-E00-008 | Oxybutynin hydrochloride 5mg | Tablet | oral |
| NCDS | 07-E00-015 | Oxybutynin hydrochloride 1mg /1ml | syrup 100ml | oral |
| NCDS | 07-E00-026 | Oxybutynin hydrochloride 2.5 mg | extended release tablet | oral |
| NCDS | 07-E00-027 | Oxybutynin hydrochloride ( or chloride ) 10mg | extended release tablet | oral |
| NCDS | 07-E00-028 | Oxybutynin hydrochloride 2.5mg /5 ml | Elixir | oral |
| NCDS | 07-E00-009 | Glycine sterile 1.5% in water | irregation solution 3000 cc | irregation |
| NCDS | 07-E00-010 | Lidocaine hydrochloride 2% | Gel | topical |
| NCDS | 07-E00-011 | Phenazopyridine hydrochloride 100mg | Tablet | oral |
| NCDS | 07-E00-017 | tolterodine L- tartrate 2 mg (eq. tolterodine 1.37 mg) | Tablet | oral |
| NCDS | 07-E00-023 | tolterodine tartarate 4 mg | extended release capsule | oral |
| NCDS | 07-E00-022 | Trospium chloride 20 mg | Tablet | oral |
| NCDS | 07-E00-024 | Solifenacine succinate 5 mg | Tablet | oral |
| NCDS | 07-E00-041 | Silodosin 8 mg | capsule | oral |
| NCDS | 07-E00-042 | Silodosin 4 mg | capsule | oral |
| NCDS | 07-E00-025 | Solifenacine succinate 10 mg | Tablet | oral |
| NCDS | 07-E00-033 | Mirabegron 25 mg | prolonged release tablet | oral |
| NCDS | 07-E00-039 | Mirabegron 50 mg | prolonged release tablet | oral |
| NCDS | 01-E00-074 | Terazosin (as hydrochloride) 2mg | Tablet | oral |
| NCDS | 01-E00-075 | Terazosin (as hydrochloride) 5mg | Tablet | oral |
| NCDS | 01-E00-063 | Tamsulosin hydrochloride 0.4mg (eq. 0.367mg Tamsulosin) | tablet or modified release capsule or tablet or prolonged release (film coated). | oral |
| NCDS | 01-E00-119 | solifenacin succinate 6 mg + Tamsulosin hydrochloride 0.4 mg | modified release tablet | oral |
| NCDS | 01-E00-001 | Alfuzosin hydrochloride 2.5mg | Tablet | oral |
| NCDS | 01-E00-002 | Alfuzosin hydrochloride 5mg | sustained release Tablet | oral |
| NCDS | 01-E00-061 | Alfuzosin hydrochloride 10mg | prolong release Tablet | oral |
| NCDS | 01-E00-106 | Doxazosin (as mesylate) 4 mg | extended release Tablet | oral |
| NCDS | 01-E00-008 | Doxazosin (as mesylate) 2mg | Scored Tablet | oral |
| NCDS | 01-E00-009 | Doxazosin (as mesylate) 1mg | Tablet | oral |
| NCDS | 01-E00-010 | Doxazosin (as mesylate ) 4mg | Tablet | oral |
| NCDS | 07-E00-037 | Propiverine hydrochloride 30 mg | modified release capsule | oral |
| NCDS | 07-E00-040 | Propiverine hydrochloride 45 mg | modified release capsule | oral |
| NCDS | 01-E00-099 | Doxazosin (as mesylate) 8mg | extended release Tablet | oral |
| NCDS | 07-E00-002 | Anhydrous citric acid 18g+ Tartaric acid 27g+ Sodium bicarbonate 51g+ Sucrose 15g/100g | Granules | oral |
| NCDS | 07-E00-003 | Sodium bicarbonate 780mg+ Sodium citrate1.82g /3.5g | Granules | oral |
| NCDS | 07-E00-031 | Anhydrous citric acid 1.189g +Anhydrous monopotassium citrate 1.73 g,+Anhydrous monosodium citrate 1.845g / sachet | Effervescent granules or Effervescent Powder sachet | oral |
| NCDS | 07-E00-032 | Sodium bicarbonate 1.76g + Anhydrous citric acid 720mg+ Tartaric acid 890mg + Anhydrous sodiun citrate 630mg / sachet | Effervescent granules or Effervescent Powder sachet | oral |
| NCDS | 07-E00-030 | potassium citrate 1H2O 2.17g+ Potassium hydrogen carbonate 2g+ anhydrous citric acid 2.057 g | effervesent tablet | oral |
| NCDS | 07-E00-029 | Potassium citrate 30% and citric acid monohydrate 5% oral (Potassium citrate mixture ) | solution | oral |
| NCDS | 07-E00-016 | potassium – soduim -hydrogen-citrate (6:6:3:5)2.4/g one measuring spoonful of 2.5 g | granules | oral |
| NCDS | 07-E00-013 | Sodium citrate 566mg+ Sodium bicarbonate 1.58g+ Tartaric acid 790mg+ Citric acid 646mg/4g sachet | Effervescent Powder | oral |
| NCDS | 07-E00-038 | Range Item 0.61- 0.63 Sod.citrate 0.7-0.75 Citric acid 0.84-0.89 Tartaric acid 1.71 -1.76 Sod.bicarbonate | Effervescent granules or Effervescent Powder sachet | oral |
| NCDS | 07-E00-034 | Potassium citrate 1080 mg | prolonged release tablet | oral |
| NCDS | 07-E00-035 | Anhydrous sodium Citrate 630mg + Anhydrous citric acid 750mg + Tartaric acid 840mg + sodium bicarbonate 1.76g/4g sachet | Effervescent granules or Effervescent Powder sachet | oral |
| NCDS | 07-E00-036 | Sodium Bicarbonate 1.76 g +Sodium citrate anhydrous 0.63g + Citric acid 0.72 mg/ 4 g sachet | Effervescent granules or Effervescent Powder sachet | oral |
| 7F | Drugs for Erectile dysfunction | |||
| NCDS | 07-F00-001 | Alprostadil (PGE1) 20 mcg | double chamber cartridges(Alprostadil +diluent) | intracavernosal injection |
| NCDS | 07-F00-003 | Alprostadil (PGE1) 10 mcg | Vial | intracavernosal injection |
| NCDS | 07-F00-002 | Alprostadil (PGE1) 250 mcg | Suppository | urethral |
| NCDS | 07-F00-004 | Alprostadil (PGE1) 500 mcg | Suppository | urethral |
| NCDS | 07-F00-005 | Papaverin 30mg-60mg | Ampoule | intracavernosal injection |
| NCDS | 07-F00-006 | Papaverin ( 30mg/ml) 2.5ml+Phentolamine(5mg/ml) 0.5ml + Alprostadil (500mcg/ml) 0.05ml } | one Kit | injection |
| NCDS | 07-F00-007 | Sildenafil (as citrate) 50mg | Tablet or orodispersible film | oral |
| NCDS | 07-F00-008 | Sildenafil (as citrate) 25mg | Tablet | oral |
| NCDS | 07-F00-009 | Sildenafil (as citrate) 100mg | Tablet | oral |
| NCDS | 07-F00-010 | Tadalafil 10mg | Tablet | oral |
| NCDS | 07-F00-011 | Tadalafil 20mg | Tablet or soft gel capsule or oral dissolvable film | oral |
| NCDS | 07-F00-015 | Tadalafil 5mg | Tablet or oral dissolvable film | oral |
| NCDS | 07-F00-016 | Avanfil 50 mg | Tablet | oral |
| NCDS | 07-H00-017 | Avanfil 100 mg | Tablet | oral |
| NCDS | 07-F00-018 | Avanfil 200 mg | Tablet | oral |
| NCDS | 07-F00-012 | Vardenafil (as hyrochloride trihydrate) 5mg | Tablet | oral |
| NCDS | 07-F00-013 | Vardenafil (as hyrochloride trihydrate) 10mg | Tablet or orodispersible tablet | oral |
| NCDS | 07-F00-014 | Vardenafil (as hyrochloride trihydrate) 20mg | Tablet | oral |
| 7G | others | |||
| NCDS | 07-G00-001 | Clonidine hyrochloride 0.2mg/day | patch | Transdermal |
| NCDS | 07-G00-002 | Water, Propylene Glycol, Hydroxyethylcellulose, Benzoic Acid, Carbomer, Sodium Hydroxide | gel | topical |
| NCDS | 07-G00-003 | Glutathione (as Sodium salt) 600 mg / 4 ml | powder and solvent for solution vial + solvent ampoule 4 ml | injection |
| NCDS | 07-G00-005 | Sodium carboxymethylcellulose 2.3%+ propylene glycol 20.0%+purified water 77.7% | gel ( 8 gm ) | topical |
| 8 | BLOOD FORMATION AND COAGULATION | |||
| 8A | ANEMIA & SOME OTHER BLOOD DISORDER | |||
| 8Aa | DRUG THERAPY FOR IRON DEFICIENCY ANAEMIAS | |||
| NCDS | 08-AA0-001 | Ferrous fumarate 200mg | Tablet | oral |
| NCDS | 08-AA0-003 | Ferrous gluconate 400mg/15ml | Syrup | oral |
| NCDS | 08-AA0-004 | Iron 66mg +Thiamine100mcg + Riboflavin 250mcg+ Nicotinamide 2mg+copper 10mcg/ml | Drop | oral |
| NCDS | 08-AA0-005 | Ferrous sulphate 200mg | Tablet | oral |
| NCDS | 08-AA0-009 | Iron (as Iron dextran) 50mg/ml | 2ml Ampoule | deep I.M or slow I.V or by Slow I.V infusion |
| NCDS | 08-AA0-014 | Iron (as Iron sucrose) 20 mg/ 1ml | 5ml Ampoule or vial | slow IV injection or IV infusion |
| NCDS | 08-AA0-013 | Iron (as Iron ( III ) hydroxide polymaltose complex) 100mg | 2ml Ampoule | IM |
| NCDS | 08-AA0-015 | Iron (as Iron ( III ) hydroxide polymaltose complex) 10mg /1 ml | syrup | oral |
| NCDS | 08-AA0-016 | Iron (as Iron ( III ) hydroxide polymaltose complex) 50mg /1 ml | drop | oral |
| NCDS | 08-AA0-017 | Iron as Iron ( III )- hydroxide polymaltose complex 100 mg | chewable Tablet | oral |
| NCDS | 08-AA0-018 | Iron (as Iron ( III ) hydroxide polymaltose complex) 100mg + 0.35 mg folic acid | chewable Tablet or film coated tablet | oral |
| NCDS | 08-AA0-020 | Iron (as Iron ( III ) hydroxide polymaltose complex) 100mg/5ml | solution single dose vial | oral |
| NCDS | 08-AA0-021 | Iron (as Ferric carboxymaltose) 50 mg/ml | 10ml vial | injection IV infusion |
| 8AB | DRUGS USED IN PLATLETS DISORDERS | |||
| NCDS | 08-AB0-001 | Romiplostim 500 mcg | powder for solution vial | injection SC injection |
| NCDS | 08-AB0-002 | Romiplostim 250 mcg | powder for solution vial | injection SC injection |
| NCDS | 08-AB0-003 | Eltrombopag 25 mg | tablet | oral |
| NCDS | 08-AB0-004 | Eltrombopag 50 mg | tablet | oral |
| 8B | DRUG THERAPY OF MEGALOBLASTIC ANAEMIA | |||
| NCDS | 08-B00-010 | Folic acid 5mg | tablet | oral |
| NCDS | 08-B00-013 | Folinic acid (as Calcium folinate or as Calcium leucovorin) 30mg/10ml | Vial | injection IV,IV infusion ,IM |
| NCDS | 08-B00-014 | Folinic acid(as Calcium folinate or as Calcium leucovorin) 30mg/ml | 3ml Ampoule or vial | injection |
| NCDS | 08-B00-015 | folinic acid 15mg (as calcium folinate or as calcium leucovorin) | tablet | oral |
| NCDS | 08-B00-019 | Folinic acid 50mg/5ml (as calcium folinate or as calcium leucovorin) | ampoule or vial | injection |
| NCDS | 08-B00-023 | folinic acid 100mg (as calcium folinate or as calcium leucovorin) | tablet | oral |
| NCDS | 08-B00-026 | Folinic acid 100 mg/10 ml (as calcium folinate ) | solution Vial | IM or IV injection or infusion |
| NCDS | 08-B00-024 | Cyanocobalamin (Vitamin B12) 1000mcg | solution( 1ml or 2 ml or 4 ml ampoule ) | injection IM. or SC or ORALLY |
| NCDS | 08-B00-016 | Hydroxycobalamin (Vitamin B12) 500 mcg/ml | 1ml Ampoule | injection IM. or SC. |
| NCDS | 08-B00-004 | Hydroxycobalamin (Vitamin B12) 250 mcg/ml | 1ml Ampoule | injection IM |
| NCDS | 08-B00-005 | Hydroxocobalamin or Hydroxocobalamin chloride or Hydroxocobalamin acetate or Hydroxocobalamin sulphate equivalent to Hydroxocobalamin 1000mcg/ml | 1ml Ampoule | injection IM or (IM ,IV) |
| 8C | DRUG THERAPY OF OTHER TYPES OF ANAEMIAS | |||
| NCDS | 08-C00-015 | Darbepoetin alfa 20 mcg | prefilled syrige or device | injection SC,IV |
| NCDS | 08-C00-016 | Darbepoetin alfa 40 mcg | prefilled syrige or device | injection SC,IV |
| NCDS | 08-C00-017 | Darbepoetin alfa 300 mcg | prefilled syrige or device | injection SC,IV |
| NCDS | 08-C00-001 | Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 2000IU | 1ml Vial or 0.5ml (Vial or prefilled syrige)Solution | injection SC,IV |
| NCDS | 08-C00-002 | Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 4000IU | 1ml Vial or prefilled syrige Solution | injection SC,IV |
| NCDS | 08-C00-004 | Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 4000IU | vial or 0.4ml PreFilled Syringe Solution | injection SC,IV |
| NCDS | 08-C00-007 | Epoetin Beta (Recombinant human erythropoietin Beta, rhEpo) 4000IU (HAS-Free ) (its imported suspended) | 0.3ml PreFilled Syring | injection SC,IV |
| NCDS | 08-C00-008 | Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 3000IU/0.3ml | prefilled Syring | injection SC,IV |
| NCDS | 08-C00-026 | Espogen :Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 2000 IU/0.5 ml | solution prefilled Syring | injection SC,IV |
| NCDS | 08-C00-027 | Espogen :Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 4000 IU/0.5 ml | solution prefilled Syring | SC and IV injection |
| NCDS | 08-C00-009 | Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 10000IU/1ml | prefilled Syring | SC and IV injection |
| NCDS | 08-C00-020 | Retacrit: Epoetin zeta (Recombinant human erythropoitin zeta)2000 IU | prefilled Syring or vial solution | SC and IV injection |
| NCDS | 08-C00-021 | Retacrit: Epoetin zeta (Recombinant human erythropoitin zeta)4000 IU | prefilled Syring or vial solution | SC and IV injection |
| NCDS | 08-C00-022 | Binocrit: Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 3000IU | prefilled Syring | SC and IV injection |
| NCDS | 08-C00-023 | Binocrit: Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 10000IU | prefilled Syring | SC and IV injection |
| NCDS | 08-C00-024 | Binocrit: Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 2000IU | prefilled Syring | SC and IV injection |
| NCDS | 08-C00-025 | Binocrit: Epoetin alfa(Recombinant human erythropoietin alfa, rhEpo) 4000IU | prefilled Syring | SC and IV injection |
| NCDS | 08-C00-010 | Methoxy polyethylene glycol-epoetin beta 50 mcg | prefilled Syring 0.3 ml solution | SC and IV injection |
| NCDS | 08-C00-011 | Methoxy polyethylene glycol-epoetin beta 75 mcg | prefilled Syring 0.3 ml solution | SC and IV injection |
| NCDS | 08-C00-012 | Methoxy polyethylene glycol-epoetin beta 100mcg | prefilled Syring 0.3 ml solution | SC and IV injection |
| NCDS | 08-C00-014 | Plerixafor 20 mg/ml | 1.2 ml vial | injection |
| NCDS | 08-C00-028 | Ravulizumab 300 mg concentrate for solution for injection | 3 ml vial | IV infusion |
| NCDS | 08-C00-029 | Ravulizumab 1100 mg concentrate for solution for injection | 11 ml vial | IV infusion |
| 8D | ANTICOAGULANTS AND PROTAMINE | |||
| NCDS | 08-D00-001 | Epoprostenol (prostacyclin) as sodium salt 500mcg | Vial | injection |
| NCDS | 08-D00-003 | Protamine sulphate 10mg/ml (with minimum of 90 anti-heparin IU/mg) | 5ml ampoule OR Vial | injectiom slow IV over 10 minutes or IV and SC |
| NCDS | 08-D00-009 | Warfarine sodium 1mg | Tablet | oral |
| NCDS | 08-D00-010 | Warfarine sodium 3mg | Tablet | oral |
| NCDS | 08-D00-011 | Warfarine sodium 5mg | Tablet | oral |
| NCDS | 08-D00-002 | Heparin sodium 5000 IU/ml | 5ml Vial | injection SC,IV |
| NCDS | 08-D00-020 | Heparin sodium1000 IU/ml | 5ml Vial | injection SC,IV |
| NCDS | 08-D00-015 | Nadroparin calcium 1900 IU Anti-xa (Axa) | prefilled Syring 0.2ml | Injection |
| NCDS | 08-D00-016 | Nadroparin calcium 2850 IU Anti Xa (Axa) | prefilled Syring 0.3ml | Injection |
| NCDS | 08-D00-017 | Nadroparin calcium 5700 IU Anti Xa (Axa) | prefilled Syring 0.6ml | Injection |
| NCDS | 08-D00-018 | Lepirudin 50mg (Recombinant ) | Vial | Injection |
| NCDS | 08-D00-019 | Lepirudin 50mg (Synthetic) | Vial | Injection |
| NCDS | 08-D00-060 | Fondaparinux Sodium 2.5 mg | 0.5 ml solution in Prefilled syringe | SC. Or IV use Injection |
| NCDS | 08-D00-021 | Enoxaparin sodium 80mg (eq. 8000 IU anti- Xa IU ) | 0.8ml prefilled syringe | Injection |
| NCDS | 08-D00-012 | Enoxaparin sodium 20mg (eq. 2000 IU anti- Xa) | 0.2ml prefilled syringe | S.C/intra arterial Injection (intravasular i-e intra arterial line only in(extra corporeal circulation)) |
| NCDS | 08-D00-013 | Enoxaparin sodium 40mg (eq.4000 IU anti- Xa) | 0.4ml prefilled syringe | S.C/intra arterial Injection (intravasular i-e intra arterial line only in(extra corporeal circulation)) |
| NCDS | 08-D00-014 | Enoxaparin sodium 60mg Injection (6000 IU anti Xa(anti thrombotic effect) | 0.6ml prefilled syringe | injection SC only |
| NCDS | 08-D00-042 | Inhixa : enoxaparin sodium 4000 IU(40mg) | 0.4 ml prefilled injection | injection |
| NCDS | 08-D00-043 | Inhixa : enoxaparin sodium 6000 IU(60mg) | 0.6 ml prefilled syringe | injection |
| NCDS | 08-D00-044 | Inhixa : enoxaparin sodium 2000 IU(20mg) | 0.2 ml prefilled syringe | injection |
| NCDS | 08-D00-047 | ENOX Anti-Xa : enoxaparin sodium 4000 IU(40mg) | 0.4 ml prefilled syringe | injection SC |
| NCDS | 08-D00-049 | ENOX Anti-Xa : enoxaparin sodium 2000 IU | 0.2 ml prefilled syringe | injection SC |
| NCDS | 08-D00-050 | ENOX Anti-Xa : enoxaparin sodium 6000 IU | 0.6 ml prefilled syringe | injection SC |
| NCDS | 08-D00-051 | Medaparin Anti-Xa : enoxaparin sodium 2000 IU | 0.2 ml prefilled syringe | injection SC |
| NCDS | 08-D00-052 | Medaparin Anti-Xa : enoxaparin sodium 4000 IU | 0.4ml prefilled syringe | injection SC |
| NCDS | 08-D00-053 | Medaparin Anti-Xa : enoxaparin sodium 6000 IU | 0.6 ml prefilled syringe | injection SC |
| NCDS | 08-D00-054 | Medaparin Anti-Xa : enoxaparin sodium 8000 IU | 0.8 ml prefilled syringe | injection SC |
| NCDS | 08-D00-055 | Enoxamed Anti-Xa: enoxaparin sodium 2000 IU | 0.2ml prefilled syringe | injection SC |
| NCDS | 08-D00-056 | Enoxamed Anti-Xa: enoxaparin sodium 4000 IU | 0.4ml prefilled syringe | injection SC |
| NCDS | 08-D00-057 | Enoxamed Anti-Xa: enoxaparin sodium 6000 IU | 0.6ml prefilled syringe | injection SC |
| NCDS | 08-D00-058 | Farinox : enoxaparin sodium 4000 IU | 0.4ml prefilled syringe | SC or IV injection |
| NCDS | 08-D00-059 | Farinox : enoxaparin sodium 6000 IU | 0.6ml prefilled syringe | SC or IV injection |
| NCDS | 08-D00-022 | Bemiparin sodium 2,500 IU anti-Xa | 0.2 ml prefilled syringe | injection SC |
| NCDS | 08-D00-023 | Bemiparin sodium 3,500 IU anti-Xa | 0.2 ml prefilled syringe | injection SC |
| NCDS | 08-D00-024 | Bemiparin sodium 5000 IU anti-Xa | 0.2 ml prefilledsyringe | injection SC |
| NCDS | 08-D00-028 | Fondaparinux 2.5mg/0.5 ml (5 mg /1 ml) | 0.5 ml prefilled syringe with an automatic safety system | injection SC or IV |
| NCDS | 08-D00-040 | Fondaparinux sodium 7.5mg/ 0.6ml (12.5mg/ 1ml ) | 0.6 ml prefilled syringe | injection SC |
| NCDS | 08-D00-030 | Tinzaparin Sodium Syringe 14000 anti-xa IU | 0.67 ml prefilled syringe | injection SC |
| NCDS | 08-D00-025 | Tinzaparin sodium 10000 anti-Xa IU | 0.5ml prefilled syringe | injection |
| NCDS | 08-D00-006 | Tinzaparin sodium 3500 anti-Xa IU | 0.35ml prefilled syringe | injection |
| NCDS | 08-D00-007 | Tinzaparin sodium 4500 anti-Xa IU | 0.45ml prefilled syringe | injection |
| NCDS | 08-D00-031 | Dabigatran etexilate (as mesilate) 150 mg | capsule | oral |
| NCDS | 08-D00-027 | Dabigatran etexilate (as mesilate) 110 mg | capsule | oral |
| NCDS | 08-D00-026 | Dabigatran etexilate (as mesilate) 75 mg | capsule | oral |
| NCDS | 08-D00-036 | Rivaroxaban 10 mg | Tablet | oral |
| NCDS | 08-D00-037 | Rivaroxaban 15 mg | Tablet | oral |
| NCDS | 08-D00-038 | Rivaroxaban 20 mg | Tablet | oral |
| NCDS | 08-D00-046 | Rivaroxaban 2.5 mg | Tablet | oral |
| NCDS | 08-D00-045 | Apixaban 5mg | Tablet | oral |
| NCDS | 08-D00-039 | Apixaban 2.5 mg | Tablet | oral |
| NCDS | 08-D00-061 | Edoxaban ( as Edoxaban tosilate ) 30 mg | Tablet | oral |
| NCDS | 08-D00-062 | Edoxaban ( as Edoxaban tosilate ) 60 mg | Tablet | oral |
| NCDS | 08-D00-034 | Trisodium citrate 46.7 % | 2ml solution | venous access device (VAD) |
| NCDS | 23-000-029 | Trisodium citrate 40mg\ml (4 % ) | vial 5 ml solution | venous access device (VAD) |
| NCDS | 23-000-030 | Trisodium citrate 300mg\ml (30 %) | vial 5 ml solution | venous access device (VAD) |
| NCDS | 08-D00-032 | Trisodium citrate 4% | 2ml solution | venous access device (VAD) |
| 8E | ANTIPLATELET DRUGS | |||
| NCDS | 08-E00-001 | Dipyridamole 75 mg | Tablet | oral |
| NCDS | 08-E00-002 | Dipyridamole 100 mg | Tablet | oral |
| NCDS | 08-E00-003 | Dipyridamole 5mg/ml | 2ml Ampoule | injection |
| NCDS | 08-E00-005 | Clopidogrel as Bisulphate = Clopidogrel as Hydrogen sulphate or Clopidogrel as Besilate or Clopidogrel as hydrochloride 75mg Clopidogrl as a base | Tablet | oral |
| NCDS | 08-E00-021 | acetylsalicylic acid 100mg (Enteric coating core ) and clopidogrel 75mg as clopidogrel sulfate 97.88mg (Immediate release outer layer) | film coated tablet | oral |
| NCDS | 08-E00-008 | Abciximab 2mg/ml | 5ml Ampoule OR Vial | injection |
| NCDS | 08-E00-012 | Eptifibatide 2mg/ml | (10ml) Vial | injection |
| NCDS | 08-E00-013 | Eptifibatide 75 mcg/ml | (100ml) Vial | injection |
| NCDS | 08-E00-014 | Aspirin 25mg +Dipyridamole 200 mg | Retard Capsule | 0ral |
| NCDS | 08-E00-015 | prasugrel ( as hydrochloride) 5 mg | tablet | 0ral |
| NCDS | 08-E00-016 | prasugrel ( as hydrochloride) 10 mg | tablet | 0ral |
| NCDS | 08-E00-020 | Ticagrelor 90 mg | tablet | 0ral |
| NCDS | 08-E00-023 | Ticagrelor 60 mg | film coated tablet | 0ral |
| 8F | FIBRINOLYTICS | |||
| NCDS | 08-F00-003 | Fibrin Foam | foam | topical |
| NCDS | 08-F00-004 | Human thrombin Injection | ||
| NCDS | 08-F00-009 | Alteplase( Recombinant human tissue type plasminogen activator) 50mg | Vial | injection |
| NCDS | 08-F00-011 | Tenecteplase ( TNK ) 10000 U (50mg) | Vial powder+ prefilled syring of solvent contain 10 ml sterile water /set | injection |
| 8G | ANTIFIBRINOLYTIC AGENTS | |||
| NCDS | 08-G00-001 | Tranexamic acid 500mg | Tablet | oral |
| NCDS | 08-G00-002 | Tranexamic acid 100mg/ml | 5ml Ampoule or vial | injection |
| NCDS | 08-G00-003 | Tranexamic acid 1 gm | sachet granules for solution | oral |
| 8H | PLASMA FRACTION FOR SPECIFIC USES | |||
| NCDS | 08-H00-001 | Recombinant Factor VIII, 250 IU | vial | IV injection |
| NCDS | 08-H00-003 | Recombinant Factor IX, 200 IU | vial | IV injection |
| NCDS | 08-H00-004 | Recombinant Factor IX, 250 IU | vial | IV injection |
| NCDS | 08-H00-005 | Factor IX 500 IU ( Recombinant IX ,SHL or human plasma derived ) vial / IV | vial | IV injection |
| NCDS | 08-H00-026 | Factor IX, 500 IU ( Recombinant coagulation factor IX ,EHL) | vial | IV injection |
| NCDS | 08-H00-029 | Recombinant coagulation factor IX 2000 IU ( Eftrenonacog alfa ) | powder and solvent for solution vial | IV injection |
| NCDS | 08-H00-025 | ALPROLIX : 500 IU Coagulation Factor IX (Recombinant), Fc Fusion Protein (rFIXFc) | vial lyophilized powder for reconstitution + diluent | IV injection |
| NCDS | 08-H00-006 | Recombinant Factor VIIa ( Eptacog alfa ) ( Activated) 1mg | vial or syringe with solvent | IV injection |
| NCDS | 08-H00-021 | Aryoseven RT: Recombinant factor VII a (eptacogalfa ) 1 mg | vial | IV injection |
| NCDS | 08-H00-007 | Plasma protein fraction (human) 5% i.v. infusion i-e 1ml contains: Human serum protein 50mg of which: Albumin approx 31mg Human Ig approx. 10mg (Ig G , Ig A, Ig M) | vial | IV injection |
| NCDS | 08-H00-008 | Factor VIII 500 IU ( Recombinant HSA Free or human plasma derived ) | vial | IV injection |
| NCDS | 08-H00-009 | Factor IX, 600 IU (Recombinant) | vial | IV injection |
| NCDS | 08-H00-013 | Recombinant Factor VIII, 1000 IU (HSA FREE) | vial | IV injection |
| NCDS | 08-H00-014 | VonWillebrand Factor / Coagulation Factor VIII Complex (Human) Vwf\Factor VIII 1:1-2:1 | vial powder +and solvent for solution | IV injection |
| NCDS | 08-H00-015 | Anti-Inhibitor Coagulant Compelx Nanofilterd &Vapor Heated:- 500 Units per Vial ( Factor VIII inhibitor Bypassing Activity | vial powder and solvent | IV injection |
| NCDS | 08-H00-016 | Fibrinogen concentrate(Human):- Lyophilized powder for reconstitution 900 mg to 1300 mg | vial for reconstitution with 50 ml of sterile water for injection | IV injection |
| NCDS | 08-H00-027 | Component 1: Human Fibrinogen ( as clottable protein) , lyophilized, 91 mg/ml , Synthetic Aprotinin 3000 KIU/ml Component 2 : human Thrombin powder , reconstituted with calcium chloride solution contains : Human thrombin , lyophilized , 500 IU/ml , Calcium chloride 40 µmol/ml | 2ml, 4ml, 10ml lyophilized vial | topical (epilesional use only) |
| NCDS | 08-H00-017 | Factor XIII concentrate ( Human) Lyophilized concentrate for reconstitution:-1000- 1600 units for reconstitution in 20 ml | vial | IV injection |
| NCDS | 08-H00-018 | Factor VIII inhibitor Bypassing Activity 1 Vial provides 200-600 mg human plasma protien with a factor VIII inhibitor Bypassing Activity of 500 units | vial | IV injection |
| NCDS | 08-H00-019 | Factor VIII inhibitor Bypassing Activity 1 Vial provides 200-600 mg human plasma protien with a factor VIII inhibitor Bypassing Activity of 1000 units | vial | IV injection |
| NCDS | 08-H00-020 | Coagulation Factor X ( Human ) 250 IU | vial | IV injection |
| NCDS | 08-H00-022 | Human Prothrombin complex powder and solvent for soluion for infusion Human coagulation factor IX 500IU Human coagulation factor II 280-760IU Human coagulation factor VII 180-480IU Human coagulation factor X 360-600IU Human protein C 260-620IU Human protein S 240-640IU | vial | IV injection |
| ANTIHAEMORRHAGICS › HAEMOSTATICS› › monoclonal antibody | ||||
| NCDS | 08-H00-023 | Emicizumab 30mg | vial solution | IV injection |
| NCDS | 08-H00-024 | Emicizumab 150mg solution | vial solution | IV injection |
| 8I | OTHERS | |||
| NCDS | 08-I00-001 | Cardioplegia Solution (St Thomas formula) Alternative to below mentioned formula(B.M*) when this B.M* is not available | solution | injection IV infusion |
| NCDS | 08-I00-002 | Cardioplegia Solution : Sodium chloride 0.8766g (15mmol/l)+Potassium chloride 0.6710g(9mmol/l)+Potassium hydrogen 2-Ketoglutarate0.1842g (1mmol/l)+Magnesium chloride 6H2O 0.8132g (4mmol/l)+Histidine Hcl .H2O 3.7733g(18mmol/l)+Histidine 27.9289g(180mmol/l)+Tryptophan 0.4085g(2mmol/l)+Mannitol 5.4651g(30mmol/l)+Calcium chloride .2H2O 0.0022g(0.015mmol/l)/1000ml ,in Water for inj Osmolality 310mosmol/Kg ,An ion CL- 50mEq ,2000ml | 2000ml solution | injection IV infusion |
| NCDS | 08-I00-003 | Cardioplegia infusion containing in 20 ml : : magnesium chloride hexahydrate 3.253 g , potassium chloride BP 1.193 g , procaine hydrochloride BP 272.8 mg , also present :disodium edentate BP. sodium hydroxide BP and water for injection | 20 ml ampoule | injection IV infusion |
| 9 | NUTRITION | |||
| 9A | VITAMINS | |||
| 9AA | Vitamin A Retinol قرار عام:- – يمنع منعاً باتاً اعطاء Vit.A الى الحوامل في الاشهر الثلاثة الاولى من الحمل وذلك لوجود مخاطر حصول تشوهات خلقية في الجنين. – ويفضل عدم اعطاءه للنساء المرضعات الا عند وجود علامات لنقص فيتامين A وبأشراف الطبيب احدث جدول بكميات فيتامين A المسموح بها بالحد الاعلى لكافة الاعمارلكلا الجنسين مع التحذير من استخدام هذه المستحضرات من قبل الحوامل (570 6000 4000 5000 3300 2000 1500 2000 2000 RDA (IU.) المسموح بها عالمياً 6000 4000 5000 4500 4500 3000 3000 3000 UL (IU.)الحد الاعلى المرضعة الاناث 11-22 سنة الذكور 11-22 سنة 7-10 سنة 4-6 سنة1- 3 سنة 7-12 شهر صفر-6 أشهر كمية فيتامين A وحدة عالمية | |||
| NCDS | 09-AA0-001 | Vitamin A 25000 units | soft gelatin Capsule | oral |
| NCDS | 09-AA0-002 | Vitamin A as palmitate 50000 IU | soft gelatin Capsule | oral |
| NCDS | 09-AA0-003 | Vitamin A 50000 units | Chewable Tablet | oral |
| NCDS | 09-AA0-007 | Vitamin A as palmitate 50000 unit/ml | (2ml) Ampoule | oral |
| NCDS | 09-AA0-008 | Vitamin A 100000 IU | Capsule | oral |
| NCDS | 09-AA0-009 | Vitamin A 200000 IU | Capsule | oral |
| 9AB | Vitamin B group | |||
| NCDS | 09-AB0-002 | Thiamine hydrochloride (Vitamin B1) 50mg/ml | 2ml Ampoule | injection |
| NCDS | 09-AB0-004 | pyridoxine hydrochloride(Vitamin B6) 50 mg/ml | 1ml or 2ml Ampoule | injection |
| NCDS | 09-AB0-007 | Thiamine hydrochloride (Vitamin B1) 100-200mg +Vit. B2 10-25mg +pyridoxine hydrochloride(Vitamin B6) 50-100mg+cyanocobolamine(Vitamin B12 )1000mcg(with or without)/2ml | Ampoule | injection |
| NCDS | 09-AB0-012 | Vitamin B+C ampoule I contain:Thiamine hydrochloride (Vitamin B1) 250mg+riboflavin(Vitamin B2) 4mg+pyridoxine hydrochloride(Vitamin B6) 50mg ampoule II contain: nicotinamide (Vitamin B3) 160mg+ Ascorbic acid (Vitamin C )500mg or high potency inj:ascorbic acid Vitamin C )500mg+Nicotinamide 160mg+pyridoxine hydrochloride(Vitamin B6 50mg+Riboflavin Vitamin B2) 4mg+Thiamine hydrochloride (Vitamin B1) 250mg /7ml | (in 2 ampoule) | injection IM |
| NCDS | 09-AB0-039 | Vitamin B + C Ampoule I contain: Thiamine hydrochloride (Vitamin B1) 250mg +riboflavin(Vitamin B2) 4mg + pyridoxine hydrochloride(Vitamin B6) 50mg Ampoule II contain: nicotinamide (Vitamin B3) 160mg +Ascorbic acid (Vitamin C )500mg or I.V High potency injection : Ascorbic acid (Vitamin C )500mg + Nicotinamide (Vitamin B3)160mg + anhydrous glucose 1g + pyridoxine hydrochloride(Vitamin B6) 50mg +riboflavin(Vitamin B2)4mg + Thiamine hydrochloride (Vitamin B1)250mg/ 10 ml | (in 2 ampoule) | injection IV |
| NCDS | 09-AB0-014 | Thiamine hydrochloride (Vitamin B1) 100mg + pyridoxine hydrochloride(Vitamin B6) 100mg +cyanocobolamine(Vitamin B12 )1000mcg/3ml | Ampoule | injection |
| NCDS | 09-AB0-015 | Thiamine hydrochloride (Vitamin B1) 100mg + pyridoxine hydrochloride(Vitamin B6)100mg +cyanocobolamine(Vitamin B12 )1000mcg/2ml | Ampoule | injection IM |
| NCDS | 09-AB0-016 | Thiamine hydrochloride (Vitamin B1) 12mg +pyridoxine hydrochloride (Vitamin B6) 4400mcg +riboflavin 5-phosphate sodium 2mg+ cyanocobolamine(Vitamin B12 ) 8mcg+ Calicium pantothenate 6mg + nicotinamide (Vitamin B3) 20mg /2ml | Ampoule | injection |
| NCDS | 09-AB0-017 | Thiamine hydrochloride (Vitamin B1)100mg + pyridoxine hydrochloride(Vitamin B6) 100mg +cyanocobolamine(Vitamin B12 )1000mcg+nicotinamide (Vitamin B3)9mg /2ml | Ampoule | injection |
| NCDS | 09-AB0-018 | Thiamine hydrochloride (Vitamin B1) 200mg + pyridoxine hydrochloride (Vitamin B6)50mg + cyanocobolamine(Vitamin B12) 1000mcg | Tablet | oral |
| NCDS | 09-AB0-033 | Thiamine hydrochloride (Vitamin B1) 100mg + pyridoxine hydrochloride (Vitamin B6)200mg + cyanocobolamine(Vitamin B12) 500mcg | Tablet | oral |
| NCDS | 09-AB0-040 | Thiamine hydrochloride (Vitamin B1) 200mg + pyridoxine hydrochloride (Vitamin B6)200mg + cyanocobolamine(Vitamin B12) 1000mcg | Tablet | oral |
| NCDS | 09-AB0-020 | Thiamine hydrochloride (Vitamin B1) 10mg + riboflavin 5-phosphate sodium 4mg +pyridoxine hydrochloride (Vitamin B6)2mg + nicotinamide (Vitamin B3) 20mg +D-panthenol (Dexpanthenol) 6mg \ 2ml | Ampoule | injection |
| NCDS | 09-AB0-021 | cyanocobolamine(Vitamin B12 ) 1mg + pyridoxine hydrochloride(Vitamin B6) 50 mg +Thiamine hydrochloride (Vitamin B1) 200mg + lidocaine hydrochloride 10 mg | 1ml or 2ml Ampoule | injection IM |
| NCDS | 09-AB0-034 | Thiamine hydrochloride (Vitamin B1)10mg +riboflavin(Vitamin B2) 4mg + pyridoxine hydrochloride(Vitamin B6) 4mg + cyanocobolamine(Vitamin B12 )8mcg + nicotinamide (Vitamin B3 ,Vitamin PP)40mg + D-panthenol (Dexpanthenol) 6mg + Biotin 0.5 mg /2ml | Ampoule | injection |
| NCDS | 09-AB0-038 | Thiamine hydrochloride (Vitamin B1)100mg +pyridoxine hydrochloride (Vitamin B6) 100mg/2ml + cyanocobolamine(Vitamin B12 ) 1000mcg/1ml | 2 double ampoule | injection |
| NCDS | 09-AB0-043 | Thiamine hydrochloride (Vitamin B1)10mg (0.5%) + riboflavin 5-phosphate sodium 5mg (0.25%) + B6 pyridoxine hydrochloride(Vitamin B6) 10mg (0.5%) +nicotinamide (Vitamin B3) 10mg (0.5%) /2ml | ampoule | injection |
| NCDS | 09-AB0-025 | Thiamine hydrochloride (Vitamin B1) 10mg +riboflavin(Vitamin B2) 5.47 mg +pyridoxine hydrochloride(Vitamin B6) 4 mg +-panthenol (Dexpanthenol) (Vitamin B5) 6 mg + nicotinamide (Vitamin B3) 40 mg /2 ml | ampoule | injection |
| NCDS | 09-AB0-028 | Methylcobalamin (Mecobalamin)500 mcg | 1 ml ampoule | IV , IM , slow IV injection |
| NCDS | 09-AB0-029 | Methylcobalamin (Mecobalamin) 1000 mcg | instant dissolve tablet | oral |
| NCDS | 09-AB0-030 | Thiamine hydrochloride (Vitamin B1) 100mg + pyridoxine hydrochloride(Vitamin B6) 200mg + cyanocobolamine(Vitamin B12 ) 200mcg | tablet | oral |
| NCDS | 09-AB0-044 | Thiamine nitrate ( B1 ) 200 mg + Pyridoxine hyrochloride ( B6 ) 100 mg + Cyanocobalamine ( B12 ) 1 mg | tablet | oral |
| 9AC | Ascorbic acid (Vitamin C) | |||
| NCDS | 09-AC0-006 | Vitamin C (Ascorbic acid) 100mg/ml | ampoule | Injection |
| NCDS | 09-AC0-007 | Vitamin C (Ascorbic acid) 200mg | ampoule | Injection |
| 9AD | Vitamin D and analogues | |||
| NCDS | 09-AD0-001 | Alfacalcidol (1alfa Hydroxycholecalciferol)0.25mcg | soft gelatin Capsule or tablet | oral |
| NCDS | 09-AD0-002 | Alfacalcidol (1alfa Hydroxycholecalciferol)1mcg | soft gelatin Capsule or tablet | oral |
| NCDS | 09-AD0-041 | Calcifedol monohydrate 0.266 mg | soft capsule | oral |
| NCDS | 09-AD0-003 | Alfacalcidol (1alfa Hydroxycholecalciferol)2mcg/ml | Drop | oral |
| NCDS | 09-AD0-025 | Alfacalcidol (1alfa-Hydroxycholecalciferol)2 mcg/ml | 1ml ampule | IV injection |
| NCDS | 09-AD0-023 | calcitriol(1,25-Dihydroxycholecalciferol) 250 ng | capsule | oral |
| NCDS | 09-AD0-024 | calcitriol(1,25-Dihydroxycholecalciferol) 1 mcg / ml | 1 ml ampoule | injection |
| NCDS | 09-AD0-042 | calcitriol(1,25-Dihydroxycholecalciferol) 500 ng | capsule | Oral |
| NCDS | 09-AD0-007 | Dihydrotachysterol 250mcg/ml | Solution | Oral |
| NCDS | 09-AD0-010 | Ergocalciferol(calciferol, vitamin D2) 400 IU (0.01mg) /0.02ml | Drop | oral |
| NCDS | 09-AD0-011 | Ergocalciferol(calciferol, vitamin D2) 1.25mg ( 50.000 IU) | Tablet or Capsule | oral |
| NCDS | 09-AD0-005 | Ergocalciferol(calciferol, vitamin D2) 15mg (600000 IU) /1.5ml | (1.5ml ) Ampoule solution | IM , oral |
| NCDS | 09-AD0-028 | Colecalciferol (Cholecalciferol; Vitamin D3 10.000 IU/ml equivalent to 0.25 mg | Drop | oral |
| NCDS | 09-AD0-029 | Colecalciferol (Cholecalciferol; Vitamin D3) 25.000 IU /2.5 ml | solution or soft gel capsule | oral |
| NCDS | 09-AD0-030 | Colecalciferol (Cholecalciferol; Vitamin D3) 10.000 IU | capsule or tablet or caplet | oral |
| NCDS | 09-AD0-009 | Colecalciferol (Cholecalciferol; Vitamin D3) 300000 unit/ml | Ampoule | IM injection or oral |
| NCDS | 09-AD0-043 | Colecalciferol (Cholecalciferol; Vitamin D3) 300000 unit | 2 ml ampoule | oral |
| NCDS | 09-AD0-035 | Colecalciferol (Cholecalciferol; Vitamin D3) 2.5 mg (100000 IU)\2 ml | Ampoule solution | Oral |
| NCDS | 09-AD0-038 | Colecalciferol (Cholecalciferol; Vitamin D3) 200000 unit/ml | 1 ml or 2ml Ampoule | injection IM or oral use |
| NCDS | 09-AD0-031 | Colecalciferol (Cholecalciferol; Vitamin D3) 50.000 IU | capsule or tablet or caplet | oral |
| NCDS | 09-AD0-032 | Colecalciferol (Cholecalciferol; Vitamin D3) 5000 IU | capsule or tablet or soft gel capsule or chewable tablet | oral |
| NCDS | 09-AD0-039 | Colecalciferol (Cholecalciferol; Vitamin D3) 2.5 mg (100000 IU)/ ml | (1ml ampoule) | oral and IM injection |
| NCDS | 09-AD0-040 | Colecalciferol (Cholecalciferol; Vitamin D3) 50.000 IU | 2.5 ml solution in container | oral |
| 9AE | Vitamin E | |||
| NCDS | 09-AE0-005 | Vitamin E 1000 IU | soft gel capsule | oral |
| 9AF | Vitamin K | |||
| NCDS | 09-AF0-001 | Menadiol sodium diphosphate eq. 10mg menadiol phosphate | Tablet | oral |
| NCDS | 09-AF0-003 | Phytomenadione (Vitamin K1) colloidal mixed micelles10mg | Soluble Tablet | oral |
| NCDS | 09-AF0-004 | Phytomenadione(Vitamin K1) colloidal mixed micelles 10mg | Chewable Tablet | oral |
| NCDS | 09-AF0-005 | Phytomenadione(Vitamin K1) colloidal mixed micelles 10mg | scored Tablet | oral |
| NCDS | 09-AF0-006 | Phytomenadione(Vitamin K1) mixed micelles 2mg/0.2ml | Ampoule | IM.and IV |
| NCDS | 09-AF0-007 | Phytomenadione (Vitamin K1) mixed micelles 10mg/ml | (1ml) Ampoule | slow IV (withen 30 sec) |
| NCDS | 09-AF0-008 | Phytomenadione (Vitamin K1) mixed micelles 1mg/ml | (1ml) Ampoule | injection IM |
| 9AG | Multivitamin preparations | |||
| NCDS | 09-AG0-001 | element iron ( 45 – 50 ) mg + folic 0.5 mg or element iron ( 60 – 65 ) mg + folic 0.25 mg | tablet or capsule | oral |
| NCDS | 09-AG0-002 | Dried Ferrous sulphate150mg(eq. 47mg or 45mg iron)+Folic acid 0.5mg | spansules Capsule | oral |
| NCDS | 09-AG0-005 | Ferrous fumarate 200mg + Ascorbic acid (Vitamin C )25mg + Folic acid 0.2mg | Capsule or Tablet | oral |
| 9B | PARENTERAL NUTRITION | |||
| NCDS | 09-B00-022 | 1000-2500 ml Triple compartment bag contain the following :- -Amino acids and electrolyte 300-1000 ml -Glucose 500- 1300 ml -Lipid emulsion 200-500 ml Or 20% according to BNF – Nitrogen 2.5-25.7 g/L – Energy 1300-12600 Kj/L – K+ 5-60 mmol/L – Mg+2 1.8-8 mmol/L – Na+ 20-140 mmol/L – Acet- 19.5-150 mmol/L – Cl- 19-100 mmol/L Other components as following :- – Ca+2 1.4-5 mmol/L – Phosphate 5- 30 mmol/L – Anhydrous glucose 50-240 g/L – Soya oil 16-300 g/L – Triglycerides 0-100 g/L – Zn+2 0-32 µmol/L ملاحظة :- المواد التي أدرجت تحت تسمية other components يعني بالتركيبة الواحدة يمكن ان تحتوي على كل المكونات المدرجة في الجدول او جزء منها او قد تحتوي على مواد اضافية اخرى حسب حاجة المريض | solution bag | PARENTERAL |
| NCDS | 09-B00-023 | 500 ml container contain Nitrogen, Electrolyte as following :- – Energy* ——— – Nitrogen 7.5-16.5 mmol/L – K+ 25-60 mmol/L – Mg+2 2.5-8 mmol/L – Na+ 43-100 mmol/L – Acet- 35-150 mmol/L – Cl- 0-100 mmol/L Other components as following :- – Ca+2 0-5 mmol/L – Malic acid or dihydro phosphate or acid phosphate. ي التركيبة الواحدة يمكن أن تحتوي التركيبة على كلها أو جزء منهاother components ملاحظة :- المواد التي أدرجت تحت تسمية . * = Exclude protein or amino acids derived energy | solution bag | PARENTERAL |
| NCDS | 09-B00-024 | 500 ml container contain Nitrogen as following :- -Electrolyte -Energy * ——- – Nitrogen 9-18 g/L – Acet- 0-110 mmol/L – Cl- 0-40 mmol/L في التركيبة الواحدة يمكن أن تحتوي التركيبة على كلها أو جزء منهاother components ملاحظة :- المواد التي أدرجت تحت تسمية * = Exclude protein or amino acids derived energy | solution bag | PARENTERAL |
| NCDS | 09-B00-030 | 1000 ml contain :Soya-Bean oil, refined 60g+ triglycerides, medium chain 60 g + olive oil, refined 50 g+ fish oil , rich in omega-3 acids 30g + all-rac-α-Tocopherol 163-225 mg + Glycerol (anhydrous) 25g + Egg lecithin 12g + sodium hydroxide to approx.. PH 8+sodium oleate 0.3g + water for injections to 1000 ml emulsion Energy content : 4.8 MJ/I ( 2000 kcal/l) PH approx.. : 8 Osmolality: 380 mosm/ kg H2O | (100ml, 250ml, 500ml bottle ) | PARENTERAL |
| NCDS | 09-B00-025 | 500 ml container ( 20%) contain Energy as following :- -ُElectrolyte ————– – Energy 8000 ± 500 Kj/L -Nitrogen ————— Other components may contain soya oil, glycerol , purified egg phospholipids, phosphate, omega-3 acid triglycerides, fish oil, palm oil , or coconut oil. في التركيبة الواحدة يمكن أن تحتوي التركيبة على كلها أو جزء منهاother components ملاحظة :- المواد التي أدرجت تحت تسمية | solution bag | PARENTERAL |
| NCDS | 09-B00-026 | 100 ml container contain Nitrogen , (used only for neonate and children) as following :- -Energy ——– -Nitrogen 9- 15 g/L -Electrolyte ——– – Cl- 0-20 mmol/L في التركيبة الواحدة يمكن أن تحتوي التركيبة على كلها أو جزء منهاother components ملاحظة :- المواد التي أدرجت تحت تسمية . | solution bag | PARENTERAL |
| NCDS | 9C | ELECTROLYTES&WATER FOR INJECTION | * | |
| 9CA | drugs used in hypokalaemia | |||
| NCDS | 09-CA0-001 | Potassium chloride 15% or 14.9% w/v (Approximately 2 mmol/ml) | (10 ml )Vial or Ampoule | injection |
| NCDS | 09-CA0-002 | Potassium chloride (KCL B.p73) 15%(150mg/ml corresponding to approximately 2mmol of each K+& Cl-/ml) strong solution | (20ml)vial or ampoule | Slow IV. infusion N.M.T 20-40mEq(mmol) per 4-6hr (According to defficiency)) |
| NCDS | 09-CA0-003 | Potassium chloride 750mg (10MEq of potassium) | durules or sustained release tablet or microencapsulated Tablet | oral |
| NCDS | 09-CA0-004 | Potassium chloride 600mg (8MEq of potassium ) | wax base Tablet | oral |
| NCDS | 09-CA0-005 | potassium chloride :potassium Bicarbonate & Chloride eq. potassium 470mg (12mmol of K+ ) & Chloride 285mg (8mmol of cl-) | EffervescentTablet | oral |
| NCDS | 09-CA0-007 | Potassium chloride 7.5% {eq.1mEq.of both K& Cl(1mmol of both K& Cl)\ml} | Syrup | oral |
| NCDS | 09-CA0-008 | Potassium chloride 600mg (8MEq of potassium ) | controlled release or modified release tablet | oral |
| NCDS | 09-CA0-009 | Potassium gluconate 4.68g eq. 20mEq of potassium/15ml | Solution | oral |
| 9CB | drugs used in hyperkalaemia | |||
| NCDS | 09-CB0-001 | Calcium gluconate injection 10% w/v( anhydrous calcium gluconate(usp) approximately 0.233 mmol = 0.465 mEq of calcium ) \ml or calcium gluconate monohydrate(Bp) approximately 0.225 mmol = 0.450 meq. of calcium)\ml | (10 ml )Vial or Ampoule | (IV infusion) or (slow IV injection,deep IM) or (slow IV injection)(IM injection |
| NCDS | 09-CB0-002 | Calcium polystyrene sulphonate resins 5gm\ sachet | Powder | oral |
| NCDS | 09-CB0-003 | Calcium polystyrene sulphonate resins 300gm\ bottle | Powder | oral |
| NCDS | 09-CB0-004 | Sodium zirconium cyclosilicate 5 gm / sachet | powder for oral suspension | oral |
| NCDS | 09-CB0-005 | Sodium zirconium cyclosilicate 10 gm / sachet | powder for oral suspension | oral |
| 9CC | sodium salts | |||
| NCDS | 09-CC0-001 | Sodium 90 mEq + Potassium 20 mEq + Chloride 80 mEq + Citrate 30 mEq + Dextrose 25g/L | powder for solution or solution | oral |
| NCDS | 09-CC0-002 | Sodium bicarbonate 300mg | Tablet | oral |
| NCDS | 09-CC0-003 | Sodium chloride 300mg | Tablet | oral |
| NCDS | 09-CC0-004 | Sodium chloride 0.52g+potassium chloride 0.3g+Tri.sodium citrate dihydrate 0.58g+anhydrous glucose 2.7g/sachet (dissolve in 200ml) | powder for solution sachet | |
| 9CD | drugs used in hypercalcemia | |||
| NCDS | 09-CD0-001 | Sodium acid phosphate Anhydrous 1.936g+Sodium bicarbonate 350mg+Potassium bicarbonate 315mg eq. Phosphorous 500mg+Sodium 468.8mg(20.4mmol Na+)+Potassium 123mg(3.1mmol K+) | EffervescentTablet | oral |
| NCDS | 09-CD0-002 | Sodium cellulose phosphate 5g \Sachet | powder for solution sachet | oral |
| 9CE | drugs used in hypocalcemia | |||
| NCDS | 09-CE0-008 | Calcium chloride dihydrate 10% 100mg/ml (27.3mg calcium or 680 micromol ca++/ml | (10ml Amp) or prefilled syringe | injection |
| NCDS | 09-CE0-009 | Calcium glubionate 1.375 g/10ml | ampoule | IM,IV injection |
| 9CF | MAGNESIUM | |||
| NCDS | 09-CF0-001 | Magnesium sulphate 7H2O 50% (eq. 2 mmol Mg+2/ ml | (5ml) Ampoule | injection slow IV, IM |
| NCDS | 09-CF0-002 | Magnesium sulphate 50% | (10ml) Ampoule | injection |
| NCDS | 09-CF0-003 | Magnesium sulphate 20% | (10 or 20ml) Ampoule | injection |
| 9CG | Water for injection | |||
| NCDS | 09-CG0-001 | Water for injection | ampoule | injection |
| 9D | INTRAVENOUS FLUIDS | |||
| NCDS | 09-D00-001 | Dextran 70 in glucose 5% (Plander D) i.e.;-(6%w/v) | 500ml solution | injection IV infusion |
| NCDS | 09-D00-002 | Dextran 70 in Sodium Chloride 0.9% (Normal saline) (plander N) i.e.;-(6%w/v) | 500ml solution | injection IV infusion |
| NCDS | 09-D00-004 | Dextran 1 | (20ml) Ampoule | injection IV |
| NCDS | 09-D00-005 | Dextran 40 in glucose 5% i.e.;-(10%w/v) | 500ml solution | injection IV infusion |
| NCDS | 09-D00-006 | Dextran 40 in Sodium Chloride 0.9% (Normal saline) i.e.;-(10%w/v) | 500ml solution | injection IV infusion |
| NCDS | 09-D00-007 | Glucose (dextrose) hydrous or anhydrous 5% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-063 | Glucose(dextrose) hydrous or anhydrous 5 % | 100ml solution | injection IV infusion |
| NCDS | 09-D00-008 | Glucose (dextrose) hydrous or anhydrous 10% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-009 | Glucose (dextrose) hydrous or anhydrous 20% | 50ml solution | injection IV infusion |
| NCDS | 09-D00-010 | Glucose (dextrose) hydrous or anhydrous 25% | (20ml) Ampoule | injection IV infusion |
| NCDS | 09-D00-011 | Glucose (dextrose) hydrous or anhydrous 50% | (20ml) Ampoule | injection IV infusion |
| NCDS | 09-D00-042 | Glucose (dextrose) hydrous or anhydrous 50% | (50ml) Ampoule | injection IV infusion |
| NCDS | 09-D00-064 | Glucose (dextrose) hydrous or anhydrous 20% | 500 ml solution in plastic bag or bottels | injection IV infusion |
| NCDS | 09-D00-013 | Succinylated gelatin 4% + Sodium Chloride 0.9% | solution | injection IV infusion |
| NCDS | 09-D00-044 | Succinylated gelatin 4% (modified fluid gelatin/average M.Wt.30000),Na + 154mmol/L,Cl-120mmol/L(comply and alternative to Hemaccel,Gelfusine,Gelfundol) | 1000ml solution | injection IV infusion |
| NCDS | 09-D00-065 | (Poly (o-2-hydroxyethyl:- Starch(HES) 60.0g+Sodium chloride 6.25g+Potassium chloride 0.30g + Calcium chloride dihydr. 0.37g + Magnesium chloride hexahydrate 0.20g +Sodium acetate trihydrate 3.27g +Malic acid 0.67g.)per 1000ml – Electrolytes mmol/L :-Na+ 140.0 +K+ 4.0 +Ca+2 2.5 + Mg++ 1+ Cl- 118 + acetate 24 + malate 5 PH 5.6-6.4 Osmolarity 296 mosm/L plasma substitute يستعمل كتعويض للبلازما | 1000ml solution | injection IV infusion |
| NCDS | 09-D00-046 | Hydrolyzed gelatin OR succinylated gelatin OR both 30-40gm /L with average M.wt of (26500 – 30000) -Na 150-154 mmolL -Cl 100-125 mmol/L -K 0- 5 mmol/L -Mg 0-1.5 mmol/L -lactate or acetate 0-30 mmol//L | 500ml solution (container) | injection IV infusion |
| NCDS | 09-D00-016 | Hydroxyethyl starch (hetastarch) 6% inSodium Chloride 0.9% or Hydroxyethyl starch (HES130\0.4) in isotonic sodium chloride | 500ml solution | injection IV infusion |
| NCDS | 09-D00-022 | Oxypolygelatin 55g/L + Other Constituants: sodium Edetate 0.19g/L + Hydrogen carbonate ions 30mmol/L +Na ions 145mmol/L* + Cl ions 100mmol/L + Ca ions (as EDTA complex) 0.5mmol/L of which* 15mmol are protein bound | solution | injection IV infusion |
| NCDS | 09-D00-015 | Human albumin 200mg/ml, low salts(87 – 160 mmol / L Na) Aids free | 100ml solution | injection IV infusion |
| NCDS | 09-D00-047 | Human albumin 200mg/ml | 50ml solution | injection IV infusion |
| NCDS | 09-D00-023 | Ringer solution for U.S.P :sodium chloride 8.6g+potassium chloride 0.3 g+ calcium chloride 0.33g in water for injection Q.S 1000ML containing the following ions conc. In meq / L :- Ca ++ 4.5 , Cl – 156, K+ 4 ,Na + 147.5 . | 500ml solution | injection IV infusion |
| NCDS | 09-D00-014 | Hartmann’s solution or (ringer lactate or lactated Ringer or Compound sodium lactate )solution intravenous infusion ,sodium chloride 0.6%,sodium lactate 0.32%or Sodium lactate 0.25% calculated as lactic acid, potassium chloride 0.04%,calcium chloride 0.027% (contains the following ions in mmol /L :Na+131,K+5,Ca++2,HCO3-(as lactate) 29,Cl-111) | 500ml solution | injection IV infusion |
| NCDS | 09-D00-024 | Sodium bicarbonate 7.5% | 50ml Ampoule or vial | injection IV infusion |
| NCDS | 09-D00-026 | Sodium bicarbonate 8.4% | 50ml Ampoule or vial | slow IV, continous IV infusion injection |
| NCDS | 09-D00-028 | Sodium bicarbonate 7.5% | 25ml Ampoule or vial | injection IV infusion |
| NCDS | 09-D00-030 | Sodium bicarbonate 8.4% | 25ml Ampoule or vial | injection IV infusion |
| NCDS | 09-D00-032 | Sodium bicarbonate 1.4% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-043 | Sodium bicarbonate 8.4% | (10ml) Ampoule | injection IV infusion |
| NCDS | 09-D00-070 | Sodium bicarbonate 8.4% | 100ml solution | injection IV infusion |
| NCDS | 09-D00-033 | Sodium chloride 0.9% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-038 | Sodium chloride 0.9% | 1000ml solution | injection IV infusion |
| NCDS | 09-D00-062 | Sodium chloride 0.9% | 100ml solution | injection IV infusion |
| NCDS | 09-D00-034 | Sodium chloride 0.45%+glucose (dextrose) hydrous or anhydrous 2.5% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-035 | Sodium chloride 0.18%+glucose (dextrose) hydrous or anhydrous 4% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-045 | Sodium chloride 0.9% +glucose (dextrose ) hydrous or anhydrous 5% | 500ml solution | injection IV infusion |
| NCDS | 09-D00-067 | Sodium chloride 3% hypretonic | solution 200ml or 250 ml bottle or bag | injection IV infusion |
| NCDS | 09-D00-069 | Sodium chloride 0.9% | solution 200ml | injection IV infusion |
| 9E | Oral nutrition | |||
| 9 Ea | Enteral nutrition | |||
| NCDS | 09-Ea0-001 | Non – disease specific Formulation :- tube feed – 500 ml Energy :1 kcal/ml Protein: 3.8-4.1 Carbohydrate : 13.8-14.4gm /100 ml Fat : 3.4-3.9 gm Fiber : 1.4-2.2 gm | liquid | oral |
| NCDS | 09-Ea0-005 | Ingredients per 100 gm :Energy value 1500 KJ ( 360 Kcal ) Fat 1 gm + of which saturated fatty acid <0.07 gm Carbohydrate ≤1 gm + of which sugars ≤1 gm + of which lactose ≤ 1 gm Fibre 0 gm Protein 87 gm Salt ( Na x 25 ) 1.38 gm Minerals : Sodium 550 mg + Potassium 1200 mg + Calcium 60 mg + Phosphorous 240 mg Caloric distribution ( energy percent %) Fat 2% , Carbohydrate ≤ 1 , fibre 0 , Proteine 97 | powder | oral |
| NCDS | 09-Ea0-002 | Therapeutic milk formula (100kcal/100ml) for sever acute malnutrition age˃6months | powder | oral |
| NCDS | 09-Ea0-003 | Therapeutic milk formula (75kcal/100ml) for sever acute malnutrition age˃6months | powder | oral |
| NCDS | 09-Ea0-004 | c.m.v therapeutic milk mean nutritional value per 1 level scoop: energy 0 kcal proteines 0 g carbohydrates 0 g lipids 0 g moisture <5% potassium 2340mg magnesium 146mg zinc 40mg copper 5.7mg iron 0mg iodine 154 μg selenium 94μg vitamin A 3000μg vitamin d 60μg vitamin e 44mg vitamin c 200mg vitamin b1 1.4mg vitamin b2 4mg vitamin b6 1.4mg vitamin b12 2μg vitamin k 80μg biotin 0.2mg folic acid 700μg pantothenic acid 6mg niacin 20mg | powder | oral |
| 9 Eb | Foods for special diets | |||
| 9Eba | LF (Lactosefree) | Indication :galactosemia(absolutely free),primary lactase deficiency,secondary lactase deficiency,temporary lactase deficiency following gastroenteritis(although it does not change the recovery time nor increase in weight after 2weeks ,and most infants can safetly continue on breast milk or standard formula milk ,but those less than 3months of age and malnourished change to lactose free formula). | ||
| NCDS | 09-Eba-001 | lactose free milk formula for age (0 _ 6 months) | powder | oral |
| NCDS | 09-Eba-002 | lactose free milk formula for age (above 6 _ 12 months) | powder | oral |
| NCDS | 09-Eba-003 | lactose free and gluten free milk formula for anti diarrhea for age (0-3 years) | powder | oral |
| NCDS | 09-Eba-004 | Lactose free milk formula from birth up to 12 months | powder | oral |
| 9Ebd | Hypoallergic and non allergic milk formula | Indication; true IgE mediated milk protein allergy,multiple food allergy,malabsorption,maldigestion,malnutrition,whole protein intolorence , Non IgE enteropathy and enterocolitis those infant will be equally allergic to soy protein | ||
| NCDS | 09-Ebd-001 | Partially hydrolyzed (from birth) | NICE: shown that insufficient evidence to suggest partially or extensively hydrolyzed to prevent or to help allergy | oral |
| NCDS | 09-Ebd-002 | Extensive hydrolyzed peptide based infant formula (from birth ) | powder | oral |
| NCDS | 09-Ebd-003 | Non allergic amino acid based formula (from birth ) | powder | oral |
| NCDS | 09-Ebd-004 | Elemental formula for non metabolic disorder suitable from birth indicated in protein intolerance and sever food allergy. (from birth ) | powder | oral |
| 9Ebf | Reanal disease | |||
| NCDS | 09-Ebf-001 | Formula for dietary management of renal disease suitable from birth Note:contain low protein content and high Whey:casein ratio | powder | oral |
| 9Ebg | Gluten free powder | |||
| NCDS | 09-Ebg-001 | Gluten free powder | powder | oral |
| NCDS | 09-Ebg-002 | MIXPROMIN low protein and gluten free all purpose baking:gluten free wheat starch, sugar,stabilizer,salt,bicarbonate of sodaguar gum,fibre | powder | oral |
| 9Ebh | Phenyketoneuria (PKU) | |||
| NCDS | 09-Ebh-001 | milk formula for phenyketoneuria (PKU) infant patients for age ( from birth-1year) Phenylalanine free | powder | oral |
| NCDS | 09-Ebh-002 | milk formula for phenyketoneuria (PKU) junior patients for age( above1 – 10years) Phenylalanine free. | powder | oral |
| 9Ebi | Maple syrup urine disease (MSUD) | |||
| NCDS | 09-Ebi-001 | milk formula for maple syrup urine disease (MSUD) patients for age (0_ 1) year | powder | oral |
| NCDS | 09-Ebi-002 | milk formula for maple syrup urine disease (MSUD) patients for age (above1 year) | powder | oral |
| 9Ebj | Tyrosinemia | |||
| NCDS | 09-Ebj-001 | milk formula for tyrosinemia for age (from birth-1year ) phenylalanine,tyrosine free | powder | oral |
| NCDS | 09-Ebj-002 | milk formula for tyrosinemia patients for age (above 1 year ) phenylalanine,tyrosine free | powder | oral |
| 9Ebk | Homocystineuria | |||
| NCDS | 09-Ebk-001 | milk formula for Homocystineuria patients for age ( from birth-1year) Methionine free | powder | oral |
| NCDS | 09-Ebk-002 | milk formula for Homocystineuria patients for age (above 1year) Methionine free | powder | oral |
| 9Ebl | Glutaric acid uria | |||
| NCDS | 09-Ebl-001 | milk formula for glutaric acid uria patients for age (from birth_ 1 year) lysine and tryptophan free | powder | oral |
| NCDS | 09-Ebl-002 | milk formula for glutaric acid uria patients for age (above 1 year) lysine and tryptophan free | powder | oral |
| 9Ebm | Galectosemia and Galectokinase | |||
| NCDS | 09-Ebm-001 | Good start soy plus DHA plus ARA from birth | powder | oral |
| NCDS | 09-Ebm-002 | Abslute free lactose and galactose ( soya protein ) milk formula for galectosemia and galectokinase patients for age (from birth _ 6 months) Note: minimum and maximum values for iron for infant formula are 0.45mg and 2.0mg respectively and for follow-on formula 0.9mg and 2.5mg respectively. For phosphorus, minimum and maximum values for both infant and follow-on formula are 30mg and 100mg respectively | powder | oral |
| NCDS | 09-Ebm-003 | Abslute free lactose and galactose ( soya protein ) milk formula for galectosemia and galectokinase patients for age (above6_ 12 months) Note: minimum and maximum values for iron for infant formula are 0.45mg and 2.0mg respectively and for follow-on formula 0.9mg and 2.5mg respectively. For phosphorus, minimum and maximum values for both infant and follow-on formula are 30mg and 100mg respectively | powder | oral |
| NCDS | 09-Ebm-004 | Elemental and semi elemental formula contain no galactose but of no benefict on long term. for infants as a sole source of nutrition or as supplementary feed for children | powder | oral |
| NCDS | 09-Ebm-005 | CHO modified formula nutritionally casein based cow s milk for lactose and galactose restricted diet(carbohydrate free mixture ). for infants as a sole source of nutrition or as supplementary feed for children | powder | oral |
| NCDS | 09-Ebn | Isovaleric academia | * | |
| NCDS | 09-Ebn-001 | • milk formula for Isovaleric acidemia patients suitable (from birth – 1year) Leucine free | powder | oral |
| NCDS | 09-Ebn-002 | • milk formula for Isovaleric acidemia patients suitable (above 1year) Leucine free | powder | oral |
| 9Ebo | Methylmalonic academia / propionic academia | |||
| NCDS | 09-Ebo-001 | milk formula for methylmalonic academia / propionic acidemia patients suitable from birth. Methionine,Threonine, and Valine free | powder | oral |
| 9Ebp | Non ketotic hyperglycinemia | |||
| NCDS | 09-Ebp-001 | milk formula for non ketotic hyperglycinemia patients suitable from birth. Glycine free | powder | oral |
| 9Ebq | Urea cycle disorder | (amino acid based formula contain essential and non essential aminoacid with increased level of branched chain amino acid and tryptophane) | ||
| NCDS | 09-Ebq-001 | milk formula for Urea cycle disorder patients for age (from birth _1year) | powder | oral |
| NCDS | 09-Ebq-002 | milk formula for Urea cycle disorder patients for age (above1year_10 years) | powder | oral |
| 9Ebr | Hyperlysinemia | |||
| NCDS | 09-Ebr-001 | milk formula for hyperlysinemia patients for age (0 _3years) Lysine free protein substitute | powder | oral |
| NCDS | 09-Ebr-002 | milk formula for hyperlysinemia patients for age (1 _10years) Lysine free protein substitute | powder | oral |
| 9Ebs | Fatty acid oxidation disorder: | Low fat and high carbohydrate (contain high medium chain triglyceride and low in long chain triglyceride) Indecation :hyperlypoproteinmia,long chain fatty acid oxidation defect ,intestinal lymphangiectasia ,chylothorax ,intractable malabsorption and steatorrhoea | ||
| NCDS | 09-Ebs-001 | milk formula for infants as a sole source of nutrition or as supplementary feed for children | powder | oral |
| 9Ebw | Lennox Gastaut Syndrome , Doose Syndrome | |||
| NCDS | 09-Ebw-001 | Ketocal 3;1 vanilla and ketocal 3;1 unflavored ( Food for special medical purposes, for the dietary management of drug resistant epilepsy or other conditions for which the ketogenic diet is indicated ) | powder | oral |
| 9F | OTHER MINERALS | |||
| NCDS | 09-F00-005 | Minerals preparation in form of Injection (Ca+2, Mg+2, Fe+2, Zn+2, Cu+2, P) e.g addamel | solution | IV injection |
| NCDS | 09-F00-008 | Zinc Sulfate monohydrate 125mg(45mg Zn) | tablet | oral |
| NCDS | 09-F00-009 | Glucose Powder 100g | powder | oral |
| 9G | ELECTROLYTE SOLUTION FOR IRRIGATION | |||
| 9H | SUPPLEMENTARY DRUG / METABOLIC DISORDERS | |||
| NCDS | 09-H00-001 | Mercaptamine (Cysteamine) as Bitartrate 50mg | capsule | oral |
| NCDS | 09-H00-002 | Mercaptamine (Cysteamine) as Bitartrate 150mg | capsule | oral |
| NCDS | 09-H00-013 | Mercaptamine (Cysteamine ) hydrochloride 0.55 % | drop | ophthalmic |
| NCDS | 09-H00-004 | Laronidase 100U/ml | 5ml vial | injection |
| NCDS | 09-H00-005 | Trientine dihydrochloride 300 mg ( eq.Trientine 200 mg base) | capsule | oral |
| NCDS | 09-H00-006 | Zinc ( as Zinc acetate) 25mg | capsule | oral |
| NCDS | 09-H00-007 | Betaine anhydrous 500 mg | tablet | oral |
| NCDS | 09-H00-023 | Betaine ( anhydrous) ( 180 or 300 gm ) | powder | oral |
| NCDS | 09-H00-008 | Nitisinone (NTBC) 2 mg | capsule or tablet | oral |
| NCDS | 09-H00-009 | Biotin (Vitamin H) 5 mg | tablet | oral |
| NCDS | 09-H00-010 | Biotin (Vitamin H) 5 mg/ml | vial or ampoule | injection |
| NCDS | 09-H00-011 | alglucosidase alfa 50 mg | vial | injection IV infusion |
| NCDS | 09-H00-016 | agalsidase beta 5mg | vial powder for reconstilution | injection IV infusion |
| NCDS | 09-H00-024 | galsulfase 1 mg\ml concentrate for | 5ml vial solution | injection IV |
| NCDS | 09-H00-012 | sodium benzoate 250 mg | capsule | oral |
| NCDS | 09-H00-017 | L-carnitine 300 mg /ml (30 %) (20 ml) | solution | oral |
| NCDS | 09-H00-018 | L-carnitine 200 mg / ml | 5ml ampoule | Injection IV ,IM |
| NCDS | 09-H00-021 | L-carnitine ( tartrate) 750 mg + Ascorbic acid (Vitamin C ) 80 mg +Vitamin ( Natural d-Alpha)15 mg + niacinamide 15 mg | tablet | oral |
| NCDS | 09-H00-022 | L-carnitine 500 mg | tablet | oral |
| NCDS | 09-H00-034 | Levocarnitine 1 g | (10 ml) vial solution | oral |
| NCDS | 09-H00-026 | Levocarnitine 2 g solution | (10 ml) vial | oral |
| NCDS | 09-H00-027 | Haem arginate (Human hemin) 25 mg / ml | 10ml ampoule concentrate for solution | injection IV infusion |
| NCDS | 09-H00-028 | Sapropterin dihydrochloride 100 mg | soluble tablet | oral |
| NCDS | 09-H00-029 | Carglumic acid 200 mg | tablet or Dispersible tablet | oral |
| NCDS | 09-H00-019 | Miglustat 100 mg | capsule | oral |
| NCDS | 09-H00-020 | imiglucerase 400 unit | vial | injection IV infusion |
| NCDS | 09-H00-030 | Eliglustat tartrate 84 mg | capsule | oral |
| NCDS | 09-H00-031 | Agalsidase beta 35mg | vial | injection |
| NCDS | 09-H00-032 | Idursulfase 2mg /ml | vial | injection |
| NCDS | 09-H00-025 | Velaglucerase alpha 400 unit | vial | injection |
| NCDS | 09-H00-033 | Elosulfase alfa 5mg/5ml | vial solution | injection IV infusion |
| IMMUNOSTIMULANTS › INTERFERONS | ||||
| NCDS | 15-B00-095 | Interferon gamma-1b (recombinant human) 200 mcg/ 1ml (100micrograms/0.5ml) | solution vial | sc injection |
| 9I | PHOSPHATE- BINDING AGENTS | granulomatous disease | ||
| NCDS | 09-I00-001 | Sevelamer carbonate 800mg | Tablet | oral |
| 9J | hypophosphataemia | |||
| NCDS | 09-J00-001 | Phosphate ( Potassium Dihydrogen Phosphate ) 13.6 % | ampoule 10ml | injection |
| 10 | MUSCULOSKELETAL DISORDERS | |||
| 10A | DRUGS USED IN CHRONIC RHEUMATIC DISEASES | |||
| 10AA | NSAID | |||
| NCDS | 10-AA0-001 | Diclofenac sodium 25mg | enteric coated Tablet | oral |
| NCDS | 10-AA0-002 | Diclofenac sodium 50mg | enteric coated Tablet | oral |
| NCDS | 10-AA0-003 | Diclofenac sodium 25mg | Suppository | rectal |
| NCDS | 10-AA0-004 | Diclofenac sodium 100mg | Suppository | rectal |
| NCDS | 10-AA0-005 | Diclofenac sodium 25mg/ml | (3ml) Ampoule | injection IM only |
| NCDS | 10-AA0-006 | Diclofenac sodium 75mg+ lidocaine hydrochloride 20mg | 2ml Ampoule | injection IM only |
| NCDS | 10-AA0-007 | Diclofenac sodium 100mg | sustained release tablet or sustained release capsule (depocaps) | oral |
| NCDS | 10-AA0-008 | Diclofenac potassium 50mg | tablet | oral |
| NCDS | 10-AA0-009 | Diclofenac potassium 25mg | tablet | oral |
| NCDS | 10-AA0-060 | Diclofenac sodium 12.5mg | Suppository | rectal |
| NCDS | 10-AA0-061 | Diclofenac potassium 50mg\ Sachet | powder | oral |
| NCDS | 10-AA0-062 | Diclofenac sodium 50 mg | Suppository | rectal |
| NCDS | 10-AA0-065 | Diclofenac sodium 140 mg | patch | transdermal |
| NCDS | 10-AA0-066 | Diclofenac sodium 25mg in enteric coated pellets+ Diclofenac sodium 50mg in sustain release pellets | sustained release capsule | oral |
| NCDS | 10-AA0-067 | Diclofenac sodium 50 mg | dispersible tablet | oral |
| NCDS | 10-AA0-071 | diclofenac sodium 12.5 mg rapid release layer + 62.5mg diclofenac sodium slow release layer (enteric coated) /2 layers tablet (75mg diclofenac sodium) | sustained release tablet | oral |
| NCDS | 10-AA0-074 | Diclofenac epolamine 1.3% corresponding to 1% Diclofenac sodium /patch | patch | transdermal |
| NCDS | 10-AA0-083 | Loxoprofen sodium hydrate 56.7 mg eq.to 50 mg Loxoprofen anhydrate | patch | transdermal |
| NCDS | 10-AA0-084 | Loxoprofen sodium hydrate 113.4 mg eq.to 100 mg Loxoprofen anhydrate | patch | transdermal |
| NCDS | 10-AA0-087 | Lornoxicam 8 mg | tablet | oral |
| NCDS | 10-AA0-072 | Aceclofenac 100 mg | tablet | oral |
| NCDS | 10-AA0-073 | Flurbiprofen 100 mg | tablet | oral |
| NCDS | 10-AA0-011 | Ibuprofen 200mg | tablet | oral |
| NCDS | 10-AA0-012 | Ibuprofen 400mg | tablet | oral |
| NCDS | 10-AA0-089 | Ibuprofen 60 mg | Suppository | rectal |
| NCDS | 10-AA0-090 | Ibuprofen 125 mg | Suppository | rectal |
| NCDS | 10-AA0-013 | Ibuprofen 100mg/5ml | suspension | oral |
| NCDS | 10-AA0-014 | Ibuprofen 600mg | sustained release tablet or sustained release capsule (depocaps) or tablet | oral |
| NCDS | 10-AA0-019 | Ibuprofen 600mg | granules in sachet | oral |
| NCDS | 10-AA0-075 | Ibuprofen 200 mg | liquid gel capsule | oral |
| NCDS | 10-AA0-080 | Ibuprofen lysine 342 mg ( eq. to Ibuprofen 200mg) | tablet | oral |
| NCDS | 10-AA0-076 | Ibuprofen 400mg | liquid gel capsule | oral |
| NCDS | 10-AA0-086 | Ibuprofen 50 mg /1.25 ml | suspension drop | oral |
| NCDS | 10-AA0-081 | Dexketoprofen ( as Dexketoprofen trometamol) 25mg | tablet | oral |
| NCDS | 10-AA0-082 | Dexketoprofen ( as Dexketoprofen trometamol) 25mg | sachet granules for solution | oral |
| NCDS | 10-AA0-085 | Dexketoprofen ( as Dexketoprofen trometamol) 50 mg | 2 ml Ampule solution | IM injection / IV infusion |
| NCDS | 10-AA0-088 | Ketoprofen 100 mg | 2 ml Ampule solution | IM injection |
| NCDS | 10-AA0-015 | Indomethacin 25mg | Capsule | oral |
| NCDS | 10-AA0-016 | Indomethacin 75mg | Retard Capsule | oral |
| NCDS | 10-AA0-017 | Indomethacin (as sodiumTrihydrate) 1mg | Vial | IV Injection |
| NCDS | 10-AA0-018 | Indomethacin 100mg | Suppository | rectal |
| NCDS | 10-AA0-022 | Nabumetone 500mg | tablet | oral |
| NCDS | 10-AA0-023 | Naproxen 250mg | tablet | oral |
| NCDS | 10-AA0-024 | Naproxen 500mg | tablet | oral |
| NCDS | 10-AA0-025 | Naproxen 500mg | Suppository | rectal |
| NCDS | 10-AA0-026 | Naproxen 125mg/5ml | suspension | oral |
| NCDS | 10-AA0-077 | Naproxen 500mg + Esomeprazole ( magnesium ) 20mg | delayed release tablet | oral |
| NCDS | 10-AA0-028 | Mefenamic acid 500mg | tablet or capsule | oral |
| NCDS | 10-AA0-029 | Mefenamic acid 50mg/5ml | suspension | oral |
| NCDS | 10-AA0-030 | Mefenamic acid 500mg | Suppository | rectal |
| NCDS | 10-AA0-052 | Mefenamic acid 250mg | capsule or tablet | oral |
| NCDS | 10-AA0-031 | Phenylbutazone 200mg | Tablet | oral |
| NCDS | 10-AA0-036 | Sulindac 100mg | Tablet | oral |
| NCDS | 10-AA0-037 | Sulindac 200mg | Tablet | oral |
| NCDS | 10-AA0-038 | Tenoxicam 20mg | Suppository | rectal |
| NCDS | 10-AA0-039 | Tenoxicam 20mg | capsule or tablet | oral |
| NCDS | 10-AA0-091 | Tenoxicam 20 mg + Solvent | lyophilized powder in vial | injection IV / IM |
| NCDS | 10-AA0-043 | Meloxicam 15mg | tablet or capsule | oral |
| NCDS | 10-AA0-044 | Meloxicam 7.5mg | capsule or tablet | oral |
| NCDS | 10-AA0-045 | Meloxicam 15 mg | Suppository | rectal |
| NCDS | 10-AA0-049 | Meloxicam 15mg | 1.5ml Ampoule | injection |
| NCDS | 10-AA0-063 | Meloxicam 7.5mg | Suppository | rectal |
| NCDS | 10-AA0-046 | Piroxicam 20mg | Suppository | rectal |
| NCDS | 10-AA0-032 | Piroxicam 10mg | capsule or tablet | oral |
| NCDS | 10-AA0-034 | Piroxicam 20mg | Orodispersible tablet or capsule or tablet | oral |
| NCDS | 10-AA0-051 | Celecoxib 200mg | capsule | oral |
| NCDS | 10-AA0-068 | Etoricoxib 60 mg | Tablet | oral |
| NCDS | 10-AA0-069 | Etoricoxib 90 mg | Tablet | oral |
| NCDS | 10-AA0-070 | Etoricoxib 120 mg | Tablet | oral |
| 10AB | ACTH and CORTICOSTEROID/See 6E | |||
| 10AC | Disease modifying drugs | |||
| NCDS | 10-AC0-001 | Auranofin 3mg | Tablet | oral |
| NCDS | 10-AC0-002 | Aurothioglucose 50mg | vial or ampoule | Injection |
| NCDS | 10-AC0-003 | Penicillamine 125mg | Scored Tablet or capsule | oral |
| NCDS | 10-AC0-006 | Penicillamine 250 mg | capsule or tablet | oral |
| NCDS | 10-AC0-007 | Sodium aurothiomalate 10mg/0.5ml | (0.5ml) Ampoule | deep IM injection |
| NCDS | 10-AC0-008 | Sodium aurothiomalate 50mg/0.5ml | (0.5ml) Ampoule | deep IM injection |
| Arthritis,IMMUNOSUPPRESSANTS › TUMOR NECROSIS FACTOR ALPHA (TNF-a) INHIBITORS | ||||
| NCDS | 10-AC0-009 | Infliximab 100mg | Vial | injection |
| NCDS | 10-AC0-016 | Remsima: infliximab 100 mg | Vial | injection |
| NCDS | 10-AC0-023 | Ixifi: Infliximab 100 mg | Vial | injection |
| NCDS | 10-AC0-010 | Etanercept 25mg | vial OR prefilled syringe | injection SC |
| NCDS | 10-AC0-012 | Etanercept 50 mg | vial OR prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-020 | Erelzi : Etanercept25mg | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-032 | Erelzi : Etanercept 50mg | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-024 | Nepexto: Etanercept 25 | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-031 | Nepexto: Etanercept 50 | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-040 | Altebrel : Etanercept 25 mg | 0.5 ml pfs | injection SC |
| NCDS | 10-AC0-039 | Altebrel : Etanercept 50 mg | 1 ml pfs | injection SC |
| NCDS | 10-AC0-011 | Adalimumab 40 mg/(0.8 ml or 0,4ml) | prefilled syringe | injection SC |
| NCDS | 10-AC0-038 | Cinnora :adalimumab 40mg /0.8ml | prefilled syringe | injection SC |
| NCDS | 10-AC0-018 | Amgevita: adalimumab 40mg | prefilled syringe or prefilled pen solution | injection SC |
| NCDS | 10-AC0-019 | Hyrimoz: adalimumab 40mg | prefilled syringe or prefilled pen solution | injection SC |
| NCDS | 10-AC0-037 | Idacio:adalimumab 40mg /0.8ml | pre-filled pen | injection SC |
| NCDS | 10-AC0-030 | AMSPARITY:adalimumab 40mg/0.8ml | prefilled syringe or prefilled pen solution | injection SC |
| Inflammatory skin conditions, IMMUNOSUPPRESSANTS › INTERLEUKIN INHIBITORS | ||||
| NCDS | 10-AC0-021 | ixekizumab 80 mg /ml | single dose autoinjector | injection SC |
| NCDS | 10-AC0-029 | Ixekizumab 80mg / ml | prefilled syringe | injection SC |
| NCDS | 10-AC0-034 | Risankizumab 150 mg/1ml | prefilled pen solution | injection SC |
| NCDS | 10-AC0-035 | Guselkumab 100 mg/1ml | prefilled pen solution | injection SC |
| Arthritis,IMMUNOSUPPRESSANTS › INTERLEUKIN INHIBITORS | ||||
| NCDS | 10-AC0-017 | Tocilizumab 200 mg | vial | injection |
| NCDS | 10-AC0-026 | ustekinumab 90 mg | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-027 | ustekinumab 130 mg | vial concentrate for solution | injection IV infusion |
| NCDS | 10-AC0-028 | ustekinumab 45 mg | prefilled syringe or prefilled pen | injection SC |
| NCDS | 10-AC0-033 | Golimumab 50 mg/0.5ml | prefilled pen solution | injection SC |
| NCDS | 10-AC0-036 | Anakinra 100 mg / 0.67 ml | prefilled syringe solution | injection SC |
| Arthritis,IMMUNOSUPPRESSANTS › JAK INHIBITORS | ||||
| NCDS | 10-AC0-025 | Tofacitinib (as citrate ) 11mg | extended release tablet | oral |
| NCDS | 10-AC0-041 | Upadacitinib hemihydrate (eq to 15 mg Upadacitinib ) | prolonged release tablet | oral |
| 10B | DRUGS USED IN THE TREATMENT OF GOUT | |||
| NCDS | 10-B00-001 | Allopurinol 100mg | Tablet | oral |
| NCDS | 10-B00-002 | Allopurinol 300mg | Tablet | oral |
| NCDS | 10-B00-003 | Colchicine 500mcg | Tablet | oral |
| NCDS | 10-B00-012 | Colchicine 1 mg | Tablet | oral |
| NCDS | 10-B00-005 | Probenecid 500mg | Tablet | oral |
| NCDS | 10-B00-006 | Sulphinpyrazone 100mg | Tablet | oral |
| NCDS | 10-B00-007 | Sulphinpyrazone 200mg | Tablet | oral |
| NCDS | 10-B00-008 | Rasburicase 1.5mg | vial (with solvent) powder for reconstitution | injection IV iinfusion |
| NCDS | 10-B00-009 | Febuxostat 40 mg | tablet | oral |
| NCDS | 10-B00-010 | Febuxostat 80 mg | tablet | oral |
| NCDS | 10-B00-011 | Febuxostat 120 mg | tablet | oral |
| 10C | DRUGS USED IN neuromuscular disorder | |||
| 10 CA | Drugs that enhance neuromuscular transmission | |||
| 10 CAa | Anticholinesterase | |||
| NCDS | 10-CAa-001 | Edrophonium chloride 10mg/ml | (1ml) Ampoule | injection |
| NCDS | 10-CAa-002 | Neostigmine Bromide 30mg | Tablet | oral |
| NCDS | 10-CAa-003 | Neostigmine Bromide 15mg | Scored Tablet | oral |
| NCDS | 10-CAa-004 | Neostigmine metilsulphate ( methylsulphate ) 2.5mg/ml | (1ml) Ampoule | injection IM,IV SC |
| NCDS | 10-CAa-007 | Pyridostigmine Bromide 60mg | Tablet | oral |
| 10 CAb | Multiple sclerosis,CHOLINERGIC RECEPTOR STIMULATING DRUGS | |||
| NCDS | 10-CAb-001 | Fampridine 10mg | prolonged release tablet | oral |
| 10D | MUSCLE RELAXANTS | |||
| NCDS | 10-D00-001 | Carisoprodol 200mg + Paracetamol 160mg+ Caffeine 32mg | Tablet | oral |
| NCDS | 10-D00-002 | Dantrolene sodium 25mg | Capsule | oral |
| NCDS | 10-D00-003 | Dantrolene sodium 50mg | Capsule | oral |
| NCDS | 10-D00-004 | Dantrolene sodium 100mg | Capsule | oral |
| NCDS | 10-D00-005 | Dantrolene sodium 20mg | Vial | injection |
| NCDS | 10-D00-006 | Orphenadrine citrate 35mg + Paracetamol 450mg | Tablet | oral |
| NCDS | 10-D00-007 | tolperisone hydrochloride 150 mg | Tablet | oral |
| NCDS | 10-D00-008 | Chlorzoxazone 250 mg + Paracetamol 300 mg | Capsule | oral |
| NCDS | 10-D00-009 | Chlorzoxazone 500 mg | Tablet | oral |
| NCDS | 10-D00-010 | Methocarbamol 380 mg + Paracetamol 300 mg | tablet | oral |
| NCDS | 04-M00-006 | Nusinersen (as Nusinersen sodium) 2.4 mg\1 ml( 12mg/5ml ) | Vial solution | injection |
| NCDS | 04-M00-007 | risdiplam 60 mg (0.75 mg/mL) | powder for reconstitution for solution | oral |
| NCDS | 04-M00-008 | Thiocolchicoside 4 mg / 2 ml solution | Ampoule | IM injection |
| 10E | DRUGS USED FOR THE RELIEF OF SOFT TISSUE INFLAMMATION | |||
| NCDS | 10-E00-001 | Alpha chymotrypsin 750 units | vial powder+ solvent | injection |
| NCDS | 10-E00-009 | Extravasation kit contents : Hydrocortisone cream 1% ( 15 gm ) + 4 ( 50 ml syringes ) + 4 ( 5ml syringes ) + 2 ( 25 g needles ) + 2 ( 19 g needles ) + lidocaine 1% injection + Hyaluronidase 1500 unit injection | Extravasation kit | injection |
| NCDS | 10-E00-008 | Hyaluronic acid ( or as Sodium salt or as Sodium hyaluronate hexadecylamide ) 20 – 100 mg | prefilled syringe | intra-articular injection |
| 10F | RUBEFACIENTS AND OTHER TOPICAL ANTIRHEUMATICS | |||
| NCDS | 10-F00-007 | Diclofenac Diethyl ammonium 1.16w/w(eq. to diclofenac sodium 1% w/w ) | Gel or creamogel or emulgel | topical |
| NCDS | 10-F00-014 | Diclofenac Diethyl ammonium 23.2 mg/g ( 2.32% ) | emulgel | topical |
| NCDS | 10-F00-010 | Piroxicam 0.5% | Gel | topical |
| NCDS | 10-F00-011 | Diclofenac sodium 1% | Gel | topical |
| NCDS | 10-F00-012 | Ketoprofen 2.5% | Gel | topical |
| NCDS | 10-F00-013 | Piroxicam 1% | cream | topical |
| NCDS | 10-F00-015 | Ibuprofen 5% + levomenthol | Gel | topical |
| NCDS | 10-F00-017 | Etofenamate 50 mg / 1 gm ( 5% ) | Gel | topical |
| 11 | DRUGS ACTING ON THE EYE | |||
| 11A | ANTI-INFECTIVE PREPARATIONS | |||
| NCDS | 11-A00-001 | Acyclovir 3% Eye | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-038 | Ganciclovir 1.5 mg /1g | gel | ophthalmic(Eye) |
| NCDS | 11-A00-002 | Chloramphenicol 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-003 | Chloramphenicol 1% | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-004 | Clotrimazole 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-005 | Ciprofloxacin( as hydrochloride) 0.3% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-040 | Ciprofloxacin ( as hydrochloride) 0.3% | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-A00-046 | Ciprofloxacin 0.2% ( as hydrochloride ) + Hydrocortisone 1% | Drop | otic suspension |
| NCDS | 11-A00-006 | Flucytosine 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-009 | fusidic acid 10 mg/g (1%) | Drop viscous suspension | ophthalmic(Eye) |
| NCDS | 11-A00-010 | Gentamicin (as sulphate) 0.3% | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-A00-011 | Gentamicin ( as sulphate) 0.3% | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-014 | Miconazole (1-2%) | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-016 | Neomycin sulphate +polymyxin B sulphate+Phenylephrine hydrochloride + Hydroxypropylmethyl cellulose | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-017 | Norfloxacin 0.3% | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-A00-018 | Rifamycin monosodium 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-022 | Tetracycline hydrochloride 1% | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-023 | Tobramycin 0.3% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-024 | Trimethoprim 1mg + polymyxin B Sulphate 10000 U/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-025 | Ofloxacin 0.3% | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-042 | Ofloxacin 0.3% | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-030 | polymyxin B sulphate 5000 IU+Neomycin sulphate 2.5mg (eq.1.75mg Neomycin base) +Gramicidin 0.025mg/1ml | Drop | ophthalmic(Eye) or ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-A00-031 | polymyxin B sulphate 16250 IU+Neomycin sulphate 5mg (eq.to 3.5mg Neomycin base)/ml | Drop | ophthalmic(Eye) or ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-A00-032 | Tobramycin 3mg (eq.3000 IU/1g) | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-033 | Rifamycin sodium 10mg/1g | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-041 | Erythromycin 0.5% | Ointment | ophthalmic(Eye) |
| NCDS | 11-A00-034 | Gatifloxacin (as sesiquihydrate or anhydrous ) 3mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-039 | Gatifloxacin (as sesiquihydrate) 5mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-035 | Moxifloxacin (as hydrochloride) 0.5%(5mg/ml ) | Drop or SDU | ophthalmic(Eye) |
| NCDS | 11-A00-047 | Moxifloxacin( as hydrochloride) 0.5% w/v + Dexamethasone phosphate (as sodium salt ) 0.1% w/v | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-036 | Levofloxacin (as hemihydrate) 0.5% | Drop or SDU | ophthalmic(Eye) |
| NCDS | 11-A00-045 | Levofloxacin (as hemihydrate )5 mg+1mg Dexamethasone (as Sodium phosphate)\1ml solution | Drop | ophthalmic(Eye) |
| NCDS | 11-A00-037 | Besifloxacin 0.6% | Drop suspension | ophthalmic(Eye) |
| 11B | ANTI-INFLAMMATORY PREPARATION INCLUDING CORTICOSTERIODS: | |||
| 11BA | Corticosteroids preparations | |||
| NCDS | 11-BA0-001 | Betamethasone sodium phosphate 0.1% | drop | ophthalmic and OTIC and nasal (Eye/Ear /nose) |
| NCDS | 11-BA0-002 | Betamethasone sodium phosphate 0.1% | Ointment | ophthalmic(Eye) |
| NCDS | 11-BA0-003 | Dexamethasone sodium Phosphate 1mg\1ml (0.1% ) or dexamethasone disodium phosphate eq.dexamethasone phosphate 1mg\1ml solution or Dexamethasone ( Base ) 1mg\1ml(0.1% ) suspention | Drop or SDU | ophthalmic(Eye) |
| NCDS | 11-BA0-017 | Dexamethasone 1mg/1g | Ointment | ophthalmic(Eye) |
| NCDS | 11-BA0-006 | Fluorometholone 0.1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-007 | Fluorometholone 0.25% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-022 | Fluorometholone micronized 0.1% + Tetrahydrozoline HCl 0.025 % | Drop suspension | ophthalmic(Eye) |
| NCDS | 11-BA0-009 | Hydrocortisone acetate 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-011 | Hydrocortisone acetate 1% | Ointment | ophthalmic(Eye) |
| NCDS | 11-BA0-012 | Medrysone 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-013 | Prednisolone acetate 0.12% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-014 | Prednisolone acetate 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-015 | Prednisolone acetate 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-018 | Prednisolone sodium phosphate 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BA0-021 | Prednisolone acetate 0.5% | Ointment | ophthalmic(Eye) |
| NCDS | 11-BA0-020 | Loteprednol Etabonate 0.5 % | suspension drop | ophthalmic(Eye) |
| NCDS | 11-BA0-019 | Loteprednol etabonate 0.5% | gel | ophthalmic(Eye) |
| 11BB | Corticosteroid-antibiotic mixtures | |||
| NCDS | 11-BB0-001 | Betamethasone Sodium phosphate 0.1%+Neomycin sulphate 0.5% | Drop | ophthalmic and OTIC and nasal (Eye/Ear /nose) |
| NCDS | 11-BB0-002 | Betamethasone Sodium phosphate 0.1%+Neomycin sulphate 0.5% | Ointment | ophthalmic(Eye) |
| NCDS | 11-BB0-028 | Prednisolone acetate 0.5% + Sulfacetamide 10%+ Neomycin sulphate 0.5% | Ointment | ophthalmic(Eye) |
| NCDS | 11-BB0-005 | Dexamethasone phosphate ( as sodium ) 0.1%+ neomycin suphate 0.5% | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-BB0-006 | Dexamethasone 0.1% +neomycin sulphate 0.35% (3500 IU/ml) + polymyxin B sulphate 6000 units/ml + Hydroxypropylmethyl cellulose | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-007 | Dexamethasone (as sodium salt) 0.05%+ Framycetin sulphate 0.5%+ Gramacidin 0.005% | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-BB0-008 | Dexamethasone 0.05%+Framycetin sulphate 0.5%+Gramacidin 0.005% | Ointment | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-BB0-009 | Hydrocortisone acetate1g +Neomycin sulphate 500mg + Naphthazoline nitrate 100mg/100ml | Drop | ophthalmic and OTIC and nasal (Eye/Ear /nose) |
| NCDS | 11-BB0-010 | Hydrocortisone acetate1g+Neomycin sulphate 500mg+ Naphthazoline nitrate 100mg/100g | Ointment | ophthalmic and OTIC and nasal (Eye/Ear /nose) |
| NCDS | 11-BB0-012 | Hydrocortisone acetate 15mg+ Oxytetracycline (as hydrochloride) 5mg + Polymyxin B sulphate10000 units/ml | Drop | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-BB0-013 | Hydrocortisone acetate10mg+ Oxytetracycline (as hydrochloride) 5mg+ Polymyxin B sulphate 10000 units/g | Ointment | ophthalmic and OTIC (Eye/Ear ) |
| NCDS | 11-BB0-014 | Prednisolone acetate 0.5%+Neomycin sulphate 0.5%+ Polymyxin B sulphate 5000 units/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-016 | Prednisolone acetate 1% + Gentamicin (as sulphate) 0.3% | Drop suspension | ophthalmic(Eye) |
| NCDS | 11-BB0-018 | Tobramycin 0.3% +Dexamethasone 0.1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-027 | Loteprednol etabonate 5 mg + Tobramycin 3 mg /ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-019 | Dexamethasone sodium Phosphate1mg + chloramphenicol 5mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-020 | Dexamethasone sodium phosphate 1mg + Gentamicin sulphate 3mg/ 1gm | Ointment | ophthalmic(Eye) |
| NCDS | 11-BB0-021 | Dexamethasone sodium phosphate 1mg + Gentamicin sulphate 3mg/ 1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-022 | Dexamethasone phosphate 1mg + Gentamicin sulfate (eq. gentamicin base) 3mg/1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-023 | Dexamethasone sodium phosphate (eq.Dexamethasone base) 1mg + Tobramycine sulfate (eq. to tobramycine base) 3mg/1g | Ointment | ophthalmic(Eye) |
| NCDS | 11-BB0-024 | Phenylephrine hydrochloride 1.2mg + Prednisolone sodium phosphate 2.5mg/1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-025 | Ofloxacin 0.3% +prednisolone acetate 0.2%+Tetrahydrozoline (Tetryzoline) hydrochloride 0.045% | Drop | ophthalmic(Eye) |
| NCDS | 11-BB0-026 | Framycetin sulphate 630000 IU+Dexamethasone sodium phosphate 100mg/100ml | Drop | ophthalmic(Eye) |
| 11BC | Other anti-inflammatory preparations | |||
| NCDS | 11-BC0-001 | Sodium Cromoglycate 2% | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-002 | Diclofenac sodium 1mg/1ml (0.1%) | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-003 | Indomethacin 0.1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-004 | Ketotifen (as hydrogen fumarate or as fumarate ) 0.25mg/ml | Drop or SDU (single dose unit) | ophthalmic(Eye) |
| NCDS | 11-BC0-013 | Bepotastine Besilate 15mg eq.to Bepotastine 10.7mg / 1 ml | solution , drop | ophthalmic(Eye) |
| NCDS | 11-BC0-005 | Olopatadine (as hydrochloride) 1mg/1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-012 | Olopatadine hydrochloride 2.22 mg (eq.olopatadine 2 mg)/ml | Drop or SDU (single dose unit) | ophthalmic(Eye) |
| NCDS | 11-BC0-014 | Alcaftadine 2.5mg / ml ( 0.25% ) | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-006 | Indomethacin 5mg+Gentamicin sulphate as base 15000 IU/5ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-007 | Lodoxamide tromethamine 1.78 mg (eq.Lodoxamide) 1mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-009 | Bromfenac Sodium or Bromfenac Sodium Sesquihydrate equivalent to Bromfenac free acid 0.9 mg / ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-010 | Nepafenac 1 mg / ml ( 0.1 % ) | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-011 | ketorolac tromethamine 0.5 % | Drop | ophthalmic(Eye) |
| NCDS | 11-BC0-008 | Flurbiprofen sodium 0.03 % | Drop | ophthalmic(Eye) |
| 11BD | Anti-histaminic-decongestant | |||
| NCDS | 11-BD0-002 | Pyrilamine maleate 0.1%+ Phenylephrine hydrochloride 0.12% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-003 | Naphazoline hydrochloride 0.1% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-008 | Naphazoline hydrochloride 0.016g + Zinc sulfophenate 0.020g / 100ml | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-004 | Naphazoline hydrochloride 0.025% + Pheniramine maleate 0.3% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-005 | Azelastine hydrochloride 0.05% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-006 | Antazoline phosphate 0.5% + Naphazoline hydrochloride 0.05% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-007 | Antazoline sulphate 0.5%+ xylometazoline hydrochloride 0.05% | Drop | ophthalmic(Eye) |
| NCDS | 11-BD0-009 | Antazoline hydrochloride 0.5 mg Tetrahydrozoline (Tetryzoline) hydrochloride 0.4 mg\1ml | Drop | ophthalmic(Eye) |
| 11C | MYDRIATICS AND CYCLOPLEGICS | |||
| NCDS | 11-C00-001 | Atropine sulphate 0.5% (with or without Hydroxypropylmethyl cellulose) | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-002 | Atropine sulphate 1% , (with or without Hydroxypropylmethyl cellulose) | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-003 | Atropine sulphate 1% | Ointment | ophthalmic(Eye) |
| NCDS | 11-C00-004 | Cyclopentolate hydrochloride 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-008 | Phenylephrine hydrochloride 10% | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-009 | Tropicamide 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-010 | Tropicamide 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-011 | Cyclopentolate hydrochloride Bp 1% w/v | Drop | ophthalmic(Eye) |
| NCDS | 11-C00-012 | Phenylephrine hydrochloride 2.5% | Drop | ophthalmic(Eye) |
| 11D | TREATMENT OF GLAUCOMA | |||
| NCDS | 11-D00-001 | Acetazolamide (as sodium salt ) 500mg | Vial powder for reconstitution | injection |
| NCDS | 11-D00-002 | Acetazolamide 250mg | Tablet | oral |
| NCDS | 11-D00-003 | Acetazolamide 500mg | Tablet | oral |
| NCDS | 11-D00-004 | Acetazolamide 500mg | sustained release Tablet | oral |
| NCDS | 11-D00-006 | Betaxolol (as hydrochloride) 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-007 | Brimonidine tartrate 0.2% | Drop or single dose unit | ophthalmic(Eye) |
| NCDS | 11-D00-041 | Brimonidine tartrate 0.1% | Drop or single dose unit | ophthalmic(Eye) |
| NCDS | 11-D00-036 | Brimonidine tartrate 1.5 mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-037 | Brimonidine tartrate 2mg +Timolol maleate 6.8 mg (eq. 5mg timolol)/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-039 | Bimatoprost 0.3 mg +Timolol (as Maleate) 5mg / 1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-010 | Dichlorphenamide 50mg | Tablet | oral |
| NCDS | 11-D00-011 | Dipivefrin hydrochloride 0.1% | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-013 | Pilocarpine hydrochloride 1% (with or without Hydroxypropylmethyl cellulose) | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-014 | Pilocarpine hydrochloride 2% (with or without Hydroxypropylmethyl cellulose ) | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-018 | Pilocarpine hydrochloride 20mg + Timolol (as Maleate) 5mg /1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-019 | Pilocarpine hydrochloride 40mg + Timolol (as Maleate) 5mg /1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-021 | Timolol (as maleate) 0.25% | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-022 | Timolol (as maleate) 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-024 | Pilocarpine nitrate 2% w/v p.h Eur with purified water | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-026 | Dorzolamide (as hydrochloride) 2% | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-027 | Latanoprost 50 mcg /ml (0.005%) | Drop or SDU (single dose unit) | ophthalmic(Eye) |
| NCDS | 11-D00-040 | Bimatoprost 0. 3mg ( 0.03%) | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-028 | Brinzolamide 10mg /ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-029 | Travoprost 40mcg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-030 | Dorzolamide (as hydrochloride) 20mg(2%)+Timolol (as maleate) 5mg(0.5%)/ml | Drop or SDU (single dose unit) | ophthalmic(Eye) |
| NCDS | 11-D00-031 | Carteolol hyrochloride 2 g /100ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-032 | Travoprost 40mcg+Timolol (as maleate) 5mg /ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-033 | Latanoprost 50 mcg+timolol (as maleate) 5mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-034 | Brinzolamide 10mg + timolol (as maleate) 5 mg/ml | Drop | ophthalmic(Eye) |
| NCDS | 11-D00-035 | Tafluprost 15 mcg /ml | Drop or SDU (single dose unit) | ophthalmic(Eye) |
| NCDS | 11-D00-038 | latanoprostene bunod 0.24 mg/ml | Drop | ophthalmic(Eye) |
| 11E | OTHER OPHTHALMIC PREPARATION | |||
| NCDS | 11-E00-001 | Atropine sulphate 1mg + Cocaine hydrochloride 5mg+Adrenaline acid tartrate 100mcg +Sodium chloride 1mg+Chlorobutol 300mcg | vial or ampoule | Injection |
| NCDS | 11-E00-002 | sodium chloride 0.64g + potassium chloride 0.075g + Calcium chloride.2H2O 0.048g + magnesium chloride.6H2O 0.03g + sodium Acetate.3H2O 0.39g + sodium Citrate. 2H2O 0.17g/100ml | 500ml solution | eye Irrigation |
| NCDS | 11-E00-004 | Chlorhexidine gluconate 0.006%+ Benzalkonium chloride 0.004%+EDTA 0.1% | solution | eye Irrigation |
| NCDS | 11-E00-010 | Chlorhexidine gluconate 0.0025%+Thiomersal 0.0025%+EDTA 0.1% | solution | eye Irrigation |
| NCDS | 11-E00-012 | Distilled witch hazel 12.5%+Boric acid 1.08%+Borax 0.215%+Allantoin 0.08%+Chlorbutol 0.04% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-013 | Distilled witch hazel 12.95%+Boric acid 2%+Sodium borate 0.5%+Allantoin 0.05%+Salicylic acid 0.025%+Chlorobutol 0.025%+Zinc sulphate 0.004% | Lotion | ophthalmic(Eye) |
| NCDS | 11-E00-006 | Dextran 5g+Chlorhexidine gluconate 0.005g/100ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-005 | Dextran “70”0.1%+ Hyperomellose 0.3% drop | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-074 | Riboflavin ( Vitamin B2 ) 0.1% + 20% Dextran 500 / 3 ml solution | preloaded glass syringe | ophthalmic(Eye) |
| NCDS | 11-E00-007 | Fluorescein sodium 10% | vial or ampoule | I.V. Injection |
| NCDS | 11-E00-024 | Fluorescein sodium BP 2.0% w/v + purified water | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-008 | Fluorescein sodium | Strips | ophthalmic(Eye) |
| NCDS | 11-E00-014 | Oxybuprocaine (Benoxinate) hydrochloride 0.4% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-015 | Zinc sulphate 0.25%+ Phenylephrine 0.12% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-017 | Sodium bicarbonate 3.5% | Lotion | ophthalmic(Eye) |
| NCDS | 11-E00-018 | Sodium chloride 0.9% | solution | eye Irrigation |
| NCDS | 11-E00-063 | Sodium chloride 5% | solution | ophthalmic(Eye) |
| NCDS | 11-E00-064 | Sodium chloride 5% | Ointment | ophthalmic(Eye) |
| NCDS | 11-E00-019 | Tetracaine (Amethocaine) hydrochloride 0.5% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-023 | tetracaine (Amethocaine) hydrochloride 1.0% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-020 | Chlorpheniramine maleate 0.1%+Boric acid 0.5%+Sulfanilamide methylene sodium sulphate 0.25%+ Zinc sulphate 0.25% + Phenylephrine 0.2% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-021 | Methyl cellulose | bottle | ophthalmic(Eye) |
| NCDS | 11-E00-022 | N-Acetylcysteine 5g/100ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-026 | Rose bengal 1.0% w/v + purified water + sodium hydroxide | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-027 | Cyclosporin (Ciclosporin)1% Eye Drop(to be available in teaching hospital only) | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-028 | N-methyl Benzoquinoline – methyl sulphate 0.3 g+ thonzylamine hydrochloride 0.1g + sodium chloride 0.9 g +Sodium borate 0.023g +P-oxybenzoic esters 0.047g +Carboxy methyl cellulose 0.033g +sterile water Q.S to 100ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-029 | Carbomer 980 (0.2%) 200mg/100g | gel | ophthalmic(Eye) |
| NCDS | 11-E00-053 | carbomer 0.2% w/w + cetrimide 0.01% w/w | gel | ophthalmic(Eye) |
| NCDS | 11-E00-054 | Propylene glycol 0.3% + povidone 0.68% eye drop | drop | ophthalmic(Eye) |
| NCDS | 11-E00-031 | Polyvinyl alcohol 14mg+Povidone 6mg/1ml | solution | ophthalmic(Eye) |
| NCDS | 11-E00-034 | polyvidone (Povidone iodine )5% | Drop or SDU ( 0.4ml single dose unit) | ophthalmic(Eye) |
| NCDS | 11-E00-038 | Ultra pure silicone oil (polydimethylsiloxane 100 % ultra pure viscosity 2000 mPas ) | 10 ml syringe | intraocular |
| NCDS | 11-E00-040 | Hydroxypropyl Guar 8A 0.16% – 0.7% + Polyethylene Glycol 0.2% – 1% +Propylene glycol 0.2% – 1% | drop or geldrop | ophthalmic(Eye) |
| NCDS | 11-E00-056 | Hydroxypropyl Guar 8A 0.175% W/V + Sodium Hyaluronate 0.15%W/V | drop | ophthalmic(Eye) |
| NCDS | 11-E00-032 | Phenylephrine hydrochloride 1.2mg + Prednisolone sodium phosphate 2.5mg/1ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-036 | Flurometholone 0.1%+sodcromoglycate 2%. | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-044 | Cyclosporin (Ciclosporin) 0.5 mg / ml | 0.4ml single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-009 | Hyaluronic acid ( as sodium Hyaluronate 10mg) | vial solution | ophthalmic(Eye) |
| NCDS | 11-E00-030 | Sodium Hyaluronate 0.1% – 0.4% | drops orgel or single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-037 | Sodium hyaluronate 10mg/1ml | 0.85ml prefilled syringe | ophthalmic(Eye) |
| NCDS | 11-E00-058 | Sodium Hyaluronate 0.30 % with Amino acids | gel | ophthalmic(Eye) |
| NCDS | 11-E00-059 | Sodium Hyaluronate 0.15 % with Amino acids | drop | ophthalmic(Eye) |
| NCDS | 11-E00-068 | Hypromellose ( HPMC ) 2% w/v | solution prefilled syringe & disposable cannula | ophthalmic(Eye) |
| NCDS | 11-E00-067 | Sodium hyaluronate 1% – 3% | solution prefilled syringe & disposable cannula | ophthalmic(Eye) |
| NCDS | 11-E00-062 | Hyaluronic acid 0.30 % + Hydroxyethylcellulose 0.10% | single dose unit gel | ophthalmic(Eye) |
| NCDS | 11-E00-055 | Hyaluronic acid ( as Sodium Hyaluronate ) 0.2% + Ectoin 2 % | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-057 | Sodium hyaluronate 1 mg +Sodium Carboxy methyl cellulose 5 mg +glycerol 9 mg +erythritol 5 mg /ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-033 | Hydroxypropyl methylcellulose ( Hypromellose) 0.32% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-011 | Hydroxypropyl methylcellulose (Hypromellose) 1% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-045 | hydroxypropyl methylcellulose (Hypromellose) 5mg\ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-046 | Hydroxypropyl methylcellulose (Hypromellose) 3 mg /ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-049 | Hydroxypropyl methylcellulose (Hypromellose) 0.3% | single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-047 | Hydroxypropyl methylcellulose (Hypromellose) 2.5 mg / ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-060 | Dextran 70 0.1%+ hydroxypropyl methylcellulose 0.3%+ Sodium Chloride 0.6% + Potassium Chloride 0.12% + Sodium Borate decahydrate ( borax) 0.35% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-048 | Dexpanthenol 50 mg \g | Gel | ophthalmic(Eye) |
| NCDS | 11-E00-072 | Sodium Hyaluronate 1mg + Dexpanthenol 50 mg / 1 ml | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-051 | sodium hyaluronate 0.24% + carbomer980( 0.625mg/g)+ Triglyceride medium chain 2mg/g | 0.5 ml single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-052 | sodium hyaluronate 0.24% + carbomer980( 0.625mg/g) +Triglyceride medium chain 2mg/g | Drop 10 ml | ophthalmic(Eye) |
| NCDS | 11-E00-073 | vitamin A palmitate 25.000IU / 100 gm (0.01%) | ointment | ophthalmic(Eye) |
| NCDS | 11-E00-069 | Carboxymethyl cellulose Sodium 5 mg / ml ( 0.5% ) | single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-075 | Sodium hyaluronate 0.1% + carboxymethyl cellulose 0.5% | single dose unit | ophthalmic(Eye) |
| NCDS | 11-E00-070 | Carboxymethylcellulose sodium 0.5%w/v + Glycerin 0.5%w/v | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-065 | Sodium Hyaluronate 0.125% +Hydroxyethylcellulose 0.1% +sodium chloride 0.5% +boric acid 0.5% +sodium tetraborate 0.08% +disodium edetate 0.02% +polyhexanide 0.0001% | Drop | ophthalmic(Eye) |
| NCDS | 11-E00-066 | Sodium Hyaluronate 0.125% +Hydroxyethylcellulose 0.1% +sodium chloride 0.5%+boric acid0.5% +Sodium teraborate 0.08% +Disodium edetate 0.02% | single dose unit | ophthalmic(Eye) |
| 11EA | Anti-VEGF Anti-Vascular Endothelial Growth Factor Inhibitors | |||
| NCDS | 11-EA0-001 | Ranibizumab 10 mg / ml (2.3mg/0.23ml ) | vial or prefilled syringe | intravitreal |
| NCDS | 11-EA0-005 | Ximluci : Ranibizumab 10 mg / ml solution for injection(2.3mg/0.23ml ) | vial | intravitreal |
| NCDS | 11-EA0-004 | Aflibercept 40 mg /ml | vial solution | intravitreal |
| NCDS | 11-EA0-006 | Faricimab 6mg / 0.05 ml | vial solution | intravitreal |
| NCDS | 11-EA0-007 | Aflibercept ( single dose 8 mg / 0.07 ml ) 30.1mg/0.263ml | vial solution for injection | intravitreal |
| 11F | Drugs used in local ansthesea of ocular surgery | |||
| NCDS | 11-F00-001 | Hyaluronidase 1500 IU | vial | Injection |
| 12 | EAR, NOSE AND OROPHARYNX | |||
| 12A | DRUGS ACTING ON THE EAR | Note:-(Propylene glycol should not be used in ear drop preparations) | ||
| NCDS | 12-A00-001 | Aluminium acetate (B.P) 13% | drop solution | otic (ear) |
| NCDS | 12-A00-002 | Chloramphenicol 5% | drop | otic (ear) |
| NCDS | 12-A00-005 | Dioctyl sodium sulphosuccinate 0.5% | drop | otic (ear) |
| NCDS | 12-A00-006 | Dioctyl sodium sulphosuccinate 5% | drop | otic (ear) |
| NCDS | 12-A00-007 | Framycetin sulphate 0.5% | drop | otic (ear) |
| NCDS | 12-A00-008 | Gentamicin (as sulphate )0.3% +hydrocortisone acetate 1% | drop | otic (ear) |
| NCDS | 12-A00-009 | Polymixcin B sulphate 10000 units+neomycin sulphate 3400 units+ hydrocortisone 10mg/ml | drop | otic (ear) |
| NCDS | 12-A00-011 | Fludrocortisone acetate 1mg + Polymyxin B sulfate 1.30 mg+ lidocaine hydrochloride 50mg /ml | drop solution | otic (ear) |
| NCDS | 12-A00-010 | Clotrimazole 1% | solution | otic (ear) |
| 12B | DRUGS ACTING ON THE NOSE | |||
| NCDS | 12-B00-001 | Azelastine hydrochloride 0.14mg/1dose (1mg/ ml ) | Spray | Nasal |
| NCDS | 12-B00-002 | Beclomethasone dipropionate 50mcg/ metered dosse inhalation | Spray | Nasal |
| NCDS | 12-B00-003 | Budesonide 32mcg/ Dose ( 0.64mg /ml) | Spray | Nasal |
| NCDS | 12-B00-004 | Budesonide 64mcg/ Dose (1.28mg /ml) | Spray | Nasal |
| NCDS | 12-B00-034 | Budesonide 100mcg/ Dose (2mg /ml) | Spray | Nasal |
| NCDS | 12-B00-038 | Olopatadine hydrochloride USP equivalent to Olopatadine 600 mcg + Mometasone furoate monohydrate ph. Eur equivalent to Mometasone furoate 25 mcg + Benzalkonium chloride NF 0.02% w/w ( as preservative ) delivered by Each spray : | Spray | Nasal |
| NCDS | 12-B00-005 | Chlorhexidine hydrochloride 0.1%+ Neomycin sulphate 0.5% | cream | Nasal |
| NCDS | 12-B00-006 | dimethindene maleate 0.25mg + Phenylephrine 2.5mg /ml | drop | Nasal |
| NCDS | 12-B00-025 | dimethindene maleate 0.25mg + Phenylephrine 2.5mg /1gm | gel | Nasal |
| NCDS | 12-B00-026 | dimethindene maleate 0.25mg + Phenylephrine 2.5mg /1ml | Spray | Nasal |
| NCDS | 12-B00-028 | dimethindene maleate 0.25mg + Phenylephrine 2.5mg /1ml | microdoser | Nasal |
| NCDS | 12-B00-007 | Naphthazoline nitrate 0.025%+ Phenylephrine hydrochloride 0.25%+ Chlorbutol 0.5% | Spray | Nasal |
| NCDS | 12-B00-008 | Ephedrine hydrochloride 500mg + Naphthazoline nitrate 125mg/100ml | Spray | Nasal |
| NCDS | 12-B00-009 | Ipratropium Bromide anhydrous 0.03% | Spray | Nasal |
| NCDS | 12-B00-010 | Oxymetazoline hydrochloride 0.05% | Spray | Nasal |
| NCDS | 12-B00-011 | Phenylephrine 0.25% | drop | Nasal |
| NCDS | 12-B00-012 | Phenylephrine 1% | drop | Nasal |
| NCDS | 12-B00-013 | Sodium cromoglycate 2% | Spray | Nasal |
| NCDS | 12-B00-014 | Sodium cromoglycate 10mg | powder | Nasal Insufflation |
| NCDS | 12-B00-015 | Sodium cromoglycate 2%+ Xylometazoline hydrochloride 0.025% | Spray | Nasal |
| NCDS | 12-B00-016 | Tetrahydrozoline (Tetryzoline) hydrochloride 0.1% | drop | Nasal |
| NCDS | 12-B00-017 | Tetrahydrozoline (Tetryzoline) hydrochloride 0.05% | drop | Nasal |
| NCDS | 12-B00-018 | Xylometazoline hydrochloride 0.1% | drop | Nasal |
| NCDS | 12-B00-019 | Xylometazoline hydrochloride 0.05% | drop | Nasal |
| NCDS | 12-B00-021 | Antazoline (sulfate or phosphate) 0.5% + Naphazoline (nitrate or hydrochloride) 0.025% | drop | Nasal and ophthalmic (nose\eye) |
| NCDS | 12-B00-023 | Oxymetazoline hydrochloride 0.05% | drop | Nasal |
| NCDS | 12-B00-037 | Oxymetazoline hydrochloride 0.025% | drop | Nasal |
| NCDS | 12-B00-024 | Xylometazoline hydrochloride 0.1% | Spray | Nasal |
| NCDS | 12-B00-039 | Xylometazoline hydrochloride 1mg + 50 mg Dexapanthenol / 1 ml | spray solution | Nasal |
| NCDS | 12-B00-036 | Xylometazoline hydrochloride 0.5 mg + Ipratropium Bromide 0.6 mg /1ml | Spray solution | Nasal |
| NCDS | 12-B00-035 | Xylometazoline hydrochloride 0.5 mg/ml (0.05%) | Spray | Nasal |
| NCDS | 12-B00-027 | Mometasone furoate monohydrate eq. 50mcg Mometasone furoate / Metered dose | Spray | Nasal |
| NCDS | 12-B00-029 | Sodium cromoglycate 2% | drop | Nasal |
| NCDS | 12-B00-030 | Sodium chloride 0.9% | drop or nasal spray | nasal only for spray or Nasal and ophthalmic (nose\eye) for drops |
| NCDS | 12-B00-031 | Ciclesonide 50mcg/metered dose | Spray | Nasal |
| NCDS | 12-B00-032 | Fluticasone 50mcg propionate | Spray | Nasal |
| NCDS | 12-B00-033 | Azelastine hydrochloride 137mcg (eq. 0.125mg base) + Fluticasone propionate 0.05 mg \dose (0.14g) Nasal spray | Spray | Nasal |
| 12C | Mouthwashes and other preparations for oropharyngeal use | |||
| NCDS | 12-C00-001 | DEQUALINIUM chloride 100mg+B- glycyrrhetinic acid 60mg +Hydrocortisone acetate 60mg+Tyrothricin 400mg+Lidocaine hydrochloride 100mg/100ml | spray | Oromucosal |
| NCDS | 12-C00-002 | Amylmetacresol 0.5% | Gargle | mouth |
| NCDS | 12-C00-003 | Benzocaine 10mg | Lozenge | mouth |
| NCDS | 12-C00-004 | Benzydamine hydrochloride 0.15% | mouth wash | mouth |
| NCDS | 12-C00-029 | Benzydamine hydrochloride 0.15% | Oromucosal spray | mouth |
| NCDS | 12-C00-006 | Carbenoxolone sodium 1% | mouth wash | mouth |
| NCDS | 12-C00-009 | Hydrocortisone (as Hydrocortisone sodium succinate) mg 2.5 | buccal tablets | muco-adhesive |
| NCDS | 12-C00-010 | Triamcinolone acetonid 0.1% | paste | dental |
| NCDS | 12-C00-011 | Ethanol 96%+Benzoic acid 0.12%+Eucalyptus 0.09%+Menthol 0.04%+Methyl salicylate 0.05%+Thymol 0.06% | Gargle | mouth |
| NCDS | 12-C00-012 | Carmellose sodium (carbnoxymethylcellulose Sodium ) 16.58%+ Pectin 16.58%+Gelatin 16.58% | paste | Orabase |
| NCDS | 12-C00-013 | Lidocaine hydrochloride 0.6%+ Cetyl pyridinium chloride 0.02%+ Menthol 0.06%+ Cineole 0.1% | Gel | dental |
| NCDS | 12-C00-014 | Menthol 0.4g+Thymol 0.4g+ Tincture Krameria 6.0ml+ Glycerin 10.0ml+ Alcohol (95%) 20ml/60ml | Gargle | mouth |
| NCDS | 12-C00-015 | Miconazole(base) 2% | oral Gel | mouth |
| NCDS | 12-C00-017 | Alumnium chloride 13.5%+Calcium chloride 3.4%+Menthol 0.12% | Gargle | mouth |
| NCDS | 12-C00-018 | Sodium fluoride 0.05% | mouth wash | mouth |
| NCDS | 12-C00-019 | Sodium fluoride Powder for rinse | ||
| NCDS | 12-C00-020 | Sodium fluoride 0.55mg | Tablet | oral |
| NCDS | 12-C00-021 | Sodium fluoride 1.1mg | Tablet | oral |
| NCDS | 12-C00-022 | Sodium fluoride 2.2mg | Tablet | oral |
| NCDS | 12-C00-023 | Sodium fluoride 0.5mg/5 Drops | drop | oral |
| NCDS | 12-C00-025 | Benzoxonium chloride 1mg+lidocaine hydrochloride 1mg | Lozenge | mouth |
| NCDS | 12-C00-026 | Pilocarpine hydrochloride 5mg | Tablet | oral |
| NCDS | 12-C00-031 | lidocaine hydrochloride 3.3 mg+ Cetylpyridinium chloride 1.0 mg / gm | oral gel | mouth |
| NCDS | 12-C00-034 | Hexetidine 0.1% W/V | Mouth wash | mouth |
| NCDS | 12-C00-008 | Chlorhexidine gluconate 0.2% | Mouth wash | mouth |
| NCDS | 12-C00-024 | Chlorhexidine gluconate 0.2% | Oromucosal spray | mouth |
| NCDS | 12-C00-027 | Chlorhexidine gluconate 0.2%+ sodium fluoride 0.05% | Mouth Wash | mouth |
| NCDS | 12-C00-007 | Chlorhexidine gluconate 1% Gel | oral gel | dental |
| NCDS | 12-C00-033 | Cetylpyridinium Chloride 0.05 g. + Sodium Fluoride 0.05 g/100 ml | Mouth Wash | mouth |
| NCDS | 12-C00-028 | Povidone Iodine 1% w/v | Mouth Wash | mouth |
| NCDS | 12-C00-030 | Povidone Iodine 0.45% | Throat spray | mouth |
| NCDS | 12-C00-035 | PVP (Polyvinylpyrrolidone) 6% | spray | mouth |
| NCDS | 12-C00-036 | PVP (Polyvinylpyrrolidone) 12 % & Xanthan 1 % | gel | oral |
| 12D | Others | |||
| NCDS | 12-D00-001 | Potassium Nitrate 50mg + Sodium monoflour phosphate 8.15mg + sodium chloride 48.16mg + Sodium Sulphate 2.58mg+ Potassium Sulphate 2.58mg+Titanium dioxide 10mg+Silica 135mg+Sodium laurylsulfate 15mg+ Flavours+Saccharin+Menthol+Peppermint oil+ Vanillin+Excip /1g | tooth paste | dental |
| NCDS | 12-D00-002 | Strontium chloride hexahydrate 10% | tooth paste | dental |
| NCDS | 12-D00-003 | Potassium Nitrate 50 mg + Sodium monoflour phosphate 8.15mg / g | tooth paste | dental |
| NCDS | 12-D00-004 | Potassium Nitrate 50 mg / g | tooth paste | dental |
| 13 | SKIN | |||
| 13A | VEHICLES | |||
| NCDS | 13-A00-002 | Lanolin | Cream or Ointment | topical |
| NCDS | 13-A00-003 | White soft Paraffin | Cream or Ointment | topical |
| NCDS | 13-A00-004 | Yellow Soft Paraffin | Cream or Ointment | topical |
| NCDS | 13-A00-005 | Emulsifying wax 30%+ white soft paraffin 50%+ Liquid paraffin 20% | Ointment | topical |
| 13B | EMOLLIENTS AND BARRIER PREPARATIONS | |||
| NCDS | 13-B00-001 | Urea 10% | Cream | topical |
| NCDS | 13-B00-020 | Urea 10% w/w + Lactic acid 5% | cream | topical |
| NCDS | 13-B00-002 | Zinc oxide 15% | Ointment | topical |
| NCDS | 13-B00-003 | Zinc oxide 7.5%+ Castor oil 50% | Ointment and cream | topical |
| NCDS | 13-B00-004 | Zinc oxide 35mg +Titanium dioxide 45mg/ 1 g | Ointment | topical |
| NCDS | 13-B00-015 | Titanium dioxide 20% w/w + Titanium peroxide 5% W/W + Titanium salicylate 3% w/w | Ointment | topical |
| NCDS | 13-B00-006 | Zinc oxid 15.25% Lanolin (hypollergic) 4.00% Benzyl benzoate 1.01% Benzyl alcohol 0.39 % Benzyl cinnamate 0.15% | Cream | topical |
| NCDS | 13-B00-005 | Zinc oxide 15% w/w cream | Cream | topical |
| NCDS | 13-B00-007 | Dimethicone 10 g + zinc oxide 7.5 g + calamine 1.5 g/100g | Cream | topical |
| NCDS | 13-B00-013 | Beta-Sitosterol 0.25%w/w + Zinc oxid 15.25 % w/w | Cream | topical |
| 13C | ANTIPRURITIC AND LOCAL ANAESTHETIC PREPARATIONS | |||
| NCDS | 13-C00-001 | Calamine 8%+Glycerin 10%+Camphor 0.1% | Cream | topical |
| NCDS | 13-C00-002 | Calamine 8% or 10% +Glycerin 10%+Camphor 0.1% | Lotion or solution | topical |
| NCDS | 13-C00-003 | Calamine 8%+Glycerin 10%+Camphor 0.1% | Lotion or solution | topical |
| NCDS | 13-C00-009 | Calamine 15% w/v + zinc oxide 5 % w/v | lotion or (100 ml or 200ml suspension ) | topical |
| NCDS | 13-C00-012 | Diphenhydramine Hydrochloride 2% ( 20 mg / gm ) | solution | topical |
| NCDS | 13-C00-005 | Crotamiton 10% Cream | Cream | topical |
| NCDS | 13-C00-006 | Crotamiton 10% | Lotion | topical |
| NCDS | 13-C00-007 | lidocaine as abase 5% | Ointment or gel | topical |
| NCDS | 13-C00-008 | Tetracaine hydrochloride 1% | Ointment | topical |
| NCDS | 13-C00-011 | Prednicarbate 0.25% | Cream | topical |
| NCDS | 13-C00-004 | Cinchocaine (as hydrochloride) 1% | Ointment | topical |
| 13D | TOPICAL CORTICOSTEROIDS | |||
| NCDS | 13-D00-001 | Betamethasone (as valerate) 0.1% | Ointment | topical |
| NCDS | 13-D00-002 | Betamethasone (as valerate) 0.1% | Cream | topical |
| NCDS | 13-D00-003 | Betamethasone (as valerate) 0.1% | Lotion | topical |
| NCDS | 13-D00-004 | Betamethasone (as dipropionate) 0.05%+ Salicylic acid 2% | Lotion | topical |
| NCDS | 13-D00-006 | Betamethasone (as valerate) 0.1% | liquid | topical |
| NCDS | 13-D00-007 | Betamethasone (as valerate) 0.1%+ Clioquinol 3% | Cream | topical |
| NCDS | 13-D00-008 | Betamethasone (as valerate) 0.1%+Clioquinol | Ointment | topical |
| NCDS | 13-D00-009 | Betamethasone (as valerate )0.1%+Gentamicin (as sulphate) 0.1% | Ointment | topical |
| NCDS | 13-D00-010 | Betamethasone (as valerate) 0.1%+ Gentamicin (as sulphate) 0.1% | Cream | topical |
| NCDS | 13-D00-011 | Betamethasone (as valerate) 0.5mg+Gentamicin( as sulphate) 1mg + Clioquinol 10mg+Tolnaftate 10mg/g | Cream | topical |
| NCDS | 13-D00-012 | Betamethasone (as valerate) 0.1% + Neomycin sulphate 0.5% | Ointment | topical |
| NCDS | 13-D00-013 | Betamethasone (as valerate) 0.1%+ Neomycin sulphate 0.5% | Cream | topical |
| NCDS | 13-D00-014 | Betamethasone (as valerate) 0.1%+ Neomycin sulphate 0.5% | Lotion | topical |
| NCDS | 13-D00-015 | Betamethasone 0.1%+ Econazole nitrate 1% | Cream | topical |
| NCDS | 13-D00-063 | Betamethasone (as dipropionate) 0.5mg + salicylic Acid 30mg/ 1g | Ointment | topical |
| NCDS | 13-D00-049 | Betamethasone (as dipropioate) 0.1% | Cream | topical |
| NCDS | 13-D00-050 | Betamethasone (as dipropioate) 0.1% | Ointment | topical |
| NCDS | 13-D00-053 | Betamethasone (as valarate) 1mg+ fusidic acid 20mg/1g | Cream | topical |
| NCDS | 13-D00-055 | Betamethasone (as dipropionate) 0.5mg /g | Cream | topical |
| NCDS | 13-D00-056 | Betamethason as dipropionate (0.05%) Ointment | Ointment and lotion | topical |
| NCDS | 13-D00-016 | Clobetasol propionate 0.05% | Ointment | topical |
| NCDS | 13-D00-017 | Clobetasol propionate 0.05% | Cream | topical |
| NCDS | 13-D00-018 | Clobetasol propionate 0.05% | Alcoholic Solution | topical |
| NCDS | 13-D00-068 | Clobetasol propionate 0.05% | foam | topical |
| NCDS | 13-D00-020 | Fluocinolone acetonide 0.025% | Ointment | topical |
| NCDS | 13-D00-021 | Fluocinolone acetonide 0.025% | Cream | topical |
| NCDS | 13-D00-022 | Fluocinolone acetonide 0.025% | Lotion | topical |
| NCDS | 13-D00-023 | Flumethasone pivalate 0.02% +Clioquinol 3% | Ointment | topical |
| NCDS | 13-D00-024 | Flumethasone pivalate 0.02% + Clioquinol 3% | Cream | topical |
| NCDS | 13-D00-025 | Fluocinolone acetonide 0.025% + Chlormidazole hydrochloride 5% | Cream | topical |
| NCDS | 13-D00-026 | Fluocinolone acetonide 0.01% + chlormidazole hydrochloride 50mg + salicylic acid 10mg /1ml | lotion or solution | topical |
| NCDS | 13-D00-028 | Fluocinolone acetonide 0.025% + Neomycin sulphate eq.Neomycin base 3.5mg/1gm | Ointment | topical |
| NCDS | 13-D00-029 | Fluocinolone acetonide 0.025% + Neomycin sulphate eq. Neomycin base 3.5mg/1gm | Cream | topical |
| NCDS | 13-D00-031 | Fluocortolone hexanoate 0.25% + Fluocortolone pivalate 0.25% | fatty Ointment | topical |
| NCDS | 13-D00-032 | Fluocortolone hexanoate 0.25%+Fluocortolone pivalate 0.25% | Cream | topical |
| NCDS | 13-D00-033 | Flumethasone 0.02% | Cream | topical |
| NCDS | 13-D00-034 | Flumethasone 0.02% | Ointment | topical |
| NCDS | 13-D00-035 | Flumethasone pivalate 0.02% + Neomycin sulphate 0.5% | Ointment | topical |
| NCDS | 13-D00-036 | Flumethasone pivalate 0.02%+ Neomycin sulphate 0.5% | Cream | topical |
| NCDS | 13-D00-037 | flurandrenolide 4mcg/cm2 | Tape | topical |
| NCDS | 13-D00-038 | Hydrocortisone 1% or Hydrocortisone acetate 1% | Cream | topical |
| NCDS | 13-D00-039 | Hydrocortisone 2.5% or Hydrocortisone acetate 2.5% | Cream | topical |
| NCDS | 13-D00-040 | Hydrocortisone 0.25%+ Clemizole hexachlorophene sulphate 2.5% Oi | Ointment | topical |
| NCDS | 13-D00-061 | Hydrocortisone 17-butyrate 1mg/gm (0.1%) | Cream | topical |
| NCDS | 13-D00-052 | Hydrocortisone as abase 1% | Cream | topical |
| NCDS | 13-D00-064 | Hydrocortisone 17-butyrate 1mg/ml (0.1%) | scalp lotion | topical |
| NCDS | 13-D00-065 | Hydrocortisone 17-butyrate 1mg/ml (0.1%) | Emulsion | topical |
| NCDS | 13-D00-066 | Hydrocortisone acetate 1% | Ointment | topical |
| NCDS | 13-D00-054 | Hydrocortisone acetate 10mg+ fusidic acid 20mg /1gm | Cream | topical |
| NCDS | 13-D00-019 | Miconazole nitrate 20mg+ Hydrocortisone 10mg/1gm | Cream | topical |
| NCDS | 13-D00-041 | Triamcinolone acetonide 0.1%+ Econazole nitrate 1% | Cream | topical |
| NCDS | 13-D00-042 | Triamcinolone 0.1% | Ointment | topical |
| NCDS | 13-D00-043 | Triamcinolone acetonide 0.1%+ Gramicidin 0.025%+ Neomycin as sulphate 0.25% (eq.3.8 mg )+ Nystatin 100000 units/1g | Cream | topical |
| NCDS | 13-D00-044 | Triamcinolone acetonide 0.1% + Gramicidin 0.025%+ Neomycin as sulphate 0.25% (eq. 3.8 mg) + Nystatin 100000 units/1g | Ointment | topical |
| NCDS | 13-D00-045 | Neomycin sulphate 300000 IU+polymyxin B sulphate 300000 IU+ Triamcinolone 0.0375 gm+ Paraffin Q.S.AD 100g | impregnated tissue | topical |
| NCDS | 13-D00-046 | Isoconazole nitrate 10mg+Diflucortolone valerate 1mg/1g | Cream | topical |
| NCDS | 13-D00-047 | Clotrimazole 10mg+betamethasone dipropionate 0.64mg (eq. betamethasone 0.5mg)/1g | Cream | topical |
| NCDS | 13-D00-057 | Mometasone furtoate 0.1% | Ointment | topical |
| NCDS | 13-D00-058 | Mometasone furtoate 0.1% | Cream | topical |
| NCDS | 13-D00-059 | Mometasone furoate 0.1%+salicylic acid 5% | Ointment | topical |
| NCDS | 13-D00-060 | Mometasone furoate 0.1%+miconazol nitrate 2% | Cream | topical |
| NCDS | 13-D00-062 | Mometasone furoate 0.1% | Lotion | topical |
| NCDS | 13-D00-067 | Fluticasone propionate 0.005% | Ointment | topical |
| 13E | PREPARATIONS FOR ECZEMA AND PSORIASIS | |||
| NCDS | 13-E00-001 | Coal tar Paste | paste | topical |
| NCDS | 13-E00-002 | Calcipotriol 50mcg /g (0.005% W/W) | Ointment | topical |
| NCDS | 13-E00-003 | Calcipotriol 50mcg /g( 0.005% W/W ) | Cream | topical |
| NCDS | 13-E00-004 | Calcipotriol 50mcg /ml | Scalp Solution | topical |
| NCDS | 13-E00-005 | Dithranol triacetate 0.25% | Cream | topical |
| NCDS | 13-E00-006 | Dithranol triacetate 0.5% | Cream | topical |
| NCDS | 13-E00-007 | Dithranol triacetate 1% | Cream | topical |
| NCDS | 13-E00-008 | Acitretin 10mg | Capsule | oral |
| NCDS | 13-E00-009 | Acitretin 25mg | Capsule | oral |
| NCDS | 13-E00-010 | Flumethasone pivalate 0.02%+Salicylic acid 1%+Coal tar 1.5% | Ointment | topical |
| NCDS | 13-E00-011 | Flumethasone pivalate 0.02%+ Salicylic acid 3% | Ointment | topical |
| NCDS | 13-E00-012 | Cetyl alcohol-coal tar distillate 4%+Precipitated sulphur 3%+Salicylic acid 3% | Ointment | topical |
| NCDS | 13-E00-013 | Dithranol 0.1% + Salicylic acid 1% | Ointment | topical |
| NCDS | 13-E00-014 | Calcipotriol (as hydrate) 50mcg + Betamethasone (as dipropionate) 0.5mg /1g | Ointment | topical |
| NCDS | 13-E00-015 | Calcipotriol (as mono-hydrate) 50mcg + Betamethasone (as dipropronate) 0.5mg /g | gel | topical |
| 13F | PREPARATIONS FOR ACNE | |||
| NCDS | 13-F00-001 | Sulphur precipitated 3%+ Resorcinol 0.5%+ Cetrimide 0.5% | Cream | topical |
| NCDS | 13-F00-002 | Benzoyl peroxide 10% | gel | topical |
| NCDS | 13-F00-003 | Benzoyl peroxide 5% | gel | topical |
| NCDS | 13-F00-022 | Benzoyl peroxide 2-8% + additive | soap | topical |
| NCDS | 13-F00-004 | Isotretinoin 5mg | Capsule or soft gelatin capsule | oral |
| NCDS | 13-F00-005 | Isotretinoin 10mg | Capsule or soft gelatin capsule | oral |
| NCDS | 13-F00-006 | Isotretinoin 20mg | Capsule or soft gelatin capsule | oral |
| NCDS | 13-F00-026 | Isotretinoin 40mg | Capsule or soft gelatin capsule | oral |
| NCDS | 13-F00-014 | Isotretinoin 0.05% w/w | gel | topical |
| NCDS | 13-F00-007 | Methylprednisolone acetate 0.25%+Neomycin sulphate 0.25%+Aluminium chlorhydroxide complex 10%+Sulphur 5% | Lotion | topical |
| NCDS | 13-F00-008 | Tretinoin (Retinoic acid) 0.01% | gel | topical |
| NCDS | 13-F00-009 | Tretinoin (Retinoic acid) Acid 0.025% | gel | topical |
| NCDS | 13-F00-010 | Tretinoin (Retinoic acid) 0.025% | Cream | topical |
| NCDS | 13-F00-011 | Tretinoin (Retinoic acid) 0.025% | Lotion | topical |
| NCDS | 13-F00-020 | Tretinoin 0.25mg + Clindamycin 10 mg (as Clindamycin phosphate) | gel | topical |
| NCDS | 13-F00-015 | Tretinoin (Retinoic acid) 0.05% | Cream | topical |
| NCDS | 13-F00-016 | Tretinoin (Retinoic acid) 0.05% | gel | topical |
| NCDS | 13-F00-017 | Tretinoin (Retinoic acid) 0.1% | Cream | topical |
| NCDS | 13-F00-012 | Azelaic acid 0.2g/1gm | Cream | topical |
| NCDS | 13-F00-027 | Adapalene 1mg/1g | Cream | topical |
| NCDS | 13-F00-013 | Adapalene 1mg/1g | gel | topical |
| NCDS | 13-F00-018 | Benzoyl peroxide 2.5 % + Adapalene 0.1 % | gel | topical |
| NCDS | 13-F00-028 | Benzoyl peroxide 2.5% | gel | topical |
| NCDS | 13-F00-019 | Ivermectin 10mg\g | Cream | topical |
| NCDS | 13-F00-025 | Metronidazole 1 % (10mg/g) | Cream | topical |
| NCDS | 13-F00-024 | Metronidazole 0.75 % (7.5mg/g) | gel | topical |
| NCDS | 13-F00-021 | Vitamin A 100000 IU per ounce | Cream | topical |
| 13G | ANTIBACTERIAL SKIN PREPARATIONS | |||
| NCDS | 13-G00-004 | Clindamycin (as phosphate) 1% | solution | topical |
| NCDS | 13-G00-023 | Clindamycin (as phosphate) 10 mg/g | gel | topical |
| NCDS | 13-G00-006 | Erythromycin as abase 2% | alcohol-based Solution | topical |
| NCDS | 13-G00-022 | Erythromycin as abase 4% +Zinc acetate 1.2% | lotion | topical |
| NCDS | 13-G00-026 | Erythromycin ( as base ) 4% | gel | topical |
| NCDS | 13-G00-007 | Framycetin sulphate 0.5% | Cream | topical |
| NCDS | 13-G00-008 | Framycetin sulphate 0.5% | Ointment | topical |
| NCDS | 13-G00-009 | Framycetin sulphate1.5%+ Gramicidin 0.005% | Ointment | topical |
| NCDS | 13-G00-018 | Framycetin sulphate 1% | impregnated tissue | topical |
| NCDS | 13-G00-010 | Gentamicin 0.3% | Cream | topical |
| NCDS | 13-G00-011 | Gentamicin 0.3% | Ointment | topical |
| NCDS | 13-G00-013 | Mafenide (as acetate) 8.5% | Cream | topical |
| NCDS | 13-G00-015 | Silver sulphadiazine 1% | Cream | topical |
| NCDS | 13-G00-016 | Sodium fusidate 2% | Ointment | topical |
| NCDS | 13-G00-017 | fusidic acid 2% | Cream | topical |
| NCDS | 13-G00-019 | Tetracycline hydrochloride 3% Skin | Ointment | topical |
| NCDS | 13-G00-020 | Neomycin sulphate 425000 I.U+polymyxin B sulphate 300000 I.U + Paraffin Q.S.AD 100g | impregnated tissue | topical |
| NCDS | 13-G00-027 | Neomycin 1338 .22 IU ( as neomycin sulfate ) + Bacitracin 103.80 IU / 1 gm | aerosol cutaneous spray powder | topical |
| NCDS | 13-G00-021 | Chlortetracycline hydrochloride 3% | Ointment | topical |
| NCDS | 13-G00-012 | Povidone Iodine | Sterile Adherent Dressing | topical |
| NCDS | 13-G00-024 | Ozenoxacin 10 mg\g | Cream | topical |
| NCDS | 13-G00-025 | Mupirocin 20mg / gm (2% w/w) | Ointment | topical |
| 13H | DESINFECTANTS, ANTISEPTICS AND CLEANSING AGENTS | 1172 تثبت الاشكال الصيدلانية مع المعقمات (gel or spray or solution or wipes) | ||
| NCDS | 13-H00-002 | Cetrimide+ Chlorhexidine gluconate | solution | external |
| NCDS | 13-H00-005 | Chlorhexidine gluconate 20% to be diluted to (0.5% alcoholic solution ) (0.05% | aqueous solution | external |
| NCDS | 13-H00-009 | Glutaraldehyde 2g in 5L plastic can and for activator : potassium carbonate 10gm + potassium phosphate 10gm + sodium bicarbonate 5gm/25gm powder or Glutaraldehyde 2% aqueos solution buffered to PH about 7.5- 8.5 | solution | external |
| NCDS | 13-H00-010 | Hydrogen peroxide UP TO 6% | solution | external |
| NCDS | 13-H00-016 | Ethanol 70 – 85 % v/v | solution | external |
| NCDS | 13-H00-126 | each 100ml contain ethanol 70ml | solution 1L | external |
| NCDS | 13-H00-020 | Formaldehyde 37% | solution | external |
| NCDS | 13-H00-023 | Potassium permanganate | crystals | external |
| NCDS | 13-H00-024 | Sodium Hypochlorite 0.5 % | solution | external |
| NCDS | 13-H00-025 | Isopropyl alcohol (propan-2-ol or isopropanol or 2-propanol) (65-80%) | solution | external |
| NCDS | 13-H00-026 | o-phthaldialdehyde 0.55% | aqueous solution | external |
| NCDS | 13-H00-031 | Peracetic acid and hydrogen peroxide | solution | external |
| NCDS | 13-H00-034 | Chloroxylenol 5% | solution | external |
| NCDS | 13-H00-040 | Sodium dichloroisocyanurate Yields 56-65%of free chlorine | solution | external |
| NCDS | 13-H00-065 | Ethanol + Formaldehyde + glyoxal + glutaraldehyde | solution | external |
| NCDS | 13-H00-066 | isopropanol +Ethanol +Benzalkoniumchloride +Glucoprotamine | solution | external |
| NCDS | 13-H00-069 | Benzalkonium chloride 5% diluted to 0.01 to 0.1% | solution | external |
| NCDS | 13-H00-070 | Formaldehyde + Glyoxal + Glutaral + Benzalkonium Chloride | solution | external |
| NCDS | 07-C00-028 | Povidone iodine 10% according to USP , BP | solution | external |
| NCDS | 13-H00-012 | Povidone iodine 7.5% according to USP , BP | solution (Surgical scrub) | external |
| NCDS | 13-H00-029 | Povidone iodine 4% according to USP , BP | solution | external |
| NCDS | 13-H00-123 | Strong Iodine 5% | solution | external |
| NCDS | 13-H00-091 | N-(3-aminopropyl)-N-dodecylpropan-1,3 diamine+ didecyldimethylammonium Chloride | solution | external |
| NCDS | 13-H00-094 | Multilayer Quaternary ammonium compounds (QAC) blend 0.0125% – 6.6% + TBTO (tributyltinoxide) 0.0011% – 0.286 % | solution | external |
| NCDS | 13-H00-095 | penta ( potassium) bisperoxymonosulphate) bis (sulphate) 497g / kg | solution | external |
| NCDS | 13-H00-097 | peracetic acid + isopropanol | solution | external |
| NCDS | 13-H00-109 | polyhexmethylenebiguanide hydochloride 0.8-1.0% | solution | external |
| NCDS | 13-H00-110 | N-(3-aminopropyl ) -N-dodeecylpropane-1,3-diamine) 3.6-10% | solution | external |
| NCDS | 13-H00-100 | Glucoprotamin 25 g / 100g | solution | external |
| NCDS | 13-H00-111 | peracetic acid 40% | solution | external |
| NCDS | 13-H00-112 | didecyldimethylammonium chloride+ ethanol+isopropanol | solution | external |
| NCDS | 13-H00-113 | didecyldimethylammonium chloride+ benzalkonium chloride | solution | external |
| NCDS | 13-H00-114 | isopropanol + benzalkoniumchloride | solution | external |
| NCDS | 13-H00-115 | didecyldimethylammonium chloride + ethanol + polyhexamethylenebigunide hydrochloride | solution | external |
| NCDS | 13-H00-116 | didecyldimethylammonium chloride + ethanol + phenoxyethanol + N-(3-aminopropyl)-N-dodecylpropane -1,3-diamine) | solution | external |
| NCDS | 13-H00-117 | quaternary ammonium propionate + guanidiuim acetate | solution | external |
| NCDS | 13-H00-118 | quaternary ammonium propionate + polyhexamethylenebiguanide hydochloride + enzymes (protease + lipase+ amylase) | solution | external |
| NCDS | 13-H00-119 | benzyl-c12-18 alkyl dimethyl ammonium chloride +N-(3-aminopropyl ) N-dodecylpropane -1.3-diaminne | solution | external |
| NCDS | 13-H00-101 | Chlorhexidine gluconate 4 % | solution | external |
| NCDS | 13-H00-103 | super oxidized solulion( Sodium hypochlorite (0.002%) + Hypochlorous acid (0.008%) +Sodium chloride (0.066%) + Sodium phosphate (1.200%) +Sodium magnesium fluorosilicate (4.500%) + Electrolyzed water (94.224%)) | hydrogel | external |
| NCDS | 13-H00-102 | super oxidized solulion (Oxidized water 99.97% + sod.chloride 0.023% + sod. Hypochlorite (NaOCl) 0.004% + Hypochlorous acid (HOCl) 0.003% ) | solution | external |
| NCDS | 13-H00-105 | Hypochlorous acid ( 0.014-0.05)% | solution | external |
| NCDS | 13-H00-104 | quaternary ammonium compounds + polyhexamethylenebiguanide hydrochloride | solution | external |
| NCDS | 13-H00-106 | Polyhexamethylenebiguanide hydrochloride 20 % | solution | external |
| NCDS | 13-H00-108 | Isopropyl alcohol + 2 – Phenoxyethanol | solution | external |
| NCDS | 13-H00-120 | Isopropyl alcohol 0.98 + Chloroxylenol 0.244 | solution | external |
| NCDS | 13-H00-121 | Propanol 17gm + 0.23gm Didecyldimethylammonium chloride / 100 gm | solution | external |
| NCDS | 13-H00-127 | each 100ml contain : didecyldimethyl ammonium chloride 10g + Benzalkonium chloride 2g concentrated solution | solution 5L | external |
| NCDS | 13-H00-128 | each 100ml contain : Didecyldimethyl ammonium chloride 0.2g + ethanol 12.5g + propan-2-ol 65g | solution 5L | external |
| NCDS | 13-H00-132 | each 100ml contain : Didecyldimethyl ammonium chloride 0.2g + ethanol 12.5g + propan-2-ol 65g | solution 750mL | external |
| NCDS | 13-H00-129 | each 100ml contain : Didecyldimethyl ammonium chloride 0.4g + benzalkonium chloride 0.25g | solution 5L | external |
| NCDS | 13-H00-133 | each 100ml contain : Didecyldimethyl ammonium chloride 0.4g + benzalkonium chloride 0.25g | solution 750mL | external |
| NCDS | 13-H00-130 | each 100ml contain : didecyl dimethyl ammonium chloride 0.25g , benzalkonium chloride 0.5g | solution 5L | external |
| NCDS | 13-H00-134 | each 100ml contain : didecyl dimethyl ammonium chloride 0.25g , benzalkonium chloride 0.5g | solution 750mL | external |
| NCDS | 13-H00-131 | enzyme (protease ,lipase ,amylase) 7% quaternary ammonium propionate , 1% polymethylenbiguanide hydrochloride | solution 5L | external |
| 13I | ANTIFUNGAL PREPARATIONS | |||
| NCDS | 13-I00-001 | Chlorphenesin 1% | Powder | topical |
| NCDS | 13-I00-002 | Chlorquinaldol 5% | Ointment | topical |
| NCDS | 13-I00-003 | Clioquinol 3% | Cream | topical |
| NCDS | 13-I00-004 | Clotrimazole 1% | Solution | topical |
| NCDS | 13-I00-005 | Econazole nitrate 1% | Cream | topical |
| NCDS | 13-I00-006 | Econazole nitrate 1% | Solution | topical |
| NCDS | 13-I00-007 | Econazole nitrate 1% | Lotion | topical |
| NCDS | 13-I00-008 | Econazole nitrate 1% | Spray | topical |
| NCDS | 13-I00-009 | Econazole nitrate 1% | Powder | topical |
| NCDS | 13-I00-010 | Econazole as abase 1% | foaming Solution | topical |
| NCDS | 13-I00-026 | Isoconazole nitrate 10mg/1gm ( 1% ) | cream | topical |
| NCDS | 13-I00-012 | Ketoconazole 2% | Shampoo | topical |
| NCDS | 13-I00-013 | Ketoconazole 2% | Cream | topical |
| NCDS | 13-I00-014 | Miconazole nitrate 2% | Lotion | topical |
| NCDS | 13-I00-015 | Salicylic acid 3%+Benzoic acid 6% | Ointment | topical |
| NCDS | 13-I00-016 | Zinc undecenoate 8%+Zinc naphthenate(10% zinc)8%+Mesulphen8%+Methyl salicylate 2.5%+Terpineol 2.5%+Chlorocresol 0.1% | Ointment | topical |
| NCDS | 13-I00-017 | Tolnafthate 1% | Solution | topical |
| NCDS | 13-I00-018 | Clotrimazole 1%(10mg/ml) | spray | topical |
| NCDS | 07-C00-004 | Clotrimazole 1% | Cream | topical |
| NCDS | 13-I00-019 | Terbinafine hydrochloride 1% | Cream | topical |
| NCDS | 13-I00-021 | Terbinafine hydrochloride 1% | spray | topical |
| NCDS | 13-I00-022 | Miconazole nitrate 2% | Cream | topical |
| NCDS | 13-I00-023 | Sertaconazole nitrate 2% | Cream | topical |
| NCDS | 13-I00-024 | Luliconazole 1% | Cream | topical |
| NCDS | 13-I00-025 | Tioconazole 1% (10mg/g) | Cream | topical |
| 13J | ANTIVIRAL SKIN PREPARATIONS | |||
| NCDS | 13-J00-001 | Acyclovir 5% Cream, | Cream | topical |
| NCDS | 13-J00-002 | Idoxuridin 0.1% Soultion | Solution | topical |
| NCDS | 13-J00-003 | Vidarabine 3% Ointment | Ointment | topical |
| 13K | ANTIPARASITIC SKIN PREPARATIONS | |||
| NCDS | 13-K00-001 | benzyl benzoate 25% | liquid | topical |
| NCDS | 13-K00-003 | Pyrethrine synthetic (bioallethrin) 0.45g+piperonyl butoxide 2.7g | canister aerosol | topical |
| NCDS | 13-K00-005 | Permethrin 1% | shampoo or rinse solution or lotion | topical |
| NCDS | 13-K00-006 | Permethrin 5% | Cream or lotion | topical |
| NCDS | 13-K00-008 | precipitated sulphur 5% | Ointment | topical |
| NCDS | 13-K00-010 | precipitated Sulphur 10% (for adult) | Ointment | topical |
| NCDS | 13-K00-013 | benzyl benzoate 20% | Cream | topical |
| NCDS | 13-K00-014 | Malathion 0.5% | Lotion or Liquid solution | topical |
| NCDS | 13-K00-016 | Phenothrin 0.5% | aqueous lotion | topical |
| NCDS | 13-K00-017 | Phenothrin 0.2 % | alcoholic Lotion | topical |
| NCDS | 13-K00-019 | Ivermectin 0.5% | lotion | topical |
| NCDS | 13-K00-020 | Dimethicone 92% | spray | topical |
| 13L | SHAMPOOS AND SCALP PREPARATIONS | |||
| NCDS | 13-L00-001 | Cetrimide 17.5% | Shampoo | topical |
| NCDS | 13-L00-002 | Coal tar (prepared) 2%+Hexachlorophene 1% | Shampoo | topical |
| NCDS | 13-L00-003 | Coal tar (Purified) fractions 2% + Sodium sulphosuccinated undecylenic monoalkylolamide 1% | Shampoo | topical |
| NCDS | 13-L00-004 | Selenium sulphide 2.5% | Shampoo | topical |
| 13M | MELANIZING AND DEMELANIZING AGENTS | |||
| NCDS | 13-M00-001 | Hydroquinone 2% + sun block (sun /u.v.block ) | Cream | topical |
| NCDS | 13-M00-018 | Hydroquinone 4% + sunblock (sun/u.v block base) | cream | topical |
| NCDS | 13-M00-019 | Hydroquinone 2% | cream | topical |
| NCDS | 13-M00-021 | Hydroquinone 2% + Tretinoin 0.025% + Mometasone furoate 0.1% | cream | topical |
| NCDS | 13-M00-022 | Hydroquinone 4% + Tretinoin 0.025% + Mometasone furoate 0.1% | cream | topical |
| NCDS | 13-M00-020 | Hydroquinone 40 mg + Tretinoin (Retinoic acid) 0.5 mg + fluocinolone acetonide0.1 mg / g | cream | topical |
| NCDS | 13-M00-002 | Hydroquinone 4% Cream | Cream | topical |
| NCDS | 13-M00-003 | Methoxsalen (ammoidin) 1% | solution | topical |
| NCDS | 13-M00-004 | Methoxsalen (ammoidin) 1% | Lotion | topical |
| NCDS | 13-M00-005 | Methoxsalen (ammoidin) 10mg + Ammidine 5mg | Tablet | oral |
| NCDS | 13-M00-006 | Methoxsalen (ammoidin) 7.5mg + Ammidine 2.5mg/ml | Paint | topical |
| NCDS | 13-M00-007 | Methoxsalen (ammoidin) 30mg /15ml (0.2%) | Paint | topical |
| NCDS | 13-M00-008 | Methoxsalen (ammoidin) 30mg /15ml (0.2%) | solution | topical |
| NCDS | 13-M00-009 | Methoxsalen (ammoidin) 10mg | Tablet | oral |
| NCDS | 13-M00-010 | Methoxsalen (ammoidin) 15mg | Tablet | oral |
| NCDS | 13-M00-016 | Methoxsalen (ammoidin) 0.1% | solution | topical |
| NCDS | 13-M00-017 | Methoxsalen (ammoidin) 0.1% | cream | topical |
| NCDS | 13-M00-011 | Monobenzone 20% | Ointment | topical |
| NCDS | 13-M00-012 | Paramethyloxyphenol 10% | Ointment | topical |
| NCDS | 13-M00-013 | Paramethyloxyphenol 20% | Ointment | topical |
| NCDS | 13-M00-014 | Trioxsalen 5mg | Tablet | oral |
| NCDS | 13-M00-015 | Trisoralen 0.1% | solution | topical |
| 13N | OTHER SKIN PREPARATIONS | |||
| NCDS | 13-N00-001 | Dexpanthenol 5% | Ointment | topical |
| NCDS | 13-N00-017 | Dexpanthenol 5% | cream | topical |
| NCDS | 13-N00-002 | Aluminium chloride hexahydrate 20% application in alcohol basis | Rolle | topical |
| NCDS | 13-N00-003 | Thiomersal 0.1%+Lidocaine 1%+Phenylphrine 0.25% | Solution | topical |
| NCDS | 13-N00-004 | Sulphated fatty alcohol (as sodium salt )58% | Skin Bar | topical |
| NCDS | 13-N00-005 | Mexenone 4% | Cream | topical |
| NCDS | 13-N00-006 | Padimate 2.5% | Lotion | topical |
| NCDS | 13-N00-007 | Podophyllum resin 20%+ Salicylic acid 25% | Ointment | topical |
| NCDS | 13-N00-008 | Polythene Dressing | adhesive Plaster | topical |
| NCDS | 13-N00-009 | Salicylic acid 40% | adhesive Plaster | topical |
| NCDS | 13-N00-010 | Minoxidil 2% | Solution | topical |
| NCDS | 13-N00-016 | Minoxidil 5% | Solution | topical |
| NCDS | 13-N00-012 | Silver nitrate 95% + Potassium nitrate 5% | Caustic Pencil | topical |
| NCDS | 13-N00-018 | Silver nitrate 40% + Potassium nitrate 60% | Caustic Pencil | topical |
| NCDS | 13-N00-013 | Pimecrolimus 1% | Cream | topical |
| NCDS | 13-N00-014 | Salicylic acid 16.7% w/w, Lactic acid 15.0% w/w | lotion | topical |
| NCDS | 13-N00-021 | Salicylic acid 16.7% + Lactic acid 16.7% | solution | topical |
| NCDS | 13-N00-015 | Podophyllotoxin 0.5 % w/v cutaneous topical | solution in alcoholic base (bottle of 3.5 ml with applicator | topical |
| NCDS | 13-H00-001 | Cetrimide 0.5% | Cream | topical |
| NCDS | 13-H00-107 | cetrimide 0.5 % w/w + chorhexidine gluconate 0.1% | Cream | topical |
| NCDS | 13-N00-019 | Eflornithino hydrochloride 139 mg / g | Cream | topical |
| NCDS | 19-000-015 | Gentian violet (Crystal violet) | Powder | topical |
| 13O | Skin & wound mangagement | |||
| NCDS | 13-O00-001 | Enbucrilate 200mg | adhesive Tissue | topical |
| NCDS | 13-O00-002 | Enbucrilate 500mg | adhesive Tissue | topical |
| NCDS | 13-O00-003 | Across -linked sterile hydrogel propylene glycol & water containing complex carbohydrate { supragel Amorphous wound care hydrogel} | gel | topical |
| NCDS | 13-O00-004 | Heparin sodium 5000 IU+ Extr.cepae 10g+ allantoin 1gm/100g | gel | topical |
| 13-P | Drugs for warts and calluses | |||
| NCDS | 13-P00-001 | Imiquimod 5 % | cream | topical |
| 14 | DRUGS USED IN ANAESTHESIA+ITU(INTENSIVE CARE UNIT ) + PAIN MANGEMENT | |||
| 14A | GENERAL ANAESTHESIA | |||
| 14AA | Intarvenous anaesthesia | |||
| NCDS | 14-AA0-036 | Ketamine (as hydrochloride) 50mg/ml | (10ml) Vial or Ampoule | injection IV ,IM |
| NCDS | 14-AA0-039 | Thiopental sodium (Thiopentone sodium) 1g | powder for solution 40ml vial | slow IV injection |
| NCDS | 14-AA0-041 | Thiopental sodium (Thiopentone sodium) 0.5g | powder for solution vial | slow IV injection |
| NCDS | 14-AA0-043 | Propofol 1% Propofol 10 mg/1 ml | (20ml)or (50ml) vial or ampoule | slow IV injection or infusion |
| 14AB | Inhalational anaesthetics drugs | |||
| NCDS | 14-AB0-009 | Isoflurane 1 ml per 1 ml | 100 ml bottle volatile liquid | inhalation |
| NCDS | 14-AB0-010 | Nitrous oxide 1 ml per 1 ml | Inhalation gas cylinder | inhalation |
| NCDS | 14-AB0-011 | sevoflurane 1 ml per 1 ml | volatile liquid bottle | inhalation vapour |
| NCDS | 14-AB0-012 | Enflurane 1 ml per 1 ml | volatile liquid bottle | inhalation vapour |
| NCDS | 14-AB0-013 | Desflurane 1 ml per 1 ml | volatile liquid bottle | inhalation vapour |
| 14AC | Muscle relaxants and its antagonists | |||
| NCDS | 14-AC0-007 | Atracurium( besilate or Besylate )10mg/ml | 2.5 ml Ampoule | IV injection or infusion |
| NCDS | 14-AC0-008 | Atracurium ( besilate or Besylate ) 10mg/ml | 5ml Ampoule or vial | IV injection or infusion |
| NCDS | 14-AC0-009 | Cisatracurium (as besilate) 2mg/ml | 5ml Ampoule or vial | IV injection or infusion |
| NCDS | 14-AC0-022 | Cisatracurium ( as besilate) 2mg/ml | 10 ml Ampoule or vial | IV injection or infusion |
| NCDS | 14-AC0-020 | Cisatracurium (as besilate) 2mg/ml | 2.5 ml Ampoule or vial | IV injection or infusion |
| NCDS | 14-AC0-010 | Pancuronium Bromide 2mg/ml | 2 ml Ampoule | IV injection or infusion |
| NCDS | 14-AC0-011 | Rocuronium bromide 10mg/ml | 5 ml vial or ampoule | IV injection or infusion |
| NCDS | 14-AC0-012 | Suxamethonium chloride 100mg | 2ml or 5ml Ampoule | IV injection or infusion |
| NCDS | 14-AC0-014 | Rocuronium bromide 10mg/ml | 10 ml vial | IV injection or infusion |
| NCDS | 14-AC0-016 | Mivacurium (as chloride) 2mg/ml | 5ml Ampoule | IV injection or infusion |
| NCDS | 14-AC0-017 | Sugammadex( as sodium) 100mg/ml | 2ml vial | IV injection or infusion |
| NCDS | 14-AC0-018 | Alcuronium chloride inj 5mg/ml, (2ml) Ampoule | 2 ml Ampoule | IV injection or infusion |
| NCDS | 14-AC0-019 | Vecuronium Bromide 4mg /2ml | Ampoule Lyophilized + water for injection | IV injection or infusion |
| NCDS | 14-AC0-021 | Vecuronium Bromide 10mg/5ml | Vial | IV injection or infusion |
| NCDS | 14-AC0-015 | Vecuronium Bromide 10mg | Vial powder | IV injection or infusion |
| NCDS | 14-AC0-023 | Vecuronium Bromide solution 2mg/ ml | 2 ml solution Ampoule | IV injection or infusion |
| 14AD | Analgesic and its antagonists | |||
| NCDS | 14-AD0-029 | Fentanyl (as citrate )50mcg/ml | 2 ml Ampoule | IV, IV infusion, IM |
| NCDS | 14-AD0-033 | Fentanyl (as citrate) 50mcg/ ml | 10ml Ampoule | IV, IV infusion, IM |
| NCDS | 14-AD0-030 | Fentanyl 100mcg/h | patch | transdermal |
| NCDS | 14-AD0-031 | Fentanyl 50 mcg /h | patch | transdermal |
| NCDS | 14-AD0-041 | Fentanyl 75mcg/h | patch | transdermal |
| NCDS | 14-AD0-042 | Fentanyl 25 mcg /h | patch | transdermal |
| NCDS | 14-AD0-044 | Fentanyl 12.5 mcg /h | patch | transdermal |
| NCDS | 14-AD0-046 | Fentanyl 100 mcg | sublingual tablet | Buccal |
| NCDS | 14-AD0-047 | Fentanyl 200 mcg | sublingual tablet | Buccal |
| NCDS | 14-AD0-034 | Ketorolac trometamol 30 mg / ml | (1ml ampoule) | I.M , slow I.V injection |
| NCDS | 14-AD0-049 | Ketorolac tromethamine 10 mg | tablet | oral |
| NCDS | 14-AD0-035 | Diamorphine hydrochloride 5mg | ampoule powder for solution | injection |
| NCDS | 14-AD0-036 | Diamorphine hydrochloride 10mg | ampoule powder for solution | injection |
| NCDS | 14-AD0-038 | Alfentanil (as hydrochloride) 500mcg /ml | (2ml) Ampoule | injection |
| NCDS | 14-AD0-039 | Sufentanil (as citrate) 5mcg/ml | (2ml) Ampoule | injection |
| NCDS | 14-AD0-040 | Sufentanil (as citrate) 5mcg/ml | (10ml ) Ampoule | injection |
| NCDS | 14-AD0-043 | Pethidine hydrochloride 25mg + Chlorpromazine hydrochloride 6.25mg + Promethazine hydrochloride 6.25mg/ml | vial or ampoule | injection |
| NCDS | 14-AD0-045 | Remifentanil (as hydrochloride)5mg | vial | injection IV |
| NCDS | 14-AD0-032 | Remifentanil (as hydrochloride) injection 2mg/ vial | vial | injection IV |
| NCDS | 14-AD0-048 | Remifentanil (as Hydrochloride) 1 mg | vial | injection IV |
| 14B | LOCAL ANAESTHESIA | |||
| NCDS | 14-B00-001 | Lidocaine Hydrochloride 24.7mg + Adrenaline 12.5mcg/2.2ml | dental carpoule | Injection |
| NCDS | 14-B00-002 | Lidocaine Hydrochloride Anhydrous 20mg/ml (2%) | (5ml ) prefilled syringe or Ampoule | Injection |
| NCDS | 14-B00-005 | Bupivacaine Hydrochloride 2.5mg/ml (0.25%) | (10ml) Vial | Injection |
| NCDS | 14-B00-010 | Lidocaine Hydrochloride 20mg/ml (2%) | Viscous Solution | oral |
| NCDS | 14-B00-025 | Lidocaine Hydrochloride 20mg/ml (2%) | (5ml) Vial | Injection |
| NCDS | 14-B00-023 | Lidocaine Hydrochloride 20mg/ml (2%) | (5ml) Ampoule | IV OR( 1V ,IM )OR (S.C ,IM)Injection |
| NCDS | 14-B00-044 | Lidocaine Hydrochloride Anhydrous 20 mg / ml (2%) | ( 20 ml vial ) | Injection |
| NCDS | 14-B00-050 | Lidocaine Hydrochloride 5mg/ml (0.5%) | (10ml) ampoule | Injection |
| NCDS | 14-B00-051 | Lidocaine Hydrochloride or Lidocaine Hydrochloride (monohydrate ) 10mg/ml ( eq. lidocaine Hydrochloride 1%) | (5 or10) ml ampoule | Injection For infiltration and nerve block |
| NCDS | 14-B00-052 | Lidocaine Hydrochloride or Lidocaine Hydrochloride (monohydrate ) 10 mg/ml (1 %) | (20ml) ampoule | Injection |
| NCDS | 14-B00-055 | Lidocaine Hydrochloride anhydrous or Lidocaine Hydrochloride monohydrate equivalent to Lidocaine Hydrochloride 2% | (50 ml vial) | Injection |
| NCDS | 14-B00-056 | Lidocaine Hydrochloride 10 mg/ml (1%) | vial | Injection |
| NCDS | 14-B00-058 | Lidocaine Hydrochloride 1.5% + Dextrose 7.5 % ( ) | hyperbaric solution vial or ampoule | injection |
| NCDS | 14-B00-037 | Lidocaine Hydrochloride 5% + Dextrose 7.5 % | 2ml ampoule hyperbaric solution | Injection |
| NCDS | 14-B00-011 | Lidocaine 10% | Spray | local |
| NCDS | 14-B00-012 | Lidocaine 5% Liquid | Spray | local |
| NCDS | 14-B00-057 | Lidocaine 2.5% + Prilocaine 2.5% | cream Tube | topical |
| NCDS | 14-B00-013 | Lidocaine 24.7mg/2.2ml | dental carpule | Injection |
| NCDS | 14-B00-015 | Epinephrine ( as Epinephrine acid tartrate ) 12.5 mcg / ml + Lidocaine Hydrochloride 2% (20 mg / ml ) ( 1: 80000) | cartridge(1.7-2.2)ml | Injection |
| NCDS | 14-B00-018 | Lidocaine Hydrochloride 2% (20mg/ml) + Epinephrine 1:100000 (0.01mg/ml) or (Epinephrine bitartarate 0.018mg/ml) | 1.7ml-2.2ml carpule | Injection |
| NCDS | 14-B00-040 | Lidocaine Hydrochloride 2% | ( 1.8) ml dental carpule | Injection |
| NCDS | 14-B00-041 | Lidocaine Hydrochloride 30 mg + Norepinephrine Hydrochloride 0.048 mg/ml | dental carpule | Injection |
| NCDS | 14-B00-042 | Lidocaine Hydrochloride 20 mg + Epinephrine Hydrochloride 0.015 mg (eq. 0.0125 mg/ml) | dental carpule | Injection |
| NCDS | 14-B00-046 | Lidocaine Hydrochloride as monohydrate or anhydrous 2% (20mg/ml) + adrenaline as acid tartrate 1:200000 (5mcg/ml) | ( 1.8) ml dental carpule | injection |
| NCDS | 14-B00-048 | Lidocaine Hydrochloride Anhydrous 2 % (20mg/ml) +adrenaline as acid tartrate 1:200000 | (20 ml vial) | injection |
| NCDS | 14-B00-017 | Bupivacaine Hydrochloride 2.5mg/ml (0.25%) | (5ml) Vial or (5ml) Ampoule | injection |
| NCDS | 14-B00-020 | Bupivacaine Hydrochloride 0.5% (5mg/ml) + Epinephrine as bitartrate 1:200000 (0.005mg/ml (5mcg/ml) | 1.7 & 2.2 ml dental carpule | injection |
| NCDS | 14-B00-021 | Bupivacaine Hydrochloride 2.5mg/ml (0.25%) | (10ml) Ampoule | injection |
| NCDS | 14-B00-026 | Prilocaine Hydrochloride 3% (30mg/ml) + Felypressin 0.03 I.U/ml | 1.7 & 2.2 ml dental carpule | injection |
| NCDS | 14-B00-036 | Mepivacaine Hydrochloride 20mg+Levonordefrin Hydrochloride 0.06mg /1ml | 1.8 ml dental carpule | injection |
| NCDS | 14-B00-038 | Bupivacaine Hydrochloride Anhydrous 5mg (0. 5% Bupivacaine ) + glucose( monohydrate or anhydrous) 80mg/ml | (4ml ) Vial OR Ampoule | injection |
| NCDS | 14-B00-039 | Mepivacaine Hydrochloride (2%) 36 mg + Epinephrine as ditartrate(bitartrate)(1:100000) 0.032 mg | 1.8 ml dental carpule | injection |
| NCDS | 14-B00-065 | Mepivacaine Hydrochloride 3 % ( 0.054 g ) | 1.8 ml dental carpule | injection |
| NCDS | 14-B00-045 | Bupivacaine Hydrochloride 5 mg / ml (0.5 %) | (10 ml or 20ml vial ) | injection |
| NCDS | 14-B00-047 | Ropivacaine Hydrochloride 0.75% (7.5 mg/ml) | 20 ml ampoule | injection |
| NCDS | 14-B00-062 | Articaine hyrochloride (68.000mg) + Adrenaline tartrate (0.030mg) +corresponding amount in adrenaline base (0.017) | 1.7ml cartridge | injection |
| NCDS | 14-B00-064 | Articaine hydrochloride 72 mg+ Adrenaline ( Epinephrine ) bitartrate 0.0327 mg corresponding to adrenaline base 0.018 mg | 1.8ml cartridge | injection |
| NCDS | 14-B00-063 | Articaine hydrochloride 40 mg + Epinphrine Bitartrate 0.009 mg corresponding to Epinephrine base 0.005 mg | 1.7ml cartridge | injection |
| 14 C | Drugs used in ITU (in addition to that used in anasethesis) | |||
| NCDS | 14-C00-001 | Dexmedetomidine (as hyrochloride) 100mcg /ml | (2ml) vial or ampoule | I.V injection |
| 14 D | Drugs adjunct to anaesthesis, ITU and pain management | |||
| 14 DA | Benzodiazepens | |||
| NCDS | 14-DA0-001 | Midazolam 5mg /ml | 1 ml ampoule | ( IV., IM ) or( IV IM or rectal adminstration) injection |
| NCDS | 14-DA0-002 | Midazolam 15mg /3ml | 3ml ampoule | ( IV., IM ) or( IV IM or rectal adminstration) injection |
| NCDS | 14-DA0-008 | Midazolam 5mg /5ml | vial or ampoule | ( IV., IM ) injection |
| NCDS | 14-DA0-003 | Diazepam emulsion 5mg/ml | (2ml) Ampoule | injection |
| NCDS | 14-DA0-004 | Flumazenil 100 mcg/ml | (5ml) Ampoule or vial | injection |
| NCDS | 14-DA0-005 | Flumazenil 50mcg/ml | (5ml) Ampoule | injection |
| NCDS | 14-DA0-007 | Midazolam 15mg | Tablet or buccal liquid | oral |
| NCDS | 14-DA0-010 | Midazolam 5 mg / 1 ml | 1.5 ml or 2 ml prefilled oral syringe solution | oromucosal |
| 14 DB | Drugs acting on cardiovascular system | |||
| NCDS | 14-DB0-001 | Glycopyrronium Bromide (Glycopyrrolate) 200mcg/ml | (1ml) Ampoule | injection |
| NCDS | 14-DB0-002 | Glycopyrronium Bromide (Glycopyrrolate) 200mcg/ml | (3ml) Ampoule | injection |
| NCDS | 14-DB0-004 | Adrenaline (as acid tartrate ) or (as hydrochloride ) 1mg/ml(1:1000 ) | (1ml) Ampoule | injection SC,IM , IV after dilution |
| NCDS | 14-DB0-005 | Adrenaline (as acid tartrate) or (as hydrochloride) 1 /10000 Dilute ( 100mcg/ml) – | injection 10ml ampoule or prefilled syringe | slow IV injection |
| NCDS | 14-DB0-003 | Atropine sulphate 1mg/ml | (1ml ampoule) | I.M,I.V,S.C Injection |
| 14DC | Others | |||
| NCDS | 14-DC0-001 | Hyoscine hydrobromide (Scopolamine hydrobromide) 400mcg/ml | (1ml) Ampoule | injection |
| 15 | CHEMOTHERAPY OF CANCER AND IMMUNOSUPPRESSION | |||
| 15A | CHEMOTHERAPY OF CANCER | |||
| 15AA | Alkylating agents | |||
| NCDS | 15-AA0-001 | Busulphan 2mg | Tablet | oral |
| NCDS | 15-AA0-002 | Carmustine 100mg | vial | IV injection |
| NCDS | 15-AA0-003 | Chlorambucil 2mg | Tablet | oral |
| NCDS | 15-AA0-005 | Cyclophosphamide 50mg | Tablet | oral |
| NCDS | 15-AA0-006 | Cyclophosphamide 100mg | vial | injection |
| NCDS | 15-AA0-007 | Cyclophosphamide 200mg | vial | injection |
| NCDS | 15-AA0-008 | Cyclophosphamide 500mg | vial | injection |
| NCDS | 15-AA0-023 | Cyclophosphamide 1g | vial | injection |
| NCDS | 15-AA0-009 | Dacarbazine 100mg | vial | IV Infusion or in certain tumer by intra-arterial perfusion |
| NCDS | 15-AA0-010 | Dacarbazine 200mg | vial powder for reconstituition | IV Infusion or in certain tumer by intra-arterial perfusion |
| NCDS | 15-AA0-011 | Ifosfamide 500mg | vial | injection |
| NCDS | 15-AA0-012 | Ifosfamide 1g | vial | IV injection |
| NCDS | 15-AA0-013 | Ifosfamide 2g | powder for reconstitution or solution for infusion vial | IV injection |
| NCDS | 15-AA0-014 | Lomustine 10mg | Capsule | oral |
| NCDS | 15-AA0-015 | Lomustine 40mg | Capsule | oral |
| NCDS | 15-AA0-018 | Melphalan 2mg | Tablet | oral |
| NCDS | 15-AA0-020 | Mesna 100mg/ml | 4ml vial or ampoule | injection |
| NCDS | 15-AA0-021 | Mesna 100mg/ml | 2ml vial or ampoule | injection |
| NCDS | 15-AA0-029 | Mesna 400mg | Tablet | oral |
| NCDS | 15-AA0-024 | Melphalan 50 mg (as hydrochloride) | vial powder for reconstitution +solvent | injection |
| NCDS | 15-AA0-025 | Busulphan 60mg | (10 ml vial) | IV Injection |
| NCDS | 15-AA0-026 | Busulphan 25mg | Tablet | oral |
| NCDS | 15-AA0-027 | Temozolomide 20mg | capsule | oral |
| NCDS | 15-AA0-028 | Temozolomide 100mg | capsule | oral |
| NCDS | 15-AA0-032 | Temozolomide 250mg | capsule | oral |
| NCDS | 15-AA0-030 | Bendamustine hydrochloride 100mg | vial powder for reconstitution | injection |
| NCDS | 15-B00-135 | Treosulfan 5g | vial Powder for solution | injection IV infusion |
| NCDS | 15-B00-136 | thiotepa 100mg lyophilized | vial powder for concentrate for solution | injection IV infusion |
| NCDS | 15-AA0-031 | Chlormethine 160 microgram/g | gel | topical |
| 15AB | Antimetabolites | |||
| NCDS | 15-AB0-005 | Cladribine (2 – CDA) 2mg /ml | (5ml) Ampoule or vial solution | injection |
| NCDS | 15-AB0-020 | Cladribine (2-CDA) 10mg | 5ml or 10ml Vial | injection |
| NCDS | 15-AB0-022 | cytarabine 1g | 10ml or20ml vial | SC, IV injection |
| NCDS | 15-AB0-001 | cytarabine 20mg/ml | 5ml vial | SC, IV,intrathecal injection |
| NCDS | 15-AB0-002 | Cytarabine ocfosfate 50mg | Tablet | oral |
| NCDS | 15-AB0-003 | Cytarabine ocfosfate 100mg | Capsule | oral |
| NCDS | 15-AB0-004 | Cytarabine ocfosfate 100mg | Tablet | oral |
| NCDS | 15-AB0-007 | 5-Flurouracil 25mg/ml | (10,20,100)ml vial | IV or IV infusion OR intra-arterial infusion |
| NCDS | 15-AB0-028 | 5-Flurouracil 50mg/ml | (10,20,50,100)ml vial | IV or IV infusion OR intra-arterial infusion |
| NCDS | 15-AB0-029 | Fluorouracil 5% | CREAM | TOPICAL |
| NCDS | 15-AB0-008 | Gemcitabine (as hydrochloride) 1g | vial powder for reconstitution or concentrate for solution | IV infusion |
| NCDS | 15-AB0-009 | 6- mercaptopurine 50mg | Tablet | oral |
| NCDS | 15-AB0-010 | Methotrexate ( as Sodium or Disodium ) 2.5mg | Tablet | oral |
| NCDS | 15-AB0-011 | Methotrexate (as sodium salt ) 2.5mg/ml | 2ml vail or ampoule | injection IV, IM , intrathecal |
| NCDS | 15-AB0-015 | Methotrexate 50mg (10 mg / ml or 25 mg /ml | lyophylized powder or solution 5ml or 2ml vial or ampoule | injection IV, IM , intrathecal |
| NCDS | 15-AB0-033 | Methotrexate 1000 mg (100 mg/ ml or 25 mg/ ml ) | 10ml or 40ml vial or ampoule | injection IV infusion |
| NCDS | 15-AB0-036 | Methotrexate 500mg (25 mg/ ml ) | ( 20ml ) vial or ampoule | injection IV infusion |
| NCDS | 15-AB0-038 | Methotrexate base or ( Methotrexate as Sodium or Methotrexate as disodium equivalent to methotrexate ) 50mg /ml (7.5mg/0.15 ml) | solution prefilled syringe | injection SC |
| NCDS | 15-AB0-043 | Methotrexate base or ( Methotrexate as Sodium or Methotrexate as disodium equivalent to methotrexate ) 50mg /ml (10mg/0.2 ml) | solution prefilled syringe | injection SC |
| NCDS | 15-AB0-044 | Methotrexate base or ( Methotrexate as Sodium or Methotrexate as disodium equivalent to methotrexate ) 15mg/0.3ml | solution prefilled syringe | injection SC |
| NCDS | 15-AB0-045 | Methotrexate base or ( Methotrexate as Sodium or Methotrexate as disodium equivalent to methotrexate ) 50mg /ml (20mg/0.4ml) | solution prefilled syringe | injection SC |
| NCDS | 15-AB0-039 | Methortexate 5000mg (100 mg /ml or 25mg/ml) | (50ml) or( 200ml) vial or falcon | injection IV infusion |
| NCDS | 15-AB0-040 | Methotrexate base or ( Methotrexate as Sodium or Methotrexate as disodium equivalent to methotrexate ) 25 mg solution | (0.5 ml or 1 ml ) prefilled syringe | injection SC |
| NCDS | 15-AB0-017 | Thioguanine 40mg | Tablet | oral |
| NCDS | 15-AB0-019 | Fludarabine phosphate 50mg | powder for reconstitution or concentrate solution vial | injection IV or IV infusion. |
| NCDS | 15-AB0-027 | Fludarabine phosphate 10mg | Tablet | oral |
| NCDS | 15-AB0-030 | liposomal encapsulated Cytarabine 50mg | vial | IT injection |
| NCDS | 15-AB0-031 | Decitabine 50mg | vial | IV injection |
| NCDS | 15-AB0-034 | Pemetrexed (as disodium) 500mg | powder for concentrate for solution or concentrate for solution vial | injection IV infusion. |
| NCDS | 15-AB0-035 | Pemetrexed (as disodium) 100mg | powder for concentrate for solution or concentrate for solution vial | injection IV infusion. |
| NCDS | 15-AB0-037 | Clofarabine 1 mg / ml | 20ml vial | injection IV infusion |
| NCDS | 15-AB0-041 | Tipiracil (as hydrochloride) 6.14 mg+ trifluridine 15mg | film coated tablet | oral |
| NCDS | 15-AB0-042 | Tipiracil (as hydrochloride) 8.19 mg+ trifluridine 20mg | film coated tablet | oral |
| NCDS | 15-AB0-046 | Azacitidine 100 mg | vial lyophilisate powder | injection S.C |
| 15AC | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | |||
| NCDS | 15-AC0-002 | Bleomycin (as sulphate) 15000 units dry powder for reconstitution | vial | injection |
| NCDS | 15-AC0-003 | Dactinomycin (Actinomycin D) 500mcg | vial | IV injection |
| NCDS | 15-AC0-004 | Daunorubicin (as hydrochloride) 20mg | powder for reconstitution or solution vial | IV injection |
| NCDS | 15-AC0-005 | Doxorubicin hydrochloride 10mg | powder in vial or 5ml solution in vial or rapid dissolution powder vial | IV injection |
| NCDS | 15-AC0-008 | Doxorubicin hydrochloride 50 mg | powder in vial or 25ml solution in vial | IV, ntra- Vesical injection |
| NCDS | 15-AC0-018 | Doxorubicin (as Doxorubicin hydrochloride liposomal pegylated) 2mg/ml concentrate | 10ml vial | IV infusion injection |
| NCDS | 15-AC0-012 | Mitomycin 2mg | powder for reconstitution vial | IV injection and bladder instillation Injection |
| NCDS | 15-AC0-013 | Mitomycin 10mg | powder for reconstitution vial | IV injection and bladder instillation Injection |
| NCDS | 15-AC0-014 | Mitoxantrone (Mitozantrone) as hydrochloride 2mg/ml | concentrate for solution 10 ml vial | injection IV infusion |
| NCDS | 15-AC0-015 | Idarubicin Hydrochloride 5mg | vial | injection |
| NCDS | 15-AC0-019 | Epirubicin hydrochloride 50 mg | powder in vial or 25ml solution in vial | injection |
| 15AD | Vinca alkaloids and etoposide | |||
| NCDS | 15-AD0-002 | Etoposide 50mg | Capsule | oral |
| NCDS | 15-AD0-003 | Etoposide 100mg | Capsule | oral |
| NCDS | 15-AD0-004 | Etoposide 20mg/ml | concentrate for solution 5 ml vial or ampoule | injection IV infusion |
| NCDS | 15-AD0-006 | Vinblastine sulphate 1 mg/ml | 10 ml vial or ampoule | injection |
| NCDS | 15-AD0-007 | Vincristine sulphate 1mg/ml | 1 ml vial or ampoule | I.V. adminstration only not for intrathecal adminstration. |
| NCDS | 15-AD0-008 | Vincristine sulphate 5mg | vial or ampoule | I.V. adminstration only not for intrathecal adminstration. |
| NCDS | 15-AD0-011 | Vinorelbine (as tartrate) 10 mg/ml | concentrate for solution 5 ml vial | injection IV infusion |
| NCDS | 15-AD0-012 | Vinorelbine (as ditartrate or as tartrate) 10mg /1ml | Vial | injection IV |
| NCDS | 15-AD0-014 | Vinorelbine (as tartrate) 20 mg | capsule | oral |
| NCDS | 15-AD0-015 | Vinorelbine (as tartrate) 30 mg | capsule | oral |
| 15AE | Enzymes | |||
| NCDS | 15-AE0-001 | L-asparginase 10000 IU source either from E.coli or from Erwinia | vial | IM, IV injection |
| NCDS | 15-AE0-002 | Pegylated L-asparginase 750 I.U / ml (3750I.U/ vial | vial | injection |
| NCDS | 15-AE0-003 | Recombinant asparginase (E-coli type ) 10.000 unit | powder for concentrate for solution vial | injection IV infusion |
| 15AF | ANTINEOPLASTIC DRUGS › MONOCLONAL ANTIBODIES and Miscellaneous agents | |||
| NCDS | 15-AF0-002 | Cisplatin inj 10mg/vial or Cisplatin 10mg/20ml | Vial | I.V. infusion, intraperitoneal instillation |
| NCDS | 15-AF0-003 | Cisplatin50mg or 50mg/50ml | Vial | I.V. infusion |
| NCDS | 15-AF0-004 | Oxaliplatin 50mg | powder for solution Vial | injection IV Infusion |
| NCDS | 15-AF0-005 | Oxaliplatin 100mg powder for reconstitution or 5mg\ml | Vial (powder) or 20 ml vial (solution)concentrate for solution | injection IV Infusion |
| NCDS | 15-AF0-049 | Oxaliplatin 5mg/ml | 10ml vial solution | injection IV Infusion |
| NCDS | 15-AF0-057 | Oxaliplatin 5mg/ml | 40 ml vial concentrate for Solution | injection IV Infusion |
| NCDS | 15-AF0-006 | Carboplatin 15mg | vial | injection IV Infusion |
| NCDS | 15-AF0-007 | Carboplatin 10mg/ml | (15ml) Vial | injection IV Infusion |
| NCDS | 15-AF0-008 | Carboplatin 10mg/ml | (45ml) Vial | injection IV Infusion |
| NCDS | 15-AF0-010 | Hydroxyurea 500mg | Capsule | oral |
| NCDS | 15-AF0-123 | Anagrelide 0.5 mg ( as Anagrelide Hydrochloride ) | Capsule | oral |
| NCDS | 15-AF0-011 | Octreotide 0.05mg/ml | vial or ampoule | Injection |
| NCDS | 15-AF0-012 | Octreotide 0.1mg/ml | vial or ampoule | Injection |
| NCDS | 15-AF0-046 | Octreotide 0.5mg/ 1ml | ampoule | injection IV Infusion ,IM ) or ( SC, IV Infusion ) |
| NCDS | 15-AF0-030 | Octreotide (as acetate) 20mg microspheres | vial powder for suspension + 2ml or 2.5ml diluent filled syringe. | injection |
| NCDS | 15-AF0-059 | Octreotide (as acetate) 30mg | vial microsphere powder for aqueous suspension + 2ml or 2.5ml diluent filled syringe | injection |
| NCDS | 15-AF0-069 | lanreotide (as acetate) 90 mg | solution prefilled syringe(Autogel) | SC injection |
| NCDS | 15-AF0-070 | lanreotide (as acetate) 120 mg | solution prefilled syringe(Autogel) | SC injection |
| NCDS | 15-AF0-052 | lanreotide (as acetate ) 30 mg | prefilled syringe or vial | IM injection |
| NCDS | 15-AF0-014 | Procarbazine 50mg | Capsule | oral |
| NCDS | 15-AF0-018 | MethylPrednisolone (As sodium Succinate) 250 mg | vial or ampoule | injection I.M, slow I.V., I.V infusion |
| NCDS | 15-AF0-019 | Methylprednisolone (as sodium Succinate) 125 mg | vial | IV,IM injection |
| NCDS | 15-AF0-055 | Methyl prednisolone (as sodium Succinate) 125 mg + diluent in the same vial | 2 ml ACT-O vial | IV,IM injection |
| NCDS | 15-AF0-020 | methylprednisolone (as sodium Succinate or as hemisuccinate )500 mg +water for injection +Benzyl alcohol 9mg/ml | vial or ampoule | IV,IM injection |
| NCDS | 15-AF0-041 | Methylprednisolone( as sodium succinate) 20mg | Vial | IV,IM injection |
| NCDS | 15-AF0-042 | Methylprednisolone (as sodium succinate) 40mg | Vial | IV,IM injection |
| NCDS | 15-AF0-031 | Tretinoin (ALL- trans Retinoic acid) | capsule | oral |
| NCDS | 15-AF0-037 | Capecitabine 150mg | tablet | oral |
| NCDS | 15-AF0-038 | Capecitabine 500mg | tablet | oral |
| NCDS | 15-AF0-045 | Recombinant Quadrivalent Human papillomavirus (HPV) vaccine of types 6(20 mcg), 11(40 mcg),16(40 mcg),18(20 mcg)) | 0.5 ml vial | injection IM |
| NCDS | 15-AF0-053 | Topotecan (as hydrochloride) 1mg | vial powder for reconstitution | injection IV infusion |
| NCDS | 15-AF0-054 | Topotecan (as hydrochloride) 4mg | vial powder for reconstitution | injection IV infusion |
| NCDS | 15-AF0-056 | Somatostatin (synthetic) as acetate 250 mcg | vial | injection IV |
| NCDS | 15-AF0-061 | Arsenic trioxide 1 mg/mL | 10-mL ampoule or vial Concentrate for solution | injection IV infusion |
| ANTINEOPLASTIC DRUGS › MONOCLONAL ANTIBODIES | ||||
| NCDS | 15-AF0-043 | Bevacizumab 100 mg | 4 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-044 | Bevacizumab 400 mg | 16 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-081 | Alymsys :Bevacizumab 400 mg | 16 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-073 | MVASI:Bevacizumab 400 mg | 16 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-079 | Zirabev :Bevacizumab 400 mg | 16 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-084 | Stivant :Bevacizumab 400 mg | 16 ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-047 | Cetuximab 5mg/ml | 20 ml vial solution | injection IV infusion |
| NCDS | 15-AF0-062 | Brentuximab Vedotin 50mg | vial | injection |
| NCDS | 15-AF0-063 | Ramucirumab 100 mg | vial | injection IV |
| NCDS | 15-AF0-064 | Ramucirumab 500 mg | vial | injection IV |
| NCDS | 15-AF0-071 | Pertuzumab 420 mg IV vial | vial | injection IV |
| NCDS | 15-AF0-036 | Trastuzumab (Recombinant HER2) 440mg | vial | injection IV infusion |
| NCDS | 15-AF0-117 | Trastuzumab Deruxtecan 100 mg powder for concentrate for solution | vial | injection IV infusion |
| NCDS | 15-AF0-075 | Trastuzumab (Recombinant HER2) 420mg | vial | injection IV infusion |
| NCDS | 15-AF0-048 | Trastuzumab (Recombinant HER2) 150mg | vial | injection IV infusion |
| NCDS | 15-AF0-072 | Trastuzumab (Recombinant HER2) 600mg | 5ml vial solution | injection SC |
| NCDS | 15-AF0-065 | Herzuma : Trastuzumab (Recombinant HER2) 420mg | vial | injection IV infusion |
| NCDS | 15-AF0-066 | Herzuma : Trastuzumab (Recombinant HER2) 150mg | vial | injection IV infusion |
| NCDS | 15-AF0-067 | Trazimera : Trastuzumab (Recombinant HER2) 420mg | vial | injection IV infusion |
| NCDS | 15-AF0-068 | Trazimera : Trastuzumab (Recombinant HER2)150mg | vial | injection IV infusion |
| NCDS | 15-AF0-076 | KANJINTI : Trastuzumab (Recombinant HER2) 420mg | vial | injection IV infusion |
| NCDS | 15-AF0-077 | KANJINTI : Trastuzumab (Recombinant HER2) 150 mg | vial | injection IV infusion |
| NCDS | 15-AF0-115 | Aryotrust : Trastuzumab (Recombinant HER2) 440 mg | vial | injection IV infusion |
| NCDS | 15-AF0-116 | Aryotrust : Trastuzumab (Recombinant HER2) 150 mg | vial | injection IV infusion |
| NCDS | 15-AF0-120 | Pertuzumab 60 mg / 1 ml+ Trastuzumab 60 mg / 1ml (600mg/600mg/10ml ) | vial solution | SC injection |
| NCDS | 15-AF0-121 | Trastuzumab emtansine 100 mg | powder for concentrate for solution vial | injection IV infusion |
| NCDS | 15-AF0-080 | Daratumumab 400mg | 20ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-083 | Daratumumab 100mg | 5ml vial concentrate for solution | injection IV infusion |
| NCDS | 15-AF0-113 | carfilzomib 60 mg | vial powder for solution | infusion |
| NCDS | 15-AF0-112 | Isatuximab 20 mg / ml | 25 ml vial oncentrate for solution | IV infusion ( use after dilution ) |
| NCDS | 15-AF0-114 | Mitotane 500 mg | tablet | oral |
| NCDS | 15-AF0-124 | Polatuzumab vedotin 140 mg | powder for concentrate for solution vial | IV infusion |
| NCDS | 15-AF0-122 | Blinatumomab 38.5 mcg ( extractable 35 mcg ) | vial powder for concentrate after reconstitution + dilution vial | IV injection |
| Targeted therapy responsive malignancy,ANTINEOPLASTIC DRUGS › PROTEASOME INHIBITORS | ||||
| NCDS | 15-AF0-051 | Bortezomib( as mannitol boronic ester )3.5 mg | vial solution or powder for solution | injection IV or SC |
| 15AG | Hormones and antagonists | |||
| NCDS | 15-AG0-002 | Flutamide 250mg | Tablet or capsule | oral |
| NCDS | 15-AG0-004 | Flutamide 125mg | Capsule | oral |
| NCDS | 15-AG0-008 | Letrozole 2.5mg | Tablet | oral |
| NCDS | 15-AG0-009 | Medroxyprogesterone acetate 150mg/ml or 500mg | (3.3ml vial) or vial | injection deep IM |
| NCDS | 15-AG0-010 | Medroxyprogesterone acetate 100mg | Tablet | oral |
| NCDS | 15-AG0-011 | Medroxyprogesterone acetate 250mg | Tablet | oral |
| NCDS | 15-AG0-012 | Tamoxifen (as citrate) 10mg | Tablet | oral |
| NCDS | 15-AG0-013 | Tamoxifen (as citrate) 20mg | Tablet | oral |
| NCDS | 15-AG0-014 | Anastrozole 1mg | Tablet | oral |
| NCDS | 15-AG0-015 | Bicalutamide 50mg | Tablet | oral |
| NCDS | 15-AG0-016 | Bicalutamide 150mg | Tablet | oral |
| NCDS | 15-AG0-017 | Cyproterone acetate 100mg | Tablet | oral |
| NCDS | 15-AG0-019 | Degarelix (as acetate) 80 mg | vial | injection SC |
| NCDS | 15-AG0-020 | Degarelix (as acetate) 120 mg | vial | injection SC |
| NCDS | 15-AG0-021 | Abiraterone acetate 250 mg | Tablet | oral |
| NCDS | 15-AG0-022 | Exemestane 25mg | film coated tablet | oral |
| NCDS | 15-AG0-023 | fulvestrant 250 mg | 5ml prefilled syringe | injection IM only |
| NCDS | 15-AG0-024 | Enzalutamide 40mg | capsule | oral |
| NCDS | 15-AG0-027 | Abiraterone acetate 500 mg | film coated tablet | oral |
| NCDS | 15-AG0-025 | Megestrol acetate 40mg | Tablet | oral |
| NCDS | 15-AG0-026 | Megestrol acetate 160mg | Tablet | oral |
| 15B | Immune system disorders and transplantation, others | |||
| NCDS | 15-B00-001 | Azathioprine 50mg | Tablet | oral |
| NCDS | 15-B00-002 | Azathioprine 50mg | vial | Injection |
| NCDS | 15-B00-006 | Cyclosporin (Ciclosporin) Microemulsion 25mg | Capsule | oral |
| NCDS | 15-B00-007 | Cyclosporin (Ciclosporin) Microemulsion 100mg | Capsule | oral |
| NCDS | 15-B00-008 | Cyclosporin (Ciclosporin) Microemulsion 100mg/ml | Solution | oral |
| NCDS | 15-B00-009 | Cyclosporin (Cyclosporin) 50mg/ml | 1ml Ampoule concentrate for solution | injection IV infusion |
| NCDS | 15-B00-010 | Cyclosporin (Ciclosporin) 50mg/ml | 5ml Ampoule concentrate for solution | injection IV infusion |
| NCDS | 15-B00-054 | Cyclosporin (Ciclosporin) Microemulsion 50mg | Capsule | oral |
| NCDS | 15-B00-134 | defibrotide 200 mg ( 80 mg / ml ) | 2.5 mL vial Concentrate for solution | injection IV infusion |
| NCDS | 15-B00-022 | Mycophenolate mofetil 250mg | Capsule | oral |
| NCDS | 15-B00-023 | Mycophenolate mofetil 500mg | Tablet | oral |
| NCDS | 15-B00-052 | Mycophenolic acid (as mycophenolate sodium) 180mg | Tablet | oral |
| NCDS | 15-B00-053 | Mycophenolic acid (as mycophenolate sodium)360mg | gastro-resistant Tablet | oral |
| NCDS | 15-B00-004 | Basiliximab 20mg | Vial | IV injection or IV infusion |
| NCDS | 15-B00-047 | Sirolimus 1mg | tablet | oral |
| NCDS | 15-B00-048 | Sirolimus 2mg | tablet | oral |
| NCDS | 15-B00-049 | Sirolimus 1mg/1ml | solution | oral |
| NCDS | 15-B00-059 | Everolimus 1mg | tablet | oral |
| NCDS | 15-B00-097 | Everolimus 5 mg | tablet | oral |
| NCDS | 15-B00-082 | Everolimus 10 mg | tablet | oral |
| NCDS | 15-B00-065 | Tacrolimus 0.5 mg | Capsule | oral |
| NCDS | 15-B00-024 | Tacrolimus 1mg | Capsule | oral |
| NCDS | 15-B00-025 | Tacrolimus 5mg | Capsule | oral |
| NCDS | 15-B00-026 | Tacrolimus concentrate 5mg/ml | 1ml Ampoule | injection IV infusion |
| NCDS | 15-B00-084 | Tacrolimus 0.5 mg | prolonged release hard gelatin capsule | oral |
| NCDS | 15-B00-085 | Tacrolimus 1 mg | prolonged release hard gelatin capsule | oral |
| NCDS | 15-B00-086 | Tacrolimus 3 mg | prolonged release hard gelatin capsule | oral |
| NCDS | 15-B00-087 | Tacrolimus 5 mg | prolonged release hard gelatin capsule | oral |
| NCDS | 15-B00-091 | Tacrolimus (as anhydrous or monohydrate) 0.03% | ointment | topical |
| NCDS | 15-B00-092 | Tacrolimus (as anhydrous or monohydrate) 0.1% | ointment | topical |
| NCDS | 15-B00-179 | Ruxolitinib ( as ruxolitinib phosphate) 1.5 % | cream | topical |
| Immune system disorders and transplantation\IMMUNOSTIMULANTS › INTERFERONS | ||||
| NCDS | 15-B00-012 | Interferon alfa 2a (Recombinant) 9 million units | prefilled syringe | injection SC |
| Multiple sclerosis.IMMUNOSTIMULANTS › INTERFERONS | ||||
| NCDS | 15-B00-037 | Interferon Beta 1a (Recombimant) 12millon IU (44mcg) | prefilled syringe | injection SC |
| NCDS | 15-B00-124 | Recigen: Interferon Beta 1a (Recombimant) 12 million IU(44mcg) | prefilled syringe | injection SC |
| NCDS | 15-B00-027 | Interferon Beta 1a (Recombinant) 6 million IU ( 30mcg) | vial or prefilled syring | injection IM |
| NCDS | 15-B00-123 | Cinnovex:Interferon Beta 1a (Recombinant) 6 million IU(30mcg) | vial | injection IM |
| NCDS | 15-B00-020 | Interferon Beta 1a (Recombimant) 6millon IU (22mcg) ml | vial | injection SC |
| NCDS | 15-B00-038 | Interferon alfa 2b ( Recombinant )25 million IU | 2.5ml vial | injection SC |
| NCDS | 15-B00-039 | Interferon alfa 2b (Recombinant )18 million IU | 3ml vial | injection SC |
| NCDS | 15-B00-013 | Interferon alfa 2a (Recombinant) 3 million units | prefilled syringe | injection SC |
| NCDS | 15-B00-014 | Interferon alfa 2a (Recombinant) 6 million units | prefilled syringe | injection SC |
| NCDS | 15-B00-015 | Interferon alfa 2b (Recombinant) 3 million IU /0.5ml | vial | injection SC IM, IV |
| NCDS | 15-B00-016 | Interferon alfa 2b (Recombinant) 5 million IU /0.5ml | vial | injection SC IM, IV |
| NCDS | 15-B00-017 | Interferon alfa 2b (Recombinant) 10 million IU /1ml | vial | injection SC IM, IV |
| NCDS | 15-B00-018 | Interferon alfa 2b (Recombinant) 15 million units/ml | PEN | injection SC or IV |
| NCDS | 15-B00-019 | Interferon alfa 2b (Recombinant) 30 million IU | PEN | injection SC |
| NCDS | 15-B00-051 | Interferon Beta 1b (Recombinant) 9.6 million IU ( 0.3mg) | vial | injection SC |
| IMMUNOSUPPRESSANTS › THALIDOMIDE AND RELATED ANALOGUES | ||||
| NCDS | 15-B00-076 | Lenalidomide 10mg | capsule or tablet | oral |
| NCDS | 15-B00-078 | Lenalidomide 25mg | capsule or tablet | oral |
| NCDS | 15-B00-158 | Lenalidomide 15mg | capsule | oral |
| NCDS | 15-B00-149 | Lenalidomide 5mg | capsule | oral |
| NCDS | 15-B00-071 | Thalidomide 50 mg | capsule or tablet | oral |
| NCDS | 15-B00-150 | pomalidomide 4mg | capsule | oral |
| Multiple sclerosis,IMMUNOSUPPRESSANTS › PYRIMIDINE SYNTHESIS INHIBITORS | ||||
| NCDS | 15-B00-126 | teriflunomide 14 mg | tablet | oral |
| NCDS | 15-B00-181 | Cladribine 10 mg | tablet | oral |
| NCDS | 15-B00-164 | Leflunomide 20 mg | tablet | oral |
| Chronic hepatitis B,IMMUNOSTIMULANTS › INTERFERONS | ||||
| NCDS | 15-B00-032 | Peginterferon alfa 2a (Recombinant) 135mcg | 1ml vial or 0.5ml prefilled syringe solution | injection |
| NCDS | 15-B00-042 | Peginterferon alfa 2b (Recombinant) 50mcg /0.5ml | vial or prefilled pen | injection SC |
| NCDS | 15-B00-043 | Peginterferon alfa 2b (Recombinant) 80mcg /0.5ml | vial or prefilled pen | injection SC |
| NCDS | 15-B00-044 | Peginterferon alfa 2b (Recombinant) 100mcg /0.5ml | vial or prefilled pen | injection SC |
| NCDS | 15-B00-045 | Peginterferon alfa 2b (Recombinant) 120mcg /0.5ml | vial or prefilled pen | injection SC |
| NCDS | 15-B00-046 | Peginterferon alfa 2b (Recombinant) 150mcg /0.5ml | vial or prefilled pen | injection SC |
| NCDS | 15-B00-033 | Peginterferon alfa 2a (Recombinant) 180mcg | solution 1ml vial or 0.5ml prefilled syringe | injection |
| Multiple sclerosis.Anti-lymphocyte monoclonal antibodies | ||||
| NCDS | 15-B00-081 | Natalizumab 20mg/ml | concentrate for solution 15 ml vial | injection IV infusion |
| NCDS | 15-B00-182 | Natalizumab 150 mg / ml | solution for injection in prefilled syringe | SC. Injection |
| NCDS | 15-B00-120 | Ocrelizumab 30mg/ml | concentrate for solution 10 ml vial | injection IV infusion |
| ANTINEOPLASTIC DRUGS › MONOCLONAL ANTIBODIES | ||||
| NCDS | 15-B00-098 | Pembrolizumab 50 mg | vial | injection IV infusion |
| NCDS | 15-B00-104 | Pembrolizumab 100 mg | vial | injection IV infusion |
| NCDS | 15-B00-184 | Toripalimab 240 mg/6 ml | vial | injection IV infusion |
| NCDS | 15-B00-128 | Atezolizumab 60 mg /ml | concentrate for solution 20ml vial | injection IV infusion |
| NCDS | 15-B00-183 | Atezolizumab 1875mg/ 15 ml solution | vial | SC. Injection |
| NCDS | 15-B00-034 | Daclizumab 5mg/ml | concentrate for solution 5ml vial | injection IV infusion |
| NCDS | 15-B00-035 | Rituximab (Recombinant) 10 mg/ml | concentrate for solution 10ml vial | injection IV infusion |
| NCDS | 15-B00-036 | Rituximab (Recombinant) 10 mg/ml | concentrate for solution 50ml vial | injection IV infusion |
| NCDS | 15-B00-101 | Rixathon: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 10ml vial | injection IV infusion |
| NCDS | 15-B00-139 | Rixathon: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 50ml vial | injection IV infusion |
| NCDS | 15-B00-100 | Truxima: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 10ml vial | injection IV infusion |
| NCDS | 15-B00-138 | Truxima: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 50ml vial | injection IV infusion |
| NCDS | 15-B00-115 | Ruxience: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 50ml vial | injection IV infusion |
| NCDS | 15-B00-116 | Ruxience: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 10ml vial | injection IV infusion |
| NCDS | 15-B00-152 | Zytux : Rituximab (Recombinant) 10 mg/ml | concentrate for solution 10ml vial | injection IV infusion |
| NCDS | 15-B00-153 | Zytux: Rituximab (Recombinant) 10 mg/ml | concentrate for solution 50ml vial | injection IV infusion |
| Targeted therapy responsive malignancy,PROTEIN KINASE INHIBITORS | ||||
| NCDS | 15-B00-099 | Gefetinib 250 mg | tablet | oral |
| NCDS | 15-B00-155 | Acalabrutinib 100 mg | capsule | oral |
| NCDS | 15-B00-102 | Ibrutinib 140 mg | tablet or capsule | oral |
| NCDS | 15-B00-103 | Afatinib 20mg | tablet | oral |
| NCDS | 15-B00-119 | Afatinib 30mg | tablet | oral |
| NCDS | 15-B00-105 | Afatinib 40mg | tablet | oral |
| NCDS | 15-B00-106 | Afatinib 50mg | tablet | oral |
| NCDS | 15-B00-096 | Sunitinib (as malate or as base ) 25 mg | capsule | oral |
| NCDS | 15-B00-066 | Sunitinib (as malate or as base ) 12.5mg | capsule | oral |
| NCDS | 15-B00-067 | Sunitinib (as malate or as base ) 50 mg | capsule | oral |
| NCDS | 15-B00-068 | Sorafenib (as tosylsate) 200 mg | tablet | oral |
| NCDS | 15-B00-069 | Dasatinib (as monohydrate) 100mg | tablet | oral |
| NCDS | 15-B00-117 | Dasatinib (as monohydrate) 50 mg | tablet | oral |
| NCDS | 15-B00-118 | Dasatinib (as monohydrate) 70 mg | tablet | oral |
| NCDS | 15-B00-070 | Nilotinib (as hydrochloride monohydrate) 200 mg | capsule | oral |
| NCDS | 15-B00-080 | Nilotinib (as hydrochloride monohydrate) 150 mg | capsule | oral |
| NCDS | 15-B00-160 | Selumetinib( as hydrogen sulfate ) 10 mg | capsule | oral |
| NCDS | 15-B00-161 | Selumetinib ( as hydrogen sulfate ) 25 mg | capsule | oral |
| NCDS | 15-B00-111 | bosutinib 100 mg | film coated tablet | oral |
| NCDS | 15-B00-112 | bosutinib 500 mg | film coated tablet | oral |
| NCDS | 15-B00-127 | bosutinib 400 mg | film coated tablet | oral |
| NCDS | 15-B00-089 | Ruxolitinib 5 mg | tablet | oral |
| NCDS | 15-B00-090 | Ruxolitinib 15 mg | tablet | oral |
| NCDS | 15-B00-094 | pazopanib hydrochloride 200mg | film coated tablet | oral |
| NCDS | 15-B00-157 | pazopanib hydrochloride 400mg | tablet | oral |
| NCDS | 15-B00-050 | Imatinib (as mesylate) 400mg | tablet or capsule | oral |
| NCDS | 15-B00-028 | Imatinib (as mesylate ) 50mg | tablet or capsule | oral |
| NCDS | 15-B00-029 | Imatinib (as mesylate) 100mg | tablet or capsule | oral |
| NCDS | 15-B00-056 | Erlotinib (as hydrochloride) 25mg | tablet | oral |
| NCDS | 15-B00-057 | Erlotinib (as hydrochloride)100mg | tablet | oral |
| NCDS | 15-B00-058 | Erlotinib (as hydrochloride)150mg | tablet | oral |
| NCDS | 15-B00-113 | palbociclib 125mg | tablet or capsule | oral |
| NCDS | 15-B00-133 | palbociclib 100mg | tablet or capsule | oral |
| NCDS | 15-B00-147 | palbociclib 75mg | capsule | oral |
| NCDS | 15-B00-121 | crizotinib 200 mg | capsule | oral |
| NCDS | 15-B00-122 | crizotinib 250 mg | capsule | oral |
| NCDS | 15-B00-114 | Abemaciclib 150mg | film coated tablet | oral |
| NCDS | 15-B00-143 | Abemaciclib 100mg | film coated tablet | oral |
| NCDS | 15-B00-144 | Abemaciclib 50mg | film coated tablet | oral |
| NCDS | 15-B00-130 | Nintedanib (as esilate ) 150mg | soft gelatin capsule | oral |
| NCDS | 15-B00-129 | Nintedanib (as esilate ) 100mg | soft gelatin capsule | oral |
| NCDS | 15-B00-131 | Ponatinib 15mg | film coated tablet | oral |
| NCDS | 15-B00-132 | Ponatinib 45mg | film coated tablet | oral |
| NCDS | 15-B00-137 | Alectinib (as hydrochloride) 150 mg | capsule | oral |
| NCDS | 15-B00-159 | Axitinib 5 mg | tablet | oral |
| NCDS | 15-B00-140 | Dacomitinib (as Dacomitinib monohydrate) 45 mg | tablet | oral |
| NCDS | 15-B00-141 | Dacomitinib (as Dacomitinib monohydrate) 15 mg | tablet | oral |
| NCDS | 15-B00-142 | Dacomitinib (as Dacomitinib monohydrate) 30mg | tablet | oral |
| NCDS | 15-B00-151 | Osimertinib 80 mg | tablet | oral |
| NCDS | 15-B00-154 | Gilteritinib 40 mg | tablet | oral |
| NCDS | 15-B00-156 | Venetoclax 100 mg | tablet | oral |
| others | ||||
| NCDS | 15-B00-021 | Cytomegalovirus immunoglobulin human normal immunoglobulin solution 10% + human plasma protein 100mg/ml there of immunoglobulin 95%) | solution 50 ml vial | injection IV |
| NCDS | 15-B00-005 | Corynebacterium parvum 7mg Injection | vial or ampoule | injection |
| NCDS | 15-B00-109 | Normal immunoglobulin human 50mg per 1 ml,100mg/ml Purity of at least 95% IgG 5% (10ml=0.5g,50ml=2.5g,100ml=5g,200ml=10g, 400ml=20g) | vial or ampoule OR bottle | injection IV |
| NCDS | 15-B00-125 | Eribulin mesilate 0.44 mg / ml | 2 ml vial Solution | injection IV |
| IMMUNE SERA AND IMMUNOGLOBULINS › IMMUNOGLOBULINS | ||||
| NCDS | 15-B00-073 | AntiThymocytic Globulin (ATG,Rabbit type) 25 mg | vial or ampoule powder for reconstitution | injection IV infusion |
| NCDS | 15-B00-003 | AntiThymocytic Globulin (ATG,Rabbit type) 20mg/ml | 5ml vial | injection IV infusion |
| NCDS | 15-B00-088 | Antithymocyte globulin (ATG, equine type) 50mg\ml | 5ml ampoule OR vial | injection IV infusion |
| 15C | DRUGS USED IN NEUTROPENIA | |||
| NCDS | 15-C00-001 | Molgramostim (Recombinant Human granulocyte macrophage -colony stimulating factor ,GM-CSF )150mcg | vial | injection |
| NCDS | 15-C00-002 | Molgramostim (Recombinant Human granulocyte macrophage -colony stimulating factor ,GM-CSF )300mcg | vial | injection |
| NCDS | 15-C00-003 | Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 300mcg(30MU) | solution 1ml vial or 0.5 ml prefilled syringe | injection SC and IV infusion |
| NCDS | 15-C00-012 | Accofil : Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 300mcg(30mega unit) | solution 0.5 ml prefilled syringe | injection SC and IV infusion |
| NCDS | 15-C00-010 | Nivestim: Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 300mcg(30MU) | solution 0.5 ml prefilled syringe | injection SC and IV infusion |
| NCDS | 15-C00-006 | Zarzio : Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 300mcg(30MU) | solution 0.5 ml prefilled syringe | injection SC and IV infusion |
| NCDS | 15-C00-014 | Zarzio : Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 480mcg(48MU) | 0.5 ml prefilled syringe solution | injection SC and IV infusion |
| NCDS | 15-C00-004 | Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 480mcg(48MU) | solution 1.6ml vial | injection SC and IV infusion |
| NCDS | 15-C00-007 | Filgrastim (Recombinant human granulocyte-colony stimulating factor; G-CSF) 480mcg(48MU) | solution 0.5 ml prefilled syringe | injection SC and IV infusion |
| NCDS | 15-C00-008 | Pegfilgrastim (Pegylated recombinant methionyl human granulocyte-colony stimulating factor) 6mg | solution 0.6ml prefilled syringe | injection SC |
| NCDS | 15-C00-013 | Pelgraz: Pegfilgrastim (Pegylated recombinant methionyl human granulocyte-colony stimulating factor) 6mg | solution 0.6ml prefilled syringe | injection SC |
| NCDS | 15-C00-009 | Lenograstim (Recombinant human granulocyte-colony stimulating factor; rHuG-CSF) 33.6 millon unit ( 263 µg) | powder for reconstitution +1 ml prefilled syringe water for injection vial | injection SC and IV infusion |
| NCDS | 15-C00-005 | Oprelvekin (Platelete growth Factor for thrombocytopenia) 5mg | vial | injection |
| 15D | TAXANE GROUP | |||
| NCDS | 15-D00-001 | Docetaxel 40mg/ml | (0.5ml vial) | injection |
| NCDS | 15-D00-002 | Docetaxel (Anhydrous or as Trihydrate ) 80mg + with or without diluent | 8ml vial or 4ml vial or 2ml Vial | injection |
| NCDS | 15-D00-005 | Docetaxel 20mg | 1ml vial or 2ml vial or prefilled syringe | injection |
| NCDS | 15-D00-010 | docetaxel 10 mg/ml | 16 ml vial | injection |
| NCDS | 15-D00-012 | Cabazitaxel 20 mg / ml | 3 ml vial | IV injection |
| NCDS | 15-D00-003 | Paclitaxel 6mg/ml | 5ml vial | injection |
| NCDS | 15-D00-011 | Paclitaxel 100 mg and approximately 900 mg human albumin in each vial ( reconstitute with 20 ml of 0.9% sodium chloride injection resulting in a suspension containing 5 mg / ml of Paclitaxel ) | vial | IV injection |
| NCDS | 15-D00-004 | Paclitaxel 6mg/ml | 50ml vial | injection |
| 15E | CYTOSTATIC TOPOISOMERASE (1) INHIBITOR | |||
| NCDS | 15-E00-001 | Irinotecan hydochloride or hydochloride Trihydrate 20mg/ml | 2ml vial | injection IV Infusion |
| NCDS | 15-E00-002 | Irinotecan hydochloride or hydochloride Trihydrate 20mg/ml | 5ml vial | injection IV Infusion |
| 15F | Immunotherapy responsive malignancy\IMMUNOSTIMULANTS › OTHER | |||
| NCDS | 15-F00-001 | 2-8×10⁸ CFU TICE BCG | vial | INTRAVESICAL INSTILLATION |
| NCDS | 15-F00-002 | 2×10⁸ – 3×10⁹ (RIVM ) BCG | vial | INTRAVESICAL INSTILLATION |
| NCDS | 15-F00-003 | SII – ONCO – BCG lyophilized : Bacillus Calmette-Guerin strain 40mg\ml between 1-19.2 ✕10⁸ colony forming unit CFU | vial | INTRAVESICAL INSTILLATION |
| NCDS | 15-F00-004 | BCG Culture SSI : Mycobacterium bovis , ( BCG ) Danish strain 1331 30 mg Sodium glutamate 40 mg | vial | INTRAVESICAL INSTILLATION |
| 16 | IMMUNOLOGICAL PRODUCTS | |||
| 16A | VACCINES & ANTISERA | |||
| NCDS | 16-A00-001 | Anti-tetanus toxoid | Injectable | injection |
| NCDS | 16-A00-002 | MMR | 10 doses vial | injection |
| NCDS | 16-A00-005 | MMR | one dose vial | injection |
| NCDS | 16-A00-003 | DT/child | 10 doses vial | injection |
| NCDS | 16-A00-004 | Diphtheria & Tetanus (adult) or Td/Adult | 10 doses vial | injection |
| NCDS | 16-A00-007 | Hepatitis B vaccine (adult) 20 mcg / 1 ml | vial | injection |
| NCDS | 16-A00-011 | Rabies vaccine | powder(Freeze dried or Lyophilised) in vial + solvent in syringe or ampoule | injection |
| NCDS | 16-A00-012 | Human or equine or avian Rabies Immunoglobulin | single dose syringe or vial | injection |
| NCDS | 16-A00-014 | Tetanus Immunoglobulin | syringe single dose | injection |
| NCDS | 16-A00-015 | Typhoid vaccine | 20 doses vial | injection |
| NCDS | 16-A00-016 | Yellow fever vaccine | syringe single dose | injection |
| NCDS | 16-A00-018 | Trivalent OPV P1 – P2 – P3 20 doses | vial | injection |
| NCDS | 16-A00-019 | Diphtheria , Tetanus , Pertusi or D.P.T | 10 doses vial | injection |
| NCDS | 16-A00-020 | B.C.G | 20 doses ampoule | injection |
| NCDS | 16-A00-021 | Measles | 10 doses vial | injection |
| NCDS | 16-A00-022 | Polysaccharide Pneumococcal vaccine (23) | syringe single dose | injection |
| NCDS | 16-A00-023 | Antiscorpion ( 5 species : Androctonus crassicauda , Buthotus saulcyi , Buthotus Schach . Odontoboyhus eupeus , Hemiscorpius lepturus ) | Ampule single dose | injection |
| NCDS | 16-A00-024 | Polyvalent Snake antivenom including Echis Carinatus | vial or Ampule single dose | injection |
| NCDS | 16-A00-062 | Polyvalent scorpion venom antiserum ( equine origin ) immunoglobuline F ( ab ) 2 fragment Buthus occitanus ≥ 50 LD50 NU/ vial + Androctonus australis ≥ 50 LD50 NU / vial + Leirus quinquestriatus quinquestriatus ≥ 50 LD50 NU / vial + Androctonus crassicanda ≥ 50 LD50 NU / vial | powder and solvent for prepearation ( 1 vial + 10 ml 0.9% NaCl isotonic solution ) | IV solution for injection |
| NCDS | 16-A00-063 | Monovalent scorpion venom antiserum ( equine origin ) immunoglobuline F ( ab ) 2 fragment Androctonus crassicanda ≥ 100 LD50 NU/ vial | powder and solvent for prepearation ( 1 vial + 10 ml 0.9% NaCl isotonic solution ) | IV solution for injection |
| NCDS | 16-A00-028 | Injectable Polio Vaccine (IPV) | Injectable | injection |
| NCDS | 16-A00-029 | Hepatitis A Vaccine (child) | syringe single dose | injection |
| NCDS | 16-A00-030 | Hepatitis A Vaccine (adult) | syringe single dose | injection |
| NCDS | 16-A00-031 | Influenza seasonal Vaccine northren strain | syringe single dose | injection |
| NCDS | 16-A00-037 | Conjugated Meningococcal (ACYW 135) | single dose syringe or vial | injection |
| NCDS | 16-A00-038 | Hepatitis B – Immunoglobulin with 50 IU/ ml anti-HBs antibodies | 2ml vial single dose | injection |
| NCDS | 16-A00-039 | Hepatitis B – Immunoglobulin with 50 IU/ ml anti-HBs antibodies | 10 ml vial -single dose | injection |
| NCDS | 16-A00-040 | Hepatitis B vaccine children )10 mcg / 0.5 ml | vial | injection |
| NCDS | 16-A00-026 | B.C.G | 20 doses vial | injection |
| NCDS | 16-A00-043 | conjugated Pneumococcal vaccine | vial | injection |
| NCDS | 16-A00-046 | Human hepatitis B immunoglobulin:1ml contains:Human protein 150mg of which at least 96%is IgG with acontent of antibodies to hepatitis B virus surface antigen(HBs)of 500 IU IgG subclass distribution:59% IgG 1 35% IgG2 3%IgG3 3%IgG4 IgA content ≤6mg/ml (500 IU/ml) | solution prefilled syringe | injection SC |
| NCDS | 16-A00-047 | Conjugated Meningococcal (ACYW 135) | 10 dose syringe | injection |
| NCDS | 16-A00-048 | Influenza seasonal Vaccine syringe-single dose southren strain | syringe single dose | injection |
| NCDS | 16-A00-050 | Hepatitis B – Immunoglobulin with 50 IU/ ml anti-HBs antibodies | 5 ml vial -single dose | injection |
| NCDS | 16-A00-051 | Rota Virus pentavalent vaccine | drop | oral |
| NCDS | 16-A00-052 | Rota Virus mono valent vaccine | drop | oral |
| NCDS | 16-A00-035 | Tetra 1-DPwT- Hib Vaccine | Injectable | injection |
| NCDS | 16-A00-055 | Penta 1 DPwT Hib – Hep- B Vaccine | Injectable | injection |
| NCDS | 16-A00-056 | Penta 2 DPaT – Hib-IPV Vaccine | Injectable | injection |
| NCDS | 16-A00-057 | Hexa -DPaT-Hib-Hep B- IPV vaccine | Injectable | injection |
| NCDS | 16-A00-058 | Bivalent oral poliomyelitis vaccine type1&3 | 10 or 20 dose vial | oral |
| NCDS | 16-A00-059 | Anti-Cytomegalovirus antibody | Injectable | injection |
| NCDS | 16-A00-041 | Diphtheria-acellular pertusis-Tetanus toxoid injectable polio vaccine | injectable | injection |
| NCDS | 16-A00-042 | Anti Black widow spider venum | injectable | injection |
| NCDS | 16-A00-025 | Antitetanus immunoglobulin 250 unit | injectable I.M | injection |
| NCDS | 16-A00-044 | Tetra 2- DPaT –IVP vaccine | injectable | injection |
| NCDS | 16-A00-061 | novel oral poliomyelitis vaccine type2 | 5ml drop | oral |
| 16B | PASSIVE IMMUNISATION | |||
| NCDS | 16-B00-002 | Anti D immunoglobulin 500 IU | solution in vial or ampoule | Injection ( IM / IV ) or I.M or I.V |
| NCDS | 16-B00-004 | Anti D immunoglobulin 1500 IU | solution in vial or ampoule or pfs | injection IV or( IV/ IM ) or I.M |
| NCDS | 16-B00-018 | Pentaglobulin (protein 50mg of which human immunoglobulin at least 95%/1ml) | solution (10ml) Ampoule | injection |
| NCDS | 16-B00-019 | Pentaglobulin( protein 50mg of which human Ig at least 95% /1ml ) | solution (20ml) Ampoule | injection |
| NCDS | 16-B00-020 | Pentaglobulin (protein 50mg of which human Ig at least 95% /1ml) | solution (50ml) Ampoule | injection |
| NCDS | 16-B00-028 | Human immunoglobulin 1ml contains:Human plasma protein 50 mg there of immunoglobulin ≥95% IgM 6mg , IgA 6mg ,IgG 38 mg | (10ml vial) | injection IV |
| NCDS | 16-B00-029 | Human immunoglobulin 1ml contains:Human plasma protein 50 mg there of immunoglobulin ≥95% (IgM 6mg , IgA 6mg ,IgG 38 mg ) | (50ml vial) | injection IV |
| NCDS | 16-B00-032 | Human normal immunoglobulin 2.5gm | 5% protein ( 50ml ) OR 10% protein (25 ml) container | injection IV |
| NCDS | 16-B00-033 | Human normal immunoglobulin 10 gm Purity of at least 95% IgG | 5% protein ( 200 ml ) OR 10% protein (100 ml) container | injection IV |
| NCDS | 16-B00-034 | Human normal immunoglobulin 5% protein, or lyophilyzed powder 2.5g IgA concentration Less than 3.7 mcg /ml | bottle | injection IV |
| NCDS | 16-B00-013 | GAMMAGARD S/D (5g) :Immune Globulin Intravenous (Human)5g . dried sterile water for injection IgA less than or equal to 2.2mg/ml in a5% | solution 96ml bottle | injection IV |
| 17 | ACUTE DRUG POISINING | |||
| 17A | ANTIDOTES AND DRUGS USED IN TREATMENT OF ACUTE POISINING | |||
| NCDS | 17-000-001 | Acetylcysteine (N-Acetylcysteine) 200mg/ml (20% w/v ) | 10ml Ampoule aqueous solution | injection IV infusion |
| NCDS | 17-000-084 | Acetylcysteine (N-Acetylcysteine) ( 300 mg /3 ml ) 10% | Ampoule solution | IM , IV , Inhalatin , Intratracheal |
| NCDS | 17-000-047 | Acetylcysteine (N-Acetylcysteine) 10% | Solution | oral and inhalation |
| NCDS | 17-000-048 | Acetylcysteine (N-Acetylcysteine) 20% | Solution | oral and inhalation |
| NCDS | 17-000-078 | Acetylcysteine (N-Acetylcysteine) 600 mg | tablet or capsule or effervescent tablet or sachet | oral |
| NCDS | 17-000-002 | Calcium Gluconate 2.5% | Gel | topical |
| NCDS | 17-000-003 | Ammonium chloride Powder | ||
| NCDS | 17-000-053 | Amyl nitrate 0.2ml | crusable glass Ampoule | injection |
| NCDS | 17-000-014 | Cyanid Antidot Kit.( Hydroxocobalamine). | ||
| NCDS | 17-000-016 | Dicobalt edetate 300mg | 20ml Ampoule | injection IV |
| NCDS | 17-000-041 | Sodium nitrite 30 mg/ 1 ml (3% ) | 10ml ampoule or vial | injection IV |
| NCDS | 17-000-042 | Sodium thiosulfate 250 mg /1 ml (25%) | 50ml ampoule solution | injection |
| NCDS | 17-000-043 | Sodium thiosulphate 50% | 50ml Ampoule | injection |
| NCDS | 17-000-006 | Atropine sulphate 2mg/ml | vial or ampoule | injection |
| NCDS | 17-000-007 | Atropine sulphate 2mg/ml | auto injector | injection |
| NCDS | 17-000-008 | Bentonite 7% | powder for aqueous suspension | oral |
| NCDS | 17-000-009 | Benztropine mesylate 1mg/ml | (2ml) Ampoule | injection |
| NCDS | 17-000-015 | Desferrioxamine mesylate (Deferoxamine Mesilate)500mg | Vial | injection |
| NCDS | 17-000-020 | Desferrioxamine mesylate (Deferoxamine Mesilate)2g | Vial | injection |
| NCDS | 17-000-056 | Deferiprone 500mg | Tablet | oral |
| NCDS | 17-000-081 | Deferiprone 1000mg | modified release Tablet | oral |
| NCDS | 17-000-069 | Deferasirox 125mg | dispersible Tablet | oral |
| NCDS | 17-000-070 | Deferasirox 250mg | dispersible Tablet | oral |
| NCDS | 17-000-071 | Deferasirox 500mg | dispersible Tablet | oral |
| NCDS | 17-000-082 | Deferasirox 360 mg | caplet | oral |
| NCDS | 17-000-083 | Deferasirox 90 mg | sprinkle capsule ( granules ) | oral |
| NCDS | 17-000-017 | Digoxin specific antibody fragment ( FAB) 40mg | Vial | injection |
| NCDS | 17-000-018 | Dimercaprol in arachis oil (solvent) 50mg/ml | 2ml Ampoule | injection |
| NCDS | 17-000-019 | Dimercaprol 10% w/v | vial or ampoule | injection |
| NCDS | 17-000-022 | ethanol Dehydrated Alcohol (Absolute Alcohol) BP | ampoule | injection IV |
| NCDS | 17-000-023 | Fullers earth (60g sterile fuller’s earth) | Powder | |
| NCDS | 17-000-025 | Magnesium sulphate B.P | Mixture | oral |
| NCDS | 17-000-026 | Methionine 250mg | Tablet | oral |
| NCDS | 17-000-027 | Methylene blue 1% | (10ml) Ampoule ) | injection IV |
| NCDS | 17-000-028 | Naloxone hydrochloride 400mcg/ml | (1ml) Ampoule orprefilled syringe or vail | injection |
| NCDS | 17-000-031 | Obidoxime 250mg/ml | vial or ampoule | injection |
| NCDS | 17-000-032 | ethanol Dehydrated Alcohol (Absolute Alcohol) BP | solution | Oral |
| NCDS | 17-000-033 | Physostigmine salicylate 2mg/2ml | (2ml) Ampoule | injection IM , IV |
| NCDS | 17-000-034 | Pralidoxime mesylate 1g/5ml | (5ml) Ampoule | injection |
| NCDS | 17-000-036 | Potassium Permanganate | Powder or Crystal | topical |
| NCDS | 17-000-039 | Disodium calcium edetate 1g/5ml | (5ml) Ampoule | injection |
| NCDS | 17-000-040 | Sodium formaldehyde sulfoxylate 20g | Ampoule | oral |
| NCDS | 17-000-044 | Starch Powder | ||
| NCDS | 17-000-045 | Thioctic acid 500mg | vial or ampoule | Injection |
| NCDS | 17-000-046 | Trivalent botulism antitoxin | 20 ml vial or ampoule | Injection |
| NCDS | 17-000-049 | Amrinone (as lactate) 5mg/ml | 20 ml vial | Injection |
| NCDS | 17-000-052 | Succimer 100mg | Capsule | oral |
| NCDS | 17-000-054 | Atropine sulphate 2mg+2-pyridine aldoxime- methiodide 600mg | 1ml auto-injection | injection |
| NCDS | 17-000-055 | Antidote Kits (all type to be available in all main hospitals ) | ||
| NCDS | 17-000-057 | Eisen(III)-hexa cyanoferrate(II){68% Fe4((Fe(CN6)3))} 500mg | Capsule | oral |
| NCDS | 17-000-077 | Potassium ferric hexacyano ferrate (Prussian blue) 500mg | Capsule | oral |
| NCDS | 17-000-058 | (RS)-2,3-bis(sulphanyl)propane -1-Sulphonic acid ,as sodium Salt Monohydrate {sodium -(RS)-2,3-dimercapto – 1-propane sulfonate (DMPS), as Monohydrate } 100mg | Capsule | oral |
| NCDS | 17-000-059 | (RS)-2,3-bis(sulphanyl)propane -1-Sulphonic acid ,as sodium Salt Monohydrate {sodium -(RS)-2,3-dimercapto – 1-propane sulfonate (DMPS), as Monohydrate } 250mg/5ml | Ampoule | injection |
| NCDS | 17-000-060 | Zinc- Trinatrium-Pentetat (Zn-DTPA) 1055mg/5ml | Ampoule | injection |
| NCDS | 17-000-061 | Calcium -trinatrium-pentetate(DTPA) 1000mg/5ml Ampoule | Ampoule | injection |
| NCDS | 17-000-068 | Sodium calcium edetate 50mg/1ml | (10ml) Ampoule | injection |
| NCDS | 17-000-072 | sorbitol | liquid | oral |
| NCDS | 17-000-073 | Activated Charcoal powder 25g /pack | suspension | oral |
| NCDS | 17-000-075 | Activated Charcoal 25g + sorbitol 48 g/120 ml | suspension | oral |
| NCDS | 17-000-076 | Activated Charcoal 50 g + sorbitol 96 g /240 ml | suspension | oral |
| NCDS | 17-000-010 | Charcoal Activated | powder | oral |
| NCDS | 17-000-011 | Charcoal Activated | 5gm sachet | oral |
| NCDS | 17-000-012 | Charcoal Hemoperfusion | ||
| NCDS | 17-000-013 | Activated Charcoal 50g | single dose plastic bottle of colloidal Suspension | oral |
| NCDS | 14-DA0-006 | Flumazenil 100mcg/ml | (10ml) Ampoule | injection |
| 18 | CONTRAST MEDIA | |||
| NCDS | 18-000-001 | Barium sulphate 100g/100ml | powder for suspension | oral |
| NCDS | 18-000-002 | Barium sulphate 100gm/100ml | unit pack(150ml bottle) Liquid | oral |
| NCDS | 18-000-003 | Barium sulphate 92% w/v | powder or suspension enema | rectal |
| NCDS | 18-000-005 | Co2 liberating agents | Effervescent Tablet | oral |
| NCDS | 18-000-006 | Co2 liberating agents | Effervescent Sachet | oral |
| NCDS | 18-000-007 | Gadodiamide 287mg (0.5mmol)/ml | 20ml Vial | injection IV |
| NCDS | 18-000-010 | Gadodiamide 287mg (0.5mmol)/ml | 10ml Vial | injection IV |
| NCDS | 18-000-008 | gadopentetic acid as dimeglumine salt( gadopentetate dimeglumin) 469mg/ml (0.5 mmol/mL) | 10ml Vial | injection |
| NCDS | 18-000-059 | gadopentetic acid as dimeglumine salt( gadopentetate dimeglumin) 469mg/ml (0.5 mmol/mL) | 20ml Vial | injection |
| NCDS | 18-000-058 | Gadoteric acid 279.32mg/ml as Meglumine salt (0.5mmol/ml) | 20ml vial solution | injection IV |
| NCDS | 18-000-060 | Gadoteric acid 279.32mg/ml as Meglumine salt (0.5mmol/ml) | 10ml vial solution | injection IV |
| NCDS | 18-000-077 | Gadoteric acid 279.32mg/ml as Meglumine salt (0.5mmol/ml) | 15ml vial solution | injection IV |
| NCDS | 18-000-052 | Gadoteric acid 279.32mg/ml as Meglumine salt (0.5mmol/ml) | 5ml vial solution | injection IV |
| NCDS | 18-000-012 | Iohexol eq. 240 mg of organic iodine/ ml | 50 ml vial | injection |
| NCDS | 18-000-013 | Iohexol eq. 300mg of organic iodine/ ml | 10ml vial | injection |
| NCDS | 18-000-015 | Iohexol eq. 300mg of organic iodine/ ml | 20ml vial | injection |
| NCDS | 18-000-016 | Iohexol eq. 300mg of organic iodine/ ml | 50ml vial | injection |
| NCDS | 18-000-080 | Iohexol eq. 300mg of organic iodine/ ml | 100ml vial | injection |
| NCDS | 18-000-017 | Iohexol eq. 350mg of organic iodine/ ml | 50ml vial | IV , intra arterially , intrathecally , orally , rectally or by instillation into body cavities |
| NCDS | 18-000-018 | Iohexol eq. 350mg of organic iodine/ ml | 200ml vial | IV , intra arterially , intrathecally , orally , rectally or by instillation into body cavities |
| NCDS | 18-000-019 | Iohexol eq. 350 mg of organic iodine/ ml | 100 ml vial | IV , intra arterially , intrathecally , orally , rectally or by instillation into body cavities |
| NCDS | 18-000-062 | Iohexol 518mg(eq. 240mg iodine)/1ml | 20ml ampoule | injection IV |
| NCDS | 18-000-014 | Iotrolan 0.641g/ml eq. 300 mg of organic iodine/ ml | 10ml vial | injection |
| NCDS | 18-000-029 | Iotrolan Iotrolan 0.5139g/ml eq. 240mg of organic iodine/ ml | 10ml vial | injection |
| NCDS | 18-000-020 | Iopamidol eq. organic iodine 300mg Iodine/1ml | 10ml vial | injection |
| NCDS | 18-000-021 | Iopamidol eq. organic iodine 300mg Iodine/1ml | 50ml vial | injection |
| NCDS | 18-000-022 | Iopamidol eq. organic iodine 300mg Iodine/1ml | 100ml vial | injection |
| NCDS | 18-000-023 | Iopamidol eq. organic iodine 370mg Iodine/1ml | 50ml vial | injection |
| NCDS | 18-000-024 | Iopamidol eq. organic iodine 370mg Iodine/1ml | 200ml vial | injection |
| NCDS | 18-000-079 | Iopamidol eq. organic iodine 370mg Iodine/1ml | 100ml vial | injection |
| NCDS | 18-000-075 | Iopromide eq. to organic iodine 370 mg /1ml | 100ml vial | injection |
| NCDS | 18-000-026 | Iopromide eq. organic iodine 370 mg /1ml | 50ml Vial | injection |
| NCDS | 18-000-025 | Iopromide eq. organic iodine 300mg /1ml | 50ml Vial | injection |
| NCDS | 18-000-046 | ioxaglate Meglumine 39.3%+ioxaglate Sodium 19.65% eq. to 320mg organic iodine /ml | 200ml Vial | IV injection |
| NCDS | 18-000-047 | ioxaglate Meglumine 39.3%+ioxaglate Sodium 19.65% eq. to 320mg organic iodine /ml | 50ml Vial | IV injection |
| NCDS | 18-000-048 | Meglumine Ioxaglate 39.3% +Sodium ioxaglate 19.65% | 50ml Vial | oral |
| NCDS | 18-000-051 | Iron oxid nano particles , osmolality 340mosm/kg ,viscosity 1.3mpa S(20c),PH 6.0-8.0 (Spio &3. Mn-DpDp) | ||
| NCDS | 18-000-061 | Gadobutrol 1 mmol / ml | 15ml vial | injection IV |
| NCDS | 18-000-078 | Gadobutrol 1 mmole/ ml | 7.5 ml prefilled syringe | injection IV |
| NCDS | 18-000-064 | gadoversetamide 0.5mmol/ ml | 20 ml vial or prefilled syringe | injection |
| NCDS | 18-000-071 | gadoversetamide 0.5mmol/ ml | 10ml prefilled syringe | injection |
| NCDS | 18-000-065 | Ioversol (74%) eq. organic iodine 350 mg/ ml | 100 ml vial | injection intravascular |
| NCDS | 18-000-069 | Ioversol (74%) eq. organic iodine 350 mg/ ml | 125 ml prefilled syringe | injection intravascular |
| NCDS | 18-000-066 | Ioversol eq. organic iodine 240mg/ ml | 125 ml prefilled syringe | injection intravascular |
| NCDS | 18-000-068 | Ioversol (68%) eq. organic iodine 320mg/ ml | 125 ml prefilled syringe | injection intravascular |
| NCDS | 18-000-067 | Ioversol (68%) eq. organic iodine 320mg/ ml | 100 ml prefilled syringe | injection intravascular |
| NCDS | 18-000-073 | Iobitridol eq. organic iodine 350mg/ml of iodine /ml | 100ml Vial | injection |
| NCDS | 18-000-074 | Iobitridol eq. organic iodine 350mg/ml of iodine /ml | 200ml Vial | injection |
| NCDS | 18-000-050 | Iodixanol (550mg/ml) eq. organic iodine 270mg /ml | 100ml-vial | injection Intra-arterial IV |
| NCDS | 18-000-049 | Iodixanol (652mg/ml) eq. organic iodine 320mg /ml | 20ml vial | injection Intra-arterial IV |
| NCDS | 18-000-076 | Iodixanol (652mg/ml) eq. organic iodine 320mg /ml | 50ml vial | injection Intra-arterial IV |
| 23 | Medical Device (class llb, lll ) and ( class lla ,which have pharmaceutical dosage form ) | |||
| 23A | Miscellaneous Medical Device | |||
| NCDS | 23-000-089 | Hyaluronic acid (or Sodium Hyaluronate ) 15- 28 mg/ml ( Cross linked or Non cross linked ) with or without Lidocaine Hydrochloride 3mg / ml | prefilled syringe | dermal filler |
| NCDS | 23-000-097 | Cross linked Hyaluronic acid 21 mg | 3 ml prefilled syringe | dermal filler |
| NCDS | 23-000-094 | Sodium hyaluronate 13.3 mg / ml ( high molecular weight ) PFS injection + Vial contains : Glycine 40 mg / ml , L Proline 30 mg / ml , Leucine 5.6 mg / ml L-Lysine hydrochloride 4.3 mg / ml | prefilled syringe + Vial | Non active soft tissue implant |
| NCDS | 23-000-096 | Sodium hyaluronate 32 mg / ml ( high and low molecular weight ) , Glycine 9 mg / ml , Proline 6.5 mg / ml , Alanine 2 mg / ml , Valine 2.5 mg / ml , Leucine 1 mg / ml Lysine hydrochloride 2.5 mg / ml Arginine hydrochloride 2.5 mg / ml , Acetyl decapeptide 3 : 0.015 mg / ml , Oligopeptide 24 : 0.015 mg / ml Acetyl tetrapeptide 5 : 0.015 mg / ml | 2.5 ml prefilled syringe | Non active soft tissue implant |
| NCDS | 23-000-098 | water 50.5%-kojic acid 4%-trichloroacetic acid 20%-mandelic acid 5%-propylene glycol 20%- xanthan gum 0.5% | vial | topical |
| NCDS | 23-000-099 | water 58.5%-kojic acid 4%-trichloroacetic acid 12%-mandelic acid 5%-propylene glycol 20%- xanthan gum 0.5% | vial | topical |
| NCDS | 23-000-009 | Not cross- linked sodium Hyaluronate 18 mg /ml +hydroxypatite 0.01% | 1 or 2.5 ml prefilled syringe | injection |
| NCDS | 23-000-010 | Cross- linked polymeric hydrogel containing 26 mglml stabilized sodium hyaluronate + hydroxyapatite 1% 1ml | 1 ml prefilled syringe | injection |
| NCDS | 23-000-017 | Cross linked hyaluronic acid 28 mg/ml+lidocaine hyrochloride 0.3% for soft tissue augmentation | prefilled syringe | injection |
| NCDS | 23-000-018 | hyaluronate sodium Cross-linked 14mg + Sodium hyaluronate 1mg+prilocaine Hydrochloride 3mg | 1ml implants for orthopaedics | injection |
| NCDS | 23-000-023 | ( N-Butyl 2 – cyanoacrylate ) Sterile high Density embolization agent Bioabsorbable | solution and Peripheral Braided micro catheter | cathatrization |
| NCDS | 23-000-024 | sodium hyaluronate 12 mg/ ml | 0.8 ml prefilled syringe | injection |
| NCDS | 23-000-025 | Sodium hyaluronate 88 mg+triamcinolone hexacetonide 18 mg | prefilled syringe | injection intra-articular |
| NCDS | 23-000-026 | Natural Agarose 1.5% + water for injectable preparation | syringe | injection |
| NCDS | 23-000-027 | Natural Agarose 2.5%+ non-crossed-linked hyaluronic acid 0.5%+water for injectable preparation | syringe | injection |
| NCDS | 23-000-028 | Natural Agarose 3.5% +non-crossed-linked hyaluronic acid0.4%, +water for injectable preparation | syringe | injection |
| NCDS | 23-000-082 | Cross-linked hyaluronic acid (as sodium salt)14mg+sodium chloride 6.9mg+water for injection/ml injectable implant syring ready to use(intra-articular inj). | syringe | injection intra-articular |
| NCDS | 23-000-050 | synthetic calcium hydroxylapatite suspended in a gel carrier and 0.3% lidocaine hydrochloride | 1.5 cc injectable Implant | injection |
| NCDS | 23-000-031 | Hyaluronic acid sodium salt 0.2% + Silver Sulfadiazine 1% | cream | topical |
| NCDS | 23-000-051 | Hyaluronic acid sodium salt 0.2 % | cream | topical |
| NCDS | 23-000-052 | Hyaluronic acid sodium salt 0.2 % + collagenase not less than 2.0 nkat / g | ointment | topical |